data_2myx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2myx _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 108.26 -1.015 . . . . 74.44 108.26 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.2 126.3 9.75 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.712 2.275 . . . . 74.32 110.645 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 m -122.99 161.29 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 O-C-N 120.954 -1.091 . . . . 62.41 110.001 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 p -124.4 166.24 16.32 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.053 0.941 . . . . 61.42 110.036 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.1 m -52.73 -41.85 64.35 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.496 1.518 . . . . 64.41 110.95 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -34.04 67.57 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.194 0.997 . . . . 62.35 111.013 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.9 mtp -70.32 -43.37 70.45 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.962 -0.755 . . . . 73.55 108.962 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.2 t -59.5 -55.98 20.23 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 C-N-CA 124.168 0.987 . . . . 74.25 110.193 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.66 -41.5 90.72 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 117.784 -1.103 . . . . 62.22 111.103 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.3 m -55.01 -60.42 3.4 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.57 1.077 . . . . 60.32 109.051 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.57 -46.22 79.03 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 CA-C-N 119.16 0.891 . . . . 62.31 109.694 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -54.9 -44.29 74.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 119.131 0.878 . . . . 74.51 112.97 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -62.85 -44.19 96.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.172 -0.677 . . . . 73.14 109.172 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.9 mt -79.41 -14.72 58.75 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.43 1.092 . . . . 74.43 113.583 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -137.33 70.87 54.17 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 127.368 2.267 . . . . 73.51 108.566 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.9 -23.16 62.32 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.584 2.189 . . . . 63.35 112.916 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.29 -14.56 62.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.523 0.729 . . . . 63.52 111.938 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.4 mt -92.36 156.69 17.07 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 119.181 0.9 . . . . 72.22 112.74 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.404 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 51.5 t-80 -79.92 143.2 57.28 Favored Pre-proline 0 C--O 1.238 0.46 0 N-CA-C 106.111 -1.811 . . . . 72.34 106.111 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 39.8 Cg_endo -65.62 -29.12 52.29 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.782 2.322 . . . . 75.41 113.032 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -40.2 48.77 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.698 -0.626 . . . . 75.24 111.727 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -60.9 -35.34 76.39 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.29 -0.633 . . . . 72.33 109.29 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.9 mt -56.57 -56.5 13.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 CA-C-O 118.164 -0.922 . . . . 64.12 108.713 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.82 -46.65 20.91 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.488 1.04 . . . . 75.44 111.048 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -64.59 -43.54 93.5 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.418 0.554 . . . . 74.23 111.911 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.2 t -64.59 -41.37 96.29 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.174 -0.676 . . . . 63.23 109.174 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.24 -37.97 84.99 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.943 0.897 . . . . 74.31 110.475 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -72.05 -34.77 69.02 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.608 0.64 . . . . 73.13 110.877 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -72.51 -50.61 24.63 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.001 -0.437 . . . . 71.34 110.808 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.3 p -72.64 -41.59 65.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.26 1.024 . . . . 71.24 111.819 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.16 -6.12 75.63 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.249 1.881 . . . . 44.41 112.538 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -145.59 152.13 39.2 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 120.897 2.348 . . . . 75.25 112.394 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.63 -50.62 64.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 106.765 -1.568 . . . . 75.23 106.765 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -52.32 -47.03 66.25 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.453 1.501 . . . . 64.44 111.754 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -63.74 -43.24 97.07 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.458 -0.942 . . . . 75.52 108.458 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.9 m -61.68 -37.05 82.68 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.422 1.089 . . . . 62.43 110.559 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.6 t -73.8 -35.95 44.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.412 1.085 . . . . 74.12 109.103 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -70.16 -40.5 74.7 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.417 1.487 . . . . 75.42 110.31 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -76.35 -30.2 57.51 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 122.084 0.945 . . . . 73.25 109.88 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -64.31 -54.59 30.8 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 121.099 -1.0 . . . . 74.23 108.932 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.15 -20.94 60.81 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.43 0.9 . . . . 61.33 113.43 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -92.23 -6.26 50.87 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.742 0.701 . . . . 74.53 109.913 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.62 36.68 58.39 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 126.528 2.013 . . . . 62.44 113.322 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -70.38 -178.68 1.79 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 118.256 1.028 . . . . 74.21 110.148 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.2 134.77 36.16 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 126.137 1.775 . . . . 74.54 111.901 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -129.07 110.51 12.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.245 1.818 . . . . 72.44 106.168 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.1 m -96.0 174.29 7.0 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.736 1.214 . . . . 73.22 108.035 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -98.1 155.6 36.82 Favored Pre-proline 0 C--N 1.33 -0.243 0 O-C-N 121.585 -0.697 . . . . 73.41 110.197 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -69.44 163.66 37.19 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.899 1.732 . . . . 72.41 111.48 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -59.89 144.6 99.43 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.887 1.724 . . . . 62.42 109.313 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.24 -12.39 58.47 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.595 1.093 . . . . 74.23 113.026 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -75.59 -46.54 31.21 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.195 1.497 . . . . 71.13 108.268 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 . . . . . 0 C--O 1.24 0.58 0 C-N-CA 124.92 1.288 . . . . 74.31 109.225 179.252 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 . . . . . 0 C--O 1.235 0.321 0 N-CA-C 111.6 0.222 . . . . 74.13 111.6 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.88 150.12 30.01 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.39 2.727 . . . . 72.53 109.841 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 m -134.28 160.83 41.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 123.988 0.915 . . . . 74.52 110.844 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.3 p -125.76 163.64 22.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.879 0.871 . . . . 74.22 110.034 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.7 m -49.61 -45.86 48.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.779 2.031 . . . . 73.11 111.593 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -62.41 -34.05 75.98 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.893 1.277 . . . . 71.43 112.614 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 94.5 mtp -65.12 -42.5 93.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.098 -1.075 . . . . 74.42 108.098 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 t -60.01 -55.34 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.458 0.703 . . . . 75.43 110.728 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -61.01 -37.67 83.34 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 119.538 -0.865 . . . . 75.41 112.059 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.0 m -60.18 -57.36 13.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 120.308 1.413 . . . . 75.31 109.525 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 t -54.97 -44.13 72.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-N 119.891 1.223 . . . . 74.31 108.438 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.6 tp60 -51.47 -50.92 58.89 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.197 0.908 . . . . 75.24 112.726 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -59.11 -44.73 92.0 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 122.837 0.455 . . . . 64.45 110.202 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.7 mt -77.71 -22.48 50.37 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.734 0.642 . . . . 74.14 112.734 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.445 ' HB1' ' CD2' ' A' ' 102' ' ' TYR . . . -130.89 75.07 79.23 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 126.374 1.87 . . . . 74.42 109.192 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.49 -18.05 54.05 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 123.492 2.795 . . . . 73.22 114.14 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.05 10.12 8.77 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.408 -0.808 . . . . 72.52 112.935 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.6 mt -112.74 155.81 23.9 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.171 0.896 . . . . 70.53 112.488 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.446 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 51.4 t-80 -80.63 145.46 58.55 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 108.626 -0.879 . . . . 75.54 108.626 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 28.9 Cg_endo -62.91 -30.53 77.17 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.228 2.619 . . . . 75.44 113.144 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.68 -39.16 37.49 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.026 -0.361 . . . . 71.52 110.026 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -59.46 -48.52 81.32 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 118.502 0.592 . . . . 72.54 109.452 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.9 mt -49.35 -58.74 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 N-CA-C 107.789 -1.189 . . . . 73.35 107.789 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.504 HH21 ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -47.3 -52.08 17.3 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.749 0.819 . . . . 75.34 112.18 179.198 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -65.43 -33.94 77.11 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.681 -1.262 . . . . 74.42 111.712 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 t -65.14 -46.12 82.21 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.204 -1.406 . . . . 54.43 107.204 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.4 -36.57 76.07 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.343 1.457 . . . . 75.32 109.095 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.504 ' CD ' HH21 ' A' ' 86' ' ' ARG . 48.5 mt-10 -70.13 -38.36 75.51 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 118.78 0.718 . . . . 71.11 111.65 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -75.78 -45.7 34.78 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.109 0.411 . . . . 71.4 112.109 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 79.6 p -74.25 -40.65 62.24 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.475 1.11 . . . . 75.31 111.044 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.98 -13.56 67.39 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 127.832 2.634 . . . . 74.43 114.226 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.8 m -143.64 148.4 35.75 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.88 1.84 . . . . 64.43 111.996 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.8 t -59.64 -48.42 87.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 126.096 1.759 . . . . 64.53 107.655 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -51.87 -47.98 64.25 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.611 1.565 . . . . 74.31 111.79 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -65.33 -43.47 90.84 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 108.257 -1.016 . . . . 75.2 108.257 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.5 m -59.26 -40.47 86.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.407 1.083 . . . . 74.35 111.638 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.9 t -74.64 -40.27 47.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 118.008 -0.996 . . . . 71.5 108.581 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -62.81 -35.2 79.13 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.016 1.726 . . . . 74.4 111.206 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -80.13 -40.69 26.92 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.203 -0.665 . . . . 73.35 109.203 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.445 ' CD2' ' HB1' ' A' ' 77' ' ' ALA . 7.6 t80 -58.74 -51.05 71.63 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.026 0.531 . . . . 74.53 110.242 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -65.48 -9.14 23.26 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 113.397 0.888 . . . . 75.34 113.397 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.09 -16.82 20.33 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.748 2.019 . . . . 73.4 109.141 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.0 26.59 21.48 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.664 1.126 . . . . 72.22 113.315 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -72.11 172.83 9.42 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.275 1.037 . . . . 62.2 113.294 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -81.85 147.59 29.27 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.401 1.481 . . . . 75.44 111.56 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -138.51 109.93 6.98 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.861 1.264 . . . . 73.51 109.873 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.1 m -91.9 165.78 13.05 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.214 1.406 . . . . 74.3 108.255 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -94.01 160.06 33.09 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 124.759 1.224 . . . . 74.14 111.708 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.11 164.01 29.32 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.357 3.371 . . . . 65.52 113.767 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.34 140.3 87.44 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.11 2.54 . . . . 75.1 111.152 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.85 -17.65 54.14 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 117.959 -1.467 . . . . 74.02 112.403 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -66.12 -51.9 53.6 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.348 1.574 . . . . 75.04 108.881 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 . . . . . 0 C--O 1.245 0.859 0 C-N-CA 125.475 1.51 . . . . 74.34 108.555 179.126 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 108.798 -0.816 . . . . 71.03 108.798 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.28 142.64 30.58 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.217 2.612 . . . . 74.31 110.272 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.37 153.39 35.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 109.058 -0.719 . . . . 74.32 109.058 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -124.84 162.69 23.8 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 125.995 1.718 . . . . 64.32 108.06 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 m -56.23 -36.37 68.42 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.839 -0.538 . . . . 64.11 111.531 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.06 -33.84 65.37 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.357 1.063 . . . . 70.33 110.987 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.8 mtp -70.02 -41.89 73.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.684 -0.858 . . . . 73.32 108.684 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 t -61.03 -55.47 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.276 1.03 . . . . 61.41 110.51 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.63 -40.86 84.56 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 118.252 -0.88 . . . . 63.42 110.391 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -58.13 -60.97 2.92 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.372 0.987 . . . . 74.32 109.597 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.3 t -52.52 -47.66 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 119.384 0.993 . . . . 74.41 109.044 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -56.3 -45.23 80.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.11 0.868 . . . . 72.32 112.188 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -59.13 -39.32 81.95 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.187 0.995 . . . . 74.35 110.528 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.3 mt -88.81 -20.28 24.88 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.203 0.816 . . . . 75.2 113.203 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.89 75.35 79.68 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 127.304 2.242 . . . . 75.22 108.858 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.7 -17.84 52.85 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.438 2.092 . . . . 75.2 113.425 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.49 -17.23 56.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.536 0.607 . . . . 74.25 112.551 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 mt -80.85 155.74 26.44 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.85 0.833 . . . . 73.43 112.634 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.432 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 57.2 t-80 -75.56 144.07 76.73 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 124.44 1.096 . . . . 71.14 109.035 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 36.8 Cg_endo -65.8 -26.55 52.42 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.836 2.357 . . . . 74.04 113.704 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.02 -40.11 16.14 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.66 1.118 . . . . 72.42 111.892 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -60.45 -32.38 71.32 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 119.175 -0.44 . . . . 71.52 111.547 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 78.1 mt -55.24 -58.26 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 118.352 -0.832 . . . . 73.55 109.748 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.422 HH21 ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -49.59 -42.29 44.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.269 0.94 . . . . 74.42 112.685 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -63.9 -43.22 96.64 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.328 -0.857 . . . . 72.02 110.696 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 t -59.41 -51.27 70.63 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 108.393 -0.966 . . . . 73.41 108.393 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.4 mt -58.34 -35.65 72.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.066 0.947 . . . . 72.22 110.775 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' A' ' 86' ' ' ARG . 2.8 mt-10 -72.54 -30.28 64.32 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.823 1.192 . . . . 62.44 109.65 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -76.35 -46.71 26.29 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.343 0.52 . . . . 73.44 112.043 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.5 p -80.19 -39.69 28.73 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.668 1.187 . . . . 64.51 111.151 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.58 -6.17 66.17 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 127.24 2.352 . . . . 71.44 112.723 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.4 m -139.56 132.46 29.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.523 1.529 . . . . 64.23 110.323 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.8 -44.77 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 125.394 1.477 . . . . 73.22 109.622 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -52.83 -47.74 67.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.822 0.849 . . . . 75.42 110.454 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -62.45 -43.09 99.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.903 -0.777 . . . . 64.41 108.903 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.9 m -58.85 -35.98 73.82 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.742 0.817 . . . . 72.14 110.477 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.5 t -75.75 -41.52 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.763 0.825 . . . . 73.53 109.91 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -63.47 -33.71 76.16 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.703 1.601 . . . . 74.55 111.349 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -83.71 -40.43 18.89 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.135 0.574 . . . . 75.32 110.286 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -53.94 -55.2 29.24 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.758 0.823 . . . . 64.31 110.563 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -59.67 -14.8 15.39 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.878 1.271 . . . . 65.12 114.135 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -9.26 39.74 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.44 1.896 . . . . 74.53 109.374 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.44 28.75 54.87 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.659 -0.977 . . . . 73.54 110.659 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -69.45 -179.75 1.78 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.28 1.04 . . . . 73.52 112.393 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -83.36 134.11 34.92 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.356 1.462 . . . . 74.13 113.251 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -134.4 110.04 9.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.357 -0.979 . . . . 71.2 108.357 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.86 179.42 4.81 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.422 -0.584 . . . . 74.14 109.422 178.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -100.08 158.75 31.46 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.823 1.249 . . . . 70.31 111.136 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.15 164.09 36.2 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.211 2.607 . . . . 72.41 111.144 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.01 153.69 67.54 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.896 1.731 . . . . 54.4 107.815 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.1 -15.32 61.28 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 118.988 -0.895 . . . . 72.42 110.899 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -71.86 -44.39 63.88 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.126 0.963 . . . . 75.01 109.177 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 . . . . . 0 C--O 1.25 1.131 0 C-N-CA 124.587 1.155 . . . . 75.42 111.145 179.684 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 107.374 -1.343 . . . . 62.25 107.374 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.2 126.45 12.38 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.315 2.01 . . . . 53.33 108.547 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.3 m -126.8 157.98 37.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 121.75 0.786 . . . . 71.4 110.084 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 p -124.25 164.44 19.54 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.999 1.72 . . . . 72.43 109.911 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.3 m -54.7 -37.37 65.74 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.964 1.706 . . . . 75.32 111.4 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -59.21 -35.93 74.5 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.285 1.034 . . . . 74.52 111.349 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.0 mtp -68.31 -41.71 80.48 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.045 -1.034 . . . . 64.41 108.896 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.5 t -60.23 -54.89 28.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 C-N-CA 124.358 1.063 . . . . 72.53 110.94 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.17 -42.33 90.55 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.428 -0.796 . . . . 74.21 110.306 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.1 m -56.35 -61.07 2.65 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.871 1.214 . . . . 70.32 109.856 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 83.9 t -53.41 -46.87 59.08 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 CA-C-N 119.136 0.88 . . . . 63.45 109.535 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.99 -41.17 67.61 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.167 0.894 . . . . 63.32 113.184 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -65.65 -43.35 89.68 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.969 0.804 . . . . 73.03 109.25 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.57 -17.42 56.15 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.674 0.62 . . . . 74.42 112.674 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.89 74.8 56.66 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 126.982 2.113 . . . . 72.23 109.743 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.89 -16.11 36.89 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.576 2.184 . . . . 74.43 111.166 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.61 15.95 2.9 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.497 1.519 . . . . 73.33 112.016 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.0 mt -124.23 152.14 43.3 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.897 1.279 . . . . 70.34 109.134 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.407 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 51.2 t-80 -76.97 143.88 71.33 Favored Pre-proline 0 N--CA 1.45 -0.454 0 N-CA-C 107.858 -1.164 . . . . 72.43 107.858 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.407 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 38.0 Cg_endo -66.21 -18.95 56.69 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.898 2.398 . . . . 71.21 113.285 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -86.11 -38.51 17.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.455 0.702 . . . . 73.41 110.231 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -58.36 -47.87 82.42 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 122.679 0.392 . . . . 73.44 109.965 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 89.1 mt -48.93 -54.08 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.683 1.593 . . . . 75.1 111.053 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.44 HH21 ' CG ' ' A' ' 111' ' ' PRO . 1.7 tmm_? -50.43 -46.93 56.83 Favored 'General case' 0 C--O 1.228 -0.051 0 CA-C-N 118.707 0.685 . . . . 74.44 110.668 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -64.91 -37.71 88.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.768 0.258 . . . . 75.41 111.181 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 m -61.46 -47.25 86.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.975 -0.75 . . . . 61.4 108.975 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.4 mt -63.16 -35.25 79.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.892 1.277 . . . . 72.32 110.428 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -70.26 -33.25 71.38 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 118.666 0.666 . . . . 73.23 109.801 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -76.62 -55.64 5.33 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.482 0.713 . . . . 75.45 111.461 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.1 p -70.6 -40.91 72.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.957 1.703 . . . . 74.41 112.796 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.88 -6.1 83.97 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.616 2.055 . . . . 64.41 113.144 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.2 m -144.28 143.18 30.89 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 119.273 1.537 . . . . 75.12 111.474 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.6 t -63.04 -49.67 82.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 C-N-CA 125.945 1.698 . . . . 75.45 106.924 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.71 -46.79 64.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.367 1.067 . . . . 74.31 111.195 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -63.03 -45.42 92.4 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 108.29 -1.004 . . . . 75.23 108.29 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.5 m -56.52 -37.52 70.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.228 0.611 . . . . 75.21 111.017 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.6 t -76.06 -39.31 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 121.363 -0.836 . . . . 75.03 109.447 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -65.95 -32.82 74.53 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.695 1.198 . . . . 74.22 111.54 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -82.38 -38.78 23.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.367 -0.975 . . . . 75.21 108.367 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -55.33 -53.95 49.65 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.954 0.902 . . . . 75.43 110.282 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -59.36 -21.21 59.49 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.582 0.586 . . . . 75.14 112.582 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -16.41 49.92 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.946 1.298 . . . . 72.11 109.526 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.2 28.66 48.36 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.245 -1.542 . . . . 71.32 109.245 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -61.15 177.32 0.35 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.739 1.616 . . . . 73.02 112.073 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -77.56 138.52 39.21 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 120.806 -1.184 . . . . 73.21 109.029 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -134.57 108.66 8.2 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.014 -1.847 . . . . 75.45 106.014 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.4 m -91.1 177.07 6.37 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.503 0.721 . . . . 73.53 109.833 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -108.83 153.71 42.22 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 107.977 -1.12 . . . . 73.22 107.977 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.44 ' CG ' HH21 ' A' ' 86' ' ' ARG . 33.2 Cg_endo -71.11 163.28 39.74 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.505 2.136 . . . . 74.43 113.182 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.5 131.4 27.84 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.481 2.12 . . . . 75.24 107.003 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.14 -9.7 46.64 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-O 117.738 -1.59 . . . . 71.44 112.097 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -86.79 -28.32 23.04 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.157 1.479 . . . . 73.24 109.49 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--O 1.255 1.354 0 N-CA-C 103.994 -2.595 . . . . 75.31 103.994 178.258 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 . . . . . 0 C--O 1.232 0.183 0 N-CA-C 109.145 -0.687 . . . . 74.21 109.145 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.88 126.17 9.23 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 121.734 1.623 . . . . 71.43 108.198 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.6 m -111.94 170.15 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 120.814 -1.179 . . . . 72.33 109.807 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 p -125.37 157.0 37.86 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.691 1.596 . . . . 64.45 107.154 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 m -54.77 -38.89 67.79 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.533 1.133 . . . . 72.31 109.609 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -33.15 68.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.675 1.19 . . . . 72.15 112.445 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 93.0 mtp -68.5 -39.7 81.18 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.793 -1.192 . . . . 64.52 108.729 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 t -59.47 -53.78 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 124.86 1.264 . . . . 73.33 110.136 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -62.56 -41.82 99.16 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 117.209 -1.377 . . . . 73.45 110.845 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.3 m -54.58 -60.16 3.72 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 120.787 1.631 . . . . 73.21 108.93 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.0 t -53.32 -47.15 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 119.154 0.888 . . . . 63.22 110.674 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -57.21 -43.73 83.03 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.171 0.804 . . . . 74.0 113.171 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -59.14 -45.89 89.78 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.42 -0.956 . . . . 74.52 108.42 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.4 mt -71.47 -37.15 71.37 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.718 0.807 . . . . 74.31 111.879 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.82 80.99 11.46 Favored Pre-proline 0 C--O 1.241 0.642 0 C-N-CA 127.507 2.323 . . . . 72.11 112.043 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.37 -2.19 11.75 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 124.746 3.631 . . . . 71.45 112.306 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -90.26 -19.67 23.85 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.97 1.708 . . . . 74.01 110.584 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.8 mt -92.46 157.34 16.62 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.219 0.463 . . . . 73.22 112.146 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.413 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 41.7 t-80 -83.01 142.67 44.79 Favored Pre-proline 0 C--O 1.237 0.43 0 N-CA-C 106.229 -1.767 . . . . 75.14 106.229 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 20.1 Cg_endo -62.73 -28.98 76.74 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.751 2.3 . . . . 64.5 112.553 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -73.62 -41.61 62.59 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 122.112 -0.368 . . . . 70.3 111.466 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -61.24 -37.94 84.88 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.69 -0.631 . . . . 73.53 110.595 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 97.5 mt -53.42 -58.3 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.47 1.108 . . . . 72.12 109.41 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.26 -47.76 18.09 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.971 0.805 . . . . 74.44 111.524 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -64.54 -42.76 95.51 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.179 0.9 . . . . 75.23 111.252 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.4 t -60.09 -46.24 90.25 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.03 -1.1 . . . . 51.33 108.03 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.28 -39.36 79.06 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.813 0.845 . . . . 62.14 111.025 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -69.42 -35.21 75.5 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.458 0.647 . . . . 74.45 111.395 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -72.39 -56.06 6.06 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.402 0.681 . . . . 75.41 110.454 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.8 p -68.73 -41.23 79.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.302 1.441 . . . . 75.3 113.341 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.86 -4.79 84.47 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.018 1.771 . . . . 74.3 113.439 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.4 m -142.23 134.58 27.83 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.507 1.153 . . . . 55.0 111.634 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.2 t -59.04 -48.48 86.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.173 0 N-CA-C 106.16 -1.792 . . . . 75.14 106.16 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.77 -42.23 64.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.904 0.882 . . . . 74.41 111.239 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -64.45 -45.04 89.17 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.53 -0.915 . . . . 70.52 108.53 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 58.3 m -59.51 -36.69 76.56 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.805 0.842 . . . . 74.12 110.315 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 65.9 t -74.67 -36.74 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.388 0.675 . . . . 74.25 110.138 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -71.47 -36.07 71.05 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.389 1.476 . . . . 71.13 111.192 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -79.34 -33.54 42.95 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.709 -0.848 . . . . 72.0 108.709 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -58.2 -55.73 31.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 118.925 -0.559 . . . . 74.53 109.59 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.41 -25.06 65.64 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.249 -0.881 . . . . 71.31 111.953 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -81.88 -8.02 59.65 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.238 0.926 . . . . 74.42 109.641 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.69 34.22 59.88 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 118.551 -1.139 . . . . 72.43 110.406 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -69.88 176.61 3.57 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 118.326 1.063 . . . . 74.3 110.127 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -75.7 147.25 39.53 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.844 -1.16 . . . . 75.22 109.33 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -138.9 109.08 6.41 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.325 -1.361 . . . . 75.44 107.325 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.4 m -94.66 164.95 12.74 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 124.237 1.015 . . . . 73.33 109.118 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -91.59 160.08 37.34 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.59 1.156 . . . . 74.43 109.7 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.39 165.35 29.23 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.213 1.942 . . . . 64.04 112.101 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.93 152.91 80.66 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.704 1.603 . . . . 73.41 108.528 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.73 -6.43 39.94 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.39 -1.228 . . . . 64.44 113.577 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -77.49 -26.13 51.0 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.462 1.631 . . . . 73.22 110.547 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 116.964 -1.493 . . . . 75.43 109.841 179.789 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 110.404 -0.221 . . . . 74.02 110.404 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.97 126.49 10.02 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.476 2.117 . . . . 63.45 109.3 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.3 m -125.13 162.52 27.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.932 0.893 . . . . 73.12 109.083 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p -120.34 172.89 7.48 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.687 1.995 . . . . 74.32 108.228 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.9 m -65.03 -40.23 94.52 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 121.423 -0.798 . . . . 72.42 110.304 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -38.38 62.91 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 124.402 1.081 . . . . 73.53 112.111 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.3 mtp -63.66 -41.52 98.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.385 -0.822 . . . . 74.14 109.413 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.93 -56.46 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 124.999 1.32 . . . . 74.44 110.464 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -59.69 -39.76 85.61 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.005 -0.998 . . . . 72.21 109.75 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.8 m -56.41 -60.42 3.55 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 120.356 1.435 . . . . 71.43 109.96 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.5 t -53.92 -45.5 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 119.374 0.988 . . . . 74.35 108.531 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -53.49 -43.15 68.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.717 1.144 . . . . 74.41 113.014 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -66.91 -35.33 79.77 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.715 0.406 . . . . 72.43 110.293 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 mt -88.22 -12.25 44.32 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.262 0.483 . . . . 74.0 112.278 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -143.78 76.77 15.37 Favored Pre-proline 0 C--O 1.241 0.607 0 C-N-CA 126.363 1.865 . . . . 60.52 108.85 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.5 -13.72 33.07 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.376 2.717 . . . . 73.13 112.405 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.6 -7.99 58.89 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.467 1.507 . . . . 75.13 112.395 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.2 mt -97.48 152.97 18.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.25 0.932 . . . . 74.04 112.005 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.43 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 58.0 t-80 -69.54 144.56 94.33 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.828 1.651 . . . . 74.52 109.394 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.43 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 41.0 Cg_endo -66.89 -24.94 45.64 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.85 2.367 . . . . 74.12 114.152 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.76 -41.33 14.21 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 120.054 1.297 . . . . 74.32 111.725 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -57.04 -35.8 69.73 Favored 'General case' 0 C--N 1.343 0.308 0 O-C-N 123.657 0.598 . . . . 74.2 110.478 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 66.8 mt -53.64 -58.16 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 118.485 -0.769 . . . . 73.41 110.035 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.72 -45.24 48.93 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.474 0.579 . . . . 73.11 111.815 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -63.32 -44.57 94.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.783 -0.573 . . . . 74.14 111.144 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 p -60.67 -44.4 96.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 118.567 -0.73 . . . . 73.3 109.998 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.4 mt -60.4 -37.07 79.66 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.82 0.848 . . . . 74.31 110.04 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.1 -33.55 74.74 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.296 0.498 . . . . 64.52 110.269 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -79.04 -42.24 26.93 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.258 1.023 . . . . 75.45 113.537 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -83.52 -34.6 25.25 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.713 1.605 . . . . 74.51 112.537 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.88 -11.12 63.09 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.418 1.961 . . . . 75.44 111.899 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 m -144.87 150.93 37.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.346 1.573 . . . . 71.41 112.106 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 78.1 t -62.63 -49.78 82.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 126.281 1.832 . . . . 71.45 107.97 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' A' ' 97' ' ' GLU . 12.6 pt-20 -45.33 -53.24 8.76 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 128.092 2.557 . . . . 75.01 111.792 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.439 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 13.1 tp10 -66.66 -41.59 87.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.638 -0.71 . . . . 75.4 109.43 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.9 m -59.26 -39.29 82.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.012 0.925 . . . . 74.45 110.463 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.8 t -74.39 -38.25 46.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 124.107 0.963 . . . . 75.32 109.924 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -68.07 -41.62 81.67 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.355 1.062 . . . . 71.34 110.495 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -74.12 -35.35 64.11 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.351 -0.843 . . . . 73.13 108.816 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -57.57 -57.33 13.15 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 118.539 -0.743 . . . . 75.3 109.457 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.29 -24.9 65.32 Favored 'General case' 0 C--N 1.339 0.118 0 O-C-N 123.575 0.547 . . . . 73.13 111.402 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -15.39 59.51 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 118.457 -0.782 . . . . 63.22 109.684 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.27 28.82 32.36 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 118.748 -1.029 . . . . 61.32 110.545 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.25 174.46 4.7 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.664 1.232 . . . . 73.51 109.02 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -86.13 147.74 26.01 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 120.587 -1.32 . . . . 65.42 108.776 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -139.1 109.72 6.63 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.632 -1.167 . . . . 75.43 109.694 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.9 m -82.12 170.71 15.18 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.382 1.073 . . . . 72.33 108.876 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -94.4 161.98 27.51 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 126.442 1.897 . . . . 73.11 110.848 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.53 158.46 57.6 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.619 2.213 . . . . 71.3 111.766 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.42 128.88 23.63 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.838 2.359 . . . . 72.2 110.612 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.61 -3.95 66.0 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 118.734 -1.037 . . . . 72.04 113.16 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -67.93 -31.18 70.76 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.416 1.608 . . . . 74.11 107.661 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 128.223 2.609 . . . . 71.35 106.835 179.227 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 118.741 -0.647 . . . . 75.01 110.545 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.99 140.2 22.58 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.898 3.065 . . . . 73.14 107.868 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.37 150.07 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.318 -0.864 . . . . 73.23 111.326 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.4 p -107.08 169.8 8.34 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.885 1.674 . . . . 73.24 111.952 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.8 m -58.22 -40.03 80.62 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.391 -0.814 . . . . 75.25 109.667 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -35.12 70.31 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 118.81 0.732 . . . . 73.3 112.066 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 92.2 mtp -66.43 -42.84 87.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.216 -0.927 . . . . 62.42 109.171 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.38 -54.79 28.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 C-N-CA 124.625 1.17 . . . . 74.24 109.4 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -64.05 -35.75 81.75 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 118.127 -0.94 . . . . 62.3 111.78 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.4 m -57.59 -59.6 4.94 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.187 1.358 . . . . 72.24 109.037 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.4 t -55.91 -45.92 80.11 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 CA-C-O 117.749 -1.12 . . . . 74.03 109.225 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -54.27 -44.8 72.19 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 120.457 1.48 . . . . 74.22 112.771 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -61.07 -44.93 96.64 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.234 -1.024 . . . . 74.33 108.234 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.7 mt -76.34 -28.93 57.06 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.1 0.778 . . . . 72.53 113.1 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.31 78.4 71.44 Favored Pre-proline 0 C--O 1.242 0.666 0 C-N-CA 127.737 2.415 . . . . 73.42 110.153 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.43 -1.1 10.89 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.89 3.727 . . . . 74.44 113.309 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -95.71 2.8 54.16 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.331 1.453 . . . . 74.14 112.021 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.0 mt -108.43 156.22 19.7 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.68 1.192 . . . . 73.35 109.556 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.461 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 54.5 t-80 -79.49 147.53 68.14 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 107.539 -1.282 . . . . 74.34 107.539 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 37.7 Cg_endo -65.14 -22.88 61.0 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.873 2.382 . . . . 74.35 113.417 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.51 -37.08 28.42 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.567 -0.708 . . . . 71.22 110.12 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -58.54 -37.02 74.81 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 109.885 -0.413 . . . . 75.1 109.885 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.2 mt -57.41 -60.8 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 117.471 -1.252 . . . . 75.55 109.813 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.45 -50.19 5.21 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.517 1.053 . . . . 75.05 110.918 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -63.2 -47.32 83.05 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.612 0.72 . . . . 75.45 111.998 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 m -57.1 -50.79 71.68 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.383 0.673 . . . . 75.2 109.23 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.0 mt -57.92 -39.83 78.93 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.3 1.04 . . . . 73.1 111.136 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -65.63 -32.0 73.33 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 122.478 0.311 . . . . 75.44 110.546 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -80.16 -51.32 9.11 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.646 -0.693 . . . . 61.32 111.094 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -71.41 -40.97 70.14 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.07 1.348 . . . . 65.31 113.145 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.52 -17.55 58.83 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.677 2.084 . . . . 73.45 113.102 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 t -143.33 147.87 35.39 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.426 1.613 . . . . 75.15 108.984 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -59.8 -46.13 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 127.32 2.248 . . . . 75.31 109.27 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -47.62 -48.57 28.44 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.381 1.472 . . . . 64.53 110.48 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -67.84 -42.38 81.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.625 -0.509 . . . . 74.31 109.625 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.2 m -58.25 -36.64 73.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.066 0.547 . . . . 72.24 110.896 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 78.8 t -75.95 -38.71 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.402 1.081 . . . . 70.32 109.614 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -66.61 -38.7 87.52 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.03 1.332 . . . . 74.53 110.37 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -76.94 -37.52 55.16 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 121.057 -1.027 . . . . 73.43 108.649 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -56.29 -53.55 55.95 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.194 0.598 . . . . 74.24 109.743 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.79 -22.94 65.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 119.345 -0.36 . . . . 64.51 111.955 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -82.37 -10.15 59.18 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.796 0.726 . . . . 75.31 109.718 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.32 37.22 42.46 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.018 -1.233 . . . . 74.2 110.018 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.76 -171.72 0.43 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 117.645 0.723 . . . . 75.42 110.734 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -90.34 139.51 30.59 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 120.346 -1.471 . . . . 64.22 110.388 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -128.89 108.76 10.69 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.358 -1.349 . . . . 74.11 107.358 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.9 m -89.74 172.4 8.95 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.802 1.641 . . . . 75.21 110.349 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -107.49 152.87 41.52 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 125.747 1.619 . . . . 74.22 108.423 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.19 170.11 19.89 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 123.706 2.937 . . . . 73.43 112.874 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.01 152.52 82.1 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 N-CA-C 107.003 -1.96 . . . . 75.21 107.003 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.08 -18.96 13.86 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 118.045 -1.419 . . . . 72.02 112.495 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -72.42 -54.75 8.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 119.536 1.668 . . . . 73.25 107.316 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 C--O 1.253 1.264 0 N-CA-C 106.266 -1.753 . . . . 75.13 106.266 179.508 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 108.304 -0.998 . . . . 74.31 108.304 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.31 126.08 9.53 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.933 1.756 . . . . 71.03 109.084 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.2 m -126.48 161.16 33.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 O-C-N 121.306 -0.871 . . . . 74.24 109.836 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 p -125.09 164.18 20.78 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.96 2.104 . . . . 75.13 109.813 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.0 m -59.17 -39.39 82.36 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.757 0.708 . . . . 72.51 110.744 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.3 -33.66 67.9 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.398 0.679 . . . . 74.12 111.983 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.8 mtp -65.72 -46.84 77.44 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 120.638 -1.289 . . . . 73.11 107.696 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.7 t -50.77 -58.66 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.499 0 C-N-CA 126.703 2.001 . . . . 72.43 109.853 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -59.73 -37.18 78.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 118.283 -0.865 . . . . 73.42 110.559 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -54.82 -60.69 3.01 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 120.272 1.396 . . . . 72.41 109.071 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.8 t -54.91 -51.89 48.63 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-O 118.06 -0.972 . . . . 74.23 108.847 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.41 -42.89 54.41 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.044 0.838 . . . . 74.25 113.05 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -65.21 -40.1 93.69 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 118.961 0.801 . . . . 73.13 109.289 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.5 mt -82.98 -16.24 48.0 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.083 0.772 . . . . 62.32 113.083 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.37 72.36 65.35 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 129.208 3.003 . . . . 73.04 109.528 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.82 -12.38 30.8 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.225 1.95 . . . . 70.13 112.486 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -84.25 13.23 5.46 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.383 1.473 . . . . 74.31 112.618 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.1 mt -121.12 158.78 27.18 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.504 1.122 . . . . 72.22 110.663 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -81.86 141.91 48.14 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 107.7 -1.222 . . . . 75.22 107.7 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -63.64 -26.35 69.05 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.654 2.236 . . . . 75.34 112.813 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.37 -39.5 53.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.748 -0.595 . . . . 64.22 111.942 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -60.25 -45.58 92.78 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.83 -0.433 . . . . 72.54 109.83 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 95.2 mt -47.53 -55.58 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 126.272 1.829 . . . . 62.41 111.03 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.419 HH21 ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -49.71 -45.69 49.33 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.911 0.778 . . . . 74.24 111.447 178.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -64.1 -40.07 95.43 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.773 -1.204 . . . . 74.41 110.955 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.0 m -57.82 -55.77 30.6 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.042 1.337 . . . . 74.51 108.256 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.11 -39.99 76.15 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.704 1.202 . . . . 73.32 111.238 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.419 ' CD ' HH21 ' A' ' 86' ' ' ARG . 52.6 mt-10 -65.19 -33.93 77.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 119.553 -0.859 . . . . 72.02 110.698 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -76.96 -48.68 17.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 118.395 -0.812 . . . . 73.21 111.969 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.4 p -73.49 -40.98 63.67 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.627 1.571 . . . . 75.22 111.5 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.14 -4.14 84.12 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 127.363 2.411 . . . . 73.31 111.853 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 m -144.54 140.76 29.02 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.798 1.239 . . . . 61.43 110.704 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.22 -45.83 95.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 124.909 1.284 . . . . 64.4 108.439 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -47.8 -48.67 30.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.345 1.858 . . . . 75.14 111.362 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.72 -47.63 77.59 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 108.591 -0.892 . . . . 72.25 108.591 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 m -54.83 -41.7 71.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.548 1.539 . . . . 75.11 112.044 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.4 t -76.76 -34.5 23.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 121.503 -0.748 . . . . 74.23 110.364 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -73.19 -32.06 64.58 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.985 0.914 . . . . 71.14 111.197 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -82.19 -34.93 28.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.42 -0.956 . . . . 73.21 108.42 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -55.92 -55.1 36.67 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 108.298 -1.001 . . . . 71.43 108.298 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.32 -24.78 66.68 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 119.335 -0.364 . . . . 74.23 111.219 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -17.23 60.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.153 0.888 . . . . 73.43 108.962 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.83 35.12 28.96 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.318 -1.513 . . . . 71.11 109.318 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -70.61 -173.0 0.69 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.129 0.964 . . . . 75.33 110.047 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -89.71 144.48 25.95 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 119.523 -1.986 . . . . 75.02 108.529 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -136.69 109.44 7.54 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.242 -1.344 . . . . 63.44 108.895 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.63 173.44 8.05 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.179 1.392 . . . . 73.22 110.932 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -103.8 158.75 31.23 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.096 1.758 . . . . 72.31 109.074 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.0 161.88 40.61 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.485 2.123 . . . . 70.51 112.867 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -67.9 136.05 37.18 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.067 1.845 . . . . 75.33 109.688 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.34 -2.55 71.2 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.488 1.042 . . . . 73.34 111.388 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -75.52 -35.98 60.62 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.03 0.915 . . . . 71.53 109.838 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 . . . . . 0 C--O 1.248 1.007 0 C-N-CA 125.847 1.659 . . . . 71.54 110.982 -179.26 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 107.529 -1.285 . . . . 75.04 107.529 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.84 148.84 36.62 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.819 2.346 . . . . 75.02 109.268 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.35 165.64 30.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-O 121.619 0.723 . . . . 75.22 110.201 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 p -125.36 157.24 37.26 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.152 1.781 . . . . 74.31 107.387 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.9 m -54.31 -36.7 64.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.354 0.662 . . . . 73.13 111.149 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -32.59 68.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.144 0.978 . . . . 74.21 111.948 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.7 mtp -69.9 -40.75 75.44 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.036 -1.098 . . . . 75.12 108.036 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 t -59.94 -58.02 9.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.971 1.308 . . . . 73.54 109.349 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -60.01 -36.05 76.37 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 118.341 -0.837 . . . . 64.14 110.877 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.2 m -58.03 -61.72 2.34 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.958 1.254 . . . . 71.12 108.863 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.3 t -54.9 -43.98 70.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 119.481 1.037 . . . . 72.25 109.39 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -55.2 -48.07 74.38 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 119.655 1.116 . . . . 74.05 111.525 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -59.03 -39.68 82.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.12 0.968 . . . . 65.23 110.324 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.2 mt -86.63 -19.75 28.86 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.109 0.781 . . . . 75.22 113.109 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.05 77.91 74.79 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.847 2.059 . . . . 64.04 109.032 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.49 -0.24 6.41 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.294 3.33 . . . . 64.41 113.602 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.45 20.51 18.12 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.287 1.035 . . . . 72.32 111.749 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.2 mt -123.37 154.5 38.89 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.905 1.282 . . . . 74.52 110.039 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.467 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 48.5 t-80 -86.27 147.72 45.47 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-O 118.495 -0.764 . . . . 71.54 109.104 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 40.3 Cg_endo -63.57 -32.1 70.17 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.315 2.677 . . . . 53.31 112.752 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.82 -44.65 48.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.884 -0.413 . . . . 75.35 109.884 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -59.27 -39.81 84.08 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 108.834 -0.802 . . . . 74.3 108.834 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 48.5 mt -57.52 -59.59 3.11 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 N-CA-C 107.84 -1.171 . . . . 75.5 107.84 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.08 -47.06 34.33 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.395 0.998 . . . . 72.4 111.596 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -62.01 -44.25 97.13 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.205 0.911 . . . . 73.51 111.494 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m -63.75 -41.29 98.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.414 -0.587 . . . . 75.34 109.414 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -61.62 -37.77 85.18 Favored 'General case' 0 C--O 1.225 -0.236 0 O-C-N 121.229 -0.92 . . . . 72.34 110.38 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -69.9 -37.31 75.96 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 117.992 0.36 . . . . 70.24 111.078 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -74.77 -53.06 9.88 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 122.171 -0.331 . . . . 73.43 111.137 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.7 p -67.14 -41.88 85.35 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.068 0.947 . . . . 73.42 111.486 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.28 -15.0 64.19 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 128.335 2.874 . . . . 73.24 113.806 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.0 m -139.55 148.5 42.66 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.636 1.718 . . . . 71.23 111.763 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.1 t -61.7 -50.99 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 106.342 -1.725 . . . . 72.12 106.342 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -50.86 -48.36 60.12 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.756 1.622 . . . . 71.22 111.101 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.71 -42.56 99.71 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.729 1.211 . . . . 73.42 109.179 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.5 m -65.0 -38.45 90.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.857 1.263 . . . . 53.23 110.807 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.9 t -73.35 -39.81 55.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 121.339 -0.85 . . . . 74.3 109.66 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -65.19 -38.97 92.18 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.474 1.51 . . . . 63.51 111.015 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -77.58 -35.53 52.92 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.592 -0.892 . . . . 71.41 108.592 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -57.17 -57.59 11.91 Favored 'General case' 0 C--O 1.233 0.226 0 O-C-N 121.255 -0.903 . . . . 74.31 110.53 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.47 -23.95 59.06 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.429 0.692 . . . . 75.1 111.179 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -12.11 59.24 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 117.845 -1.074 . . . . 65.21 111.464 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.06 22.7 51.67 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.786 -1.008 . . . . 73.51 112.317 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -67.25 172.99 4.19 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.635 1.217 . . . . 72.35 111.101 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -77.19 144.59 38.21 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.822 1.649 . . . . 74.02 109.985 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -137.43 110.11 7.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.895 1.278 . . . . 73.4 107.804 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -92.97 167.99 11.44 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.503 -1.226 . . . . 71.2 110.169 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -94.21 158.81 35.32 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 124.671 1.189 . . . . 74.22 109.221 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -67.99 166.99 22.87 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.473 2.782 . . . . 72.5 114.483 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.42 143.92 89.61 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.025 1.817 . . . . 64.43 108.147 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.12 3.45 88.33 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.094 -0.837 . . . . 61.32 112.915 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -84.36 -41.37 16.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.425 1.613 . . . . 74.33 110.981 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 C--O 1.254 1.302 0 CA-C-O 118.013 -0.994 . . . . 72.24 110.86 -179.091 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 109.389 -0.597 . . . . 74.21 109.389 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.3 125.93 7.36 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.568 2.845 . . . . 74.1 110.321 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.92 143.61 29.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 122.747 1.26 . . . . 75.0 111.731 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p -112.04 161.02 16.93 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.579 1.951 . . . . 70.33 109.197 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.7 m -52.67 -38.96 61.38 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.82 1.248 . . . . 71.12 111.917 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -59.47 -31.67 69.54 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.483 1.113 . . . . 71.22 112.317 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 91.6 mtp -71.91 -45.87 59.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.455 -0.943 . . . . 75.21 108.455 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.4 t -59.98 -52.33 62.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.893 0.877 . . . . 73.42 109.883 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.53 -41.1 98.49 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-O 117.342 -1.313 . . . . 74.34 110.315 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.3 m -52.6 -60.38 3.32 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 120.602 1.546 . . . . 70.44 108.71 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.8 t -55.27 -50.53 64.02 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 CA-C-O 118.052 -0.975 . . . . 74.05 109.206 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -54.72 -44.41 73.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 119.716 1.144 . . . . 74.44 113.838 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -59.88 -43.77 94.57 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.931 1.293 . . . . 64.03 108.64 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.9 mt -81.59 -26.82 34.62 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.049 0.759 . . . . 75.31 113.049 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.93 73.39 35.27 Favored Pre-proline 0 N--CA 1.447 -0.578 0 C-N-CA 127.655 2.382 . . . . 72.53 111.498 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.81 -3.6 13.48 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.522 2.148 . . . . 71.13 111.312 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.11 18.68 10.35 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 128.345 2.658 . . . . 74.52 111.094 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.7 mt -133.83 154.82 50.75 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.351 1.461 . . . . 74.05 111.001 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -80.53 142.32 53.58 Favored Pre-proline 0 C--O 1.236 0.383 0 N-CA-C 107.416 -1.327 . . . . 72.32 107.416 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.33 -29.02 46.63 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.642 2.228 . . . . 64.41 113.022 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -75.43 -41.1 56.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.756 -0.59 . . . . 74.12 110.809 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -59.73 -41.92 91.97 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.634 -0.506 . . . . 74.41 109.634 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 86.3 mt -51.36 -58.51 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 124.066 0.946 . . . . 72.13 108.984 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.05 -47.01 11.76 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.548 0.739 . . . . 74.13 111.619 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -64.53 -48.49 74.89 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.419 0.628 . . . . 73.24 111.489 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.4 m -56.92 -47.7 79.99 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 108.173 -1.047 . . . . 70.25 108.173 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.52 -39.74 77.23 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 124.584 1.154 . . . . 74.45 111.095 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -66.94 -31.64 72.35 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.168 0.44 . . . . 75.42 110.784 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -77.66 -50.59 12.15 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.209 0.448 . . . . 72.35 112.209 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -74.58 -41.94 59.62 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.952 1.701 . . . . 63.45 112.794 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.14 -12.02 69.11 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 126.671 2.081 . . . . 71.4 116.507 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 t -145.32 123.1 11.9 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 121.467 2.633 . . . . 72.42 111.706 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.6 t -41.88 -41.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 120.366 1.439 . . . . 72.05 112.819 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -49.89 -43.61 49.55 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 124.694 1.246 . . . . 73.54 111.67 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -67.63 -42.83 81.68 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 121.092 -1.005 . . . . 75.13 109.489 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.8 m -60.45 -39.01 86.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.131 0.572 . . . . 75.15 111.114 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.36 -39.1 76.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.21 -0.663 . . . . 74.21 109.21 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -66.83 -41.02 88.13 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.622 0.769 . . . . 75.33 111.456 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -75.4 -35.36 61.04 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 121.104 -0.997 . . . . 73.43 109.619 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -57.4 -57.4 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.212 -0.93 . . . . 73.05 110.009 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.69 -22.16 56.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.951 0.722 . . . . 74.4 112.951 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -5.19 56.53 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.796 0.725 . . . . 64.24 110.953 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.15 36.81 50.28 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 118.519 0.6 . . . . 73.43 112.322 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -69.98 -178.46 1.6 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.211 1.006 . . . . 72.04 111.013 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.75 131.26 35.21 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.698 -1.251 . . . . 74.11 110.257 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -130.92 109.89 10.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.462 -1.681 . . . . 74.52 106.462 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.3 m -96.79 168.6 10.4 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.707 0.803 . . . . 60.45 110.084 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -91.23 155.91 44.16 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 107.326 -1.361 . . . . 73.44 107.326 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.57 168.51 21.1 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.759 2.306 . . . . 74.01 113.722 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.33 149.44 91.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.37 2.047 . . . . 73.02 108.921 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.12 -12.07 13.7 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.564 -1.131 . . . . 62.34 113.207 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -68.96 -24.41 64.25 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.715 1.758 . . . . 74.3 109.381 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 130.757 3.623 . . . . 71.15 105.212 178.183 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 119.188 -0.434 . . . . 64.31 110.605 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.79 143.7 21.26 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.884 3.056 . . . . 73.21 111.127 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.0 m -134.17 167.07 27.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-O 122.026 0.917 . . . . 73.21 109.943 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 p -125.36 161.15 27.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.119 1.768 . . . . 72.42 107.802 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.5 m -57.96 -38.01 75.22 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.124 0.57 . . . . 74.42 110.588 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -35.9 69.45 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 119.336 -0.364 . . . . 73.34 111.63 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.0 mtp -64.29 -38.88 92.62 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.044 0.838 . . . . 75.32 109.537 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.0 t -63.96 -57.41 11.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 124.552 1.141 . . . . 75.22 110.767 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -59.62 -40.23 86.86 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 118.444 -0.789 . . . . 75.23 110.73 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.2 m -58.62 -58.21 9.58 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.321 1.419 . . . . 71.53 108.57 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.0 t -52.52 -50.23 40.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 CA-C-O 118.249 -0.881 . . . . 74.22 109.469 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -54.08 -45.58 71.81 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.928 0.785 . . . . 71.35 111.375 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -59.49 -36.84 76.8 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.016 0.926 . . . . 74.1 110.688 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.0 mt -89.84 -14.92 33.35 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.034 0.753 . . . . 74.32 113.034 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.27 71.12 61.21 Favored Pre-proline 0 N--CA 1.448 -0.551 0 C-N-CA 126.927 2.091 . . . . 75.31 110.993 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.67 -15.41 49.19 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.286 1.99 . . . . 74.13 112.408 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.32 -13.86 59.85 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.072 1.349 . . . . 72.13 112.003 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.2 mt -92.05 156.48 17.37 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.315 0.961 . . . . 71.14 111.376 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.444 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 58.3 t-80 -80.42 146.11 60.94 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 106.474 -1.676 . . . . 74.13 106.474 178.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 36.4 Cg_endo -65.45 -30.16 52.97 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.092 1.862 . . . . 63.33 113.187 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.58 -34.92 46.51 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 121.77 -0.582 . . . . 74.42 110.863 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -64.47 -35.92 82.49 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.677 -0.86 . . . . 74.12 108.677 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.3 mt -54.94 -60.82 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 C-N-CA 124.583 1.153 . . . . 73.55 109.749 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -46.63 -48.64 19.85 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 118.558 0.617 . . . . 74.22 110.8 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -59.37 -44.9 92.67 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.812 0.815 . . . . 73.33 112.391 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 p -62.79 -43.4 98.89 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.165 -0.47 . . . . 73.22 110.01 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.0 mt -60.35 -38.47 83.91 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.816 -0.552 . . . . 72.22 111.678 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -70.57 -28.44 64.9 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.169 0.587 . . . . 73.2 109.834 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -85.33 -43.59 13.56 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 114.453 1.279 . . . . 75.4 114.453 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.7 p -79.57 -41.44 27.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.692 1.197 . . . . 73.41 111.411 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.51 0.86 88.02 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 118.745 -1.031 . . . . 64.25 112.379 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.27 129.5 18.74 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.393 1.477 . . . . 71.55 111.297 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.56 -46.51 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 105.551 -2.018 . . . . 74.45 105.551 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -55.89 -45.66 78.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.48 -0.772 . . . . 74.33 110.013 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -59.03 -43.8 91.67 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.74 0.7 . . . . 72.34 110.029 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.1 m -61.17 -42.41 98.51 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.297 1.839 . . . . 74.14 110.872 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.0 t -74.63 -38.27 45.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 121.672 -0.642 . . . . 75.02 109.966 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -66.62 -37.49 84.97 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 125.191 1.396 . . . . 72.02 111.056 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -77.81 -39.58 43.31 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.861 -1.162 . . . . 74.0 107.861 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -55.23 -52.07 64.56 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 120.564 -1.335 . . . . 73.44 111.908 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.5 -16.13 33.97 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 113.662 0.986 . . . . 74.22 113.662 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.58 -11.66 42.05 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.813 0.845 . . . . 73.3 109.569 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.72 28.45 32.14 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 118.707 -1.052 . . . . 63.42 111.375 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -64.33 -178.22 0.35 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.859 1.263 . . . . 74.23 112.987 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -87.08 137.91 31.94 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 126.449 1.9 . . . . 64.23 111.549 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -141.85 109.91 5.87 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.19 1.396 . . . . 75.21 111.93 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.2 m -83.11 176.95 8.82 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.843 0.857 . . . . 73.25 110.369 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -105.54 157.17 35.13 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 127.366 2.266 . . . . 74.22 107.308 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.42 154.5 73.64 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.125 1.883 . . . . 75.13 112.197 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -60.98 123.34 12.73 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 124.457 3.438 . . . . 72.44 110.703 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.8 -4.22 53.13 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 124.842 1.21 . . . . 62.52 111.811 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -78.22 -34.37 49.32 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.83 1.815 . . . . 64.14 109.606 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 . . . . . 0 C--O 1.247 0.937 0 C-N-CA 125.452 1.501 . . . . 74.42 111.542 -178.526 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 107.291 -1.374 . . . . 74.43 107.291 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.28 142.44 27.05 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 121.99 1.793 . . . . 60.31 108.96 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.12 160.89 40.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.187 0.995 . . . . 71.23 108.323 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -124.62 159.11 31.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.296 -1.742 . . . . 65.14 106.296 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -59.73 -30.02 68.54 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 120.961 -1.087 . . . . 74.25 112.543 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -33.57 68.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.465 1.029 . . . . 74.41 111.047 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.1 mtp -66.96 -43.37 83.28 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.229 -0.919 . . . . 75.25 108.61 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 t -57.1 -56.36 15.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 125.184 1.394 . . . . 74.54 110.827 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -59.09 -38.57 79.81 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 117.704 -1.141 . . . . 72.51 109.464 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.4 m -56.59 -58.97 5.77 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 120.278 1.399 . . . . 74.11 110.393 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.9 t -53.55 -45.77 59.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-N 119.384 0.993 . . . . 74.54 109.037 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.07 -50.14 67.43 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.209 0.913 . . . . 71.32 112.687 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -58.85 -40.87 85.54 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.693 0.797 . . . . 65.34 110.98 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.9 mt -83.9 -22.54 31.55 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.663 0.616 . . . . 73.21 112.663 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.17 72.54 81.35 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 127.104 2.162 . . . . 71.11 109.826 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.54 -6.26 18.06 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.007 3.138 . . . . 63.44 113.964 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.6 4.89 50.04 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.82 -1.175 . . . . 71.12 111.016 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.3 mt -109.93 161.02 15.89 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 120.678 -1.264 . . . . 70.02 110.419 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -81.89 144.9 52.45 Favored Pre-proline 0 N--CA 1.453 -0.317 0 C-N-CA 124.604 1.162 . . . . 72.31 108.551 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.6 -25.32 24.85 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.009 2.473 . . . . 74.13 113.634 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.65 -39.17 32.04 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.665 0.666 . . . . 75.45 110.328 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -57.29 -44.2 83.84 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.034 0.534 . . . . 75.13 110.629 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 59.9 mt -47.56 -54.75 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 C-N-CA 125.04 1.336 . . . . 72.25 112.471 -177.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.43 -46.34 37.49 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.34 0.518 . . . . 75.21 111.475 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -65.29 -42.74 92.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.633 -0.667 . . . . 74.04 111.263 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 m -60.0 -47.01 87.6 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 122.922 0.489 . . . . 74.33 109.721 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.41 -37.41 85.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.826 0.85 . . . . 72.12 110.697 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -69.92 -34.31 73.32 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.594 0.633 . . . . 74.22 110.38 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -74.87 -46.99 32.53 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.575 0.75 . . . . 61.33 112.485 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.9 p -77.77 -41.03 38.87 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.321 1.049 . . . . 71.41 111.49 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.92 -14.01 64.43 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 127.413 2.435 . . . . 72.13 112.588 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.2 m -144.09 150.08 37.57 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 120.115 1.957 . . . . 45.52 112.658 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.68 -50.97 73.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 126.275 1.83 . . . . 74.02 107.148 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -49.99 -46.76 52.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.151 1.38 . . . . 73.33 109.987 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -65.07 -46.57 80.6 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.374 0.67 . . . . 75.25 109.936 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 89.0 m -59.05 -37.07 76.14 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.873 1.269 . . . . 75.45 111.729 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.2 t -77.55 -36.72 23.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 123.62 0.768 . . . . 74.12 109.583 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -66.16 -35.33 80.2 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 125.151 1.38 . . . . 72.1 110.873 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -81.4 -36.12 29.89 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.94 -1.1 . . . . 75.32 108.608 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -56.67 -55.36 35.05 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.614 -0.679 . . . . 74.33 110.366 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -59.87 -19.97 54.41 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.34 0.867 . . . . 74.13 113.34 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -13.22 41.43 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.105 0.562 . . . . 74.45 110.426 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.25 20.98 39.86 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 118.921 -0.933 . . . . 64.4 113.469 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -63.71 174.35 1.42 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.442 1.097 . . . . 74.53 111.221 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -83.12 141.54 31.9 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.673 1.189 . . . . 75.35 111.712 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -128.58 109.91 11.78 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.268 1.827 . . . . 74.11 108.433 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.2 m -93.78 173.9 7.45 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.205 1.002 . . . . 61.11 111.404 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -105.03 156.62 35.8 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.963 1.305 . . . . 74.22 108.873 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.65 158.59 56.47 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.75 2.3 . . . . 75.21 114.488 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.39 116.82 4.7 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 105.769 -2.435 . . . . 75.4 105.769 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.25 -17.62 7.47 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-O 117.683 -1.621 . . . . 75.2 111.83 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -66.09 -27.75 68.3 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.577 1.189 . . . . 74.5 111.803 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 . . . . . 0 C--O 1.248 1.018 0 N-CA-C 105.167 -2.16 . . . . 74.43 105.167 178.363 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 . . . . . 0 C--O 1.236 0.374 0 CA-C-O 119.353 -0.356 . . . . 64.21 110.409 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.67 133.89 16.12 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.701 2.934 . . . . 75.21 108.905 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 m -134.85 152.6 33.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.644 0.778 . . . . 65.42 109.942 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.35 164.04 21.26 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.706 1.203 . . . . 72.12 110.488 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -45.54 -47.46 14.34 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.154 2.181 . . . . 72.31 112.313 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -57.53 -34.59 69.29 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.715 0.806 . . . . 62.32 112.761 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 84.4 mtp -67.93 -39.78 83.43 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.968 -0.753 . . . . 74.53 108.968 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 t -58.88 -57.41 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.037 1.335 . . . . 71.2 110.485 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -58.6 -42.08 87.28 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-O 117.989 -1.005 . . . . 73.34 110.02 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -55.78 -60.13 3.89 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 120.057 1.299 . . . . 74.45 109.841 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.0 t -51.67 -49.49 34.65 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-O 118.836 -0.602 . . . . 75.55 109.969 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -51.26 -48.16 62.24 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.516 0.726 . . . . 73.43 112.211 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -59.49 -43.41 93.33 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.506 -0.553 . . . . 73.22 109.506 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mt -80.41 -13.07 59.44 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.972 0.73 . . . . 73.11 112.972 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.14 69.86 34.54 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.993 2.117 . . . . 71.33 110.861 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.28 -2.86 9.76 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.164 2.576 . . . . 72.53 113.254 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -86.69 -10.88 52.77 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.629 1.572 . . . . 64.04 110.465 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.69 158.52 15.46 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.494 -0.754 . . . . 75.23 112.277 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -81.93 147.14 57.38 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.971 -1.122 . . . . 74.11 107.971 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.94 -29.97 67.13 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.392 2.061 . . . . 72.42 112.837 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.28 -39.43 28.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.946 -0.471 . . . . 65.3 112.173 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -60.66 -41.42 94.98 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.62 -0.511 . . . . 65.54 109.62 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.1 mt -51.86 -59.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.556 0.742 . . . . 73.51 109.09 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.95 -44.75 30.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.425 0.69 . . . . 74.33 111.388 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -65.92 -43.42 88.18 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.145 -0.972 . . . . 72.44 112.817 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -66.99 -37.65 84.61 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.346 -0.983 . . . . 63.05 108.346 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.4 mt -61.25 -38.19 85.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.547 -1.279 . . . . 75.13 107.547 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -67.58 -34.44 77.03 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.949 0.795 . . . . 75.12 109.676 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -71.74 -51.85 20.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 119.008 -0.52 . . . . 71.4 112.364 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.9 p -74.77 -40.99 60.87 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.497 1.519 . . . . 64.41 112.708 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.66 -4.14 86.18 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.624 1.107 . . . . 71.42 111.447 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -144.48 135.03 24.67 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.806 1.803 . . . . 71.15 111.836 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.2 t -55.12 -52.43 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.9 1.68 . . . . 74.25 108.631 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -47.55 -47.45 28.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 126.571 1.949 . . . . 74.23 111.574 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -65.21 -44.65 87.65 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.17 -0.678 . . . . 74.42 109.17 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -56.92 -43.01 80.98 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.827 1.251 . . . . 72.35 111.319 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.0 t -73.89 -36.1 44.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 120.717 -1.239 . . . . 71.42 109.519 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -65.78 -45.09 83.76 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.584 1.154 . . . . 74.25 110.383 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -69.06 -36.43 77.64 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.748 -1.22 . . . . 75.13 108.681 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -58.25 -57.22 13.86 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.68 -0.489 . . . . 63.43 109.68 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.15 -23.3 63.8 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.912 -0.566 . . . . 74.42 111.927 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 ptm85 -82.83 -12.07 57.73 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.408 1.004 . . . . 73.24 110.598 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.11 22.91 39.76 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 125.83 1.681 . . . . 45.35 113.65 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.4 169.08 14.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.856 1.328 . . . . 70.44 110.742 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -80.32 146.85 31.37 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.698 0.999 . . . . 70.42 113.698 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -130.32 109.92 11.13 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.011 1.324 . . . . 73.24 107.826 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.7 m -87.66 176.54 7.38 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.213 -1.358 . . . . 64.11 108.802 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -108.27 156.18 38.94 Favored Pre-proline 0 N--CA 1.467 0.379 0 C-N-CA 124.462 1.105 . . . . 74.41 109.193 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.62 157.24 59.28 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.76 2.307 . . . . 74.12 112.661 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.7 149.82 88.32 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.748 1.632 . . . . 71.14 108.604 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.08 -16.41 59.67 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.575 -1.125 . . . . 65.44 111.733 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -77.9 -43.49 29.91 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.132 1.466 . . . . 71.14 108.708 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 C--O 1.246 0.871 0 CA-C-O 117.481 -1.247 . . . . 73.44 109.277 178.411 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 110.088 -0.338 . . . . 71.12 110.088 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.53 126.78 9.23 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.736 2.957 . . . . 61.43 109.12 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 m -122.83 162.16 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.156 0.583 . . . . 73.4 109.65 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.9 p -124.17 167.65 13.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.453 1.101 . . . . 71.42 110.178 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.62 -43.46 72.27 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.6 1.16 . . . . 64.25 111.296 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -32.8 67.19 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 125.528 1.531 . . . . 71.22 111.655 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 93.5 mtp -67.07 -45.31 77.71 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.462 -0.94 . . . . 70.12 108.462 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 t -57.58 -57.24 11.09 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 CA-C-O 119.061 -0.495 . . . . 73.0 110.477 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -57.64 -39.93 78.11 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 117.638 -1.172 . . . . 75.54 111.138 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.8 m -56.34 -61.81 2.15 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.222 1.374 . . . . 74.42 108.29 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.6 t -57.26 -45.1 84.86 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 CA-C-N 119.16 0.891 . . . . 75.52 110.055 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.66 -39.03 67.65 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.451 1.478 . . . . 71.45 113.757 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -69.61 -44.6 70.38 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.103 -1.073 . . . . 65.04 108.103 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 37.6 mt -71.45 -28.4 63.93 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.054 -0.521 . . . . 64.5 111.207 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.13 75.76 67.65 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 128.997 2.919 . . . . 74.24 111.001 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.61 -4.92 16.2 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.431 2.087 . . . . 63.22 111.148 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -91.19 5.57 48.55 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.939 1.695 . . . . 74.31 112.417 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.3 mt -118.41 162.79 17.74 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.81 1.244 . . . . 72.11 110.817 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.424 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 49.7 t-80 -87.85 146.22 38.37 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 107.386 -1.338 . . . . 75.2 107.386 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 33.7 Cg_endo -64.29 -23.76 65.58 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.667 2.245 . . . . 74.45 112.123 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -78.13 -43.58 28.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 121.327 -0.858 . . . . 74.11 112.385 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -58.35 -45.51 88.03 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.777 -0.823 . . . . 74.25 108.777 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 63.8 mt -51.89 -59.07 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.369 1.068 . . . . 73.51 108.491 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.474 HH21 ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -47.33 -47.37 25.78 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.402 1.001 . . . . 75.42 112.161 179.509 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -65.85 -38.01 87.71 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 122.77 1.271 . . . . 74.53 111.675 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.5 t -62.48 -50.32 71.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.556 -1.276 . . . . 63.15 107.556 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.3 mt -57.91 -35.97 71.79 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 126.117 1.767 . . . . 75.4 109.333 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.474 ' CD ' HH21 ' A' ' 86' ' ' ARG . 36.2 mt-10 -67.86 -36.82 80.96 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.521 1.055 . . . . 74.3 109.526 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -76.87 -53.15 8.26 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.232 0.469 . . . . 65.51 111.992 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.7 p -67.01 -40.96 87.41 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.87 1.268 . . . . 61.02 110.897 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.92 -6.12 81.96 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.867 2.175 . . . . 75.42 113.247 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.5 m -144.28 143.75 31.16 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.163 1.482 . . . . 62.54 110.82 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -61.96 -47.81 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 C-N-CA 126.184 1.793 . . . . 75.35 108.171 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -50.38 -48.51 55.78 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.204 1.002 . . . . 53.21 111.717 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -63.78 -39.13 93.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.132 0.492 . . . . 73.31 109.939 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.5 m -63.77 -37.31 86.91 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.287 1.435 . . . . 75.42 110.498 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.09 -41.43 59.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.904 -1.147 . . . . 64.22 107.904 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -63.3 -35.17 79.48 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.76 1.224 . . . . 75.33 111.693 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -81.01 -39.0 26.55 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.254 -0.647 . . . . 74.42 109.254 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -56.55 -52.67 63.89 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.53 -0.731 . . . . 75.25 111.333 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.94 -19.97 61.55 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.744 0.646 . . . . 75.0 112.744 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -86.6 -12.57 48.21 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.167 -0.92 . . . . 74.35 110.334 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.81 37.06 13.98 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 108.63 -1.788 . . . . 74.24 108.63 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -74.84 172.36 12.34 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.582 -0.952 . . . . 72.42 110.999 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -78.99 131.61 36.37 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.423 1.089 . . . . 63.22 110.147 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -129.1 109.95 11.61 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.502 -1.296 . . . . 74.52 107.502 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.4 m -97.2 177.57 5.53 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.178 1.391 . . . . 73.12 108.954 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -104.84 158.64 31.58 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.42 1.088 . . . . 75.42 110.41 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.36 162.65 41.71 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.479 2.12 . . . . 52.43 112.97 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.68 133.98 45.03 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.383 2.055 . . . . 75.1 109.109 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.03 -11.52 64.02 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 118.811 -0.994 . . . . 73.03 112.641 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -77.17 -28.46 54.08 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.642 1.721 . . . . 74.45 111.717 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.021 -0.99 . . . . 64.31 110.334 -179.166 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 . . . . . 0 CA--C 1.534 0.347 0 N-CA-C 108.193 -1.04 . . . . 73.12 108.193 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.86 140.51 32.02 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.038 1.825 . . . . 74.43 110.245 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.81 165.65 30.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 124.725 1.21 . . . . 74.23 108.707 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -124.31 163.62 21.3 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.541 1.537 . . . . 74.21 108.247 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -55.06 -42.35 72.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.406 1.482 . . . . 73.43 110.409 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -33.31 65.44 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.345 1.458 . . . . 73.4 112.197 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.4 mtp -68.55 -41.42 79.81 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.939 1.245 . . . . 75.5 109.518 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.8 t -59.23 -54.86 28.49 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 123.988 0.915 . . . . 65.5 109.286 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -60.08 -37.17 79.13 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 117.562 -1.209 . . . . 64.43 110.59 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.5 m -55.15 -64.41 0.85 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.748 1.613 . . . . 71.11 108.555 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.7 t -53.52 -45.94 59.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.375 0 CA-C-O 118.184 -0.912 . . . . 72.03 110.313 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.1 tp60 -55.69 -48.63 74.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.342 0.974 . . . . 75.24 112.29 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -57.97 -43.33 86.44 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.164 0.586 . . . . 71.31 109.446 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 17.9 mt -80.54 -18.6 47.92 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.868 0.692 . . . . 64.23 112.868 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.14 76.44 77.94 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 127.428 2.291 . . . . 74.34 110.118 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.05 -15.1 42.67 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 121.695 1.596 . . . . 65.51 111.698 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.66 -22.74 53.61 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.324 2.249 . . . . 72.44 112.907 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.5 mt -85.14 156.36 21.07 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 114.008 1.114 . . . . 73.43 114.008 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.403 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 60.1 t-80 -74.54 145.66 82.56 Favored Pre-proline 0 C--O 1.236 0.355 0 N-CA-C 107.192 -1.41 . . . . 73.41 107.192 178.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.403 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 55.7 Cg_endo -66.52 -26.8 46.77 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.482 2.121 . . . . 74.13 114.096 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.33 -37.66 18.25 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.888 -0.412 . . . . 75.35 109.888 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -58.99 -36.97 75.79 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 109.499 -0.556 . . . . 75.12 109.499 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.0 mt -58.07 -61.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.092 -1.077 . . . . 63.42 108.092 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -48.27 -50.22 30.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 119.155 0.888 . . . . 75.42 110.876 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -60.39 -41.39 93.74 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 119.401 -0.92 . . . . 74.45 112.513 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.6 t -63.01 -48.66 77.86 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 107.495 -1.298 . . . . 74.32 107.495 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.8 mt -55.09 -42.12 72.45 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.514 1.126 . . . . 74.33 111.176 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -66.67 -33.74 76.32 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.848 0.459 . . . . 73.23 110.177 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -82.21 -46.25 13.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 118.139 -0.934 . . . . 73.42 113.366 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p -73.21 -41.3 63.95 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.361 1.464 . . . . 75.11 110.487 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.86 5.64 89.94 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 126.387 1.946 . . . . 51.03 112.357 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.8 m -142.63 127.13 17.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.913 1.357 . . . . 62.3 110.182 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.0 t -58.95 -49.35 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 105.846 -1.909 . . . . 73.24 105.846 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -52.99 -42.82 65.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.77 0.828 . . . . 74.35 111.209 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -61.14 -43.64 98.57 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 108.779 -0.823 . . . . 72.11 108.779 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.3 m -61.59 -40.38 94.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.849 2.06 . . . . 71.42 111.48 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.3 -37.07 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 O-C-N 121.29 -0.881 . . . . 74.32 108.856 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.36 -31.82 70.49 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 125.077 1.351 . . . . 72.4 112.225 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -83.12 -36.04 25.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.219 -1.03 . . . . 75.22 108.219 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -58.16 -56.09 26.48 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.39 -0.819 . . . . 75.35 109.805 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -57.5 -25.55 59.96 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-O 119.071 -0.49 . . . . 74.11 111.32 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.76 -8.2 59.3 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.742 0.701 . . . . 74.31 111.682 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.17 28.54 53.31 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 123.804 0.716 . . . . 54.42 111.704 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -67.14 173.81 3.56 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 117.207 0.503 . . . . 74.15 112.092 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -80.98 140.57 35.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.895 1.278 . . . . 72.13 109.253 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -132.63 109.42 9.72 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.813 -1.551 . . . . 75.14 106.813 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 t -83.79 169.95 14.66 Favored 'General case' 0 C--O 1.24 0.574 0 O-C-N 121.638 -0.664 . . . . 63.42 110.386 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -100.38 150.26 36.78 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 125.069 1.347 . . . . 74.5 108.321 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.48 166.99 19.95 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.922 3.081 . . . . 73.21 113.97 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -63.32 139.91 74.12 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.064 2.509 . . . . 71.11 111.804 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.2 -0.29 68.34 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 118.457 -1.191 . . . . 53.24 113.878 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -70.58 -34.43 72.18 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.289 1.545 . . . . 74.14 109.027 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 126.857 2.063 . . . . 63.13 111.866 179.642 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.238 0.448 0 N-CA-C 109.004 -0.739 . . . . 75.15 109.004 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.04 136.98 15.15 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.468 2.779 . . . . 73.12 109.874 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.4 m -128.26 158.2 40.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 O-C-N 121.4 -0.812 . . . . 71.03 110.436 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -125.43 163.39 22.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.039 1.336 . . . . 74.13 110.104 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.1 m -49.52 -45.8 47.75 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.743 1.617 . . . . 70.51 110.634 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -35.96 65.79 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.434 1.894 . . . . 74.32 112.75 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.7 mtp -68.48 -44.74 74.12 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.985 -1.072 . . . . 74.11 109.231 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.1 t -60.98 -51.61 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.012 0.925 . . . . 75.45 110.815 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -61.48 -43.42 98.9 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 117.247 -1.358 . . . . 64.51 110.335 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.2 m -57.8 -55.87 29.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.949 1.704 . . . . 72.0 109.803 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.1 t -55.0 -46.85 77.29 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 CA-C-N 119.865 1.211 . . . . 74.23 109.084 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -56.08 -43.54 78.12 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.543 1.065 . . . . 75.53 112.205 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -61.91 -35.74 79.27 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.027 1.331 . . . . 73.31 111.838 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.6 mt -94.06 -12.78 27.82 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.969 1.308 . . . . 73.51 112.454 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.95 67.44 56.53 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 127.828 2.451 . . . . 73.44 108.468 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.76 -9.4 22.75 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.385 2.056 . . . . 64.3 112.763 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.17 -12.01 48.2 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.887 0.875 . . . . 71.45 111.73 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.1 mt -88.32 152.93 21.59 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.345 0.975 . . . . 74.22 111.902 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -72.94 140.07 80.45 Favored Pre-proline 0 N--CA 1.448 -0.565 0 N-CA-C 106.617 -1.623 . . . . 74.15 106.617 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.29 -23.44 44.87 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.985 2.457 . . . . 73.54 113.765 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -40.09 17.76 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.42 0.554 . . . . 74.34 109.594 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -60.92 -40.32 92.71 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-O 118.141 -0.933 . . . . 72.54 109.658 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.78 -56.49 7.2 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 C-N-CA 124.265 1.026 . . . . 64.53 109.42 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -45.67 -54.35 7.91 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.128 0.422 . . . . 70.11 110.867 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -61.64 -36.19 80.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.826 0.306 . . . . 73.41 111.826 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.2 m -61.42 -49.65 76.02 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.368 -0.975 . . . . 62.23 108.368 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.8 mt -59.69 -35.5 74.6 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.197 0.999 . . . . 75.41 110.478 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -67.75 -33.82 75.61 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.666 -0.494 . . . . 73.41 109.666 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -79.46 -50.2 11.14 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.862 1.265 . . . . 74.45 114.093 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.6 p -74.56 -41.77 59.97 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.53 1.532 . . . . 73.54 110.872 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.28 -18.1 58.0 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 127.947 2.689 . . . . 61.43 112.551 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -139.35 151.15 46.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 123.718 1.723 . . . . 75.14 112.235 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.33 -47.44 89.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 113.008 -1.905 . . . . 73.34 107.989 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -50.91 -51.03 56.01 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.367 1.467 . . . . 75.01 110.204 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -62.82 -42.36 99.69 Favored 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 109.863 -0.421 . . . . 74.44 109.863 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.1 m -60.36 -39.8 88.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.287 1.035 . . . . 74.23 111.833 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.59 -37.67 44.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 121.399 -0.813 . . . . 73.22 109.436 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -66.7 -38.13 86.14 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.483 1.113 . . . . 65.42 111.251 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -78.6 -33.87 47.14 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.493 -0.754 . . . . 75.11 109.216 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -59.62 -59.6 5.18 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.674 -1.266 . . . . 72.04 111.349 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -56.54 -28.95 61.33 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.509 0.724 . . . . 71.41 111.93 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -18.7 56.4 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.757 -0.64 . . . . 74.22 110.936 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.9 28.05 14.92 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.581 -1.122 . . . . 74.53 112.357 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -68.34 -179.25 1.26 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.939 1.296 . . . . 75.2 111.83 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -82.6 144.06 30.59 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.78 1.232 . . . . 75.51 111.564 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -138.84 109.18 6.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.628 -0.878 . . . . 64.52 108.628 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.2 m -84.96 177.13 8.06 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.773 1.229 . . . . 62.33 110.903 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -111.66 153.9 44.14 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 105.683 -1.969 . . . . 75.45 105.683 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.87 166.14 29.96 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.407 2.071 . . . . 64.43 111.641 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -63.03 156.17 56.37 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.404 2.069 . . . . 72.12 109.622 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.5 -28.53 3.43 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 118.312 -1.271 . . . . 74.22 111.587 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -66.81 -53.46 32.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 119.376 1.588 . . . . 74.31 111.024 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 . . . . . 0 C--O 1.249 1.062 0 C-N-CA 125.069 1.348 . . . . 72.41 107.513 -179.574 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 107.924 -1.139 . . . . 72.42 107.924 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.01 142.78 31.72 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.99 1.793 . . . . 72.34 110.979 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 m -128.75 164.85 29.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.291 1.036 . . . . 74.15 109.509 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.2 p -124.3 162.79 23.02 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.399 1.48 . . . . 73.02 109.163 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -53.02 -38.99 62.83 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.101 0.961 . . . . 71.42 110.777 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -44.29 95.34 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 118.579 -0.724 . . . . 70.41 112.043 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 5.2 mtm -59.53 -35.2 73.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.421 -0.912 . . . . 75.4 110.703 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.7 t -65.44 -52.76 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.061 -0.718 . . . . 74.41 109.061 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -64.09 -35.52 81.01 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.708 -1.139 . . . . 75.51 110.718 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.3 m -57.18 -60.12 4.08 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 121.107 1.776 . . . . 74.14 108.082 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.5 t -54.5 -47.99 70.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 CA-C-O 117.571 -1.204 . . . . 75.42 108.596 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 tp60 -52.55 -45.48 66.38 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 120.153 1.342 . . . . 75.32 111.97 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -62.73 -36.4 82.88 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.402 -0.812 . . . . 72.13 110.469 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.7 mt -89.67 -14.65 34.36 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.85 -0.595 . . . . 75.53 112.54 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -138.33 73.55 43.16 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 129.111 2.965 . . . . 74.03 111.685 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -69.79 -5.67 16.77 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.904 3.069 . . . . 72.42 113.515 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.5 -15.69 36.87 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 120.745 -1.222 . . . . 74.14 111.981 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.8 mt -91.14 160.09 15.74 Favored 'General case' 0 N--CA 1.458 -0.074 0 C-N-CA 123.236 0.614 . . . . 74.52 111.571 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.479 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 56.0 t-80 -85.26 149.42 52.4 Favored Pre-proline 0 C--O 1.239 0.521 0 N-CA-C 106.171 -1.788 . . . . 73.14 106.171 178.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 33.2 Cg_endo -63.93 -30.07 67.25 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.548 2.165 . . . . 74.11 112.456 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.28 -34.22 55.65 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 112.717 0.636 . . . . 71.21 112.717 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -61.3 -46.1 91.69 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.609 -0.886 . . . . 63.12 108.609 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.0 mt -52.49 -59.63 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 125.002 1.321 . . . . 75.44 108.299 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -49.47 12.95 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.618 1.099 . . . . 75.11 111.888 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -64.41 -45.71 86.43 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.919 0.781 . . . . 75.05 113.085 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.7 p -65.7 -37.99 87.99 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.574 -0.704 . . . . 75.31 109.472 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.35 -38.16 88.43 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.105 -0.997 . . . . 74.32 109.062 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -68.39 -35.33 77.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.569 0.622 . . . . 71.14 110.062 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -72.51 -55.05 7.58 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.935 -0.478 . . . . 71.24 111.091 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.0 p -67.19 -41.36 85.98 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.911 1.284 . . . . 73.24 112.021 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.83 -11.85 67.61 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.87 1.224 . . . . 71.42 113.429 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -144.44 144.11 31.23 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 119.031 1.415 . . . . 74.31 109.336 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.1 t -59.63 -43.37 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 125.181 1.393 . . . . 74.24 109.025 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -46.93 -47.75 21.55 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.895 1.278 . . . . 75.13 111.011 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -69.82 -40.56 75.84 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.445 -0.784 . . . . 73.33 109.967 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.8 m -58.96 -37.12 76.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.161 0.584 . . . . 72.13 110.28 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 85.7 t -74.95 -36.96 40.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 123.919 0.888 . . . . 72.34 109.157 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -68.76 -39.61 80.2 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.352 1.061 . . . . 71.1 111.263 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -74.33 -37.11 63.66 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.122 -1.066 . . . . 73.31 108.122 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -58.03 -56.32 23.49 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.613 0.765 . . . . 73.13 109.935 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 pp -60.62 -22.49 63.85 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.284 -0.885 . . . . 73.15 112.055 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -16.72 48.7 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.846 0.748 . . . . 73.32 109.898 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.25 36.67 9.62 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 119.032 0.833 . . . . 61.1 112.168 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -76.76 173.38 11.72 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 117.986 0.893 . . . . 64.1 109.827 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -81.58 135.73 35.57 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.481 -1.303 . . . . 75.14 107.481 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -118.42 110.94 18.05 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.138 -2.542 . . . . 75.41 104.138 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.7 m -97.79 178.59 5.09 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 125.063 1.345 . . . . 64.14 110.086 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -110.88 158.79 34.72 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 125.371 1.469 . . . . 75.2 111.283 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.33 164.07 36.75 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.358 2.705 . . . . 74.13 113.898 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.09 139.53 84.72 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.967 2.444 . . . . 72.15 109.707 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.14 -18.41 56.88 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.508 1.052 . . . . 73.4 111.096 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -71.61 -45.29 62.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 119.243 1.522 . . . . 75.24 109.427 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.021 -0.99 . . . . 73.3 111.439 -178.962 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 . . . . . 0 CA--C 1.529 0.154 0 N-CA-C 109.127 -0.694 . . . . 73.44 109.127 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.27 138.12 38.57 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.033 1.822 . . . . 74.43 109.957 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 m -134.46 159.55 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.337 -0.986 . . . . 71.45 108.337 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.31 162.43 23.77 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.445 -0.946 . . . . 75.1 108.445 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 m -51.36 -39.1 56.4 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.607 1.963 . . . . 75.22 111.393 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.83 -38.05 77.81 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 124.561 1.144 . . . . 75.52 110.248 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.1 mtp -63.87 -38.14 89.98 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 120.407 -1.433 . . . . 73.54 109.377 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 t -61.08 -54.26 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.308 -0.627 . . . . 70.34 109.308 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -62.95 -38.24 90.28 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-O 117.294 -1.336 . . . . 74.1 110.588 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.6 m -53.98 -61.1 2.52 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 121.138 1.79 . . . . 72.42 108.087 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.7 t -55.51 -48.52 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 118.138 -0.934 . . . . 75.23 110.411 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -56.37 -42.24 77.5 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.074 0.852 . . . . 71.45 111.839 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -62.64 -43.6 98.39 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.618 -0.882 . . . . 65.0 108.618 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 mt -75.85 -26.91 57.57 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.735 -0.603 . . . . 75.44 111.476 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.77 83.37 62.57 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 128.054 2.542 . . . . 62.53 111.848 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.8 -21.3 38.49 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.575 1.517 . . . . 72.33 112.802 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.07 -19.29 51.69 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.754 1.222 . . . . 61.24 113.523 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 mt -79.53 154.52 28.76 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.786 0.721 . . . . 73.12 109.756 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -79.6 144.19 60.46 Favored Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 107.352 -1.351 . . . . 74.42 107.352 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.53 -29.53 52.79 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.924 1.75 . . . . 65.13 112.228 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -75.39 -41.52 56.0 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 112.491 0.552 . . . . 75.03 112.491 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -63.14 -35.19 79.48 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.893 0.477 . . . . 73.32 110.05 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 75.2 mt -56.64 -60.37 2.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 109.297 -0.631 . . . . 72.55 109.297 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.89 -40.77 61.21 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.653 1.115 . . . . 73.54 112.271 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -61.93 -46.96 87.04 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.126 0.965 . . . . 74.23 111.092 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.8 p -63.49 -44.8 93.32 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.78 -1.1 . . . . 64.41 108.595 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.5 mt -56.86 -39.3 74.06 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.186 0.903 . . . . 74.52 109.814 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.39 -34.93 75.25 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.73 1.15 . . . . 73.21 110.071 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.54 -47.4 48.6 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.222 0.609 . . . . 71.23 111.5 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.5 p -79.07 -35.51 42.32 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 127.574 2.35 . . . . 70.41 113.547 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.39 -12.24 55.95 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 125.864 1.697 . . . . 71.1 113.135 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.0 m -143.91 146.17 32.79 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 118.854 1.327 . . . . 72.31 111.962 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.41 -47.53 89.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.127 -1.434 . . . . 65.42 107.127 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -45.86 -46.07 15.52 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.953 1.301 . . . . 73.42 111.481 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -65.45 -53.58 40.74 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.061 1.744 . . . . 72.1 108.358 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.9 m -54.75 -37.59 66.15 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.98 1.312 . . . . 75.24 111.392 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.56 -39.68 54.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 124.124 0.97 . . . . 75.41 109.444 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -64.04 -44.41 92.56 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.279 1.432 . . . . 75.55 109.772 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -74.32 -32.47 62.84 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.46 -0.775 . . . . 74.13 110.909 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -62.9 -54.51 37.56 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.464 -0.772 . . . . 62.54 110.451 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.79 -25.85 67.73 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 118.209 -0.901 . . . . 74.24 111.78 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -81.41 -11.61 59.21 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.757 0.661 . . . . 74.23 110.2 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.78 36.62 25.12 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-O 119.06 -0.856 . . . . 61.32 111.203 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -74.73 -175.89 2.63 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.14 0.97 . . . . 70.21 111.456 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -86.69 138.72 31.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.608 1.163 . . . . 72.1 111.221 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -138.51 110.3 7.16 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.022 1.329 . . . . 75.43 109.895 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.8 m -89.58 -179.78 5.87 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.534 1.534 . . . . 52.24 109.71 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -110.05 159.13 33.02 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 126.352 1.861 . . . . 74.33 110.032 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.64 166.92 27.49 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.584 2.856 . . . . 74.44 114.782 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.85 137.22 40.97 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.532 2.154 . . . . 75.43 107.139 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.2 -10.37 59.89 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.997 1.284 . . . . 65.11 111.065 -178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -77.33 -29.01 53.31 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.571 1.685 . . . . 71.02 109.986 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 . . . . . 0 C--O 1.25 1.112 0 C-N-CA 125.439 1.496 . . . . 74.25 108.936 179.508 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 107.772 -1.195 . . . . 72.44 107.772 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.0 127.38 15.1 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.7 2.933 . . . . 72.4 114.035 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.8 m -107.91 166.82 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.432 1.093 . . . . 72.32 109.934 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.2 p -124.26 157.68 34.3 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.931 -1.877 . . . . 74.45 105.931 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -56.12 -35.75 67.45 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 119.105 -0.474 . . . . 75.13 110.811 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -36.84 73.01 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.753 0.706 . . . . 73.24 111.756 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.1 mtp -66.36 -33.39 75.62 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.089 -1.007 . . . . 74.2 109.29 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.87 -53.95 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 123.93 0.892 . . . . 74.32 109.475 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -60.33 -40.99 92.61 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.56 -1.209 . . . . 74.24 109.367 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.9 m -56.22 -57.38 12.48 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.676 1.58 . . . . 75.1 108.624 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.5 t -55.43 -50.8 63.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-O 118.456 -0.783 . . . . 73.13 109.699 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -52.08 -44.12 64.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 118.893 0.77 . . . . 74.25 112.767 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -62.86 -42.52 99.78 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.891 0.876 . . . . 75.51 110.363 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.8 mt -86.34 -10.83 53.64 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.843 0.683 . . . . 72.42 112.843 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.68 70.7 58.83 Favored Pre-proline 0 N--CA 1.447 -0.597 0 C-N-CA 127.186 2.195 . . . . 73.33 108.673 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -68.54 0.23 5.05 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.279 3.32 . . . . 71.25 112.633 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.16 12.83 29.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.453 1.501 . . . . 72.34 112.071 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.9 mt -114.77 157.53 23.1 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.545 1.138 . . . . 73.51 109.25 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.425 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 57.3 t-80 -85.46 145.59 42.6 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 108.276 -1.009 . . . . 74.53 108.276 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 33.0 Cg_endo -62.67 -29.87 78.1 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.938 2.426 . . . . 73.43 113.232 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -77.41 -42.99 34.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.967 -0.458 . . . . 75.22 110.931 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -58.27 -42.63 86.91 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 122.028 -0.42 . . . . 72.52 110.075 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 76.2 mt -50.59 -58.86 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 124.786 1.234 . . . . 74.43 109.692 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.05 -50.29 10.98 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.568 0.622 . . . . 75.3 111.342 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -61.34 -45.37 94.72 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.702 -0.624 . . . . 74.01 112.33 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 p -63.35 -42.63 98.93 Favored 'General case' 0 C--O 1.218 -0.583 0 C-N-CA 120.216 -0.593 . . . . 62.11 110.153 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.2 mt -60.21 -34.76 74.1 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.618 0.767 . . . . 72.13 110.114 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.85 -36.54 78.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.356 -0.609 . . . . 72.41 109.356 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -78.26 -44.5 25.34 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.07 0.767 . . . . 74.13 113.07 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.9 p -76.25 -36.18 58.59 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.787 1.635 . . . . 74.34 111.423 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.49 -17.82 46.25 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.921 1.248 . . . . 73.34 113.298 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.5 t -145.11 150.1 36.2 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.657 1.228 . . . . 74.14 108.991 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.9 t -65.12 -41.8 92.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 126.373 1.869 . . . . 74.55 109.285 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -46.52 -48.01 19.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.389 1.476 . . . . 71.41 111.491 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -68.35 -44.85 74.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.378 1.471 . . . . 75.31 108.845 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.6 m -56.96 -39.16 74.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.945 0.898 . . . . 74.22 110.791 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.3 t -74.4 -37.72 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.273 -0.87 . . . . 71.42 110.074 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -66.69 -43.66 83.81 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.173 0.989 . . . . 55.33 110.126 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -72.59 -35.66 67.95 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.295 -0.878 . . . . 72.3 109.98 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -57.91 -57.39 13.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 121.133 -0.979 . . . . 72.15 110.482 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.22 -26.09 62.43 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.195 0.452 . . . . 72.13 111.269 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -12.17 59.96 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.599 -0.688 . . . . 74.44 110.364 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.65 37.35 40.34 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 125.054 1.312 . . . . 73.14 110.715 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.2 -171.17 0.88 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.207 1.004 . . . . 63.12 112.126 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.45 139.05 34.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 120.961 -1.087 . . . . 73.4 109.582 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -129.85 108.72 10.36 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 104.862 -2.273 . . . . 73.12 104.862 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.7 m -96.26 163.92 12.88 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.732 1.213 . . . . 73.04 111.786 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -97.11 156.52 36.23 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 124.542 1.137 . . . . 72.31 108.835 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.94 164.74 30.59 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.803 2.335 . . . . 75.31 112.211 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.23 142.43 66.92 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.037 1.825 . . . . 64.21 110.324 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.22 -9.37 73.1 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 118.607 -1.107 . . . . 64.31 113.286 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -76.78 -22.8 53.19 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.897 1.349 . . . . 70.03 110.459 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 C--O 1.247 0.926 0 C-N-CA 126.351 1.86 . . . . 75.32 112.64 179.811 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 . . . . . 0 C--O 1.236 0.367 0 N-CA-C 109.671 -0.492 . . . . 70.31 109.671 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.75 141.08 21.42 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.201 1.934 . . . . 75.12 109.308 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 m -134.64 160.15 41.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.427 -0.953 . . . . 62.21 108.427 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.98 157.76 37.0 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.889 1.276 . . . . 71.11 108.768 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 m -42.75 -48.37 5.61 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.762 2.425 . . . . 72.21 111.522 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -53.97 -36.71 63.17 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 126.933 2.093 . . . . 62.01 112.324 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 87.3 mtp -66.81 -42.39 85.98 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.661 -0.866 . . . . 75.33 108.661 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.78 -57.93 9.01 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 CA-C-N 117.92 0.327 . . . . 73.42 110.601 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -58.04 -40.78 81.77 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 118.14 -0.933 . . . . 74.01 110.725 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.8 m -58.01 -62.0 2.13 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.09 1.314 . . . . 74.02 109.524 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.4 t -52.42 -46.42 46.95 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 CA-C-O 118.354 -0.832 . . . . 73.01 108.999 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.19 -38.31 79.53 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.698 1.136 . . . . 72.45 113.336 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -65.41 -40.89 93.95 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.152 0.887 . . . . 72.43 108.846 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mt -78.98 -34.53 44.09 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 112.248 0.462 . . . . 74.31 112.248 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.11 75.46 4.15 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 127.33 2.252 . . . . 74.52 109.532 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.08 -13.69 40.72 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.267 1.978 . . . . 64.12 112.2 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -83.12 -6.63 59.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.872 1.269 . . . . 74.23 113.08 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.2 mt -98.06 155.24 17.22 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 120.92 -1.113 . . . . 73.24 109.355 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.439 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 53.7 t-80 -78.34 146.43 70.41 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 105.607 -1.997 . . . . 73.43 105.607 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 32.2 Cg_endo -63.88 -31.85 66.97 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.651 1.567 . . . . 64.21 112.281 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -74.88 -38.33 61.92 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.281 -0.887 . . . . 75.14 111.912 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -58.56 -45.12 89.65 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.81 -0.441 . . . . 64.24 109.81 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.1 mt -49.22 -56.31 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 117.812 -1.089 . . . . 75.21 110.123 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -48.7 -48.51 40.25 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.558 1.072 . . . . 74.12 111.712 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.419 ' CE1' ' HD3' ' A' ' 112' ' ' PRO . 9.2 t80 -62.25 -41.16 98.2 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.807 0.731 . . . . 73.33 111.704 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.2 m -63.6 -48.66 76.44 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.756 -0.831 . . . . 74.14 108.756 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -57.32 -37.34 72.35 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.021 1.328 . . . . 74.41 110.309 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -68.18 -38.0 81.57 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.042 -0.725 . . . . 72.35 109.042 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -76.68 -48.34 19.25 Favored 'General case' 0 C--N 1.334 -0.097 0 O-C-N 121.457 -0.777 . . . . 72.11 112.106 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.3 p -71.47 -38.33 71.27 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.567 1.147 . . . . 72.55 111.369 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.55 -2.94 87.57 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.906 2.193 . . . . 74.1 111.447 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -144.31 145.06 31.77 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.137 1.469 . . . . 51.53 112.608 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.93 -52.48 53.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.517 -1.66 . . . . 74.11 106.517 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -49.17 -51.99 29.25 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.316 1.847 . . . . 74.41 110.674 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.49 -43.49 93.31 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.852 0.861 . . . . 74.13 109.527 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.7 m -61.52 -39.42 90.95 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.969 0.908 . . . . 72.54 110.501 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.5 t -75.2 -34.62 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 121.247 -0.908 . . . . 75.54 110.131 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -68.18 -39.29 82.54 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 126.113 1.765 . . . . 75.22 111.23 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -79.02 -37.08 40.04 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.877 -0.786 . . . . 75.2 108.877 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -54.67 -54.36 42.7 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.943 0.897 . . . . 72.41 109.705 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.13 -18.06 56.02 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.168 0.803 . . . . 74.42 113.168 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -19.26 42.17 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.714 -1.217 . . . . 75.33 107.714 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 83.3 31.7 27.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 125.656 1.598 . . . . 70.03 109.658 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -62.59 176.79 0.6 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.866 1.666 . . . . 73.24 111.382 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -83.47 139.11 33.13 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 123.076 0.55 . . . . 70.45 110.284 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -135.88 109.04 7.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.284 1.033 . . . . 75.2 108.83 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.5 m -91.52 176.1 6.67 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.851 0.861 . . . . 75.24 109.033 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -103.14 155.71 36.3 Favored Pre-proline 0 N--CA 1.45 -0.457 0 C-N-CA 124.873 1.269 . . . . 74.21 108.779 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -69.27 161.57 45.34 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.907 2.405 . . . . 54.14 113.628 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HD3' ' CE1' ' A' ' 87' ' ' TYR . 37.2 Cg_endo -63.36 145.95 93.08 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 121.94 1.76 . . . . 71.11 107.992 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.47 -5.38 82.59 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.418 -1.212 . . . . 62.22 111.599 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -86.36 -28.32 23.71 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.632 1.716 . . . . 74.15 111.845 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 123.805 0.842 . . . . 74.24 111.236 179.114 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.16 0 N-CA-C 109.144 -1.582 . . . . 73.41 109.144 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.76 174.4 8.47 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 117.86 0.83 . . . . 71.12 109.248 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 24.2 ptp -155.26 166.65 32.89 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.713 1.605 . . . . 71.41 107.667 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.76 80.96 0.03 OUTLIER Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.345 -1.253 . . . . 55.53 110.232 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.21 -9.29 25.62 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.991 2.461 . . . . 63.54 115.124 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 26.91 73.53 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.749 2.82 . . . . 63.31 114.634 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.36 106.72 0.33 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.459 -1.457 . . . . 43.33 109.459 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.2 m -97.05 169.48 9.79 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.515 1.126 . . . . 72.41 109.412 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 51' ' ' ASN . 3.1 p -77.47 95.99 4.61 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.748 -1.22 . . . . 62.42 107.765 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -70.99 29.34 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.555 1.542 . . . . 62.33 114.41 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.408 ' H ' ' C ' ' A' ' 49' ' ' THR . 49.7 t-20 -87.35 81.75 7.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.831 1.652 . . . . 74.33 108.921 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.28 -178.73 0.38 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.903 0.881 . . . . 72.33 110.964 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.4 tt -49.32 139.56 11.31 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.966 1.307 . . . . 64.42 110.881 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -45.88 134.82 7.6 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.251 1.42 . . . . 73.13 111.127 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -43.66 114.01 0.59 Allowed 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.482 1.513 . . . . 74.32 110.652 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.2 p -73.17 165.39 25.13 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.935 0.894 . . . . 73.24 109.876 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.69 -56.77 3.25 Favored Glycine 0 C--O 1.237 0.327 0 O-C-N 121.196 -0.94 . . . . 51.33 112.068 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -146.73 112.11 5.53 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.787 1.235 . . . . 74.41 109.138 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.2 m -82.14 103.11 8.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 105.584 -2.006 . . . . 72.14 105.584 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.59 -172.89 3.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.802 2.841 . . . . 75.11 107.766 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.37 34.78 6.22 Favored Glycine 0 CA--C 1.522 0.52 0 O-C-N 121.434 -0.791 . . . . 73.21 111.933 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.19 135.92 6.92 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.2 -1.56 . . . . 75.54 109.2 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -129.91 151.09 77.64 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 126.372 1.869 . . . . 74.44 108.26 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.2 126.3 9.75 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.712 2.275 . . . . 74.32 110.645 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 m -122.99 161.29 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 O-C-N 120.954 -1.091 . . . . 62.41 110.001 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 p -124.4 166.24 16.32 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.053 0.941 . . . . 61.42 110.036 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.1 m -52.73 -41.85 64.35 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.496 1.518 . . . . 64.41 110.95 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -34.04 67.57 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.194 0.997 . . . . 62.35 111.013 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.9 mtp -70.32 -43.37 70.45 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.962 -0.755 . . . . 73.55 108.962 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.2 t -59.5 -55.98 20.23 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 C-N-CA 124.168 0.987 . . . . 74.25 110.193 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.66 -41.5 90.72 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 117.784 -1.103 . . . . 62.22 111.103 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.3 m -55.01 -60.42 3.4 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.57 1.077 . . . . 60.32 109.051 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.57 -46.22 79.03 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 CA-C-N 119.16 0.891 . . . . 62.31 109.694 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -54.9 -44.29 74.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 119.131 0.878 . . . . 74.51 112.97 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -62.85 -44.19 96.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.172 -0.677 . . . . 73.14 109.172 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.9 mt -79.41 -14.72 58.75 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.43 1.092 . . . . 74.43 113.583 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -137.33 70.87 54.17 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 127.368 2.267 . . . . 73.51 108.566 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.9 -23.16 62.32 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.584 2.189 . . . . 63.35 112.916 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.29 -14.56 62.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.523 0.729 . . . . 63.52 111.938 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.4 mt -92.36 156.69 17.07 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 119.181 0.9 . . . . 72.22 112.74 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.404 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 51.5 t-80 -79.92 143.2 57.28 Favored Pre-proline 0 C--O 1.238 0.46 0 N-CA-C 106.111 -1.811 . . . . 72.34 106.111 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 39.8 Cg_endo -65.62 -29.12 52.29 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.782 2.322 . . . . 75.41 113.032 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -40.2 48.77 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.698 -0.626 . . . . 75.24 111.727 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -60.9 -35.34 76.39 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.29 -0.633 . . . . 72.33 109.29 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.9 mt -56.57 -56.5 13.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 CA-C-O 118.164 -0.922 . . . . 64.12 108.713 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.82 -46.65 20.91 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.488 1.04 . . . . 75.44 111.048 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -64.59 -43.54 93.5 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.418 0.554 . . . . 74.23 111.911 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.2 t -64.59 -41.37 96.29 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.174 -0.676 . . . . 63.23 109.174 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.24 -37.97 84.99 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.943 0.897 . . . . 74.31 110.475 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -72.05 -34.77 69.02 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.608 0.64 . . . . 73.13 110.877 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -72.51 -50.61 24.63 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.001 -0.437 . . . . 71.34 110.808 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.3 p -72.64 -41.59 65.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.26 1.024 . . . . 71.24 111.819 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.16 -6.12 75.63 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.249 1.881 . . . . 44.41 112.538 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -145.59 152.13 39.2 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 120.897 2.348 . . . . 75.25 112.394 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.63 -50.62 64.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 106.765 -1.568 . . . . 75.23 106.765 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -52.32 -47.03 66.25 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.453 1.501 . . . . 64.44 111.754 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -63.74 -43.24 97.07 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.458 -0.942 . . . . 75.52 108.458 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.9 m -61.68 -37.05 82.68 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.422 1.089 . . . . 62.43 110.559 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.6 t -73.8 -35.95 44.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.412 1.085 . . . . 74.12 109.103 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -70.16 -40.5 74.7 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.417 1.487 . . . . 75.42 110.31 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -76.35 -30.2 57.51 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 122.084 0.945 . . . . 73.25 109.88 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -64.31 -54.59 30.8 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 121.099 -1.0 . . . . 74.23 108.932 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.15 -20.94 60.81 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.43 0.9 . . . . 61.33 113.43 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -92.23 -6.26 50.87 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.742 0.701 . . . . 74.53 109.913 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.62 36.68 58.39 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 126.528 2.013 . . . . 62.44 113.322 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -70.38 -178.68 1.79 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 118.256 1.028 . . . . 74.21 110.148 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.2 134.77 36.16 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 126.137 1.775 . . . . 74.54 111.901 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -129.07 110.51 12.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.245 1.818 . . . . 72.44 106.168 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.1 m -96.0 174.29 7.0 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.736 1.214 . . . . 73.22 108.035 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -98.1 155.6 36.82 Favored Pre-proline 0 C--N 1.33 -0.243 0 O-C-N 121.585 -0.697 . . . . 73.41 110.197 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -69.44 163.66 37.19 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.899 1.732 . . . . 72.41 111.48 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -59.89 144.6 99.43 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.887 1.724 . . . . 62.42 109.313 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.24 -12.39 58.47 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.595 1.093 . . . . 74.23 113.026 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -75.59 -46.54 31.21 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.195 1.497 . . . . 71.13 108.268 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 . . . . . 0 C--O 1.24 0.58 0 C-N-CA 124.92 1.288 . . . . 74.31 109.225 179.252 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.175 0 N-CA-C 109.411 -1.476 . . . . 70.24 109.411 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 64.85 -12.85 0.12 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.18 2.192 . . . . 64.04 115.87 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.9 164.44 22.1 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.071 1.305 . . . . 74.34 108.477 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 141.55 -72.81 0.39 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.384 -2.287 . . . . 64.32 107.384 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.51 1.03 5.33 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.915 2.41 . . . . 75.31 112.296 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -142.52 137.0 29.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 103.628 -2.73 . . . . 74.14 103.628 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.3 -142.61 3.48 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.301 1.905 . . . . 75.43 108.878 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.8 t -148.92 170.46 18.25 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.209 1.004 . . . . 72.43 108.622 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.3 t -167.64 -171.43 1.64 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.859 1.664 . . . . 72.25 108.378 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -129.7 35.21 4.21 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.44 2.296 . . . . 64.14 109.327 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -63.35 99.46 0.2 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 125.706 1.602 . . . . 74.4 107.269 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.26 167.06 23.03 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.243 1.417 . . . . 63.54 110.146 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.53 -169.92 2.28 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.219 1.808 . . . . 54.43 110.372 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.95 168.16 5.48 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 122.02 0.914 . . . . 73.01 113.178 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -74.14 -177.56 3.0 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.805 0.842 . . . . 73.21 109.671 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 t -129.31 174.6 9.46 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.651 0.781 . . . . 75.25 110.191 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.58 -77.8 0.55 Allowed Glycine 0 C--O 1.225 -0.464 0 N-CA-C 109.463 -1.455 . . . . 74.24 109.463 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 2.51 81.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 129.486 3.114 . . . . 72.41 113.995 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -125.68 157.38 35.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.767 -1.197 . . . . 65.1 107.767 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -70.07 157.61 37.22 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.494 -0.928 . . . . 71.33 108.494 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.51 47.36 0.02 OUTLIER Glycine 0 CA--C 1.52 0.366 0 CA-C-O 118.797 -1.002 . . . . 60.45 112.127 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.94 -133.46 0.19 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.762 -1.335 . . . . 74.42 109.762 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -119.0 153.92 52.98 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 123.98 0.912 . . . . 74.13 111.6 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.88 150.12 30.01 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.39 2.727 . . . . 72.53 109.841 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 m -134.28 160.83 41.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 123.988 0.915 . . . . 74.52 110.844 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.3 p -125.76 163.64 22.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.879 0.871 . . . . 74.22 110.034 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.7 m -49.61 -45.86 48.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.779 2.031 . . . . 73.11 111.593 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -62.41 -34.05 75.98 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.893 1.277 . . . . 71.43 112.614 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 94.5 mtp -65.12 -42.5 93.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.098 -1.075 . . . . 74.42 108.098 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 t -60.01 -55.34 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.458 0.703 . . . . 75.43 110.728 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -61.01 -37.67 83.34 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 119.538 -0.865 . . . . 75.41 112.059 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.0 m -60.18 -57.36 13.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 120.308 1.413 . . . . 75.31 109.525 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 t -54.97 -44.13 72.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-N 119.891 1.223 . . . . 74.31 108.438 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.6 tp60 -51.47 -50.92 58.89 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.197 0.908 . . . . 75.24 112.726 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -59.11 -44.73 92.0 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 122.837 0.455 . . . . 64.45 110.202 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.7 mt -77.71 -22.48 50.37 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.734 0.642 . . . . 74.14 112.734 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.445 ' HB1' ' CD2' ' A' ' 102' ' ' TYR . . . -130.89 75.07 79.23 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 126.374 1.87 . . . . 74.42 109.192 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.49 -18.05 54.05 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 123.492 2.795 . . . . 73.22 114.14 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.05 10.12 8.77 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.408 -0.808 . . . . 72.52 112.935 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.6 mt -112.74 155.81 23.9 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.171 0.896 . . . . 70.53 112.488 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.446 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 51.4 t-80 -80.63 145.46 58.55 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 108.626 -0.879 . . . . 75.54 108.626 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 28.9 Cg_endo -62.91 -30.53 77.17 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.228 2.619 . . . . 75.44 113.144 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.68 -39.16 37.49 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.026 -0.361 . . . . 71.52 110.026 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -59.46 -48.52 81.32 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 118.502 0.592 . . . . 72.54 109.452 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 67.9 mt -49.35 -58.74 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 N-CA-C 107.789 -1.189 . . . . 73.35 107.789 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.504 HH21 ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -47.3 -52.08 17.3 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.749 0.819 . . . . 75.34 112.18 179.198 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -65.43 -33.94 77.11 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.681 -1.262 . . . . 74.42 111.712 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 t -65.14 -46.12 82.21 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.204 -1.406 . . . . 54.43 107.204 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.4 -36.57 76.07 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.343 1.457 . . . . 75.32 109.095 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.504 ' CD ' HH21 ' A' ' 86' ' ' ARG . 48.5 mt-10 -70.13 -38.36 75.51 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 118.78 0.718 . . . . 71.11 111.65 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -75.78 -45.7 34.78 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.109 0.411 . . . . 71.4 112.109 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 79.6 p -74.25 -40.65 62.24 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.475 1.11 . . . . 75.31 111.044 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.98 -13.56 67.39 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 127.832 2.634 . . . . 74.43 114.226 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.8 m -143.64 148.4 35.75 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.88 1.84 . . . . 64.43 111.996 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.8 t -59.64 -48.42 87.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 126.096 1.759 . . . . 64.53 107.655 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -51.87 -47.98 64.25 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.611 1.565 . . . . 74.31 111.79 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -65.33 -43.47 90.84 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 108.257 -1.016 . . . . 75.2 108.257 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.5 m -59.26 -40.47 86.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.407 1.083 . . . . 74.35 111.638 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.9 t -74.64 -40.27 47.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 118.008 -0.996 . . . . 71.5 108.581 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -62.81 -35.2 79.13 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.016 1.726 . . . . 74.4 111.206 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -80.13 -40.69 26.92 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.203 -0.665 . . . . 73.35 109.203 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.445 ' CD2' ' HB1' ' A' ' 77' ' ' ALA . 7.6 t80 -58.74 -51.05 71.63 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.026 0.531 . . . . 74.53 110.242 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -65.48 -9.14 23.26 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 113.397 0.888 . . . . 75.34 113.397 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.09 -16.82 20.33 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.748 2.019 . . . . 73.4 109.141 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.0 26.59 21.48 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.664 1.126 . . . . 72.22 113.315 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -72.11 172.83 9.42 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.275 1.037 . . . . 62.2 113.294 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -81.85 147.59 29.27 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.401 1.481 . . . . 75.44 111.56 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -138.51 109.93 6.98 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.861 1.264 . . . . 73.51 109.873 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.1 m -91.9 165.78 13.05 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.214 1.406 . . . . 74.3 108.255 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -94.01 160.06 33.09 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 124.759 1.224 . . . . 74.14 111.708 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.11 164.01 29.32 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.357 3.371 . . . . 65.52 113.767 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.34 140.3 87.44 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.11 2.54 . . . . 75.1 111.152 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.85 -17.65 54.14 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 117.959 -1.467 . . . . 74.02 112.403 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -66.12 -51.9 53.6 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.348 1.574 . . . . 75.04 108.881 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 . . . . . 0 C--O 1.245 0.859 0 C-N-CA 125.475 1.51 . . . . 74.34 108.555 179.126 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.548 0 N-CA-C 109.248 -1.541 . . . . 74.02 109.248 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.64 161.89 37.22 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.573 1.949 . . . . 63.43 106.641 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 56.4 ttm -74.37 -79.45 0.09 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.377 -0.601 . . . . 75.03 109.377 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.16 -168.34 4.17 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.539 1.066 . . . . 73.34 113.82 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.48 169.98 21.29 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.502 2.802 . . . . 75.13 111.711 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.28 -5.49 12.36 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.038 1.335 . . . . 74.24 112.145 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 55.23 79.74 0.09 OUTLIER Glycine 0 CA--C 1.524 0.642 0 C-N-CA 126.177 1.846 . . . . 75.41 115.585 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.11 141.6 57.32 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.408 -0.96 . . . . 74.52 108.408 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.8 t -153.48 151.29 29.67 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.126 -1.064 . . . . 74.34 108.126 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -157.12 120.56 4.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.958 0.903 . . . . 75.22 108.771 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -75.84 -75.7 0.18 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 107.075 -1.454 . . . . 55.12 107.075 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.54 -178.81 7.62 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.638 1.575 . . . . 72.24 109.613 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.2 tp -169.73 163.45 9.91 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.022 2.129 . . . . 73.02 107.507 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -73.42 165.91 24.2 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 106.166 -1.791 . . . . 75.13 106.166 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -129.67 84.93 2.25 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 106.923 -1.51 . . . . 75.22 106.923 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.5 t -148.32 162.96 38.47 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.435 -1.321 . . . . 75.41 107.435 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.27 162.78 54.6 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.004 -1.238 . . . . 72.53 110.004 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -113.67 -178.23 3.33 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.381 1.872 . . . . 74.13 106.539 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.13 -35.8 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 108.159 -1.052 . . . . 75.02 108.159 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -74.31 169.92 16.66 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.993 1.317 . . . . 70.51 110.204 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.35 -165.47 27.53 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.403 1.002 . . . . 71.24 111.516 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.26 71.09 0.1 OUTLIER Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.337 0.97 . . . . 73.25 112.566 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -107.84 155.58 39.65 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.508 1.123 . . . . 71.03 108.798 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.28 142.64 30.58 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.217 2.612 . . . . 74.31 110.272 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.37 153.39 35.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 109.058 -0.719 . . . . 74.32 109.058 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -124.84 162.69 23.8 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 125.995 1.718 . . . . 64.32 108.06 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 m -56.23 -36.37 68.42 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.839 -0.538 . . . . 64.11 111.531 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.06 -33.84 65.37 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.357 1.063 . . . . 70.33 110.987 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.8 mtp -70.02 -41.89 73.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.684 -0.858 . . . . 73.32 108.684 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 t -61.03 -55.47 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.276 1.03 . . . . 61.41 110.51 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.63 -40.86 84.56 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 118.252 -0.88 . . . . 63.42 110.391 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 88.8 m -58.13 -60.97 2.92 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.372 0.987 . . . . 74.32 109.597 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.3 t -52.52 -47.66 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 119.384 0.993 . . . . 74.41 109.044 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -56.3 -45.23 80.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.11 0.868 . . . . 72.32 112.188 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -59.13 -39.32 81.95 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.187 0.995 . . . . 74.35 110.528 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.3 mt -88.81 -20.28 24.88 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.203 0.816 . . . . 75.2 113.203 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.89 75.35 79.68 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 127.304 2.242 . . . . 75.22 108.858 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.7 -17.84 52.85 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.438 2.092 . . . . 75.2 113.425 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.49 -17.23 56.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.536 0.607 . . . . 74.25 112.551 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 mt -80.85 155.74 26.44 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.85 0.833 . . . . 73.43 112.634 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.432 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 57.2 t-80 -75.56 144.07 76.73 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 124.44 1.096 . . . . 71.14 109.035 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 36.8 Cg_endo -65.8 -26.55 52.42 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.836 2.357 . . . . 74.04 113.704 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.02 -40.11 16.14 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.66 1.118 . . . . 72.42 111.892 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -60.45 -32.38 71.32 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 119.175 -0.44 . . . . 71.52 111.547 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 78.1 mt -55.24 -58.26 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 118.352 -0.832 . . . . 73.55 109.748 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.422 HH21 ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -49.59 -42.29 44.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.269 0.94 . . . . 74.42 112.685 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -63.9 -43.22 96.64 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.328 -0.857 . . . . 72.02 110.696 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 t -59.41 -51.27 70.63 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 108.393 -0.966 . . . . 73.41 108.393 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.4 mt -58.34 -35.65 72.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.066 0.947 . . . . 72.22 110.775 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' A' ' 86' ' ' ARG . 2.8 mt-10 -72.54 -30.28 64.32 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.823 1.192 . . . . 62.44 109.65 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -76.35 -46.71 26.29 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.343 0.52 . . . . 73.44 112.043 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.5 p -80.19 -39.69 28.73 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.668 1.187 . . . . 64.51 111.151 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.58 -6.17 66.17 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 127.24 2.352 . . . . 71.44 112.723 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.4 m -139.56 132.46 29.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.523 1.529 . . . . 64.23 110.323 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.8 -44.77 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 125.394 1.477 . . . . 73.22 109.622 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -52.83 -47.74 67.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.822 0.849 . . . . 75.42 110.454 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -62.45 -43.09 99.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.903 -0.777 . . . . 64.41 108.903 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.9 m -58.85 -35.98 73.82 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.742 0.817 . . . . 72.14 110.477 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.5 t -75.75 -41.52 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.763 0.825 . . . . 73.53 109.91 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -63.47 -33.71 76.16 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.703 1.601 . . . . 74.55 111.349 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -83.71 -40.43 18.89 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.135 0.574 . . . . 75.32 110.286 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -53.94 -55.2 29.24 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.758 0.823 . . . . 64.31 110.563 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -59.67 -14.8 15.39 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.878 1.271 . . . . 65.12 114.135 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -9.26 39.74 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.44 1.896 . . . . 74.53 109.374 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.44 28.75 54.87 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.659 -0.977 . . . . 73.54 110.659 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -69.45 -179.75 1.78 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.28 1.04 . . . . 73.52 112.393 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -83.36 134.11 34.92 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.356 1.462 . . . . 74.13 113.251 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -134.4 110.04 9.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.357 -0.979 . . . . 71.2 108.357 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.86 179.42 4.81 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.422 -0.584 . . . . 74.14 109.422 178.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -100.08 158.75 31.46 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.823 1.249 . . . . 70.31 111.136 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.15 164.09 36.2 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.211 2.607 . . . . 72.41 111.144 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.01 153.69 67.54 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.896 1.731 . . . . 54.4 107.815 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.1 -15.32 61.28 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 118.988 -0.895 . . . . 72.42 110.899 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -71.86 -44.39 63.88 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.126 0.963 . . . . 75.01 109.177 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 . . . . . 0 C--O 1.25 1.131 0 C-N-CA 124.587 1.155 . . . . 75.42 111.145 179.684 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.575 0 N-CA-C 110.234 -1.147 . . . . 74.35 110.234 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.42 155.41 40.5 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.319 -0.993 . . . . 74.42 108.319 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.9 ptp -126.37 173.02 9.66 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.003 0.921 . . . . 75.42 111.284 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.58 164.59 36.23 Favored Glycine 0 CA--C 1.536 1.365 0 N-CA-C 109.022 -1.631 . . . . 64.34 109.022 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.63 165.18 28.36 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.529 2.152 . . . . 70.51 111.936 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -111.84 -5.1 14.43 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.762 1.225 . . . . 75.04 110.868 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.37 172.07 18.62 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 124.501 1.048 . . . . 60.24 110.701 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.9 m -129.22 34.24 4.43 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.029 1.332 . . . . 75.43 111.181 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.29 146.06 50.85 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 104.135 -2.543 . . . . 75.04 104.135 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -148.58 168.73 22.0 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 118.737 0.699 . . . . 74.44 112.352 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -146.28 -13.51 0.46 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.79 1.636 . . . . 71.31 111.308 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.65 78.98 2.2 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.957 1.303 . . . . 73.24 111.054 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 tp -93.1 105.79 17.83 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.604 -0.685 . . . . 73.34 111.077 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.423 ' H ' ' HA2' ' A' ' 113' ' ' GLY . 2.8 mpt_? 50.15 35.85 11.08 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.892 1.677 . . . . 74.23 112.014 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -57.98 167.29 1.25 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.504 1.121 . . . . 74.44 111.421 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -75.17 135.27 41.09 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 107.142 -1.429 . . . . 75.34 107.142 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.05 -159.63 8.1 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 125.74 1.638 . . . . 62.13 110.329 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.95 75.18 1.68 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 117.417 0.608 . . . . 72.13 109.502 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -58.33 146.2 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.089 -1.448 . . . . 74.53 107.089 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.5 m120 60.59 6.45 1.11 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.426 1.49 . . . . 72.12 114.036 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.79 33.0 2.14 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.002 1.287 . . . . 71.11 111.613 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -148.88 -137.89 2.89 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 127.61 2.529 . . . . 73.3 107.163 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -129.58 148.87 71.15 Favored Pre-proline 0 C--N 1.321 -0.635 0 C-N-CA 125.623 1.569 . . . . 62.25 107.374 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.2 126.45 12.38 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.315 2.01 . . . . 53.33 108.547 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.3 m -126.8 157.98 37.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 121.75 0.786 . . . . 71.4 110.084 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 p -124.25 164.44 19.54 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.999 1.72 . . . . 72.43 109.911 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.3 m -54.7 -37.37 65.74 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.964 1.706 . . . . 75.32 111.4 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -59.21 -35.93 74.5 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.285 1.034 . . . . 74.52 111.349 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.0 mtp -68.31 -41.71 80.48 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.045 -1.034 . . . . 64.41 108.896 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.5 t -60.23 -54.89 28.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 C-N-CA 124.358 1.063 . . . . 72.53 110.94 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.17 -42.33 90.55 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.428 -0.796 . . . . 74.21 110.306 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.1 m -56.35 -61.07 2.65 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.871 1.214 . . . . 70.32 109.856 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 83.9 t -53.41 -46.87 59.08 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 CA-C-N 119.136 0.88 . . . . 63.45 109.535 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.99 -41.17 67.61 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.167 0.894 . . . . 63.32 113.184 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -65.65 -43.35 89.68 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.969 0.804 . . . . 73.03 109.25 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.57 -17.42 56.15 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.674 0.62 . . . . 74.42 112.674 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.89 74.8 56.66 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 126.982 2.113 . . . . 72.23 109.743 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.89 -16.11 36.89 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.576 2.184 . . . . 74.43 111.166 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.61 15.95 2.9 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.497 1.519 . . . . 73.33 112.016 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.0 mt -124.23 152.14 43.3 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.897 1.279 . . . . 70.34 109.134 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.407 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 51.2 t-80 -76.97 143.88 71.33 Favored Pre-proline 0 N--CA 1.45 -0.454 0 N-CA-C 107.858 -1.164 . . . . 72.43 107.858 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.407 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 38.0 Cg_endo -66.21 -18.95 56.69 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.898 2.398 . . . . 71.21 113.285 -179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -86.11 -38.51 17.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.455 0.702 . . . . 73.41 110.231 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -58.36 -47.87 82.42 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 122.679 0.392 . . . . 73.44 109.965 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 89.1 mt -48.93 -54.08 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.683 1.593 . . . . 75.1 111.053 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.44 HH21 ' CG ' ' A' ' 111' ' ' PRO . 1.7 tmm_? -50.43 -46.93 56.83 Favored 'General case' 0 C--O 1.228 -0.051 0 CA-C-N 118.707 0.685 . . . . 74.44 110.668 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -64.91 -37.71 88.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.768 0.258 . . . . 75.41 111.181 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 m -61.46 -47.25 86.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.975 -0.75 . . . . 61.4 108.975 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.4 mt -63.16 -35.25 79.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.892 1.277 . . . . 72.32 110.428 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -70.26 -33.25 71.38 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 118.666 0.666 . . . . 73.23 109.801 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -76.62 -55.64 5.33 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.482 0.713 . . . . 75.45 111.461 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.1 p -70.6 -40.91 72.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.957 1.703 . . . . 74.41 112.796 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.88 -6.1 83.97 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.616 2.055 . . . . 64.41 113.144 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.2 m -144.28 143.18 30.89 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 119.273 1.537 . . . . 75.12 111.474 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.6 t -63.04 -49.67 82.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 C-N-CA 125.945 1.698 . . . . 75.45 106.924 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.71 -46.79 64.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.367 1.067 . . . . 74.31 111.195 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -63.03 -45.42 92.4 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 108.29 -1.004 . . . . 75.23 108.29 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.5 m -56.52 -37.52 70.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.228 0.611 . . . . 75.21 111.017 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.6 t -76.06 -39.31 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 121.363 -0.836 . . . . 75.03 109.447 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -65.95 -32.82 74.53 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.695 1.198 . . . . 74.22 111.54 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -82.38 -38.78 23.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.367 -0.975 . . . . 75.21 108.367 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -55.33 -53.95 49.65 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.954 0.902 . . . . 75.43 110.282 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -59.36 -21.21 59.49 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.582 0.586 . . . . 75.14 112.582 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -16.41 49.92 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.946 1.298 . . . . 72.11 109.526 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.2 28.66 48.36 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.245 -1.542 . . . . 71.32 109.245 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -61.15 177.32 0.35 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.739 1.616 . . . . 73.02 112.073 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -77.56 138.52 39.21 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 120.806 -1.184 . . . . 73.21 109.029 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -134.57 108.66 8.2 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.014 -1.847 . . . . 75.45 106.014 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.4 m -91.1 177.07 6.37 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.503 0.721 . . . . 73.53 109.833 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -108.83 153.71 42.22 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 107.977 -1.12 . . . . 73.22 107.977 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.44 ' CG ' HH21 ' A' ' 86' ' ' ARG . 33.2 Cg_endo -71.11 163.28 39.74 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.505 2.136 . . . . 74.43 113.182 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.5 131.4 27.84 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.481 2.12 . . . . 75.24 107.003 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.423 ' HA2' ' H ' ' A' ' 54' ' ' ARG . . . 105.14 -9.7 46.64 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-O 117.738 -1.59 . . . . 71.44 112.097 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -86.79 -28.32 23.04 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.157 1.479 . . . . 73.24 109.49 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--O 1.255 1.354 0 N-CA-C 103.994 -2.595 . . . . 75.31 103.994 178.258 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.738 0 N-CA-C 110.522 -1.031 . . . . 74.23 110.522 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.68 -176.76 4.67 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.235 1.414 . . . . 73.14 108.598 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -136.99 172.8 12.47 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.19 1.396 . . . . 73.22 107.69 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.9 178.9 43.9 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.099 -1.2 . . . . 70.1 110.099 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.87 117.55 4.54 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.193 2.595 . . . . 63.41 109.579 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -67.19 104.97 1.58 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.929 -1.508 . . . . 72.35 106.929 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.08 -135.66 3.58 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 108.729 -1.748 . . . . 63.41 108.729 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 t -72.41 64.92 0.61 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.449 1.099 . . . . 70.25 111.427 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.408 ' C ' ' H ' ' A' ' 51' ' ' ASN . 15.1 t -66.48 -15.0 63.02 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.001 -1.062 . . . . 74.43 110.955 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -65.27 22.63 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.253 2.621 . . . . 71.22 116.625 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.408 ' H ' ' C ' ' A' ' 49' ' ' THR . 9.0 t30 -73.14 -50.73 21.07 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 123.711 0.805 . . . . 62.04 110.735 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.27 73.46 1.81 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.128 0.971 . . . . 75.43 112.057 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.2 mt -119.29 153.83 34.44 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.554 1.142 . . . . 72.04 112.705 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 56.3 13.39 1.24 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 118.082 2.623 . . . . 70.13 118.082 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -66.54 -29.78 69.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.82 1.191 . . . . 74.12 111.052 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.4 p -64.31 157.59 25.71 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.243 0.929 . . . . 74.32 109.326 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.73 170.93 14.27 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.955 1.264 . . . . 53.4 110.582 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.63 90.02 0.55 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.825 0.85 . . . . 74.51 112.13 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.86 157.33 3.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.687 -1.227 . . . . 71.32 107.687 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.1 m120 46.0 56.58 5.94 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.135 2.174 . . . . 73.14 112.539 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.73 -151.7 25.39 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.541 1.067 . . . . 63.51 112.702 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.61 58.08 0.09 OUTLIER Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.207 1.86 . . . . 73.34 111.849 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -72.01 141.72 84.45 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 118.042 0.921 . . . . 74.21 109.145 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.88 126.17 9.23 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 121.734 1.623 . . . . 71.43 108.198 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.6 m -111.94 170.15 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 120.814 -1.179 . . . . 72.33 109.807 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 p -125.37 157.0 37.86 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.691 1.596 . . . . 64.45 107.154 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 m -54.77 -38.89 67.79 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.533 1.133 . . . . 72.31 109.609 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -33.15 68.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.675 1.19 . . . . 72.15 112.445 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 93.0 mtp -68.5 -39.7 81.18 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.793 -1.192 . . . . 64.52 108.729 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 t -59.47 -53.78 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 124.86 1.264 . . . . 73.33 110.136 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -62.56 -41.82 99.16 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 117.209 -1.377 . . . . 73.45 110.845 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.3 m -54.58 -60.16 3.72 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 120.787 1.631 . . . . 73.21 108.93 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.0 t -53.32 -47.15 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 119.154 0.888 . . . . 63.22 110.674 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -57.21 -43.73 83.03 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.171 0.804 . . . . 74.0 113.171 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -59.14 -45.89 89.78 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.42 -0.956 . . . . 74.52 108.42 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.4 mt -71.47 -37.15 71.37 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.718 0.807 . . . . 74.31 111.879 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.82 80.99 11.46 Favored Pre-proline 0 C--O 1.241 0.642 0 C-N-CA 127.507 2.323 . . . . 72.11 112.043 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.37 -2.19 11.75 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 124.746 3.631 . . . . 71.45 112.306 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -90.26 -19.67 23.85 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.97 1.708 . . . . 74.01 110.584 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.8 mt -92.46 157.34 16.62 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.219 0.463 . . . . 73.22 112.146 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.413 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 41.7 t-80 -83.01 142.67 44.79 Favored Pre-proline 0 C--O 1.237 0.43 0 N-CA-C 106.229 -1.767 . . . . 75.14 106.229 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 20.1 Cg_endo -62.73 -28.98 76.74 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.751 2.3 . . . . 64.5 112.553 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -73.62 -41.61 62.59 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 122.112 -0.368 . . . . 70.3 111.466 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -61.24 -37.94 84.88 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.69 -0.631 . . . . 73.53 110.595 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 97.5 mt -53.42 -58.3 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.47 1.108 . . . . 72.12 109.41 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.26 -47.76 18.09 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.971 0.805 . . . . 74.44 111.524 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -64.54 -42.76 95.51 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.179 0.9 . . . . 75.23 111.252 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.4 t -60.09 -46.24 90.25 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.03 -1.1 . . . . 51.33 108.03 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.28 -39.36 79.06 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.813 0.845 . . . . 62.14 111.025 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -69.42 -35.21 75.5 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.458 0.647 . . . . 74.45 111.395 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -72.39 -56.06 6.06 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.402 0.681 . . . . 75.41 110.454 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.8 p -68.73 -41.23 79.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.302 1.441 . . . . 75.3 113.341 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.86 -4.79 84.47 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.018 1.771 . . . . 74.3 113.439 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.4 m -142.23 134.58 27.83 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.507 1.153 . . . . 55.0 111.634 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.2 t -59.04 -48.48 86.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.173 0 N-CA-C 106.16 -1.792 . . . . 75.14 106.16 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.77 -42.23 64.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.904 0.882 . . . . 74.41 111.239 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -64.45 -45.04 89.17 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.53 -0.915 . . . . 70.52 108.53 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 58.3 m -59.51 -36.69 76.56 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.805 0.842 . . . . 74.12 110.315 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 65.9 t -74.67 -36.74 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.388 0.675 . . . . 74.25 110.138 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -71.47 -36.07 71.05 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.389 1.476 . . . . 71.13 111.192 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -79.34 -33.54 42.95 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.709 -0.848 . . . . 72.0 108.709 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -58.2 -55.73 31.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 118.925 -0.559 . . . . 74.53 109.59 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.41 -25.06 65.64 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.249 -0.881 . . . . 71.31 111.953 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -81.88 -8.02 59.65 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.238 0.926 . . . . 74.42 109.641 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.69 34.22 59.88 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 118.551 -1.139 . . . . 72.43 110.406 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -69.88 176.61 3.57 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 118.326 1.063 . . . . 74.3 110.127 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -75.7 147.25 39.53 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.844 -1.16 . . . . 75.22 109.33 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -138.9 109.08 6.41 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.325 -1.361 . . . . 75.44 107.325 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.4 m -94.66 164.95 12.74 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 124.237 1.015 . . . . 73.33 109.118 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -91.59 160.08 37.34 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.59 1.156 . . . . 74.43 109.7 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.39 165.35 29.23 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.213 1.942 . . . . 64.04 112.101 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.93 152.91 80.66 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.704 1.603 . . . . 73.41 108.528 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.73 -6.43 39.94 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.39 -1.228 . . . . 64.44 113.577 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -77.49 -26.13 51.0 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.462 1.631 . . . . 73.22 110.547 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 116.964 -1.493 . . . . 75.43 109.841 179.789 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.782 0 CA-C-O 119.595 -0.558 . . . . 65.45 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.98 115.14 1.17 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.899 1.28 . . . . 64.33 111.879 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 31.1 mtt 51.34 17.11 0.47 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.881 1.673 . . . . 74.15 113.75 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -139.58 79.46 0.29 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 107.553 -2.219 . . . . 74.31 107.553 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -70.58 -179.25 3.14 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.17 1.914 . . . . 73.33 109.557 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.13 173.19 0.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.158 0.504 . . . . 75.23 110.625 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.96 48.58 0.86 Allowed Glycine 0 C--N 1.33 0.215 0 N-CA-C 109.234 -1.546 . . . . 72.44 109.234 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.6 t -79.65 100.03 7.65 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.346 -2.094 . . . . 75.22 105.346 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.1 t -61.14 -27.24 68.25 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.991 -0.744 . . . . 73.11 108.991 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 37.69 54.47 1.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.55 2.34 . . . . 72.13 111.377 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -65.17 171.96 3.38 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.183 0.993 . . . . 75.13 112.249 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.67 -176.72 4.26 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.651 2.38 . . . . 71.4 105.731 177.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.78 33.05 1.6 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.528 -0.733 . . . . 74.23 112.352 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -158.37 170.18 22.81 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.446 1.498 . . . . 74.14 109.517 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -133.13 104.52 6.55 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.396 -1.335 . . . . 74.45 107.396 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 m -76.67 -45.09 31.09 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.438 -0.949 . . . . 74.35 108.438 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.47 -177.07 17.89 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.748 -0.941 . . . . 71.54 110.748 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 65.3 mtt-85 -145.09 170.29 16.48 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 127.43 2.292 . . . . 74.42 106.203 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.7 t -111.15 -51.76 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.864 -1.532 . . . . 73.42 106.864 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -99.34 37.11 1.62 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.282 1.833 . . . . 74.22 110.361 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.02 -162.31 30.19 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.957 -1.257 . . . . 71.21 109.957 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.61 -110.22 0.06 OUTLIER Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.638 0.637 . . . . 73.11 111.978 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -129.63 154.87 80.97 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 118.39 1.095 . . . . 74.02 110.404 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.97 126.49 10.02 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.476 2.117 . . . . 63.45 109.3 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.3 m -125.13 162.52 27.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.932 0.893 . . . . 73.12 109.083 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p -120.34 172.89 7.48 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.687 1.995 . . . . 74.32 108.228 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.9 m -65.03 -40.23 94.52 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 121.423 -0.798 . . . . 72.42 110.304 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -38.38 62.91 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 124.402 1.081 . . . . 73.53 112.111 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.3 mtp -63.66 -41.52 98.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.385 -0.822 . . . . 74.14 109.413 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.93 -56.46 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 124.999 1.32 . . . . 74.44 110.464 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -59.69 -39.76 85.61 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.005 -0.998 . . . . 72.21 109.75 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 57.8 m -56.41 -60.42 3.55 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 120.356 1.435 . . . . 71.43 109.96 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.5 t -53.92 -45.5 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 119.374 0.988 . . . . 74.35 108.531 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -53.49 -43.15 68.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.717 1.144 . . . . 74.41 113.014 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -66.91 -35.33 79.77 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.715 0.406 . . . . 72.43 110.293 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 mt -88.22 -12.25 44.32 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.262 0.483 . . . . 74.0 112.278 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -143.78 76.77 15.37 Favored Pre-proline 0 C--O 1.241 0.607 0 C-N-CA 126.363 1.865 . . . . 60.52 108.85 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.5 -13.72 33.07 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.376 2.717 . . . . 73.13 112.405 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.6 -7.99 58.89 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.467 1.507 . . . . 75.13 112.395 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.2 mt -97.48 152.97 18.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.25 0.932 . . . . 74.04 112.005 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.43 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 58.0 t-80 -69.54 144.56 94.33 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.828 1.651 . . . . 74.52 109.394 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.43 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 41.0 Cg_endo -66.89 -24.94 45.64 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.85 2.367 . . . . 74.12 114.152 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.76 -41.33 14.21 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 120.054 1.297 . . . . 74.32 111.725 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -57.04 -35.8 69.73 Favored 'General case' 0 C--N 1.343 0.308 0 O-C-N 123.657 0.598 . . . . 74.2 110.478 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 66.8 mt -53.64 -58.16 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 118.485 -0.769 . . . . 73.41 110.035 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.72 -45.24 48.93 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.474 0.579 . . . . 73.11 111.815 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -63.32 -44.57 94.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.783 -0.573 . . . . 74.14 111.144 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 p -60.67 -44.4 96.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 118.567 -0.73 . . . . 73.3 109.998 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.4 mt -60.4 -37.07 79.66 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.82 0.848 . . . . 74.31 110.04 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.1 -33.55 74.74 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.296 0.498 . . . . 64.52 110.269 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -79.04 -42.24 26.93 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.258 1.023 . . . . 75.45 113.537 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -83.52 -34.6 25.25 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.713 1.605 . . . . 74.51 112.537 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.88 -11.12 63.09 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.418 1.961 . . . . 75.44 111.899 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 m -144.87 150.93 37.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.346 1.573 . . . . 71.41 112.106 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 78.1 t -62.63 -49.78 82.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 126.281 1.832 . . . . 71.45 107.97 178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' A' ' 97' ' ' GLU . 12.6 pt-20 -45.33 -53.24 8.76 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 128.092 2.557 . . . . 75.01 111.792 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.439 ' H ' ' HG2' ' A' ' 96' ' ' GLU . 13.1 tp10 -66.66 -41.59 87.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.638 -0.71 . . . . 75.4 109.43 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.9 m -59.26 -39.29 82.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.012 0.925 . . . . 74.45 110.463 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.8 t -74.39 -38.25 46.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 124.107 0.963 . . . . 75.32 109.924 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -68.07 -41.62 81.67 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.355 1.062 . . . . 71.34 110.495 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -74.12 -35.35 64.11 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.351 -0.843 . . . . 73.13 108.816 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -57.57 -57.33 13.15 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 118.539 -0.743 . . . . 75.3 109.457 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.29 -24.9 65.32 Favored 'General case' 0 C--N 1.339 0.118 0 O-C-N 123.575 0.547 . . . . 73.13 111.402 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -15.39 59.51 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 118.457 -0.782 . . . . 63.22 109.684 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.27 28.82 32.36 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 118.748 -1.029 . . . . 61.32 110.545 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.25 174.46 4.7 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.664 1.232 . . . . 73.51 109.02 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -86.13 147.74 26.01 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 120.587 -1.32 . . . . 65.42 108.776 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -139.1 109.72 6.63 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.632 -1.167 . . . . 75.43 109.694 -179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.9 m -82.12 170.71 15.18 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.382 1.073 . . . . 72.33 108.876 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -94.4 161.98 27.51 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 126.442 1.897 . . . . 73.11 110.848 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.53 158.46 57.6 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.619 2.213 . . . . 71.3 111.766 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.42 128.88 23.63 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.838 2.359 . . . . 72.2 110.612 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.61 -3.95 66.0 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 118.734 -1.037 . . . . 72.04 113.16 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -67.93 -31.18 70.76 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.416 1.608 . . . . 74.11 107.661 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 128.223 2.609 . . . . 71.35 106.835 179.227 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.644 0 N-CA-C 110.524 -1.031 . . . . 50.14 110.524 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.69 51.51 0.11 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.309 2.244 . . . . 75.32 113.191 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -59.81 -18.23 42.18 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.849 -1.157 . . . . 74.4 113.001 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.24 74.79 0.71 Allowed Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.35 -1.9 . . . . 72.42 108.35 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -82.5 10.88 3.39 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 124.086 3.19 . . . . 74.33 112.161 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -145.55 38.62 1.14 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 127.583 2.353 . . . . 74.24 108.101 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.46 -169.88 38.74 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-O 123.055 1.364 . . . . 62.33 112.784 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.9 m -126.99 167.05 16.42 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.983 2.113 . . . . 74.0 107.756 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.7 t -156.72 -30.3 0.09 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.775 0.43 . . . . 71.43 111.552 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -59.12 133.28 55.96 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.802 0.841 . . . . 75.2 109.532 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -87.49 -5.12 58.94 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.555 0.742 . . . . 73.15 112.581 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.64 104.73 3.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.628 -1.99 . . . . 73.14 105.628 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -152.65 179.88 8.21 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 118.287 0.494 . . . . 73.21 111.171 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -57.3 118.2 4.86 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.886 -1.154 . . . . 73.13 107.886 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -61.86 99.52 0.12 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 118.819 -0.61 . . . . 73.01 110.677 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 t -167.49 169.32 12.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.854 -1.536 . . . . 61.35 106.854 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.53 175.03 36.77 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.422 -0.671 . . . . 72.11 111.422 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.62 149.58 45.36 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.609 -1.626 . . . . 74.35 106.609 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 p -159.64 161.47 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.92 -0.771 . . . . 75.15 108.92 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -145.14 164.11 32.27 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.698 1.999 . . . . 73.5 106.405 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.65 17.67 78.57 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 116.042 1.177 . . . . 72.31 116.042 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.15 80.81 0.09 OUTLIER Glycine 0 C--N 1.334 0.464 0 CA-C-N 120.485 2.142 . . . . 61.41 111.497 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -128.99 142.45 45.17 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.944 0.898 . . . . 75.01 110.545 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.99 140.2 22.58 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.898 3.065 . . . . 73.14 107.868 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.37 150.07 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.318 -0.864 . . . . 73.23 111.326 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.4 p -107.08 169.8 8.34 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.885 1.674 . . . . 73.24 111.952 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.8 m -58.22 -40.03 80.62 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.391 -0.814 . . . . 75.25 109.667 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -35.12 70.31 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 118.81 0.732 . . . . 73.3 112.066 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 92.2 mtp -66.43 -42.84 87.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.216 -0.927 . . . . 62.42 109.171 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.38 -54.79 28.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 C-N-CA 124.625 1.17 . . . . 74.24 109.4 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -64.05 -35.75 81.75 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 118.127 -0.94 . . . . 62.3 111.78 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.4 m -57.59 -59.6 4.94 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.187 1.358 . . . . 72.24 109.037 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.4 t -55.91 -45.92 80.11 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 CA-C-O 117.749 -1.12 . . . . 74.03 109.225 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -54.27 -44.8 72.19 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 120.457 1.48 . . . . 74.22 112.771 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -61.07 -44.93 96.64 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.234 -1.024 . . . . 74.33 108.234 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.7 mt -76.34 -28.93 57.06 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.1 0.778 . . . . 72.53 113.1 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.31 78.4 71.44 Favored Pre-proline 0 C--O 1.242 0.666 0 C-N-CA 127.737 2.415 . . . . 73.42 110.153 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.43 -1.1 10.89 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.89 3.727 . . . . 74.44 113.309 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -95.71 2.8 54.16 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.331 1.453 . . . . 74.14 112.021 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.0 mt -108.43 156.22 19.7 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.68 1.192 . . . . 73.35 109.556 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.461 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 54.5 t-80 -79.49 147.53 68.14 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 107.539 -1.282 . . . . 74.34 107.539 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.461 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 37.7 Cg_endo -65.14 -22.88 61.0 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.873 2.382 . . . . 74.35 113.417 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.51 -37.08 28.42 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.567 -0.708 . . . . 71.22 110.12 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -58.54 -37.02 74.81 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 109.885 -0.413 . . . . 75.1 109.885 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.2 mt -57.41 -60.8 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 117.471 -1.252 . . . . 75.55 109.813 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.45 -50.19 5.21 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.517 1.053 . . . . 75.05 110.918 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -63.2 -47.32 83.05 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.612 0.72 . . . . 75.45 111.998 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 m -57.1 -50.79 71.68 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.383 0.673 . . . . 75.2 109.23 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.0 mt -57.92 -39.83 78.93 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.3 1.04 . . . . 73.1 111.136 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -65.63 -32.0 73.33 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 122.478 0.311 . . . . 75.44 110.546 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -80.16 -51.32 9.11 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.646 -0.693 . . . . 61.32 111.094 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -71.41 -40.97 70.14 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.07 1.348 . . . . 65.31 113.145 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.52 -17.55 58.83 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.677 2.084 . . . . 73.45 113.102 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 t -143.33 147.87 35.39 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.426 1.613 . . . . 75.15 108.984 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 31.1 t -59.8 -46.13 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 127.32 2.248 . . . . 75.31 109.27 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -47.62 -48.57 28.44 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.381 1.472 . . . . 64.53 110.48 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -67.84 -42.38 81.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.625 -0.509 . . . . 74.31 109.625 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.2 m -58.25 -36.64 73.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.066 0.547 . . . . 72.24 110.896 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 78.8 t -75.95 -38.71 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.402 1.081 . . . . 70.32 109.614 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -66.61 -38.7 87.52 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.03 1.332 . . . . 74.53 110.37 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -76.94 -37.52 55.16 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 121.057 -1.027 . . . . 73.43 108.649 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -56.29 -53.55 55.95 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.194 0.598 . . . . 74.24 109.743 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.79 -22.94 65.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 119.345 -0.36 . . . . 64.51 111.955 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -82.37 -10.15 59.18 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.796 0.726 . . . . 75.31 109.718 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.32 37.22 42.46 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.018 -1.233 . . . . 74.2 110.018 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.76 -171.72 0.43 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 117.645 0.723 . . . . 75.42 110.734 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -90.34 139.51 30.59 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 120.346 -1.471 . . . . 64.22 110.388 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -128.89 108.76 10.69 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.358 -1.349 . . . . 74.11 107.358 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.9 m -89.74 172.4 8.95 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.802 1.641 . . . . 75.21 110.349 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -107.49 152.87 41.52 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 125.747 1.619 . . . . 74.22 108.423 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.19 170.11 19.89 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 123.706 2.937 . . . . 73.43 112.874 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.01 152.52 82.1 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 N-CA-C 107.003 -1.96 . . . . 75.21 107.003 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.08 -18.96 13.86 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 118.045 -1.419 . . . . 72.02 112.495 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -72.42 -54.75 8.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 119.536 1.668 . . . . 73.25 107.316 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 C--O 1.253 1.264 0 N-CA-C 106.266 -1.753 . . . . 75.13 106.266 179.508 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.74 0 N-CA-C 109.106 -1.598 . . . . 73.33 109.106 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.03 156.63 46.52 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.296 1.438 . . . . 72.31 107.19 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 24.8 mmt -130.25 160.92 32.41 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.613 1.165 . . . . 75.51 108.459 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.65 82.03 0.2 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 105.711 -2.955 . . . . 60.23 105.711 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.21 162.34 38.85 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.021 1.814 . . . . 65.41 111.143 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -86.41 164.17 17.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.603 0.761 . . . . 73.14 109.212 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.64 -87.45 0.34 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 106.438 -2.665 . . . . 55.01 106.438 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.6 m -148.71 176.35 10.43 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.792 1.637 . . . . 75.54 107.994 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 t -57.77 132.13 52.39 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.382 -0.824 . . . . 75.31 109.61 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -130.0 146.9 51.7 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.573 -1.269 . . . . 73.23 107.573 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -87.42 60.24 5.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.05 -1.463 . . . . 75.34 107.05 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.05 172.0 1.99 Allowed 'General case' 0 C--O 1.237 0.447 0 O-C-N 121.6 -0.687 . . . . 75.2 110.564 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -148.37 38.02 0.86 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.924 0.89 . . . . 75.22 110.534 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.9 ttt-85 -131.39 28.48 4.67 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.843 0.857 . . . . 64.33 113.214 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 60.49 40.09 17.48 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.627 1.103 . . . . 75.24 108.449 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.8 p -129.06 15.61 6.25 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.524 1.93 . . . . 74.31 112.397 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -134.71 169.48 23.16 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.219 -1.152 . . . . 63.41 110.219 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -67.35 -0.26 3.46 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 116.228 1.936 . . . . 72.45 116.228 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.02 73.74 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 123.031 1.396 . . . . 75.5 110.794 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.05 126.99 47.78 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 103.757 -2.682 . . . . 71.52 103.757 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.44 60.24 0.49 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-N 119.054 0.843 . . . . 72.14 112.363 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.52 108.05 0.2 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-N 117.981 0.891 . . . . 74.15 111.68 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -130.92 155.96 80.74 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 126.851 2.06 . . . . 74.31 108.304 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.31 126.08 9.53 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.933 1.756 . . . . 71.03 109.084 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.2 m -126.48 161.16 33.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 O-C-N 121.306 -0.871 . . . . 74.24 109.836 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 p -125.09 164.18 20.78 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.96 2.104 . . . . 75.13 109.813 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.0 m -59.17 -39.39 82.36 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.757 0.708 . . . . 72.51 110.744 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.3 -33.66 67.9 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.398 0.679 . . . . 74.12 111.983 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.8 mtp -65.72 -46.84 77.44 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 120.638 -1.289 . . . . 73.11 107.696 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.7 t -50.77 -58.66 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.499 0 C-N-CA 126.703 2.001 . . . . 72.43 109.853 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -59.73 -37.18 78.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 118.283 -0.865 . . . . 73.42 110.559 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -54.82 -60.69 3.01 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 120.272 1.396 . . . . 72.41 109.071 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.8 t -54.91 -51.89 48.63 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-O 118.06 -0.972 . . . . 74.23 108.847 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.41 -42.89 54.41 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.044 0.838 . . . . 74.25 113.05 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -65.21 -40.1 93.69 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 118.961 0.801 . . . . 73.13 109.289 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.5 mt -82.98 -16.24 48.0 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.083 0.772 . . . . 62.32 113.083 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.37 72.36 65.35 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 129.208 3.003 . . . . 73.04 109.528 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.82 -12.38 30.8 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.225 1.95 . . . . 70.13 112.486 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -84.25 13.23 5.46 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.383 1.473 . . . . 74.31 112.618 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.1 mt -121.12 158.78 27.18 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.504 1.122 . . . . 72.22 110.663 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -81.86 141.91 48.14 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 107.7 -1.222 . . . . 75.22 107.7 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -63.64 -26.35 69.05 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.654 2.236 . . . . 75.34 112.813 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.37 -39.5 53.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.748 -0.595 . . . . 64.22 111.942 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -60.25 -45.58 92.78 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.83 -0.433 . . . . 72.54 109.83 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 95.2 mt -47.53 -55.58 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 126.272 1.829 . . . . 62.41 111.03 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.419 HH21 ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -49.71 -45.69 49.33 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.911 0.778 . . . . 74.24 111.447 178.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -64.1 -40.07 95.43 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.773 -1.204 . . . . 74.41 110.955 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.0 m -57.82 -55.77 30.6 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.042 1.337 . . . . 74.51 108.256 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.11 -39.99 76.15 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.704 1.202 . . . . 73.32 111.238 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.419 ' CD ' HH21 ' A' ' 86' ' ' ARG . 52.6 mt-10 -65.19 -33.93 77.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 119.553 -0.859 . . . . 72.02 110.698 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -76.96 -48.68 17.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 118.395 -0.812 . . . . 73.21 111.969 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.4 p -73.49 -40.98 63.67 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.627 1.571 . . . . 75.22 111.5 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.14 -4.14 84.12 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 127.363 2.411 . . . . 73.31 111.853 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 m -144.54 140.76 29.02 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.798 1.239 . . . . 61.43 110.704 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.22 -45.83 95.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 124.909 1.284 . . . . 64.4 108.439 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -47.8 -48.67 30.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.345 1.858 . . . . 75.14 111.362 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.72 -47.63 77.59 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 108.591 -0.892 . . . . 72.25 108.591 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 m -54.83 -41.7 71.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.548 1.539 . . . . 75.11 112.044 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.4 t -76.76 -34.5 23.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 121.503 -0.748 . . . . 74.23 110.364 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -73.19 -32.06 64.58 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.985 0.914 . . . . 71.14 111.197 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -82.19 -34.93 28.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.42 -0.956 . . . . 73.21 108.42 177.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -55.92 -55.1 36.67 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 108.298 -1.001 . . . . 71.43 108.298 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.32 -24.78 66.68 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 119.335 -0.364 . . . . 74.23 111.219 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -17.23 60.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.153 0.888 . . . . 73.43 108.962 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.83 35.12 28.96 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.318 -1.513 . . . . 71.11 109.318 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -70.61 -173.0 0.69 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.129 0.964 . . . . 75.33 110.047 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -89.71 144.48 25.95 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 119.523 -1.986 . . . . 75.02 108.529 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -136.69 109.44 7.54 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.242 -1.344 . . . . 63.44 108.895 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.63 173.44 8.05 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.179 1.392 . . . . 73.22 110.932 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -103.8 158.75 31.23 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.096 1.758 . . . . 72.31 109.074 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.0 161.88 40.61 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.485 2.123 . . . . 70.51 112.867 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -67.9 136.05 37.18 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.067 1.845 . . . . 75.33 109.688 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.34 -2.55 71.2 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.488 1.042 . . . . 73.34 111.388 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -75.52 -35.98 60.62 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.03 0.915 . . . . 71.53 109.838 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 . . . . . 0 C--O 1.248 1.007 0 C-N-CA 125.847 1.659 . . . . 71.54 110.982 -179.26 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.302 0 N-CA-C 109.342 -1.503 . . . . 65.14 109.342 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.22 176.3 10.99 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.551 1.54 . . . . 65.41 107.614 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -156.55 -179.96 8.69 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.869 2.068 . . . . 74.22 107.428 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.18 172.84 29.98 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 110.565 -1.014 . . . . 74.34 110.565 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.85 138.98 35.46 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.046 2.498 . . . . 73.35 110.352 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -87.73 -7.17 57.7 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.019 0.748 . . . . 73.35 113.019 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.21 -167.05 54.72 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 110.758 -0.937 . . . . 53.42 110.758 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 p -160.52 171.99 17.99 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.124 1.37 . . . . 74.41 108.783 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.8 t -161.02 177.71 10.07 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.509 1.524 . . . . 74.14 107.368 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -146.0 176.35 9.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.138 1.775 . . . . 74.44 109.236 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -129.19 174.4 9.61 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.304 1.842 . . . . 73.33 110.741 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.52 72.04 0.33 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 127.723 2.409 . . . . 51.34 112.538 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -142.36 131.46 23.25 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.138 -0.69 . . . . 65.51 109.138 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -156.36 146.54 21.36 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.79 -1.189 . . . . 74.01 107.79 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -62.83 -17.61 61.61 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.542 1.137 . . . . 73.0 112.853 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.8 t -66.37 172.28 4.13 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.522 1.055 . . . . 75.43 109.826 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.62 -45.24 0.06 OUTLIER Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.107 -1.197 . . . . 54.32 110.107 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.5 52.87 7.33 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.387 1.075 . . . . 74.43 111.172 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.42 168.68 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.129 -0.941 . . . . 75.43 110.678 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -63.76 147.21 52.3 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.48 -0.782 . . . . 75.11 110.173 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.47 2.47 0.26 Allowed Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.08 -0.844 . . . . 70.42 114.057 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.8 84.46 0.09 OUTLIER Glycine 0 C--N 1.335 0.493 0 CA-C-N 119.595 1.697 . . . . 71.34 109.48 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -96.08 144.98 28.76 Favored Pre-proline 0 N--CA 1.447 -0.592 0 N-CA-C 107.529 -1.285 . . . . 75.04 107.529 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.84 148.84 36.62 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.819 2.346 . . . . 75.02 109.268 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.35 165.64 30.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-O 121.619 0.723 . . . . 75.22 110.201 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 p -125.36 157.24 37.26 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.152 1.781 . . . . 74.31 107.387 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.9 m -54.31 -36.7 64.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.354 0.662 . . . . 73.13 111.149 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -32.59 68.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.144 0.978 . . . . 74.21 111.948 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.7 mtp -69.9 -40.75 75.44 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.036 -1.098 . . . . 75.12 108.036 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 t -59.94 -58.02 9.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.971 1.308 . . . . 73.54 109.349 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -60.01 -36.05 76.37 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 118.341 -0.837 . . . . 64.14 110.877 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.2 m -58.03 -61.72 2.34 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.958 1.254 . . . . 71.12 108.863 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.3 t -54.9 -43.98 70.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 119.481 1.037 . . . . 72.25 109.39 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -55.2 -48.07 74.38 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 119.655 1.116 . . . . 74.05 111.525 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -59.03 -39.68 82.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.12 0.968 . . . . 65.23 110.324 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.2 mt -86.63 -19.75 28.86 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.109 0.781 . . . . 75.22 113.109 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.05 77.91 74.79 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.847 2.059 . . . . 64.04 109.032 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.49 -0.24 6.41 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.294 3.33 . . . . 64.41 113.602 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.45 20.51 18.12 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.287 1.035 . . . . 72.32 111.749 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.2 mt -123.37 154.5 38.89 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.905 1.282 . . . . 74.52 110.039 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.467 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 48.5 t-80 -86.27 147.72 45.47 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-O 118.495 -0.764 . . . . 71.54 109.104 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 40.3 Cg_endo -63.57 -32.1 70.17 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.315 2.677 . . . . 53.31 112.752 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.82 -44.65 48.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.884 -0.413 . . . . 75.35 109.884 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -59.27 -39.81 84.08 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 108.834 -0.802 . . . . 74.3 108.834 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 48.5 mt -57.52 -59.59 3.11 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 N-CA-C 107.84 -1.171 . . . . 75.5 107.84 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.08 -47.06 34.33 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.395 0.998 . . . . 72.4 111.596 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -62.01 -44.25 97.13 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.205 0.911 . . . . 73.51 111.494 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m -63.75 -41.29 98.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.414 -0.587 . . . . 75.34 109.414 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -61.62 -37.77 85.18 Favored 'General case' 0 C--O 1.225 -0.236 0 O-C-N 121.229 -0.92 . . . . 72.34 110.38 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -69.9 -37.31 75.96 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 117.992 0.36 . . . . 70.24 111.078 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -74.77 -53.06 9.88 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 122.171 -0.331 . . . . 73.43 111.137 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.7 p -67.14 -41.88 85.35 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.068 0.947 . . . . 73.42 111.486 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.28 -15.0 64.19 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 128.335 2.874 . . . . 73.24 113.806 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.0 m -139.55 148.5 42.66 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.636 1.718 . . . . 71.23 111.763 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.1 t -61.7 -50.99 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 106.342 -1.725 . . . . 72.12 106.342 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -50.86 -48.36 60.12 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.756 1.622 . . . . 71.22 111.101 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.71 -42.56 99.71 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.729 1.211 . . . . 73.42 109.179 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.5 m -65.0 -38.45 90.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.857 1.263 . . . . 53.23 110.807 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.9 t -73.35 -39.81 55.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 121.339 -0.85 . . . . 74.3 109.66 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -65.19 -38.97 92.18 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.474 1.51 . . . . 63.51 111.015 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -77.58 -35.53 52.92 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.592 -0.892 . . . . 71.41 108.592 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -57.17 -57.59 11.91 Favored 'General case' 0 C--O 1.233 0.226 0 O-C-N 121.255 -0.903 . . . . 74.31 110.53 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.47 -23.95 59.06 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.429 0.692 . . . . 75.1 111.179 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -12.11 59.24 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 117.845 -1.074 . . . . 65.21 111.464 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.06 22.7 51.67 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.786 -1.008 . . . . 73.51 112.317 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -67.25 172.99 4.19 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.635 1.217 . . . . 72.35 111.101 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -77.19 144.59 38.21 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.822 1.649 . . . . 74.02 109.985 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -137.43 110.11 7.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.895 1.278 . . . . 73.4 107.804 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -92.97 167.99 11.44 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.503 -1.226 . . . . 71.2 110.169 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -94.21 158.81 35.32 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 124.671 1.189 . . . . 74.22 109.221 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -67.99 166.99 22.87 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.473 2.782 . . . . 72.5 114.483 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.42 143.92 89.61 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.025 1.817 . . . . 64.43 108.147 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.12 3.45 88.33 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.094 -0.837 . . . . 61.32 112.915 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -84.36 -41.37 16.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.425 1.613 . . . . 74.33 110.981 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 C--O 1.254 1.302 0 CA-C-O 118.013 -0.994 . . . . 72.24 110.86 -179.091 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.169 0 N-CA-C 108.79 -1.724 . . . . 70.44 108.79 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.91 168.79 16.15 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.189 0.995 . . . . 72.25 109.031 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 55.1 mtt -147.91 169.52 19.65 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.952 2.101 . . . . 75.2 106.452 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.04 -82.06 0.35 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.239 -1.544 . . . . 71.34 109.239 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.82 127.81 22.56 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.77 2.314 . . . . 73.12 109.922 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -159.43 169.88 22.98 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.849 2.06 . . . . 74.3 107.141 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.34 -171.37 28.77 Favored Glycine 0 CA--C 1.521 0.469 0 N-CA-C 110.365 -1.094 . . . . 73.25 110.365 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.2 m -159.03 165.3 34.31 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.491 1.916 . . . . 55.41 107.094 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.0 t -160.75 -171.12 2.98 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.532 -1.285 . . . . 54.35 107.532 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -129.73 179.12 6.02 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.84 2.056 . . . . 75.43 107.369 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -136.25 156.15 49.08 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.343 -0.848 . . . . 72.55 109.45 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.98 92.93 3.02 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.052 -1.832 . . . . 73.31 106.052 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -134.71 159.54 40.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.843 1.657 . . . . 74.43 108.04 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? 51.15 19.54 0.73 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.633 1.173 . . . . 74.4 113.653 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -60.84 -66.58 0.51 Allowed 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 120.27 1.396 . . . . 73.31 110.766 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -61.89 148.12 44.52 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.19 -0.671 . . . . 73.52 109.19 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.69 157.65 20.51 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 123.648 0.642 . . . . 74.14 111.972 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.4 135.7 33.4 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.127 -1.064 . . . . 74.32 108.127 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.44 153.9 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 107.322 -1.362 . . . . 72.22 107.322 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -90.2 167.82 12.41 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.156 -0.965 . . . . 72.11 110.283 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.53 163.76 33.76 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 126.195 1.855 . . . . 63.32 111.638 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.18 36.24 81.44 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.808 -0.517 . . . . 75.3 111.808 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -82.82 149.02 58.95 Favored Pre-proline 0 CA--C 1.539 0.529 0 O-C-N 121.849 -0.795 . . . . 74.21 109.389 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.3 125.93 7.36 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.568 2.845 . . . . 74.1 110.321 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.92 143.61 29.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 122.747 1.26 . . . . 75.0 111.731 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p -112.04 161.02 16.93 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.579 1.951 . . . . 70.33 109.197 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.7 m -52.67 -38.96 61.38 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.82 1.248 . . . . 71.12 111.917 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -59.47 -31.67 69.54 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.483 1.113 . . . . 71.22 112.317 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 91.6 mtp -71.91 -45.87 59.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.455 -0.943 . . . . 75.21 108.455 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.4 t -59.98 -52.33 62.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.893 0.877 . . . . 73.42 109.883 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.53 -41.1 98.49 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-O 117.342 -1.313 . . . . 74.34 110.315 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.3 m -52.6 -60.38 3.32 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 120.602 1.546 . . . . 70.44 108.71 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.8 t -55.27 -50.53 64.02 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 CA-C-O 118.052 -0.975 . . . . 74.05 109.206 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -54.72 -44.41 73.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 119.716 1.144 . . . . 74.44 113.838 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -59.88 -43.77 94.57 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.931 1.293 . . . . 64.03 108.64 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.9 mt -81.59 -26.82 34.62 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.049 0.759 . . . . 75.31 113.049 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.93 73.39 35.27 Favored Pre-proline 0 N--CA 1.447 -0.578 0 C-N-CA 127.655 2.382 . . . . 72.53 111.498 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.81 -3.6 13.48 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.522 2.148 . . . . 71.13 111.312 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.11 18.68 10.35 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 128.345 2.658 . . . . 74.52 111.094 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.7 mt -133.83 154.82 50.75 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.351 1.461 . . . . 74.05 111.001 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -80.53 142.32 53.58 Favored Pre-proline 0 C--O 1.236 0.383 0 N-CA-C 107.416 -1.327 . . . . 72.32 107.416 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.33 -29.02 46.63 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.642 2.228 . . . . 64.41 113.022 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -75.43 -41.1 56.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.756 -0.59 . . . . 74.12 110.809 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -59.73 -41.92 91.97 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.634 -0.506 . . . . 74.41 109.634 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 86.3 mt -51.36 -58.51 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 124.066 0.946 . . . . 72.13 108.984 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.05 -47.01 11.76 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.548 0.739 . . . . 74.13 111.619 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -64.53 -48.49 74.89 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.419 0.628 . . . . 73.24 111.489 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.4 m -56.92 -47.7 79.99 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 108.173 -1.047 . . . . 70.25 108.173 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.52 -39.74 77.23 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 124.584 1.154 . . . . 74.45 111.095 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -66.94 -31.64 72.35 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.168 0.44 . . . . 75.42 110.784 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -77.66 -50.59 12.15 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.209 0.448 . . . . 72.35 112.209 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -74.58 -41.94 59.62 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.952 1.701 . . . . 63.45 112.794 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.14 -12.02 69.11 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 126.671 2.081 . . . . 71.4 116.507 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 t -145.32 123.1 11.9 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 121.467 2.633 . . . . 72.42 111.706 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.6 t -41.88 -41.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 120.366 1.439 . . . . 72.05 112.819 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -49.89 -43.61 49.55 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 124.694 1.246 . . . . 73.54 111.67 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -67.63 -42.83 81.68 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 121.092 -1.005 . . . . 75.13 109.489 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.8 m -60.45 -39.01 86.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.131 0.572 . . . . 75.15 111.114 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.36 -39.1 76.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.21 -0.663 . . . . 74.21 109.21 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -66.83 -41.02 88.13 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.622 0.769 . . . . 75.33 111.456 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -75.4 -35.36 61.04 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 121.104 -0.997 . . . . 73.43 109.619 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -57.4 -57.4 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.212 -0.93 . . . . 73.05 110.009 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.69 -22.16 56.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.951 0.722 . . . . 74.4 112.951 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -5.19 56.53 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.796 0.725 . . . . 64.24 110.953 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.15 36.81 50.28 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 118.519 0.6 . . . . 73.43 112.322 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -69.98 -178.46 1.6 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.211 1.006 . . . . 72.04 111.013 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.75 131.26 35.21 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.698 -1.251 . . . . 74.11 110.257 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -130.92 109.89 10.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.462 -1.681 . . . . 74.52 106.462 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.3 m -96.79 168.6 10.4 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.707 0.803 . . . . 60.45 110.084 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -91.23 155.91 44.16 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 107.326 -1.361 . . . . 73.44 107.326 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.57 168.51 21.1 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.759 2.306 . . . . 74.01 113.722 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.33 149.44 91.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.37 2.047 . . . . 73.02 108.921 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.12 -12.07 13.7 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.564 -1.131 . . . . 62.34 113.207 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -68.96 -24.41 64.25 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.715 1.758 . . . . 74.3 109.381 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 130.757 3.623 . . . . 71.15 105.212 178.183 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.264 0 N-CA-C 109.267 -1.533 . . . . 73.04 109.267 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.39 120.47 13.38 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.232 1.016 . . . . 73.02 108.347 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.1 tpp -164.63 153.35 12.73 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 105.951 -1.87 . . . . 71.4 105.951 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.48 175.27 34.26 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.615 -0.994 . . . . 71.4 110.615 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.15 166.71 28.92 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.06 2.507 . . . . 72.22 110.702 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.84 -172.31 2.54 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.421 1.888 . . . . 75.32 109.752 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 49' ' ' THR . . . 171.54 -178.13 44.02 Favored Glycine 0 CA--C 1.525 0.66 0 O-C-N 121.432 -0.792 . . . . 63.32 111.266 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.7 m -67.86 21.16 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 128.274 2.63 . . . . 75.01 113.951 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.404 ' H ' ' C ' ' A' ' 47' ' ' GLY . 8.9 t 157.91 170.84 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 1 C-N-CA 132.681 4.392 . . . . 74.34 105.231 -179.317 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -111.27 156.69 21.12 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 105.748 -1.945 . . . . 74.23 105.748 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -60.69 158.77 12.0 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.47 -0.567 . . . . 72.14 109.47 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -128.51 174.2 9.57 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.933 1.293 . . . . 71.11 110.946 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.6 tt -64.01 144.5 57.05 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.377 -1.342 . . . . 75.32 107.377 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.1 ttp85 -44.13 151.76 0.22 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.74 1.616 . . . . 73.32 111.818 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 55.77 46.56 22.15 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.606 1.162 . . . . 74.12 108.54 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 t -56.7 -30.42 63.43 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.108 1.363 . . . . 72.53 111.71 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.8 -173.77 40.93 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 119.309 0.959 . . . . 72.34 111.982 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -76.8 176.56 8.38 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.164 0.985 . . . . 74.44 110.898 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 p -144.19 156.51 15.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.629 -1.989 . . . . 75.21 105.629 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -65.68 152.02 45.19 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 122.921 0.488 . . . . 75.33 110.42 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.53 98.94 2.5 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 115.174 0.83 . . . . 72.14 115.174 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.92 82.7 0.66 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 124.917 1.246 . . . . 55.13 111.71 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -111.12 160.36 29.31 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 125.51 1.524 . . . . 64.31 110.605 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.79 143.7 21.26 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.884 3.056 . . . . 73.21 111.127 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.0 m -134.17 167.07 27.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-O 122.026 0.917 . . . . 73.21 109.943 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 p -125.36 161.15 27.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.119 1.768 . . . . 72.42 107.802 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.5 m -57.96 -38.01 75.22 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.124 0.57 . . . . 74.42 110.588 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -35.9 69.45 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 119.336 -0.364 . . . . 73.34 111.63 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.0 mtp -64.29 -38.88 92.62 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.044 0.838 . . . . 75.32 109.537 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.0 t -63.96 -57.41 11.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 124.552 1.141 . . . . 75.22 110.767 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -59.62 -40.23 86.86 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 118.444 -0.789 . . . . 75.23 110.73 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.2 m -58.62 -58.21 9.58 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.321 1.419 . . . . 71.53 108.57 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.0 t -52.52 -50.23 40.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 CA-C-O 118.249 -0.881 . . . . 74.22 109.469 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -54.08 -45.58 71.81 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.928 0.785 . . . . 71.35 111.375 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -59.49 -36.84 76.8 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.016 0.926 . . . . 74.1 110.688 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.0 mt -89.84 -14.92 33.35 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.034 0.753 . . . . 74.32 113.034 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.27 71.12 61.21 Favored Pre-proline 0 N--CA 1.448 -0.551 0 C-N-CA 126.927 2.091 . . . . 75.31 110.993 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.67 -15.41 49.19 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.286 1.99 . . . . 74.13 112.408 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.32 -13.86 59.85 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.072 1.349 . . . . 72.13 112.003 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.2 mt -92.05 156.48 17.37 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.315 0.961 . . . . 71.14 111.376 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.444 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 58.3 t-80 -80.42 146.11 60.94 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 106.474 -1.676 . . . . 74.13 106.474 178.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 36.4 Cg_endo -65.45 -30.16 52.97 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.092 1.862 . . . . 63.33 113.187 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.58 -34.92 46.51 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 121.77 -0.582 . . . . 74.42 110.863 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -64.47 -35.92 82.49 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.677 -0.86 . . . . 74.12 108.677 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.3 mt -54.94 -60.82 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 C-N-CA 124.583 1.153 . . . . 73.55 109.749 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -46.63 -48.64 19.85 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 118.558 0.617 . . . . 74.22 110.8 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -59.37 -44.9 92.67 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.812 0.815 . . . . 73.33 112.391 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 p -62.79 -43.4 98.89 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.165 -0.47 . . . . 73.22 110.01 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 52.0 mt -60.35 -38.47 83.91 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.816 -0.552 . . . . 72.22 111.678 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -70.57 -28.44 64.9 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.169 0.587 . . . . 73.2 109.834 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -85.33 -43.59 13.56 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 114.453 1.279 . . . . 75.4 114.453 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.7 p -79.57 -41.44 27.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.692 1.197 . . . . 73.41 111.411 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.51 0.86 88.02 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 118.745 -1.031 . . . . 64.25 112.379 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.27 129.5 18.74 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.393 1.477 . . . . 71.55 111.297 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 44.3 t -61.56 -46.51 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 105.551 -2.018 . . . . 74.45 105.551 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -55.89 -45.66 78.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.48 -0.772 . . . . 74.33 110.013 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -59.03 -43.8 91.67 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.74 0.7 . . . . 72.34 110.029 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.1 m -61.17 -42.41 98.51 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.297 1.839 . . . . 74.14 110.872 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.0 t -74.63 -38.27 45.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 121.672 -0.642 . . . . 75.02 109.966 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -66.62 -37.49 84.97 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 125.191 1.396 . . . . 72.02 111.056 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -77.81 -39.58 43.31 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.861 -1.162 . . . . 74.0 107.861 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -55.23 -52.07 64.56 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 120.564 -1.335 . . . . 73.44 111.908 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.5 -16.13 33.97 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 113.662 0.986 . . . . 74.22 113.662 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.58 -11.66 42.05 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.813 0.845 . . . . 73.3 109.569 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.72 28.45 32.14 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 118.707 -1.052 . . . . 63.42 111.375 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -64.33 -178.22 0.35 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.859 1.263 . . . . 74.23 112.987 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -87.08 137.91 31.94 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 126.449 1.9 . . . . 64.23 111.549 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -141.85 109.91 5.87 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.19 1.396 . . . . 75.21 111.93 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.2 m -83.11 176.95 8.82 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.843 0.857 . . . . 73.25 110.369 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -105.54 157.17 35.13 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 127.366 2.266 . . . . 74.22 107.308 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.42 154.5 73.64 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.125 1.883 . . . . 75.13 112.197 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -60.98 123.34 12.73 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 124.457 3.438 . . . . 72.44 110.703 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.8 -4.22 53.13 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 124.842 1.21 . . . . 62.52 111.811 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -78.22 -34.37 49.32 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.83 1.815 . . . . 64.14 109.606 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 . . . . . 0 C--O 1.247 0.937 0 C-N-CA 125.452 1.501 . . . . 74.42 111.542 -178.526 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.732 0 N-CA-C 109.965 -1.254 . . . . 74.22 109.965 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.88 -178.39 7.19 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 128.027 2.531 . . . . 71.33 105.793 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.1 ttt -152.77 -48.45 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 118.822 0.737 . . . . 63.15 111.17 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.1 62.29 5.32 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.437 -1.201 . . . . 72.04 110.58 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.25 132.94 31.12 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 123.189 2.592 . . . . 64.35 111.995 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -76.48 162.97 27.39 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.193 -1.04 . . . . 74.23 108.193 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 167.68 68.47 0.03 OUTLIER Glycine 0 C--O 1.228 -0.245 0 N-CA-C 108.638 -1.785 . . . . 74.03 108.638 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.6 t -152.25 -172.19 4.16 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.503 1.921 . . . . 62.34 106.608 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.9 p -79.75 113.49 17.94 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.447 -1.316 . . . . 72.15 107.447 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -64.63 121.73 15.16 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.877 -1.157 . . . . 72.44 107.877 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.17 98.35 2.13 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 117.114 2.265 . . . . 70.44 117.114 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.37 133.44 48.72 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.071 -1.455 . . . . 54.22 107.071 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -136.08 0.38 2.6 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.11 1.364 . . . . 75.53 113.344 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -117.76 105.6 12.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.54 1.536 . . . . 75.5 110.34 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.51 157.36 34.47 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.539 1.536 . . . . 75.01 109.682 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.5 p -121.07 -92.22 0.54 Allowed 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.163 -1.421 . . . . 74.42 107.163 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.31 -54.38 0.36 Allowed Glycine 0 C--N 1.335 0.485 0 CA-C-N 118.886 0.766 . . . . 62.35 113.576 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -71.49 179.74 2.86 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 117.677 0.739 . . . . 75.11 109.322 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.3 p -121.59 -27.09 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.758 0.823 . . . . 73.54 112.858 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 53.97 -13.99 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 130.608 3.563 . . . . 71.33 117.766 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.23 114.59 0.64 Allowed Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 104.387 -3.485 . . . . 71.34 104.387 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -152.69 98.44 0.18 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 109.623 -1.391 . . . . 74.04 109.623 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -114.86 156.95 44.38 Favored Pre-proline 0 C--N 1.321 -0.664 0 C-N-CA 126.274 1.83 . . . . 74.43 107.291 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.28 142.44 27.05 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 121.99 1.793 . . . . 60.31 108.96 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.12 160.89 40.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.187 0.995 . . . . 71.23 108.323 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -124.62 159.11 31.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.296 -1.742 . . . . 65.14 106.296 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -59.73 -30.02 68.54 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 120.961 -1.087 . . . . 74.25 112.543 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -33.57 68.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.465 1.029 . . . . 74.41 111.047 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.1 mtp -66.96 -43.37 83.28 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.229 -0.919 . . . . 75.25 108.61 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 t -57.1 -56.36 15.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 125.184 1.394 . . . . 74.54 110.827 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -59.09 -38.57 79.81 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 117.704 -1.141 . . . . 72.51 109.464 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.4 m -56.59 -58.97 5.77 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 120.278 1.399 . . . . 74.11 110.393 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.9 t -53.55 -45.77 59.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-N 119.384 0.993 . . . . 74.54 109.037 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.07 -50.14 67.43 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.209 0.913 . . . . 71.32 112.687 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -58.85 -40.87 85.54 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.693 0.797 . . . . 65.34 110.98 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.9 mt -83.9 -22.54 31.55 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.663 0.616 . . . . 73.21 112.663 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.17 72.54 81.35 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 127.104 2.162 . . . . 71.11 109.826 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.54 -6.26 18.06 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.007 3.138 . . . . 63.44 113.964 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.6 4.89 50.04 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.82 -1.175 . . . . 71.12 111.016 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.3 mt -109.93 161.02 15.89 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 120.678 -1.264 . . . . 70.02 110.419 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -81.89 144.9 52.45 Favored Pre-proline 0 N--CA 1.453 -0.317 0 C-N-CA 124.604 1.162 . . . . 72.31 108.551 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.6 -25.32 24.85 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.009 2.473 . . . . 74.13 113.634 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.65 -39.17 32.04 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.665 0.666 . . . . 75.45 110.328 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -57.29 -44.2 83.84 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.034 0.534 . . . . 75.13 110.629 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 59.9 mt -47.56 -54.75 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 C-N-CA 125.04 1.336 . . . . 72.25 112.471 -177.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.43 -46.34 37.49 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.34 0.518 . . . . 75.21 111.475 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -65.29 -42.74 92.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.633 -0.667 . . . . 74.04 111.263 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 m -60.0 -47.01 87.6 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 122.922 0.489 . . . . 74.33 109.721 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.41 -37.41 85.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.826 0.85 . . . . 72.12 110.697 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -69.92 -34.31 73.32 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.594 0.633 . . . . 74.22 110.38 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -74.87 -46.99 32.53 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.575 0.75 . . . . 61.33 112.485 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.9 p -77.77 -41.03 38.87 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.321 1.049 . . . . 71.41 111.49 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.92 -14.01 64.43 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 127.413 2.435 . . . . 72.13 112.588 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.2 m -144.09 150.08 37.57 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 120.115 1.957 . . . . 45.52 112.658 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.68 -50.97 73.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 126.275 1.83 . . . . 74.02 107.148 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -49.99 -46.76 52.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.151 1.38 . . . . 73.33 109.987 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -65.07 -46.57 80.6 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.374 0.67 . . . . 75.25 109.936 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 89.0 m -59.05 -37.07 76.14 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.873 1.269 . . . . 75.45 111.729 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.2 t -77.55 -36.72 23.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 123.62 0.768 . . . . 74.12 109.583 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -66.16 -35.33 80.2 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 125.151 1.38 . . . . 72.1 110.873 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -81.4 -36.12 29.89 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.94 -1.1 . . . . 75.32 108.608 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -56.67 -55.36 35.05 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.614 -0.679 . . . . 74.33 110.366 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -59.87 -19.97 54.41 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.34 0.867 . . . . 74.13 113.34 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -13.22 41.43 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.105 0.562 . . . . 74.45 110.426 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.25 20.98 39.86 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 118.921 -0.933 . . . . 64.4 113.469 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -63.71 174.35 1.42 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.442 1.097 . . . . 74.53 111.221 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -83.12 141.54 31.9 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.673 1.189 . . . . 75.35 111.712 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -128.58 109.91 11.78 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.268 1.827 . . . . 74.11 108.433 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.2 m -93.78 173.9 7.45 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.205 1.002 . . . . 61.11 111.404 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -105.03 156.62 35.8 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.963 1.305 . . . . 74.22 108.873 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.65 158.59 56.47 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.75 2.3 . . . . 75.21 114.488 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.39 116.82 4.7 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 105.769 -2.435 . . . . 75.4 105.769 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.25 -17.62 7.47 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-O 117.683 -1.621 . . . . 75.2 111.83 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -66.09 -27.75 68.3 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.577 1.189 . . . . 74.5 111.803 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 . . . . . 0 C--O 1.248 1.018 0 N-CA-C 105.167 -2.16 . . . . 74.43 105.167 178.363 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.542 0 N-CA-C 110.737 -0.945 . . . . 71.45 110.737 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.14 171.38 13.67 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.195 -0.669 . . . . 74.43 109.195 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 21.1 ptp -130.25 -5.21 4.35 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.24 1.016 . . . . 74.53 111.564 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.33 -175.19 46.96 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.158 0.885 . . . . 61.53 111.437 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.61 166.41 17.8 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.828 2.352 . . . . 72.32 111.6 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -126.97 169.82 12.93 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 126.03 1.732 . . . . 72.44 109.992 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.36 -127.68 2.66 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 108.553 -1.819 . . . . 74.24 108.553 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.19 87.45 3.05 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.937 -1.134 . . . . 64.44 107.937 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.3 p -71.33 112.48 7.49 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.666 -1.235 . . . . 72.41 107.666 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -130.53 157.04 43.76 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.232 -0.917 . . . . 74.42 108.72 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -158.25 162.29 37.81 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.329 1.052 . . . . 74.45 110.1 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.96 101.08 0.35 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.869 1.268 . . . . 73.14 110.522 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.4 tp -150.31 173.14 14.32 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.451 0.7 . . . . 75.15 109.26 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -82.15 -34.05 29.3 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.753 0.649 . . . . 74.24 112.753 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -72.37 154.72 40.77 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 107.209 -1.404 . . . . 75.35 107.209 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.5 p -141.63 17.48 2.18 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.256 0.622 . . . . 73.11 112.061 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.94 -76.24 0.31 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 107.266 -2.334 . . . . 72.33 107.266 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.69 165.72 33.5 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.736 0.814 . . . . 73.41 108.82 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.9 t -131.58 96.95 2.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 104.157 -2.534 . . . . 73.23 104.157 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -140.13 -171.93 3.3 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.608 2.363 . . . . 71.13 107.457 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.01 -86.97 1.82 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.693 1.139 . . . . 62.54 110.827 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.66 -100.69 0.17 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.561 -1.016 . . . . 74.41 110.561 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -105.64 159.57 29.1 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 127.032 2.133 . . . . 64.21 110.409 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.67 133.89 16.12 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.701 2.934 . . . . 75.21 108.905 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 m -134.85 152.6 33.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.644 0.778 . . . . 65.42 109.942 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.35 164.04 21.26 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.706 1.203 . . . . 72.12 110.488 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -45.54 -47.46 14.34 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.154 2.181 . . . . 72.31 112.313 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -57.53 -34.59 69.29 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.715 0.806 . . . . 62.32 112.761 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 84.4 mtp -67.93 -39.78 83.43 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.968 -0.753 . . . . 74.53 108.968 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 t -58.88 -57.41 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.037 1.335 . . . . 71.2 110.485 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -58.6 -42.08 87.28 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-O 117.989 -1.005 . . . . 73.34 110.02 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -55.78 -60.13 3.89 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 120.057 1.299 . . . . 74.45 109.841 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.0 t -51.67 -49.49 34.65 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-O 118.836 -0.602 . . . . 75.55 109.969 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -51.26 -48.16 62.24 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.516 0.726 . . . . 73.43 112.211 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -59.49 -43.41 93.33 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.506 -0.553 . . . . 73.22 109.506 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mt -80.41 -13.07 59.44 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.972 0.73 . . . . 73.11 112.972 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.14 69.86 34.54 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.993 2.117 . . . . 71.33 110.861 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.28 -2.86 9.76 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.164 2.576 . . . . 72.53 113.254 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -86.69 -10.88 52.77 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.629 1.572 . . . . 64.04 110.465 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.69 158.52 15.46 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.494 -0.754 . . . . 75.23 112.277 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -81.93 147.14 57.38 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.971 -1.122 . . . . 74.11 107.971 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.94 -29.97 67.13 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.392 2.061 . . . . 72.42 112.837 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.28 -39.43 28.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.946 -0.471 . . . . 65.3 112.173 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -60.66 -41.42 94.98 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.62 -0.511 . . . . 65.54 109.62 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.1 mt -51.86 -59.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.556 0.742 . . . . 73.51 109.09 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.95 -44.75 30.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.425 0.69 . . . . 74.33 111.388 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -65.92 -43.42 88.18 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.145 -0.972 . . . . 72.44 112.817 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -66.99 -37.65 84.61 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.346 -0.983 . . . . 63.05 108.346 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.4 mt -61.25 -38.19 85.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.547 -1.279 . . . . 75.13 107.547 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -67.58 -34.44 77.03 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.949 0.795 . . . . 75.12 109.676 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -71.74 -51.85 20.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 119.008 -0.52 . . . . 71.4 112.364 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.9 p -74.77 -40.99 60.87 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.497 1.519 . . . . 64.41 112.708 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.66 -4.14 86.18 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.624 1.107 . . . . 71.42 111.447 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -144.48 135.03 24.67 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.806 1.803 . . . . 71.15 111.836 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.2 t -55.12 -52.43 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.9 1.68 . . . . 74.25 108.631 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -47.55 -47.45 28.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 126.571 1.949 . . . . 74.23 111.574 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -65.21 -44.65 87.65 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.17 -0.678 . . . . 74.42 109.17 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -56.92 -43.01 80.98 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.827 1.251 . . . . 72.35 111.319 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.0 t -73.89 -36.1 44.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 120.717 -1.239 . . . . 71.42 109.519 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -65.78 -45.09 83.76 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.584 1.154 . . . . 74.25 110.383 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -69.06 -36.43 77.64 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.748 -1.22 . . . . 75.13 108.681 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -58.25 -57.22 13.86 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.68 -0.489 . . . . 63.43 109.68 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.15 -23.3 63.8 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.912 -0.566 . . . . 74.42 111.927 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 ptm85 -82.83 -12.07 57.73 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.408 1.004 . . . . 73.24 110.598 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.11 22.91 39.76 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 125.83 1.681 . . . . 45.35 113.65 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.4 169.08 14.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.856 1.328 . . . . 70.44 110.742 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -80.32 146.85 31.37 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.698 0.999 . . . . 70.42 113.698 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -130.32 109.92 11.13 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.011 1.324 . . . . 73.24 107.826 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.7 m -87.66 176.54 7.38 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.213 -1.358 . . . . 64.11 108.802 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -108.27 156.18 38.94 Favored Pre-proline 0 N--CA 1.467 0.379 0 C-N-CA 124.462 1.105 . . . . 74.41 109.193 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.62 157.24 59.28 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.76 2.307 . . . . 74.12 112.661 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.7 149.82 88.32 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.748 1.632 . . . . 71.14 108.604 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.08 -16.41 59.67 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.575 -1.125 . . . . 65.44 111.733 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -77.9 -43.49 29.91 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.132 1.466 . . . . 71.14 108.708 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 C--O 1.246 0.871 0 CA-C-O 117.481 -1.247 . . . . 73.44 109.277 178.411 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.423 0 N-CA-C 109.812 -1.315 . . . . 71.31 109.812 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.33 75.06 9.27 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.463 -1.31 . . . . 63.12 107.463 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 81.4 mmm -58.55 -41.6 85.95 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.735 1.614 . . . . 74.23 110.643 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.49 71.23 0.94 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.912 -0.938 . . . . 72.34 111.474 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -70.74 -177.31 2.12 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.319 2.679 . . . . 71.32 111.246 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -87.97 -170.25 2.91 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.715 1.206 . . . . 74.22 108.421 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.17 -66.98 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 106.862 -2.495 . . . . 71.15 106.862 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -138.49 -170.87 2.92 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 126.459 1.904 . . . . 44.23 106.873 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.1 p -100.13 160.22 14.5 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 105.667 -1.975 . . . . 71.41 105.667 178.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -138.98 73.92 1.45 Allowed 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.261 -1.385 . . . . 64.34 107.261 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -93.06 146.73 23.42 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.046 -1.094 . . . . 74.2 108.046 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.36 160.04 42.99 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.958 1.303 . . . . 75.34 108.873 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -102.5 -5.53 23.91 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.784 1.031 . . . . 74.12 113.784 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -135.84 134.94 39.38 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.049 -1.032 . . . . 74.0 110.573 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.08 179.36 6.3 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.698 1.999 . . . . 72.24 109.779 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.6 p -128.75 99.5 5.35 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.964 1.706 . . . . 73.1 108.532 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.27 76.49 0.16 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 126.465 1.983 . . . . 64.33 111.803 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.89 132.4 11.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 115.609 1.707 . . . . 75.52 115.609 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.11 176.77 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 126.786 2.035 . . . . 71.53 110.009 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -139.62 -178.34 5.36 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.16 1.384 . . . . 74.13 109.859 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.1 -87.29 0.06 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 110.352 -1.099 . . . . 74.23 110.352 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -93.76 -148.54 23.89 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-O 122.8 1.222 . . . . 54.34 111.099 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -114.15 152.11 45.57 Favored Pre-proline 0 C--N 1.322 -0.594 0 C-N-CA 127.227 2.211 . . . . 71.12 110.088 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.53 126.78 9.23 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.736 2.957 . . . . 61.43 109.12 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 m -122.83 162.16 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.156 0.583 . . . . 73.4 109.65 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.9 p -124.17 167.65 13.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.453 1.101 . . . . 71.42 110.178 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.62 -43.46 72.27 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.6 1.16 . . . . 64.25 111.296 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -32.8 67.19 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 125.528 1.531 . . . . 71.22 111.655 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 93.5 mtp -67.07 -45.31 77.71 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.462 -0.94 . . . . 70.12 108.462 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 t -57.58 -57.24 11.09 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 CA-C-O 119.061 -0.495 . . . . 73.0 110.477 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -57.64 -39.93 78.11 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 117.638 -1.172 . . . . 75.54 111.138 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.8 m -56.34 -61.81 2.15 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.222 1.374 . . . . 74.42 108.29 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.6 t -57.26 -45.1 84.86 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 CA-C-N 119.16 0.891 . . . . 75.52 110.055 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.66 -39.03 67.65 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.451 1.478 . . . . 71.45 113.757 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -69.61 -44.6 70.38 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.103 -1.073 . . . . 65.04 108.103 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 37.6 mt -71.45 -28.4 63.93 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.054 -0.521 . . . . 64.5 111.207 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.13 75.76 67.65 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 128.997 2.919 . . . . 74.24 111.001 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.61 -4.92 16.2 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.431 2.087 . . . . 63.22 111.148 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -91.19 5.57 48.55 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.939 1.695 . . . . 74.31 112.417 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.3 mt -118.41 162.79 17.74 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.81 1.244 . . . . 72.11 110.817 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.424 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 49.7 t-80 -87.85 146.22 38.37 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 107.386 -1.338 . . . . 75.2 107.386 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 33.7 Cg_endo -64.29 -23.76 65.58 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.667 2.245 . . . . 74.45 112.123 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -78.13 -43.58 28.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 121.327 -0.858 . . . . 74.11 112.385 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -58.35 -45.51 88.03 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.777 -0.823 . . . . 74.25 108.777 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 63.8 mt -51.89 -59.07 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.369 1.068 . . . . 73.51 108.491 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.474 HH21 ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -47.33 -47.37 25.78 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.402 1.001 . . . . 75.42 112.161 179.509 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -65.85 -38.01 87.71 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 122.77 1.271 . . . . 74.53 111.675 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.5 t -62.48 -50.32 71.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.556 -1.276 . . . . 63.15 107.556 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.3 mt -57.91 -35.97 71.79 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 126.117 1.767 . . . . 75.4 109.333 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.474 ' CD ' HH21 ' A' ' 86' ' ' ARG . 36.2 mt-10 -67.86 -36.82 80.96 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.521 1.055 . . . . 74.3 109.526 179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -76.87 -53.15 8.26 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.232 0.469 . . . . 65.51 111.992 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.7 p -67.01 -40.96 87.41 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.87 1.268 . . . . 61.02 110.897 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.92 -6.12 81.96 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.867 2.175 . . . . 75.42 113.247 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.5 m -144.28 143.75 31.16 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.163 1.482 . . . . 62.54 110.82 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 42.2 t -61.96 -47.81 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 C-N-CA 126.184 1.793 . . . . 75.35 108.171 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -50.38 -48.51 55.78 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.204 1.002 . . . . 53.21 111.717 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -63.78 -39.13 93.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.132 0.492 . . . . 73.31 109.939 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.5 m -63.77 -37.31 86.91 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.287 1.435 . . . . 75.42 110.498 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.09 -41.43 59.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.904 -1.147 . . . . 64.22 107.904 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -63.3 -35.17 79.48 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.76 1.224 . . . . 75.33 111.693 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -81.01 -39.0 26.55 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.254 -0.647 . . . . 74.42 109.254 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -56.55 -52.67 63.89 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.53 -0.731 . . . . 75.25 111.333 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.94 -19.97 61.55 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.744 0.646 . . . . 75.0 112.744 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -86.6 -12.57 48.21 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.167 -0.92 . . . . 74.35 110.334 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.81 37.06 13.98 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 108.63 -1.788 . . . . 74.24 108.63 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -74.84 172.36 12.34 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.582 -0.952 . . . . 72.42 110.999 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -78.99 131.61 36.37 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.423 1.089 . . . . 63.22 110.147 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -129.1 109.95 11.61 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.502 -1.296 . . . . 74.52 107.502 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.4 m -97.2 177.57 5.53 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.178 1.391 . . . . 73.12 108.954 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -104.84 158.64 31.58 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.42 1.088 . . . . 75.42 110.41 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.36 162.65 41.71 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.479 2.12 . . . . 52.43 112.97 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.68 133.98 45.03 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.383 2.055 . . . . 75.1 109.109 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.03 -11.52 64.02 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 118.811 -0.994 . . . . 73.03 112.641 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -77.17 -28.46 54.08 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.642 1.721 . . . . 74.45 111.717 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.021 -0.99 . . . . 64.31 110.334 -179.166 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.846 0 N-CA-C 108.845 -1.702 . . . . 71.15 108.845 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -31.4 72.55 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.647 1.224 . . . . 75.42 111.077 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 71.0 mtm -92.99 83.47 4.72 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.328 -2.471 . . . . 72.21 104.328 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.88 62.53 0.05 OUTLIER Glycine 0 CA--C 1.529 0.921 0 CA-C-O 118.71 -1.05 . . . . 74.05 112.814 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.93 161.12 44.42 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.363 2.042 . . . . 71.23 109.596 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -60.04 155.4 17.02 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.94 0.896 . . . . 73.32 111.379 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.26 -170.06 21.35 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 124.574 1.083 . . . . 73.31 111.154 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.0 m -148.29 179.48 7.74 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.373 1.469 . . . . 74.14 109.476 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 p -126.58 4.59 6.82 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.067 2.147 . . . . 72.52 111.707 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.0 77.76 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.004 2.521 . . . . 74.32 113.186 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -77.86 -21.16 51.82 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.418 1.487 . . . . 65.33 109.875 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -96.36 127.91 42.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.51 -1.663 . . . . 71.43 106.51 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.7 mt -135.64 165.55 25.29 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.791 0.836 . . . . 74.53 110.14 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -42.71 118.47 1.24 Allowed 'General case' 0 C--O 1.24 0.566 0 C-N-CA 126.483 1.913 . . . . 73.52 111.321 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -89.28 104.32 16.88 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 104.868 -2.271 . . . . 72.24 104.868 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -127.69 139.21 52.85 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.954 -1.498 . . . . 74.53 106.954 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.27 173.79 14.45 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.282 -0.727 . . . . 74.32 111.282 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -119.78 178.6 4.53 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.941 1.296 . . . . 74.11 109.82 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 m -115.44 46.85 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.034 1.734 . . . . 72.42 108.144 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -81.44 71.38 8.44 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.598 -0.89 . . . . 74.25 108.598 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.51 -14.12 1.96 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.699 1.142 . . . . 73.43 114.915 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.98 -156.27 13.29 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 107.568 -2.213 . . . . 70.45 107.568 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -104.55 153.71 38.97 Favored Pre-proline 0 C--N 1.319 -0.727 0 C-N-CA 129.044 2.938 . . . . 73.12 108.193 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.86 140.51 32.02 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.038 1.825 . . . . 74.43 110.245 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.81 165.65 30.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 124.725 1.21 . . . . 74.23 108.707 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -124.31 163.62 21.3 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.541 1.537 . . . . 74.21 108.247 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -55.06 -42.35 72.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.406 1.482 . . . . 73.43 110.409 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -33.31 65.44 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.345 1.458 . . . . 73.4 112.197 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.4 mtp -68.55 -41.42 79.81 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.939 1.245 . . . . 75.5 109.518 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.8 t -59.23 -54.86 28.49 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 123.988 0.915 . . . . 65.5 109.286 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -60.08 -37.17 79.13 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 117.562 -1.209 . . . . 64.43 110.59 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.5 m -55.15 -64.41 0.85 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.748 1.613 . . . . 71.11 108.555 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.7 t -53.52 -45.94 59.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.375 0 CA-C-O 118.184 -0.912 . . . . 72.03 110.313 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.1 tp60 -55.69 -48.63 74.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.342 0.974 . . . . 75.24 112.29 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -57.97 -43.33 86.44 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.164 0.586 . . . . 71.31 109.446 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 17.9 mt -80.54 -18.6 47.92 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.868 0.692 . . . . 64.23 112.868 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.14 76.44 77.94 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 127.428 2.291 . . . . 74.34 110.118 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.05 -15.1 42.67 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 121.695 1.596 . . . . 65.51 111.698 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.66 -22.74 53.61 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.324 2.249 . . . . 72.44 112.907 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.5 mt -85.14 156.36 21.07 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 114.008 1.114 . . . . 73.43 114.008 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.403 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 60.1 t-80 -74.54 145.66 82.56 Favored Pre-proline 0 C--O 1.236 0.355 0 N-CA-C 107.192 -1.41 . . . . 73.41 107.192 178.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.403 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 55.7 Cg_endo -66.52 -26.8 46.77 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.482 2.121 . . . . 74.13 114.096 -178.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.33 -37.66 18.25 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.888 -0.412 . . . . 75.35 109.888 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -58.99 -36.97 75.79 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 109.499 -0.556 . . . . 75.12 109.499 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.0 mt -58.07 -61.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.092 -1.077 . . . . 63.42 108.092 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -48.27 -50.22 30.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 119.155 0.888 . . . . 75.42 110.876 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -60.39 -41.39 93.74 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 119.401 -0.92 . . . . 74.45 112.513 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.6 t -63.01 -48.66 77.86 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 107.495 -1.298 . . . . 74.32 107.495 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.8 mt -55.09 -42.12 72.45 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.514 1.126 . . . . 74.33 111.176 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -66.67 -33.74 76.32 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.848 0.459 . . . . 73.23 110.177 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -82.21 -46.25 13.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 118.139 -0.934 . . . . 73.42 113.366 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p -73.21 -41.3 63.95 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.361 1.464 . . . . 75.11 110.487 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.86 5.64 89.94 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 126.387 1.946 . . . . 51.03 112.357 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.8 m -142.63 127.13 17.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.913 1.357 . . . . 62.3 110.182 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.0 t -58.95 -49.35 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 105.846 -1.909 . . . . 73.24 105.846 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -52.99 -42.82 65.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.77 0.828 . . . . 74.35 111.209 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -61.14 -43.64 98.57 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 108.779 -0.823 . . . . 72.11 108.779 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.3 m -61.59 -40.38 94.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.849 2.06 . . . . 71.42 111.48 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.3 -37.07 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 O-C-N 121.29 -0.881 . . . . 74.32 108.856 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.36 -31.82 70.49 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 125.077 1.351 . . . . 72.4 112.225 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -83.12 -36.04 25.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.219 -1.03 . . . . 75.22 108.219 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -58.16 -56.09 26.48 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.39 -0.819 . . . . 75.35 109.805 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -57.5 -25.55 59.96 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-O 119.071 -0.49 . . . . 74.11 111.32 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.76 -8.2 59.3 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.742 0.701 . . . . 74.31 111.682 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.17 28.54 53.31 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 123.804 0.716 . . . . 54.42 111.704 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -67.14 173.81 3.56 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 117.207 0.503 . . . . 74.15 112.092 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -80.98 140.57 35.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.895 1.278 . . . . 72.13 109.253 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -132.63 109.42 9.72 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.813 -1.551 . . . . 75.14 106.813 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 t -83.79 169.95 14.66 Favored 'General case' 0 C--O 1.24 0.574 0 O-C-N 121.638 -0.664 . . . . 63.42 110.386 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -100.38 150.26 36.78 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 125.069 1.347 . . . . 74.5 108.321 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.48 166.99 19.95 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.922 3.081 . . . . 73.21 113.97 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -63.32 139.91 74.12 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.064 2.509 . . . . 71.11 111.804 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.2 -0.29 68.34 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 118.457 -1.191 . . . . 53.24 113.878 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -70.58 -34.43 72.18 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.289 1.545 . . . . 74.14 109.027 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 126.857 2.063 . . . . 63.13 111.866 179.642 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.597 0 N-CA-C 110.79 -0.924 . . . . 60.22 110.79 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 45.15 68.28 0.59 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.346 2.258 . . . . 65.42 111.793 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -114.76 0.32 13.79 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.56 0.744 . . . . 75.33 112.997 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 42.76 62.96 2.09 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.2 1.857 . . . . 60.3 115.292 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.03 -26.57 83.27 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.238 2.625 . . . . 74.53 114.043 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -82.28 -15.33 53.37 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.778 -0.576 . . . . 74.22 110.086 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.8 -103.12 1.3 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 106.357 -2.697 . . . . 64.15 106.357 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.1 t -116.54 161.21 19.49 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.413 1.085 . . . . 75.51 109.718 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.6 p -77.78 51.18 0.91 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.827 2.051 . . . . 74.22 109.844 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -73.31 159.53 33.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.57 1.948 . . . . 75.32 110.336 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -64.55 124.3 21.49 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.402 -0.962 . . . . 72.4 108.402 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.2 162.61 39.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.076 -1.453 . . . . 61.3 107.076 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.6 162.98 34.48 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.471 -0.937 . . . . 73.3 108.471 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -71.44 122.09 19.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.307 -0.627 . . . . 72.54 109.307 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.69 151.58 46.21 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 106.283 -1.747 . . . . 53.35 106.283 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 m -129.37 109.97 11.53 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 106.966 -1.494 . . . . 74.02 106.966 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.76 41.45 0.07 OUTLIER Glycine 0 C--O 1.227 -0.307 0 N-CA-C 111.036 -0.826 . . . . 63.42 111.036 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.57 174.27 8.37 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.092 1.357 . . . . 75.52 109.094 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 t -46.35 155.94 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 128.554 2.742 . . . . 64.12 112.294 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -73.71 -172.27 1.22 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.817 1.247 . . . . 74.1 109.103 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.21 59.41 0.5 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 108.406 -1.878 . . . . 72.14 108.406 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -143.7 88.07 0.17 Allowed Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.333 -1.107 . . . . 65.33 110.333 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -122.13 155.59 61.1 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 125.391 1.476 . . . . 75.15 109.004 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.04 136.98 15.15 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.468 2.779 . . . . 73.12 109.874 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.4 m -128.26 158.2 40.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 O-C-N 121.4 -0.812 . . . . 71.03 110.436 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -125.43 163.39 22.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.039 1.336 . . . . 74.13 110.104 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.1 m -49.52 -45.8 47.75 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.743 1.617 . . . . 70.51 110.634 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -35.96 65.79 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.434 1.894 . . . . 74.32 112.75 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.7 mtp -68.48 -44.74 74.12 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.985 -1.072 . . . . 74.11 109.231 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.1 t -60.98 -51.61 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.012 0.925 . . . . 75.45 110.815 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -61.48 -43.42 98.9 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 117.247 -1.358 . . . . 64.51 110.335 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.2 m -57.8 -55.87 29.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.949 1.704 . . . . 72.0 109.803 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.1 t -55.0 -46.85 77.29 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 CA-C-N 119.865 1.211 . . . . 74.23 109.084 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -56.08 -43.54 78.12 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.543 1.065 . . . . 75.53 112.205 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -61.91 -35.74 79.27 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.027 1.331 . . . . 73.31 111.838 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.6 mt -94.06 -12.78 27.82 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.969 1.308 . . . . 73.51 112.454 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.95 67.44 56.53 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 127.828 2.451 . . . . 73.44 108.468 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.76 -9.4 22.75 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.385 2.056 . . . . 64.3 112.763 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.17 -12.01 48.2 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.887 0.875 . . . . 71.45 111.73 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.1 mt -88.32 152.93 21.59 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.345 0.975 . . . . 74.22 111.902 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -72.94 140.07 80.45 Favored Pre-proline 0 N--CA 1.448 -0.565 0 N-CA-C 106.617 -1.623 . . . . 74.15 106.617 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.29 -23.44 44.87 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.985 2.457 . . . . 73.54 113.765 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -40.09 17.76 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.42 0.554 . . . . 74.34 109.594 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -60.92 -40.32 92.71 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-O 118.141 -0.933 . . . . 72.54 109.658 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.78 -56.49 7.2 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 C-N-CA 124.265 1.026 . . . . 64.53 109.42 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -45.67 -54.35 7.91 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.128 0.422 . . . . 70.11 110.867 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -61.64 -36.19 80.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.826 0.306 . . . . 73.41 111.826 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.2 m -61.42 -49.65 76.02 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.368 -0.975 . . . . 62.23 108.368 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.8 mt -59.69 -35.5 74.6 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.197 0.999 . . . . 75.41 110.478 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -67.75 -33.82 75.61 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.666 -0.494 . . . . 73.41 109.666 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -79.46 -50.2 11.14 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.862 1.265 . . . . 74.45 114.093 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.6 p -74.56 -41.77 59.97 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.53 1.532 . . . . 73.54 110.872 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.28 -18.1 58.0 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 127.947 2.689 . . . . 61.43 112.551 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -139.35 151.15 46.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 123.718 1.723 . . . . 75.14 112.235 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.33 -47.44 89.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 113.008 -1.905 . . . . 73.34 107.989 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -50.91 -51.03 56.01 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.367 1.467 . . . . 75.01 110.204 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -62.82 -42.36 99.69 Favored 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 109.863 -0.421 . . . . 74.44 109.863 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.1 m -60.36 -39.8 88.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.287 1.035 . . . . 74.23 111.833 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.59 -37.67 44.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 121.399 -0.813 . . . . 73.22 109.436 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -66.7 -38.13 86.14 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.483 1.113 . . . . 65.42 111.251 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -78.6 -33.87 47.14 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.493 -0.754 . . . . 75.11 109.216 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -59.62 -59.6 5.18 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.674 -1.266 . . . . 72.04 111.349 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -56.54 -28.95 61.33 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.509 0.724 . . . . 71.41 111.93 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -18.7 56.4 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.757 -0.64 . . . . 74.22 110.936 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.9 28.05 14.92 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.581 -1.122 . . . . 74.53 112.357 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -68.34 -179.25 1.26 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.939 1.296 . . . . 75.2 111.83 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -82.6 144.06 30.59 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.78 1.232 . . . . 75.51 111.564 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -138.84 109.18 6.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.628 -0.878 . . . . 64.52 108.628 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.2 m -84.96 177.13 8.06 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.773 1.229 . . . . 62.33 110.903 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -111.66 153.9 44.14 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 105.683 -1.969 . . . . 75.45 105.683 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.87 166.14 29.96 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.407 2.071 . . . . 64.43 111.641 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -63.03 156.17 56.37 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.404 2.069 . . . . 72.12 109.622 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.5 -28.53 3.43 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 118.312 -1.271 . . . . 74.22 111.587 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -66.81 -53.46 32.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 119.376 1.588 . . . . 74.31 111.024 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 . . . . . 0 C--O 1.249 1.062 0 C-N-CA 125.069 1.348 . . . . 72.41 107.513 -179.574 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.272 0 N-CA-C 109.284 -1.526 . . . . 61.34 109.284 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.26 155.28 42.56 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.061 -1.459 . . . . 75.33 107.061 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 90.0 mmm -79.43 73.93 6.07 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.435 0.694 . . . . 62.11 109.919 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.92 -100.99 0.51 Allowed Glycine 0 CA--C 1.525 0.684 0 CA-C-O 117.232 -1.871 . . . . 64.54 108.69 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.37 108.04 0.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.526 2.817 . . . . 70.34 111.057 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -145.58 123.32 11.89 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 103.025 -2.954 . . . . 71.55 103.025 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.79 94.13 0.14 Allowed Glycine 0 C--N 1.336 0.541 0 CA-C-N 120.324 1.42 . . . . 73.21 111.193 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.408 ' H ' ' HB3' ' A' ' 51' ' ' ASN . 7.2 m -149.4 -172.85 4.23 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.977 1.311 . . . . 74.21 109.764 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.2 p -59.19 126.63 28.46 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.336 1.054 . . . . 73.34 108.665 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 46.0 38.29 4.51 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.496 1.518 . . . . 74.1 113.607 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.408 ' HB3' ' H ' ' A' ' 48' ' ' SER . 9.9 p30 -60.4 123.42 17.24 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.549 1.14 . . . . 74.43 109.024 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.24 109.48 7.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.958 1.303 . . . . 63.13 110.797 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.665 ' CD1' ' H ' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -146.16 -174.63 4.49 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 106.57 -1.641 . . . . 70.3 106.57 178.444 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.665 ' H ' ' CD1' ' A' ' 53' ' ' LEU . 27.7 mmm180 -105.04 174.34 5.92 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 127.25 2.22 . . . . 72.54 107.181 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.78 85.82 2.26 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.373 -0.602 . . . . 71.13 109.373 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.1 t -69.29 155.39 40.49 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 105.038 -2.208 . . . . 73.51 105.038 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.83 -165.26 18.01 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.704 -0.958 . . . . 45.31 110.704 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.91 116.06 21.59 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 105.617 -1.994 . . . . 74.22 105.617 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.69 22.13 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 125.454 1.502 . . . . 74.01 113.635 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -52.76 -39.21 62.01 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.461 1.282 . . . . 72.34 114.461 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.0 -66.49 0.24 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 106.025 -2.83 . . . . 73.23 106.025 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -112.84 -149.49 10.64 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 107.78 -2.128 . . . . 73.44 107.78 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -70.85 150.46 95.16 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 125.02 1.328 . . . . 72.42 107.924 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.01 142.78 31.72 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.99 1.793 . . . . 72.34 110.979 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 m -128.75 164.85 29.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.291 1.036 . . . . 74.15 109.509 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.2 p -124.3 162.79 23.02 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.399 1.48 . . . . 73.02 109.163 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -53.02 -38.99 62.83 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.101 0.961 . . . . 71.42 110.777 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -44.29 95.34 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 118.579 -0.724 . . . . 70.41 112.043 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 5.2 mtm -59.53 -35.2 73.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.421 -0.912 . . . . 75.4 110.703 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.7 t -65.44 -52.76 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.061 -0.718 . . . . 74.41 109.061 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -64.09 -35.52 81.01 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.708 -1.139 . . . . 75.51 110.718 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.3 m -57.18 -60.12 4.08 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 121.107 1.776 . . . . 74.14 108.082 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.5 t -54.5 -47.99 70.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 CA-C-O 117.571 -1.204 . . . . 75.42 108.596 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 tp60 -52.55 -45.48 66.38 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 120.153 1.342 . . . . 75.32 111.97 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -62.73 -36.4 82.88 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.402 -0.812 . . . . 72.13 110.469 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.7 mt -89.67 -14.65 34.36 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.85 -0.595 . . . . 75.53 112.54 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -138.33 73.55 43.16 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 129.111 2.965 . . . . 74.03 111.685 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -69.79 -5.67 16.77 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.904 3.069 . . . . 72.42 113.515 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.5 -15.69 36.87 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 120.745 -1.222 . . . . 74.14 111.981 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.8 mt -91.14 160.09 15.74 Favored 'General case' 0 N--CA 1.458 -0.074 0 C-N-CA 123.236 0.614 . . . . 74.52 111.571 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.479 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 56.0 t-80 -85.26 149.42 52.4 Favored Pre-proline 0 C--O 1.239 0.521 0 N-CA-C 106.171 -1.788 . . . . 73.14 106.171 178.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 33.2 Cg_endo -63.93 -30.07 67.25 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.548 2.165 . . . . 74.11 112.456 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.28 -34.22 55.65 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 112.717 0.636 . . . . 71.21 112.717 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -61.3 -46.1 91.69 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.609 -0.886 . . . . 63.12 108.609 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.0 mt -52.49 -59.63 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 125.002 1.321 . . . . 75.44 108.299 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -49.47 12.95 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.618 1.099 . . . . 75.11 111.888 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -64.41 -45.71 86.43 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.919 0.781 . . . . 75.05 113.085 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.7 p -65.7 -37.99 87.99 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.574 -0.704 . . . . 75.31 109.472 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.35 -38.16 88.43 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.105 -0.997 . . . . 74.32 109.062 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -68.39 -35.33 77.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.569 0.622 . . . . 71.14 110.062 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -72.51 -55.05 7.58 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.935 -0.478 . . . . 71.24 111.091 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.0 p -67.19 -41.36 85.98 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.911 1.284 . . . . 73.24 112.021 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.83 -11.85 67.61 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.87 1.224 . . . . 71.42 113.429 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -144.44 144.11 31.23 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 119.031 1.415 . . . . 74.31 109.336 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.1 t -59.63 -43.37 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 125.181 1.393 . . . . 74.24 109.025 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -46.93 -47.75 21.55 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.895 1.278 . . . . 75.13 111.011 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -69.82 -40.56 75.84 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.445 -0.784 . . . . 73.33 109.967 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.8 m -58.96 -37.12 76.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.161 0.584 . . . . 72.13 110.28 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 85.7 t -74.95 -36.96 40.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 123.919 0.888 . . . . 72.34 109.157 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -68.76 -39.61 80.2 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.352 1.061 . . . . 71.1 111.263 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -74.33 -37.11 63.66 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.122 -1.066 . . . . 73.31 108.122 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -58.03 -56.32 23.49 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.613 0.765 . . . . 73.13 109.935 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 pp -60.62 -22.49 63.85 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.284 -0.885 . . . . 73.15 112.055 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -16.72 48.7 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.846 0.748 . . . . 73.32 109.898 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.25 36.67 9.62 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 119.032 0.833 . . . . 61.1 112.168 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -76.76 173.38 11.72 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 117.986 0.893 . . . . 64.1 109.827 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -81.58 135.73 35.57 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.481 -1.303 . . . . 75.14 107.481 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -118.42 110.94 18.05 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.138 -2.542 . . . . 75.41 104.138 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.7 m -97.79 178.59 5.09 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 125.063 1.345 . . . . 64.14 110.086 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -110.88 158.79 34.72 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 125.371 1.469 . . . . 75.2 111.283 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.33 164.07 36.75 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.358 2.705 . . . . 74.13 113.898 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.09 139.53 84.72 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.967 2.444 . . . . 72.15 109.707 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.14 -18.41 56.88 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.508 1.052 . . . . 73.4 111.096 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -71.61 -45.29 62.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 119.243 1.522 . . . . 75.24 109.427 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.021 -0.99 . . . . 73.3 111.439 -178.962 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.215 0 N-CA-C 109.227 -1.549 . . . . 74.42 109.227 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.34 175.39 8.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 117.822 0.811 . . . . 75.43 109.204 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.1 mtt -144.71 175.03 10.47 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.016 2.126 . . . . 71.21 106.845 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.06 173.94 37.58 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.772 -1.331 . . . . 71.34 109.772 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.76 102.05 0.84 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.44 2.76 . . . . 73.11 110.384 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -133.05 107.12 8.05 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.98 -1.118 . . . . 74.21 107.98 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.52 76.26 2.21 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 107.0 -2.44 . . . . 45.41 107.0 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 p -68.43 -32.11 71.9 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.395 0.678 . . . . 45.11 112.439 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.5 t -170.4 161.58 8.05 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.848 1.659 . . . . 73.22 106.996 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -148.57 161.47 41.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.725 1.21 . . . . 74.14 109.941 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -150.58 160.2 43.96 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.369 -1.345 . . . . 75.33 107.369 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.42 -159.4 0.79 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.759 1.624 . . . . 74.44 107.814 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.4 tp -59.44 158.13 10.09 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.586 0.754 . . . . 74.12 110.241 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -65.06 175.29 1.62 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.209 1.004 . . . . 73.23 109.055 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.59 158.72 27.95 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.183 1.393 . . . . 75.13 107.888 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 m -102.96 -54.49 2.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.859 0.864 . . . . 73.2 111.56 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.57 33.0 80.09 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 119.032 0.833 . . . . 70.53 111.655 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 66.01 13.65 9.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.417 1.487 . . . . 71.43 112.981 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 66.1 t -91.71 139.25 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 121.203 0.525 . . . . 73.23 111.683 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -143.65 172.5 12.73 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.379 2.272 . . . . 74.54 108.858 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.93 114.1 1.62 Allowed Glycine 0 C--O 1.237 0.29 0 N-CA-C 108.573 -1.811 . . . . 62.52 108.573 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.5 79.94 1.37 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 106.437 -2.665 . . . . 72.54 106.437 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -124.84 149.55 63.12 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 125.991 1.717 . . . . 73.44 109.127 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.27 138.12 38.57 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.033 1.822 . . . . 74.43 109.957 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 m -134.46 159.55 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.337 -0.986 . . . . 71.45 108.337 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.31 162.43 23.77 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.445 -0.946 . . . . 75.1 108.445 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 m -51.36 -39.1 56.4 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.607 1.963 . . . . 75.22 111.393 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.83 -38.05 77.81 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 124.561 1.144 . . . . 75.52 110.248 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.1 mtp -63.87 -38.14 89.98 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 120.407 -1.433 . . . . 73.54 109.377 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 t -61.08 -54.26 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.308 -0.627 . . . . 70.34 109.308 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -62.95 -38.24 90.28 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-O 117.294 -1.336 . . . . 74.1 110.588 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.6 m -53.98 -61.1 2.52 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 121.138 1.79 . . . . 72.42 108.087 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.7 t -55.51 -48.52 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 118.138 -0.934 . . . . 75.23 110.411 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -56.37 -42.24 77.5 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.074 0.852 . . . . 71.45 111.839 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -62.64 -43.6 98.39 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.618 -0.882 . . . . 65.0 108.618 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 mt -75.85 -26.91 57.57 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.735 -0.603 . . . . 75.44 111.476 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.77 83.37 62.57 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 128.054 2.542 . . . . 62.53 111.848 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.8 -21.3 38.49 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.575 1.517 . . . . 72.33 112.802 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.07 -19.29 51.69 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.754 1.222 . . . . 61.24 113.523 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 mt -79.53 154.52 28.76 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.786 0.721 . . . . 73.12 109.756 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -79.6 144.19 60.46 Favored Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 107.352 -1.351 . . . . 74.42 107.352 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.53 -29.53 52.79 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.924 1.75 . . . . 65.13 112.228 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -75.39 -41.52 56.0 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 112.491 0.552 . . . . 75.03 112.491 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -63.14 -35.19 79.48 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.893 0.477 . . . . 73.32 110.05 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 75.2 mt -56.64 -60.37 2.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 109.297 -0.631 . . . . 72.55 109.297 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.89 -40.77 61.21 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.653 1.115 . . . . 73.54 112.271 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -61.93 -46.96 87.04 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.126 0.965 . . . . 74.23 111.092 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.8 p -63.49 -44.8 93.32 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.78 -1.1 . . . . 64.41 108.595 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.5 mt -56.86 -39.3 74.06 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.186 0.903 . . . . 74.52 109.814 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.39 -34.93 75.25 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.73 1.15 . . . . 73.21 110.071 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.54 -47.4 48.6 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.222 0.609 . . . . 71.23 111.5 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.5 p -79.07 -35.51 42.32 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 127.574 2.35 . . . . 70.41 113.547 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.39 -12.24 55.95 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 125.864 1.697 . . . . 71.1 113.135 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.0 m -143.91 146.17 32.79 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 118.854 1.327 . . . . 72.31 111.962 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.41 -47.53 89.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.127 -1.434 . . . . 65.42 107.127 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -45.86 -46.07 15.52 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.953 1.301 . . . . 73.42 111.481 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -65.45 -53.58 40.74 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.061 1.744 . . . . 72.1 108.358 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.9 m -54.75 -37.59 66.15 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.98 1.312 . . . . 75.24 111.392 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.56 -39.68 54.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 124.124 0.97 . . . . 75.41 109.444 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -64.04 -44.41 92.56 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.279 1.432 . . . . 75.55 109.772 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -74.32 -32.47 62.84 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.46 -0.775 . . . . 74.13 110.909 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -62.9 -54.51 37.56 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.464 -0.772 . . . . 62.54 110.451 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.79 -25.85 67.73 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 118.209 -0.901 . . . . 74.24 111.78 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -81.41 -11.61 59.21 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.757 0.661 . . . . 74.23 110.2 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.78 36.62 25.12 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-O 119.06 -0.856 . . . . 61.32 111.203 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -74.73 -175.89 2.63 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.14 0.97 . . . . 70.21 111.456 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -86.69 138.72 31.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.608 1.163 . . . . 72.1 111.221 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -138.51 110.3 7.16 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.022 1.329 . . . . 75.43 109.895 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.8 m -89.58 -179.78 5.87 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.534 1.534 . . . . 52.24 109.71 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -110.05 159.13 33.02 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 126.352 1.861 . . . . 74.33 110.032 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.64 166.92 27.49 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.584 2.856 . . . . 74.44 114.782 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.85 137.22 40.97 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.532 2.154 . . . . 75.43 107.139 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.2 -10.37 59.89 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.997 1.284 . . . . 65.11 111.065 -178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -77.33 -29.01 53.31 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.571 1.685 . . . . 71.02 109.986 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 . . . . . 0 C--O 1.25 1.112 0 C-N-CA 125.439 1.496 . . . . 74.25 108.936 179.508 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.147 0 N-CA-C 106.836 -2.506 . . . . 64.34 106.836 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.45 162.97 21.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.279 -1.378 . . . . 74.05 107.279 177.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -113.63 -89.96 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 105.483 -2.043 . . . . 75.5 105.483 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.4 74.42 0.04 OUTLIER Glycine 0 CA--C 1.522 0.511 0 N-CA-C 107.063 -2.415 . . . . 74.33 107.063 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.85 -19.44 40.67 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.398 2.066 . . . . 74.22 113.978 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -162.83 176.2 10.48 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.406 1.083 . . . . 73.44 110.076 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.38 82.35 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 108.91 -1.676 . . . . 61.24 108.91 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.4 m -148.41 126.84 12.32 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.47 -1.678 . . . . 75.41 106.47 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 t -83.29 164.19 20.22 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.951 0.9 . . . . 74.44 108.991 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -119.71 109.59 15.81 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.816 0.846 . . . . 72.33 110.849 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.63 169.11 18.18 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.122 1.369 . . . . 62.53 108.739 178.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.06 162.45 14.14 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.753 -0.592 . . . . 72.25 110.144 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.28 148.96 47.02 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.652 1.581 . . . . 74.34 108.451 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -61.78 155.77 22.13 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 124.216 0.947 . . . . 73.13 110.13 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -74.88 141.37 44.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 106.752 -1.573 . . . . 74.13 106.752 177.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.03 -21.61 0.71 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 118.701 -0.666 . . . . 72.43 110.999 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.7 159.97 53.12 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.015 -1.234 . . . . 74.03 110.015 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -74.61 177.58 5.98 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 125.827 1.651 . . . . 75.14 110.348 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 p -59.67 -22.55 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 123.272 0.629 . . . . 74.55 111.687 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -70.86 147.85 48.42 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.45 1.1 . . . . 62.11 109.688 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.44 -61.58 7.31 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 124.587 1.089 . . . . 71.24 112.124 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -127.9 -168.16 12.41 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 107.99 -2.044 . . . . 75.23 107.99 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -90.96 138.39 26.15 Favored Pre-proline 0 C--N 1.316 -0.887 0 C-N-CA 127.618 2.367 . . . . 72.44 107.772 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.0 127.38 15.1 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.7 2.933 . . . . 72.4 114.035 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.8 m -107.91 166.82 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.432 1.093 . . . . 72.32 109.934 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.2 p -124.26 157.68 34.3 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.931 -1.877 . . . . 74.45 105.931 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -56.12 -35.75 67.45 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 119.105 -0.474 . . . . 75.13 110.811 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -36.84 73.01 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.753 0.706 . . . . 73.24 111.756 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.1 mtp -66.36 -33.39 75.62 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.089 -1.007 . . . . 74.2 109.29 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.87 -53.95 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 123.93 0.892 . . . . 74.32 109.475 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -60.33 -40.99 92.61 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.56 -1.209 . . . . 74.24 109.367 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 85.9 m -56.22 -57.38 12.48 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.676 1.58 . . . . 75.1 108.624 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.5 t -55.43 -50.8 63.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-O 118.456 -0.783 . . . . 73.13 109.699 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -52.08 -44.12 64.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 118.893 0.77 . . . . 74.25 112.767 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -62.86 -42.52 99.78 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.891 0.876 . . . . 75.51 110.363 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.8 mt -86.34 -10.83 53.64 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.843 0.683 . . . . 72.42 112.843 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.68 70.7 58.83 Favored Pre-proline 0 N--CA 1.447 -0.597 0 C-N-CA 127.186 2.195 . . . . 73.33 108.673 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -68.54 0.23 5.05 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.279 3.32 . . . . 71.25 112.633 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.16 12.83 29.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.453 1.501 . . . . 72.34 112.071 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.9 mt -114.77 157.53 23.1 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.545 1.138 . . . . 73.51 109.25 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.425 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 57.3 t-80 -85.46 145.59 42.6 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 108.276 -1.009 . . . . 74.53 108.276 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 33.0 Cg_endo -62.67 -29.87 78.1 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.938 2.426 . . . . 73.43 113.232 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -77.41 -42.99 34.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.967 -0.458 . . . . 75.22 110.931 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -58.27 -42.63 86.91 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 122.028 -0.42 . . . . 72.52 110.075 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 76.2 mt -50.59 -58.86 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 124.786 1.234 . . . . 74.43 109.692 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.05 -50.29 10.98 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.568 0.622 . . . . 75.3 111.342 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -61.34 -45.37 94.72 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.702 -0.624 . . . . 74.01 112.33 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 p -63.35 -42.63 98.93 Favored 'General case' 0 C--O 1.218 -0.583 0 C-N-CA 120.216 -0.593 . . . . 62.11 110.153 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.2 mt -60.21 -34.76 74.1 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.618 0.767 . . . . 72.13 110.114 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.85 -36.54 78.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.356 -0.609 . . . . 72.41 109.356 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -78.26 -44.5 25.34 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.07 0.767 . . . . 74.13 113.07 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.9 p -76.25 -36.18 58.59 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.787 1.635 . . . . 74.34 111.423 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.49 -17.82 46.25 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.921 1.248 . . . . 73.34 113.298 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.5 t -145.11 150.1 36.2 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.657 1.228 . . . . 74.14 108.991 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.9 t -65.12 -41.8 92.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 126.373 1.869 . . . . 74.55 109.285 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -46.52 -48.01 19.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.389 1.476 . . . . 71.41 111.491 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -68.35 -44.85 74.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.378 1.471 . . . . 75.31 108.845 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.6 m -56.96 -39.16 74.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.945 0.898 . . . . 74.22 110.791 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.3 t -74.4 -37.72 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.273 -0.87 . . . . 71.42 110.074 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -66.69 -43.66 83.81 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.173 0.989 . . . . 55.33 110.126 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -72.59 -35.66 67.95 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.295 -0.878 . . . . 72.3 109.98 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -57.91 -57.39 13.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 121.133 -0.979 . . . . 72.15 110.482 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.22 -26.09 62.43 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.195 0.452 . . . . 72.13 111.269 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -12.17 59.96 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.599 -0.688 . . . . 74.44 110.364 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.65 37.35 40.34 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 125.054 1.312 . . . . 73.14 110.715 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.2 -171.17 0.88 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.207 1.004 . . . . 63.12 112.126 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.45 139.05 34.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 120.961 -1.087 . . . . 73.4 109.582 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -129.85 108.72 10.36 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 104.862 -2.273 . . . . 73.12 104.862 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.7 m -96.26 163.92 12.88 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.732 1.213 . . . . 73.04 111.786 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -97.11 156.52 36.23 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 124.542 1.137 . . . . 72.31 108.835 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.94 164.74 30.59 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.803 2.335 . . . . 75.31 112.211 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.23 142.43 66.92 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.037 1.825 . . . . 64.21 110.324 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.22 -9.37 73.1 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 118.607 -1.107 . . . . 64.31 113.286 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -76.78 -22.8 53.19 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.897 1.349 . . . . 70.03 110.459 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 C--O 1.247 0.926 0 C-N-CA 126.351 1.86 . . . . 75.32 112.64 179.811 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 N-CA-C 110.285 -1.126 . . . . 72.2 110.285 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.54 -23.32 14.32 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.742 0.771 . . . . 62.13 111.945 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 77.0 mtp 46.73 67.93 0.7 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.984 1.714 . . . . 75.41 113.286 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.87 -177.21 43.13 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.521 0.581 . . . . 74.51 112.801 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.93 157.62 34.69 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 125.243 3.962 . . . . 70.14 111.175 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -79.88 -16.54 55.17 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.271 1.028 . . . . 75.21 113.16 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.04 156.75 6.89 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 108.077 -2.009 . . . . 53.01 108.077 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.9 t -158.16 -164.35 1.48 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 118.441 1.121 . . . . 71.21 109.02 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 p 45.37 62.27 2.23 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.859 1.664 . . . . 72.21 110.267 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.01 163.75 9.34 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 122.27 1.033 . . . . 73.13 111.86 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -105.69 178.4 4.57 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.982 2.113 . . . . 75.15 108.731 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 49.8 28.63 2.83 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.919 1.288 . . . . 70.55 113.035 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -67.46 177.25 2.0 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.818 1.647 . . . . 71.43 112.654 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.43 137.54 52.81 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.543 1.137 . . . . 75.14 110.739 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -62.24 106.97 0.81 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.92 1.688 . . . . 73.21 111.401 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.6 p -145.29 -176.55 5.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.672 0.789 . . . . 74.53 109.077 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.94 -41.58 0.37 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 125.082 1.325 . . . . 61.22 111.76 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -146.69 136.81 23.52 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.248 -1.019 . . . . 74.13 108.248 -178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.04 159.43 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.661 1.184 . . . . 74.52 107.822 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.87 164.61 3.7 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.853 1.261 . . . . 75.14 111.618 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.14 -111.76 4.32 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 108.744 -1.742 . . . . 53.33 108.744 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.77 -152.78 6.81 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 117.908 0.854 . . . . 73.03 111.534 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -77.13 162.41 69.74 Favored Pre-proline 0 C--N 1.32 -0.679 0 C-N-CA 129.82 3.248 . . . . 70.31 109.671 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.75 141.08 21.42 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.201 1.934 . . . . 75.12 109.308 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 m -134.64 160.15 41.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.427 -0.953 . . . . 62.21 108.427 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.98 157.76 37.0 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.889 1.276 . . . . 71.11 108.768 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 m -42.75 -48.37 5.61 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.762 2.425 . . . . 72.21 111.522 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -53.97 -36.71 63.17 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 126.933 2.093 . . . . 62.01 112.324 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 87.3 mtp -66.81 -42.39 85.98 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.661 -0.866 . . . . 75.33 108.661 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.78 -57.93 9.01 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 CA-C-N 117.92 0.327 . . . . 73.42 110.601 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -58.04 -40.78 81.77 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 118.14 -0.933 . . . . 74.01 110.725 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.8 m -58.01 -62.0 2.13 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.09 1.314 . . . . 74.02 109.524 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.4 t -52.42 -46.42 46.95 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 CA-C-O 118.354 -0.832 . . . . 73.01 108.999 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.19 -38.31 79.53 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.698 1.136 . . . . 72.45 113.336 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -65.41 -40.89 93.95 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.152 0.887 . . . . 72.43 108.846 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mt -78.98 -34.53 44.09 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 112.248 0.462 . . . . 74.31 112.248 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.11 75.46 4.15 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 127.33 2.252 . . . . 74.52 109.532 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.08 -13.69 40.72 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.267 1.978 . . . . 64.12 112.2 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -83.12 -6.63 59.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.872 1.269 . . . . 74.23 113.08 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.2 mt -98.06 155.24 17.22 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 120.92 -1.113 . . . . 73.24 109.355 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.439 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 53.7 t-80 -78.34 146.43 70.41 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 105.607 -1.997 . . . . 73.43 105.607 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 32.2 Cg_endo -63.88 -31.85 66.97 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.651 1.567 . . . . 64.21 112.281 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -74.88 -38.33 61.92 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.281 -0.887 . . . . 75.14 111.912 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -58.56 -45.12 89.65 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.81 -0.441 . . . . 64.24 109.81 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.1 mt -49.22 -56.31 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 117.812 -1.089 . . . . 75.21 110.123 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.6 tmm_? -48.7 -48.51 40.25 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.558 1.072 . . . . 74.12 111.712 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.419 ' CE1' ' HD3' ' A' ' 112' ' ' PRO . 9.2 t80 -62.25 -41.16 98.2 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.807 0.731 . . . . 73.33 111.704 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.2 m -63.6 -48.66 76.44 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.756 -0.831 . . . . 74.14 108.756 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -57.32 -37.34 72.35 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.021 1.328 . . . . 74.41 110.309 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -68.18 -38.0 81.57 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.042 -0.725 . . . . 72.35 109.042 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -76.68 -48.34 19.25 Favored 'General case' 0 C--N 1.334 -0.097 0 O-C-N 121.457 -0.777 . . . . 72.11 112.106 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.3 p -71.47 -38.33 71.27 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.567 1.147 . . . . 72.55 111.369 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.55 -2.94 87.57 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.906 2.193 . . . . 74.1 111.447 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -144.31 145.06 31.77 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.137 1.469 . . . . 51.53 112.608 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.93 -52.48 53.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.517 -1.66 . . . . 74.11 106.517 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -49.17 -51.99 29.25 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.316 1.847 . . . . 74.41 110.674 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.49 -43.49 93.31 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.852 0.861 . . . . 74.13 109.527 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.7 m -61.52 -39.42 90.95 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.969 0.908 . . . . 72.54 110.501 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.5 t -75.2 -34.62 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 121.247 -0.908 . . . . 75.54 110.131 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -68.18 -39.29 82.54 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 126.113 1.765 . . . . 75.22 111.23 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -79.02 -37.08 40.04 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.877 -0.786 . . . . 75.2 108.877 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -54.67 -54.36 42.7 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.943 0.897 . . . . 72.41 109.705 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.13 -18.06 56.02 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.168 0.803 . . . . 74.42 113.168 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -19.26 42.17 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.714 -1.217 . . . . 75.33 107.714 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 83.3 31.7 27.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 125.656 1.598 . . . . 70.03 109.658 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -62.59 176.79 0.6 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.866 1.666 . . . . 73.24 111.382 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -83.47 139.11 33.13 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 123.076 0.55 . . . . 70.45 110.284 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -135.88 109.04 7.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.284 1.033 . . . . 75.2 108.83 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.5 m -91.52 176.1 6.67 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.851 0.861 . . . . 75.24 109.033 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -103.14 155.71 36.3 Favored Pre-proline 0 N--CA 1.45 -0.457 0 C-N-CA 124.873 1.269 . . . . 74.21 108.779 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -69.27 161.57 45.34 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.907 2.405 . . . . 54.14 113.628 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.419 ' HD3' ' CE1' ' A' ' 87' ' ' TYR . 37.2 Cg_endo -63.36 145.95 93.08 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 121.94 1.76 . . . . 71.11 107.992 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.47 -5.38 82.59 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.418 -1.212 . . . . 62.22 111.599 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -86.36 -28.32 23.71 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.632 1.716 . . . . 74.15 111.845 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 123.805 0.842 . . . . 74.24 111.236 179.114 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 108.26 -1.015 . . . . 74.44 108.26 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.2 126.3 9.75 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.712 2.275 . . . . 72.53 110.645 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 m -122.99 161.29 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 O-C-N 120.954 -1.091 . . . . 52.54 110.001 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 p -124.4 166.24 16.32 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.053 0.941 . . . . 52.12 110.036 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.1 m -52.73 -41.85 64.35 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.496 1.518 . . . . 64.41 110.95 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -34.04 67.57 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.194 0.997 . . . . 62.35 111.013 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.9 mtp -70.32 -43.37 70.45 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.962 -0.755 . . . . 73.55 108.962 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.2 t -59.5 -55.98 20.23 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 C-N-CA 124.168 0.987 . . . . 74.25 110.193 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.66 -41.5 90.72 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 117.784 -1.103 . . . . 62.22 111.103 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.3 m -55.01 -60.42 3.4 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.57 1.077 . . . . 52.34 109.051 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.57 -46.22 79.03 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 CA-C-N 119.16 0.891 . . . . 62.31 109.694 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -54.9 -44.29 74.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 119.131 0.878 . . . . 74.51 112.97 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -62.85 -44.19 96.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.172 -0.677 . . . . 72.13 109.172 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.9 mt -79.41 -14.72 58.75 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.43 1.092 . . . . 74.43 113.583 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -137.33 70.87 54.17 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 127.368 2.267 . . . . 61.33 108.566 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.9 -23.16 62.32 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.584 2.189 . . . . 61.42 112.916 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.29 -14.56 62.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.523 0.729 . . . . 62.31 111.938 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.4 mt -92.36 156.69 17.07 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 119.181 0.9 . . . . 72.22 112.74 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -79.92 143.2 57.28 Favored Pre-proline 0 C--O 1.238 0.46 0 N-CA-C 106.111 -1.811 . . . . 62.14 106.111 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.62 -29.12 52.29 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.782 2.322 . . . . 54.21 113.032 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -40.2 48.77 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.698 -0.626 . . . . 75.24 111.727 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -60.9 -35.34 76.39 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.29 -0.633 . . . . 72.33 109.29 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.9 mt -56.57 -56.5 13.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 CA-C-O 118.164 -0.922 . . . . 64.12 108.713 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.82 -46.65 20.91 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.488 1.04 . . . . 75.33 111.048 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -64.59 -43.54 93.5 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.418 0.554 . . . . 72.25 111.911 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.2 t -64.59 -41.37 96.29 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.174 -0.676 . . . . 63.23 109.174 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.24 -37.97 84.99 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.943 0.897 . . . . 74.31 110.475 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -72.05 -34.77 69.02 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.608 0.64 . . . . 71.53 110.877 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -72.51 -50.61 24.63 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.001 -0.437 . . . . 43.22 110.808 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.3 p -72.64 -41.59 65.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.26 1.024 . . . . 71.24 111.819 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.16 -6.12 75.63 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.249 1.881 . . . . 44.41 112.538 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -145.59 152.13 39.2 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 120.897 2.348 . . . . 73.22 112.394 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.63 -50.62 64.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 106.765 -1.568 . . . . 73.41 106.765 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -52.32 -47.03 66.25 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.453 1.501 . . . . 64.44 111.754 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -63.74 -43.24 97.07 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.458 -0.942 . . . . 74.23 108.458 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.9 m -61.68 -37.05 82.68 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.422 1.089 . . . . 40.34 110.559 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.6 t -73.8 -35.95 44.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.412 1.085 . . . . 74.12 109.103 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -70.16 -40.5 74.7 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.417 1.487 . . . . 71.23 110.31 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -76.35 -30.2 57.51 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 122.084 0.945 . . . . 73.25 109.88 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -64.31 -54.59 30.8 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 121.099 -1.0 . . . . 74.23 108.932 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.15 -20.94 60.81 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.43 0.9 . . . . 61.33 113.43 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -92.23 -6.26 50.87 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.742 0.701 . . . . 73.21 109.913 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.62 36.68 58.39 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 126.528 2.013 . . . . 62.44 113.322 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -70.38 -178.68 1.79 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 118.256 1.028 . . . . 63.13 110.148 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.2 134.77 36.16 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 126.137 1.775 . . . . 73.32 111.901 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -129.07 110.51 12.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.245 1.818 . . . . 72.41 106.168 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.1 m -96.0 174.29 7.0 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.736 1.214 . . . . 60.44 108.035 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -98.1 155.6 36.82 Favored Pre-proline 0 C--N 1.33 -0.243 0 O-C-N 121.585 -0.697 . . . . 73.41 110.197 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -69.44 163.66 37.19 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.899 1.732 . . . . 72.11 111.48 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -59.89 144.6 99.43 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.887 1.724 . . . . 53.03 109.313 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.24 -12.39 58.47 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.595 1.093 . . . . 73.33 113.026 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -75.59 -46.54 31.21 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.195 1.497 . . . . 65.53 108.268 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 . . . . . 0 C--O 1.24 0.58 0 C-N-CA 124.92 1.288 . . . . 74.31 109.225 179.252 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 . . . . . 0 C--O 1.235 0.321 0 N-CA-C 111.6 0.222 . . . . 63.55 111.6 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.88 150.12 30.01 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.39 2.727 . . . . 62.42 109.841 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 m -134.28 160.83 41.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 123.988 0.915 . . . . 44.31 110.844 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.3 p -125.76 163.64 22.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.879 0.871 . . . . 74.22 110.034 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.7 m -49.61 -45.86 48.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.779 2.031 . . . . 51.25 111.593 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -62.41 -34.05 75.98 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.893 1.277 . . . . 32.44 112.614 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 94.5 mtp -65.12 -42.5 93.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.098 -1.075 . . . . 74.42 108.098 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 t -60.01 -55.34 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.458 0.703 . . . . 72.44 110.728 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -61.01 -37.67 83.34 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 119.538 -0.865 . . . . 75.41 112.059 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.0 m -60.18 -57.36 13.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 120.308 1.413 . . . . 75.31 109.525 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 t -54.97 -44.13 72.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-N 119.891 1.223 . . . . 74.31 108.438 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.6 tp60 -51.47 -50.92 58.89 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.197 0.908 . . . . 50.21 112.726 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -59.11 -44.73 92.0 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 122.837 0.455 . . . . 64.45 110.202 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.7 mt -77.71 -22.48 50.37 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.734 0.642 . . . . 74.14 112.734 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.89 75.07 79.23 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 126.374 1.87 . . . . 44.23 109.192 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.49 -18.05 54.05 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 123.492 2.795 . . . . 73.22 114.14 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.05 10.12 8.77 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.408 -0.808 . . . . 71.44 112.935 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.6 mt -112.74 155.81 23.9 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.171 0.896 . . . . 70.53 112.488 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.444 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 51.4 t-80 -80.63 145.46 58.55 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 108.626 -0.879 . . . . 75.54 108.626 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 28.9 Cg_endo -62.91 -30.53 77.17 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.228 2.619 . . . . 74.54 113.144 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.68 -39.16 37.49 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.026 -0.361 . . . . 62.01 110.026 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -59.46 -48.52 81.32 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 118.502 0.592 . . . . 64.41 109.452 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 82' ' ' PRO . 67.9 mt -49.35 -58.74 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 N-CA-C 107.789 -1.189 . . . . 73.24 107.789 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.538 HH21 ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -47.3 -52.08 17.3 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.749 0.819 . . . . 75.34 112.18 179.198 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -65.43 -33.94 77.11 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.681 -1.262 . . . . 64.22 111.712 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 t -65.14 -46.12 82.21 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.204 -1.406 . . . . 45.44 107.204 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.4 -36.57 76.07 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.343 1.457 . . . . 74.43 109.095 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.538 ' CD ' HH21 ' A' ' 86' ' ' ARG . 48.5 mt-10 -70.13 -38.36 75.51 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 118.78 0.718 . . . . 71.11 111.65 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -75.78 -45.7 34.78 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.109 0.411 . . . . 71.4 112.109 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 79.6 p -74.25 -40.65 62.24 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.475 1.11 . . . . 75.31 111.044 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.98 -13.56 67.39 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 127.832 2.634 . . . . 74.43 114.226 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.8 m -143.64 148.4 35.75 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.88 1.84 . . . . 64.43 111.996 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.8 t -59.64 -48.42 87.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 126.096 1.759 . . . . 64.53 107.655 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -51.87 -47.98 64.25 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.611 1.565 . . . . 74.31 111.79 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -65.33 -43.47 90.84 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 108.257 -1.016 . . . . 75.2 108.257 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.5 m -59.26 -40.47 86.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.407 1.083 . . . . 74.31 111.638 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.9 t -74.64 -40.27 47.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 118.008 -0.996 . . . . 71.5 108.581 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -62.81 -35.2 79.13 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.016 1.726 . . . . 71.03 111.206 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -80.13 -40.69 26.92 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.203 -0.665 . . . . 73.35 109.203 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -58.74 -51.05 71.63 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.026 0.531 . . . . 74.53 110.242 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -65.48 -9.14 23.26 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 113.397 0.888 . . . . 75.34 113.397 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.09 -16.82 20.33 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.748 2.019 . . . . 73.4 109.141 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.0 26.59 21.48 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.664 1.126 . . . . 72.22 113.315 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -72.11 172.83 9.42 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.275 1.037 . . . . 33.4 113.294 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -81.85 147.59 29.27 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.401 1.481 . . . . 75.04 111.56 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -138.51 109.93 6.98 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.861 1.264 . . . . 73.51 109.873 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.1 m -91.9 165.78 13.05 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.214 1.406 . . . . 74.3 108.255 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -94.01 160.06 33.09 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 124.759 1.224 . . . . 73.44 111.708 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.11 164.01 29.32 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.357 3.371 . . . . 65.52 113.767 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.34 140.3 87.44 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.11 2.54 . . . . 75.1 111.152 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.85 -17.65 54.14 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 117.959 -1.467 . . . . 74.02 112.403 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -66.12 -51.9 53.6 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.348 1.574 . . . . 75.04 108.881 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 . . . . . 0 C--O 1.245 0.859 0 C-N-CA 125.475 1.51 . . . . 74.34 108.555 179.126 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 108.798 -0.816 . . . . 64.5 108.798 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.28 142.64 30.58 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.217 2.612 . . . . 71.44 110.272 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.37 153.39 35.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 109.058 -0.719 . . . . 61.4 109.058 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -124.84 162.69 23.8 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 125.995 1.718 . . . . 64.32 108.06 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 m -56.23 -36.37 68.42 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.839 -0.538 . . . . 62.35 111.531 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.06 -33.84 65.37 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.357 1.063 . . . . 63.21 110.987 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.8 mtp -70.02 -41.89 73.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.684 -0.858 . . . . 51.13 108.684 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 t -61.03 -55.47 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.276 1.03 . . . . 61.41 110.51 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.63 -40.86 84.56 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 118.252 -0.88 . . . . 63.42 110.391 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.415 ' CG2' HG11 ' A' ' 95' ' ' VAL . 88.8 m -58.13 -60.97 2.92 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.372 0.987 . . . . 63.14 109.597 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.3 t -52.52 -47.66 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 119.384 0.993 . . . . 74.41 109.044 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -56.3 -45.23 80.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.11 0.868 . . . . 53.33 112.188 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -59.13 -39.32 81.95 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.187 0.995 . . . . 74.35 110.528 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.3 mt -88.81 -20.28 24.88 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.203 0.816 . . . . 73.41 113.203 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.89 75.35 79.68 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 127.304 2.242 . . . . 62.3 108.858 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.7 -17.84 52.85 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.438 2.092 . . . . 75.2 113.425 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.49 -17.23 56.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.536 0.607 . . . . 64.21 112.551 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 mt -80.85 155.74 26.44 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.85 0.833 . . . . 73.43 112.634 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.439 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 57.2 t-80 -75.56 144.07 76.73 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 124.44 1.096 . . . . 71.14 109.035 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 36.8 Cg_endo -65.8 -26.55 52.42 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.836 2.357 . . . . 74.04 113.704 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.02 -40.11 16.14 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.66 1.118 . . . . 72.42 111.892 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -60.45 -32.38 71.32 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 119.175 -0.44 . . . . 45.23 111.547 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 78.1 mt -55.24 -58.26 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 118.352 -0.832 . . . . 63.32 109.748 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -42.29 44.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.269 0.94 . . . . 74.42 112.685 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -63.9 -43.22 96.64 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.328 -0.857 . . . . 72.02 110.696 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 t -59.41 -51.27 70.63 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 108.393 -0.966 . . . . 73.41 108.393 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.4 mt -58.34 -35.65 72.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.066 0.947 . . . . 72.22 110.775 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -72.54 -30.28 64.32 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.823 1.192 . . . . 62.44 109.65 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -76.35 -46.71 26.29 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.343 0.52 . . . . 73.44 112.043 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.5 p -80.19 -39.69 28.73 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.668 1.187 . . . . 64.51 111.151 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.58 -6.17 66.17 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 127.24 2.352 . . . . 32.44 112.723 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.4 m -139.56 132.46 29.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.523 1.529 . . . . 64.23 110.323 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.415 HG11 ' CG2' ' A' ' 72' ' ' THR . 53.1 t -58.8 -44.77 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 125.394 1.477 . . . . 72.11 109.622 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -52.83 -47.74 67.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.822 0.849 . . . . 74.13 110.454 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -62.45 -43.09 99.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.903 -0.777 . . . . 64.41 108.903 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.9 m -58.85 -35.98 73.82 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.742 0.817 . . . . 65.2 110.477 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.5 t -75.75 -41.52 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.763 0.825 . . . . 63.14 109.91 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -63.47 -33.71 76.16 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.703 1.601 . . . . 73.43 111.349 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -83.71 -40.43 18.89 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.135 0.574 . . . . 63.15 110.286 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -53.94 -55.2 29.24 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.758 0.823 . . . . 64.31 110.563 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -59.67 -14.8 15.39 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.878 1.271 . . . . 65.12 114.135 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -9.26 39.74 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.44 1.896 . . . . 74.33 109.374 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.44 28.75 54.87 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.659 -0.977 . . . . 73.5 110.659 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -69.45 -179.75 1.78 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.28 1.04 . . . . 73.52 112.393 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -83.36 134.11 34.92 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.356 1.462 . . . . 72.25 113.251 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -134.4 110.04 9.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.357 -0.979 . . . . 61.04 108.357 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.86 179.42 4.81 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.422 -0.584 . . . . 72.42 109.422 178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -100.08 158.75 31.46 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.823 1.249 . . . . 64.14 111.136 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.15 164.09 36.2 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.211 2.607 . . . . 72.41 111.144 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.01 153.69 67.54 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.896 1.731 . . . . 54.4 107.815 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.1 -15.32 61.28 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 118.988 -0.895 . . . . 72.42 110.899 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -71.86 -44.39 63.88 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.126 0.963 . . . . 75.01 109.177 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 . . . . . 0 C--O 1.25 1.131 0 C-N-CA 124.587 1.155 . . . . 75.42 111.145 179.684 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 107.374 -1.343 . . . . 50.52 107.374 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.2 126.45 12.38 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.315 2.01 . . . . 42.33 108.547 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.3 m -126.8 157.98 37.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 121.75 0.786 . . . . 63.15 110.084 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 p -124.25 164.44 19.54 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.999 1.72 . . . . 71.52 109.911 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.3 m -54.7 -37.37 65.74 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.964 1.706 . . . . 65.22 111.4 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -59.21 -35.93 74.5 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.285 1.034 . . . . 65.12 111.349 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.0 mtp -68.31 -41.71 80.48 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.045 -1.034 . . . . 64.41 108.896 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.5 t -60.23 -54.89 28.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 C-N-CA 124.358 1.063 . . . . 63.12 110.94 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.17 -42.33 90.55 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.428 -0.796 . . . . 74.21 110.306 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.1 m -56.35 -61.07 2.65 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.871 1.214 . . . . 70.32 109.856 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 83.9 t -53.41 -46.87 59.08 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 CA-C-N 119.136 0.88 . . . . 55.22 109.535 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.99 -41.17 67.61 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.167 0.894 . . . . 63.32 113.184 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -65.65 -43.35 89.68 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.969 0.804 . . . . 73.03 109.25 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.57 -17.42 56.15 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.674 0.62 . . . . 74.42 112.674 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.89 74.8 56.66 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 126.982 2.113 . . . . 70.52 109.743 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.89 -16.11 36.89 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.576 2.184 . . . . 74.21 111.166 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -83.61 15.95 2.9 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.497 1.519 . . . . 73.33 112.016 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.0 mt -124.23 152.14 43.3 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.897 1.279 . . . . 52.44 109.134 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -76.97 143.88 71.33 Favored Pre-proline 0 N--CA 1.45 -0.454 0 N-CA-C 107.858 -1.164 . . . . 71.35 107.858 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.21 -18.95 56.69 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.898 2.398 . . . . 50.44 113.285 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -86.11 -38.51 17.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.455 0.702 . . . . 73.41 110.231 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -58.36 -47.87 82.42 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 122.679 0.392 . . . . 73.44 109.965 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 89.1 mt -48.93 -54.08 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.683 1.593 . . . . 75.1 111.053 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.58 HH21 ' CG ' ' A' ' 111' ' ' PRO . 1.7 tmm_? -50.43 -46.93 56.83 Favored 'General case' 0 C--O 1.228 -0.051 0 CA-C-N 118.707 0.685 . . . . 74.3 110.668 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -64.91 -37.71 88.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.768 0.258 . . . . 70.44 111.181 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 m -61.46 -47.25 86.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.975 -0.75 . . . . 61.4 108.975 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.4 mt -63.16 -35.25 79.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.892 1.277 . . . . 70.51 110.428 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -70.26 -33.25 71.38 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 118.666 0.666 . . . . 73.23 109.801 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -76.62 -55.64 5.33 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.482 0.713 . . . . 75.45 111.461 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.1 p -70.6 -40.91 72.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.957 1.703 . . . . 74.12 112.796 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.88 -6.1 83.97 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.616 2.055 . . . . 62.24 113.144 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.2 m -144.28 143.18 30.89 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 119.273 1.537 . . . . 73.22 111.474 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.6 t -63.04 -49.67 82.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 C-N-CA 125.945 1.698 . . . . 55.12 106.924 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.71 -46.79 64.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.367 1.067 . . . . 72.41 111.195 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -63.03 -45.42 92.4 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 108.29 -1.004 . . . . 74.41 108.29 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.5 m -56.52 -37.52 70.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.228 0.611 . . . . 61.45 111.017 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.6 t -76.06 -39.31 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 121.363 -0.836 . . . . 75.03 109.447 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -65.95 -32.82 74.53 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.695 1.198 . . . . 65.14 111.54 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -82.38 -38.78 23.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.367 -0.975 . . . . 75.21 108.367 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -55.33 -53.95 49.65 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.954 0.902 . . . . 75.43 110.282 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -59.36 -21.21 59.49 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.582 0.586 . . . . 74.43 112.582 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -16.41 49.92 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.946 1.298 . . . . 71.43 109.526 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.2 28.66 48.36 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.245 -1.542 . . . . 71.32 109.245 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -61.15 177.32 0.35 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.739 1.616 . . . . 73.02 112.073 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -77.56 138.52 39.21 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 120.806 -1.184 . . . . 73.21 109.029 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -134.57 108.66 8.2 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.014 -1.847 . . . . 75.45 106.014 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.4 m -91.1 177.07 6.37 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.503 0.721 . . . . 73.15 109.833 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -108.83 153.71 42.22 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 107.977 -1.12 . . . . 70.15 107.977 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.58 ' CG ' HH21 ' A' ' 86' ' ' ARG . 33.2 Cg_endo -71.11 163.28 39.74 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.505 2.136 . . . . 74.22 113.182 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.5 131.4 27.84 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.481 2.12 . . . . 63.25 107.003 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.14 -9.7 46.64 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-O 117.738 -1.59 . . . . 71.44 112.097 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -86.79 -28.32 23.04 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.157 1.479 . . . . 63.23 109.49 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--O 1.255 1.354 0 N-CA-C 103.994 -2.595 . . . . 75.31 103.994 178.258 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 . . . . . 0 C--O 1.232 0.183 0 N-CA-C 109.145 -0.687 . . . . 71.01 109.145 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.88 126.17 9.23 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 121.734 1.623 . . . . 71.43 108.198 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.6 m -111.94 170.15 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 120.814 -1.179 . . . . 72.33 109.807 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 p -125.37 157.0 37.86 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.691 1.596 . . . . 54.24 107.154 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 m -54.77 -38.89 67.79 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.533 1.133 . . . . 54.13 109.609 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -33.15 68.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.675 1.19 . . . . 72.15 112.445 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 93.0 mtp -68.5 -39.7 81.18 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.793 -1.192 . . . . 63.14 108.729 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 t -59.47 -53.78 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 124.86 1.264 . . . . 61.02 110.136 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -62.56 -41.82 99.16 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 117.209 -1.377 . . . . 65.03 110.845 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.3 m -54.58 -60.16 3.72 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 120.787 1.631 . . . . 62.23 108.93 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.0 t -53.32 -47.15 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 119.154 0.888 . . . . 63.22 110.674 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -57.21 -43.73 83.03 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.171 0.804 . . . . 72.32 113.171 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -59.14 -45.89 89.78 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.42 -0.956 . . . . 74.52 108.42 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.4 mt -71.47 -37.15 71.37 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.718 0.807 . . . . 74.31 111.879 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.82 80.99 11.46 Favored Pre-proline 0 C--O 1.241 0.642 0 C-N-CA 127.507 2.323 . . . . 72.11 112.043 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.37 -2.19 11.75 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 124.746 3.631 . . . . 70.12 112.306 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -90.26 -19.67 23.85 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.97 1.708 . . . . 74.01 110.584 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.8 mt -92.46 157.34 16.62 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.219 0.463 . . . . 73.22 112.146 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.4 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 41.7 t-80 -83.01 142.67 44.79 Favored Pre-proline 0 C--O 1.237 0.43 0 N-CA-C 106.229 -1.767 . . . . 75.14 106.229 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.5 ' HA ' HD12 ' A' ' 85' ' ' ILE . 20.1 Cg_endo -62.73 -28.98 76.74 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.751 2.3 . . . . 64.5 112.553 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HG2' ' CD1' ' A' ' 114' ' ' PHE . 2.2 tp10 -73.62 -41.61 62.59 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 122.112 -0.368 . . . . 63.03 111.466 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -61.24 -37.94 84.88 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.69 -0.631 . . . . 73.53 110.595 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 82' ' ' PRO . 97.5 mt -53.42 -58.3 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.47 1.108 . . . . 71.44 109.41 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.26 -47.76 18.09 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.971 0.805 . . . . 74.44 111.524 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -64.54 -42.76 95.51 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.179 0.9 . . . . 75.23 111.252 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.4 t -60.09 -46.24 90.25 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.03 -1.1 . . . . 45.3 108.03 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.28 -39.36 79.06 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.813 0.845 . . . . 62.14 111.025 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -69.42 -35.21 75.5 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.458 0.647 . . . . 74.45 111.395 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -72.39 -56.06 6.06 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.402 0.681 . . . . 73.3 110.454 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.8 p -68.73 -41.23 79.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.302 1.441 . . . . 73.02 113.341 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.86 -4.79 84.47 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.018 1.771 . . . . 74.3 113.439 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.4 m -142.23 134.58 27.83 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.507 1.153 . . . . 43.4 111.634 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.2 t -59.04 -48.48 86.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.173 0 N-CA-C 106.16 -1.792 . . . . 75.14 106.16 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.77 -42.23 64.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.904 0.882 . . . . 71.44 111.239 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -64.45 -45.04 89.17 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.53 -0.915 . . . . 70.52 108.53 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 58.3 m -59.51 -36.69 76.56 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.805 0.842 . . . . 74.12 110.315 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 65.9 t -74.67 -36.74 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.388 0.675 . . . . 72.23 110.138 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -71.47 -36.07 71.05 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.389 1.476 . . . . 71.13 111.192 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -79.34 -33.54 42.95 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.709 -0.848 . . . . 72.0 108.709 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -58.2 -55.73 31.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 118.925 -0.559 . . . . 74.53 109.59 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.41 -25.06 65.64 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.249 -0.881 . . . . 55.13 111.953 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -81.88 -8.02 59.65 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.238 0.926 . . . . 53.2 109.641 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.69 34.22 59.88 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 118.551 -1.139 . . . . 63.44 110.406 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -69.88 176.61 3.57 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 118.326 1.063 . . . . 74.3 110.127 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -75.7 147.25 39.53 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.844 -1.16 . . . . 73.55 109.33 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -138.9 109.08 6.41 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.325 -1.361 . . . . 75.44 107.325 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.4 m -94.66 164.95 12.74 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 124.237 1.015 . . . . 71.2 109.118 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -91.59 160.08 37.34 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.59 1.156 . . . . 74.43 109.7 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.39 165.35 29.23 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.213 1.942 . . . . 63.44 112.101 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.93 152.91 80.66 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.704 1.603 . . . . 73.41 108.528 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.73 -6.43 39.94 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.39 -1.228 . . . . 64.44 113.577 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . 0.415 ' CD1' ' HG2' ' A' ' 83' ' ' GLU . 85.9 t80 -77.49 -26.13 51.0 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.462 1.631 . . . . 73.22 110.547 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 116.964 -1.493 . . . . 74.3 109.841 179.789 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 110.404 -0.221 . . . . 73.42 110.404 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.97 126.49 10.02 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.476 2.117 . . . . 61.34 109.3 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.3 m -125.13 162.52 27.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.932 0.893 . . . . 62.52 109.083 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p -120.34 172.89 7.48 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.687 1.995 . . . . 73.11 108.228 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.9 m -65.03 -40.23 94.52 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 121.423 -0.798 . . . . 62.1 110.304 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -38.38 62.91 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 124.402 1.081 . . . . 73.34 112.111 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.3 mtp -63.66 -41.52 98.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.385 -0.822 . . . . 70.43 109.413 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.93 -56.46 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 124.999 1.32 . . . . 74.44 110.464 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -59.69 -39.76 85.61 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.005 -0.998 . . . . 72.21 109.75 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.403 ' CG2' HG11 ' A' ' 95' ' ' VAL . 57.8 m -56.41 -60.42 3.55 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 120.356 1.435 . . . . 71.43 109.96 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.5 t -53.92 -45.5 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 119.374 0.988 . . . . 52.24 108.531 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -53.49 -43.15 68.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.717 1.144 . . . . 62.33 113.014 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -66.91 -35.33 79.77 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.715 0.406 . . . . 72.43 110.293 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 mt -88.22 -12.25 44.32 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.262 0.483 . . . . 62.53 112.278 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -143.78 76.77 15.37 Favored Pre-proline 0 C--O 1.241 0.607 0 C-N-CA 126.363 1.865 . . . . 52.34 108.85 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.5 -13.72 33.07 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.376 2.717 . . . . 73.13 112.405 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.6 -7.99 58.89 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.467 1.507 . . . . 75.13 112.395 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.2 mt -97.48 152.97 18.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.25 0.932 . . . . 63.13 112.005 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.42 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 58.0 t-80 -69.54 144.56 94.33 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.828 1.651 . . . . 74.52 109.394 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 41.0 Cg_endo -66.89 -24.94 45.64 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.85 2.367 . . . . 74.12 114.152 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.76 -41.33 14.21 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 120.054 1.297 . . . . 63.45 111.725 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -57.04 -35.8 69.73 Favored 'General case' 0 C--N 1.343 0.308 0 O-C-N 123.657 0.598 . . . . 74.2 110.478 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 66.8 mt -53.64 -58.16 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 118.485 -0.769 . . . . 62.42 110.035 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.72 -45.24 48.93 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.474 0.579 . . . . 65.32 111.815 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -63.32 -44.57 94.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.783 -0.573 . . . . 74.14 111.144 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 p -60.67 -44.4 96.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 118.567 -0.73 . . . . 73.3 109.998 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.4 mt -60.4 -37.07 79.66 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.82 0.848 . . . . 74.31 110.04 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.1 -33.55 74.74 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.296 0.498 . . . . 64.52 110.269 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -79.04 -42.24 26.93 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.258 1.023 . . . . 75.45 113.537 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -83.52 -34.6 25.25 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.713 1.605 . . . . 74.42 112.537 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.88 -11.12 63.09 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.418 1.961 . . . . 33.1 111.899 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 m -144.87 150.93 37.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.346 1.573 . . . . 71.41 112.106 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.403 HG11 ' CG2' ' A' ' 72' ' ' THR . 78.1 t -62.63 -49.78 82.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 126.281 1.832 . . . . 63.4 107.97 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -45.33 -53.24 8.76 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 128.092 2.557 . . . . 75.01 111.792 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -66.66 -41.59 87.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.638 -0.71 . . . . 73.21 109.43 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.9 m -59.26 -39.29 82.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.012 0.925 . . . . 73.53 110.463 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.8 t -74.39 -38.25 46.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 124.107 0.963 . . . . 73.42 109.924 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -68.07 -41.62 81.67 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.355 1.062 . . . . 60.13 110.495 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 108' ' ' PHE . 5.6 ptm180 -74.12 -35.35 64.11 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.351 -0.843 . . . . 72.01 108.816 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -57.57 -57.33 13.15 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 118.539 -0.743 . . . . 74.34 109.457 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.29 -24.9 65.32 Favored 'General case' 0 C--N 1.339 0.118 0 O-C-N 123.575 0.547 . . . . 53.54 111.402 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -15.39 59.51 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 118.457 -0.782 . . . . 53.04 109.684 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.27 28.82 32.36 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 118.748 -1.029 . . . . 34.44 110.545 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.25 174.46 4.7 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.664 1.232 . . . . 71.55 109.02 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -86.13 147.74 26.01 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 120.587 -1.32 . . . . 65.42 108.776 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 101' ' ' ARG . 34.9 m-85 -139.1 109.72 6.63 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.632 -1.167 . . . . 72.22 109.694 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.9 m -82.12 170.71 15.18 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.382 1.073 . . . . 63.13 108.876 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -94.4 161.98 27.51 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 126.442 1.897 . . . . 73.11 110.848 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.53 158.46 57.6 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.619 2.213 . . . . 61.25 111.766 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.42 128.88 23.63 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.838 2.359 . . . . 72.2 110.612 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.61 -3.95 66.0 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 118.734 -1.037 . . . . 72.04 113.16 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -67.93 -31.18 70.76 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.416 1.608 . . . . 74.11 107.661 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 128.223 2.609 . . . . 63.41 106.835 179.227 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 118.741 -0.647 . . . . 75.01 110.545 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.99 140.2 22.58 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.898 3.065 . . . . 64.22 107.868 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.37 150.07 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.318 -0.864 . . . . 64.54 111.326 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.4 p -107.08 169.8 8.34 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.885 1.674 . . . . 73.24 111.952 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.8 m -58.22 -40.03 80.62 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.391 -0.814 . . . . 64.42 109.667 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -57.76 -35.12 70.31 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 118.81 0.732 . . . . 73.3 112.066 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 92.2 mtp -66.43 -42.84 87.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.216 -0.927 . . . . 62.42 109.171 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.38 -54.79 28.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 C-N-CA 124.625 1.17 . . . . 74.24 109.4 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -64.05 -35.75 81.75 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 118.127 -0.94 . . . . 44.45 111.78 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.415 ' CG2' HG11 ' A' ' 95' ' ' VAL . 27.4 m -57.59 -59.6 4.94 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.187 1.358 . . . . 72.24 109.037 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.4 t -55.91 -45.92 80.11 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 CA-C-O 117.749 -1.12 . . . . 53.12 109.225 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -54.27 -44.8 72.19 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 120.457 1.48 . . . . 74.22 112.771 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -61.07 -44.93 96.64 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.234 -1.024 . . . . 74.33 108.234 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.7 mt -76.34 -28.93 57.06 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.1 0.778 . . . . 63.53 113.1 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.31 78.4 71.44 Favored Pre-proline 0 C--O 1.242 0.666 0 C-N-CA 127.737 2.415 . . . . 73.24 110.153 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.43 -1.1 10.89 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.89 3.727 . . . . 74.44 113.309 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -95.71 2.8 54.16 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.331 1.453 . . . . 72.14 112.021 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.0 mt -108.43 156.22 19.7 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.68 1.192 . . . . 73.35 109.556 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.452 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 54.5 t-80 -79.49 147.53 68.14 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 107.539 -1.282 . . . . 74.34 107.539 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 37.7 Cg_endo -65.14 -22.88 61.0 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.873 2.382 . . . . 73.44 113.417 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.51 -37.08 28.42 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.567 -0.708 . . . . 71.22 110.12 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -58.54 -37.02 74.81 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 109.885 -0.413 . . . . 71.41 109.885 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 82' ' ' PRO . 47.2 mt -57.41 -60.8 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 117.471 -1.252 . . . . 70.43 109.813 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.45 -50.19 5.21 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.517 1.053 . . . . 75.05 110.918 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -63.2 -47.32 83.05 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.612 0.72 . . . . 75.45 111.998 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 m -57.1 -50.79 71.68 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.383 0.673 . . . . 54.12 109.23 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.0 mt -57.92 -39.83 78.93 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.3 1.04 . . . . 65.12 111.136 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -65.63 -32.0 73.33 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 122.478 0.311 . . . . 75.31 110.546 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -80.16 -51.32 9.11 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.646 -0.693 . . . . 50.45 111.094 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -71.41 -40.97 70.14 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.07 1.348 . . . . 65.31 113.145 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.52 -17.55 58.83 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.677 2.084 . . . . 21.14 113.102 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 t -143.33 147.87 35.39 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.426 1.613 . . . . 75.15 108.984 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.415 HG11 ' CG2' ' A' ' 72' ' ' THR . 31.1 t -59.8 -46.13 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 127.32 2.248 . . . . 75.31 109.27 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -47.62 -48.57 28.44 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.381 1.472 . . . . 64.53 110.48 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -67.84 -42.38 81.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.625 -0.509 . . . . 74.31 109.625 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.2 m -58.25 -36.64 73.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.066 0.547 . . . . 72.24 110.896 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 78.8 t -75.95 -38.71 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.402 1.081 . . . . 64.32 109.614 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -66.61 -38.7 87.52 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.03 1.332 . . . . 52.3 110.37 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -76.94 -37.52 55.16 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 121.057 -1.027 . . . . 73.43 108.649 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -56.29 -53.55 55.95 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.194 0.598 . . . . 74.24 109.743 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.79 -22.94 65.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 119.345 -0.36 . . . . 63.33 111.955 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -82.37 -10.15 59.18 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.796 0.726 . . . . 75.31 109.718 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.32 37.22 42.46 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.018 -1.233 . . . . 74.2 110.018 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.76 -171.72 0.43 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 117.645 0.723 . . . . 70.11 110.734 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -90.34 139.51 30.59 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 120.346 -1.471 . . . . 64.22 110.388 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -128.89 108.76 10.69 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.358 -1.349 . . . . 74.11 107.358 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.9 m -89.74 172.4 8.95 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.802 1.641 . . . . 75.21 110.349 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -107.49 152.87 41.52 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 125.747 1.619 . . . . 62.2 108.423 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.19 170.11 19.89 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 123.706 2.937 . . . . 71.13 112.874 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.01 152.52 82.1 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 N-CA-C 107.003 -1.96 . . . . 75.21 107.003 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.08 -18.96 13.86 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 118.045 -1.419 . . . . 62.42 112.495 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -72.42 -54.75 8.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 119.536 1.668 . . . . 73.25 107.316 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 C--O 1.253 1.264 0 N-CA-C 106.266 -1.753 . . . . 75.13 106.266 179.508 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 35.6 m80 . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 108.304 -0.998 . . . . 64.14 108.304 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.31 126.08 9.53 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.933 1.756 . . . . 71.03 109.084 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.2 m -126.48 161.16 33.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 O-C-N 121.306 -0.871 . . . . 43.12 109.836 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 p -125.09 164.18 20.78 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.96 2.104 . . . . 70.44 109.813 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.0 m -59.17 -39.39 82.36 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.757 0.708 . . . . 72.51 110.744 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.3 -33.66 67.9 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.398 0.679 . . . . 74.12 111.983 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.8 mtp -65.72 -46.84 77.44 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 120.638 -1.289 . . . . 71.02 107.696 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.7 t -50.77 -58.66 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.499 0 C-N-CA 126.703 2.001 . . . . 72.43 109.853 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -59.73 -37.18 78.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 118.283 -0.865 . . . . 73.42 110.559 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -54.82 -60.69 3.01 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 120.272 1.396 . . . . 63.05 109.071 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.8 t -54.91 -51.89 48.63 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-O 118.06 -0.972 . . . . 71.21 108.847 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.41 -42.89 54.41 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.044 0.838 . . . . 74.25 113.05 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -65.21 -40.1 93.69 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 118.961 0.801 . . . . 73.13 109.289 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.5 mt -82.98 -16.24 48.0 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.083 0.772 . . . . 53.45 113.083 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.37 72.36 65.35 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 129.208 3.003 . . . . 73.04 109.528 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.82 -12.38 30.8 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.225 1.95 . . . . 64.4 112.486 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -84.25 13.23 5.46 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.383 1.473 . . . . 74.31 112.618 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.1 mt -121.12 158.78 27.18 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.504 1.122 . . . . 55.5 110.663 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -81.86 141.91 48.14 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 107.7 -1.222 . . . . 75.22 107.7 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.464 ' HA ' HD12 ' A' ' 85' ' ' ILE . 38.7 Cg_endo -63.64 -26.35 69.05 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.654 2.236 . . . . 75.34 112.813 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.37 -39.5 53.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.748 -0.595 . . . . 54.13 111.942 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -60.25 -45.58 92.78 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.83 -0.433 . . . . 60.33 109.83 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 82' ' ' PRO . 95.2 mt -47.53 -55.58 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 126.272 1.829 . . . . 50.0 111.03 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -45.69 49.33 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.911 0.778 . . . . 73.51 111.447 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -64.1 -40.07 95.43 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.773 -1.204 . . . . 72.5 110.955 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.0 m -57.82 -55.77 30.6 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.042 1.337 . . . . 74.3 108.256 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.11 -39.99 76.15 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.704 1.202 . . . . 73.32 111.238 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.19 -33.93 77.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 119.553 -0.859 . . . . 70.14 110.698 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -76.96 -48.68 17.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 118.395 -0.812 . . . . 73.21 111.969 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.4 p -73.49 -40.98 63.67 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.627 1.571 . . . . 75.22 111.5 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.14 -4.14 84.12 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 127.363 2.411 . . . . 63.02 111.853 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 m -144.54 140.76 29.02 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.798 1.239 . . . . 61.43 110.704 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.22 -45.83 95.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 124.909 1.284 . . . . 51.21 108.439 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -47.8 -48.67 30.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.345 1.858 . . . . 62.32 111.362 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.72 -47.63 77.59 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 108.591 -0.892 . . . . 71.32 108.591 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 m -54.83 -41.7 71.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.548 1.539 . . . . 73.21 112.044 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.4 t -76.76 -34.5 23.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 121.503 -0.748 . . . . 53.04 110.364 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -73.19 -32.06 64.58 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.985 0.914 . . . . 71.14 111.197 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.464 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 3.9 ptm180 -82.19 -34.93 28.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.42 -0.956 . . . . 73.21 108.42 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -55.92 -55.1 36.67 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 108.298 -1.001 . . . . 62.12 108.298 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.32 -24.78 66.68 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 119.335 -0.364 . . . . 72.22 111.219 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 101' ' ' ARG . 0.1 OUTLIER -74.68 -17.23 60.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.153 0.888 . . . . 70.12 108.962 178.205 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.83 35.12 28.96 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.318 -1.513 . . . . 71.11 109.318 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -70.61 -173.0 0.69 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.129 0.964 . . . . 73.13 110.047 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -89.71 144.48 25.95 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 119.523 -1.986 . . . . 75.02 108.529 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -136.69 109.44 7.54 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.242 -1.344 . . . . 63.44 108.895 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.63 173.44 8.05 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.179 1.392 . . . . 73.22 110.932 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -103.8 158.75 31.23 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.096 1.758 . . . . 72.31 109.074 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.0 161.88 40.61 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.485 2.123 . . . . 70.51 112.867 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -67.9 136.05 37.18 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.067 1.845 . . . . 52.43 109.688 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.34 -2.55 71.2 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.488 1.042 . . . . 73.34 111.388 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -75.52 -35.98 60.62 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.03 0.915 . . . . 71.53 109.838 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 . . . . . 0 C--O 1.248 1.007 0 C-N-CA 125.847 1.659 . . . . 71.54 110.982 -179.26 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 107.529 -1.285 . . . . 75.04 107.529 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.84 148.84 36.62 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.819 2.346 . . . . 74.53 109.268 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.35 165.64 30.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-O 121.619 0.723 . . . . 75.22 110.201 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 p -125.36 157.24 37.26 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.152 1.781 . . . . 74.31 107.387 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.9 m -54.31 -36.7 64.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.354 0.662 . . . . 73.13 111.149 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -32.59 68.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.144 0.978 . . . . 73.42 111.948 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.7 mtp -69.9 -40.75 75.44 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.036 -1.098 . . . . 71.33 108.036 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 t -59.94 -58.02 9.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.971 1.308 . . . . 73.54 109.349 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -60.01 -36.05 76.37 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 118.341 -0.837 . . . . 64.14 110.877 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.436 ' CG2' HG11 ' A' ' 95' ' ' VAL . 82.2 m -58.03 -61.72 2.34 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.958 1.254 . . . . 61.44 108.863 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.411 HG21 HD21 ' A' ' 89' ' ' LEU . 61.3 t -54.9 -43.98 70.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 119.481 1.037 . . . . 71.22 109.39 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -55.2 -48.07 74.38 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 119.655 1.116 . . . . 43.52 111.525 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -59.03 -39.68 82.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.12 0.968 . . . . 65.23 110.324 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.2 mt -86.63 -19.75 28.86 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.109 0.781 . . . . 75.22 113.109 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.05 77.91 74.79 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.847 2.059 . . . . 43.42 109.032 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.49 -0.24 6.41 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.294 3.33 . . . . 64.1 113.602 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.45 20.51 18.12 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.287 1.035 . . . . 72.32 111.749 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.2 mt -123.37 154.5 38.89 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.905 1.282 . . . . 73.14 110.039 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.467 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 48.5 t-80 -86.27 147.72 45.47 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-O 118.495 -0.764 . . . . 71.54 109.104 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 40.3 Cg_endo -63.57 -32.1 70.17 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.315 2.677 . . . . 53.21 112.752 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 81' ' ' HIS . 0.1 OUTLIER -74.82 -44.65 48.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.884 -0.413 . . . . 75.35 109.884 -178.329 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -59.27 -39.81 84.08 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 108.834 -0.802 . . . . 71.24 108.834 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 82' ' ' PRO . 48.5 mt -57.52 -59.59 3.11 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 N-CA-C 107.84 -1.171 . . . . 75.5 107.84 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.08 -47.06 34.33 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.395 0.998 . . . . 70.12 111.596 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -62.01 -44.25 97.13 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.205 0.911 . . . . 71.43 111.494 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m -63.75 -41.29 98.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.414 -0.587 . . . . 75.34 109.414 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.411 HD21 HG21 ' A' ' 73' ' ' VAL . 87.9 mt -61.62 -37.77 85.18 Favored 'General case' 0 C--O 1.225 -0.236 0 O-C-N 121.229 -0.92 . . . . 72.34 110.38 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -69.9 -37.31 75.96 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 117.992 0.36 . . . . 62.02 111.078 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -74.77 -53.06 9.88 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 122.171 -0.331 . . . . 73.43 111.137 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.7 p -67.14 -41.88 85.35 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.068 0.947 . . . . 73.42 111.486 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.28 -15.0 64.19 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 128.335 2.874 . . . . 73.24 113.806 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.0 m -139.55 148.5 42.66 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.636 1.718 . . . . 71.23 111.763 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.436 HG11 ' CG2' ' A' ' 72' ' ' THR . 51.1 t -61.7 -50.99 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 106.342 -1.725 . . . . 65.03 106.342 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -50.86 -48.36 60.12 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.756 1.622 . . . . 71.22 111.101 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.71 -42.56 99.71 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.729 1.211 . . . . 73.42 109.179 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.5 m -65.0 -38.45 90.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.857 1.263 . . . . 52.42 110.807 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.9 t -73.35 -39.81 55.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 121.339 -0.85 . . . . 62.11 109.66 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -65.19 -38.97 92.18 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.474 1.51 . . . . 60.2 111.015 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -77.58 -35.53 52.92 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.592 -0.892 . . . . 61.53 108.592 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -57.17 -57.59 11.91 Favored 'General case' 0 C--O 1.233 0.226 0 O-C-N 121.255 -0.903 . . . . 74.31 110.53 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.47 -23.95 59.06 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.429 0.692 . . . . 74.54 111.179 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -12.11 59.24 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 117.845 -1.074 . . . . 50.51 111.464 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.06 22.7 51.67 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.786 -1.008 . . . . 73.51 112.317 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -67.25 172.99 4.19 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.635 1.217 . . . . 61.44 111.101 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -77.19 144.59 38.21 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.822 1.649 . . . . 74.02 109.985 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -137.43 110.11 7.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.895 1.278 . . . . 61.33 107.804 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -92.97 167.99 11.44 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.503 -1.226 . . . . 71.2 110.169 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -94.21 158.81 35.32 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 124.671 1.189 . . . . 74.22 109.221 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -67.99 166.99 22.87 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.473 2.782 . . . . 51.35 114.483 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.42 143.92 89.61 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.025 1.817 . . . . 63.12 108.147 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.12 3.45 88.33 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.094 -0.837 . . . . 45.32 112.915 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -84.36 -41.37 16.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.425 1.613 . . . . 74.33 110.981 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 C--O 1.254 1.302 0 CA-C-O 118.013 -0.994 . . . . 72.11 110.86 -179.091 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 41.5 m80 . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 109.389 -0.597 . . . . 74.21 109.389 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.3 125.93 7.36 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.568 2.845 . . . . 74.1 110.321 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.92 143.61 29.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 122.747 1.26 . . . . 45.15 111.731 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p -112.04 161.02 16.93 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.579 1.951 . . . . 70.33 109.197 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.7 m -52.67 -38.96 61.38 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.82 1.248 . . . . 71.12 111.917 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -59.47 -31.67 69.54 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.483 1.113 . . . . 71.22 112.317 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 91.6 mtp -71.91 -45.87 59.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.455 -0.943 . . . . 63.24 108.455 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.4 t -59.98 -52.33 62.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.893 0.877 . . . . 73.42 109.883 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.53 -41.1 98.49 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-O 117.342 -1.313 . . . . 74.34 110.315 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.475 ' CG2' HG11 ' A' ' 95' ' ' VAL . 61.3 m -52.6 -60.38 3.32 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 120.602 1.546 . . . . 70.44 108.71 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.473 HG23 HG13 ' A' ' 95' ' ' VAL . 92.8 t -55.27 -50.53 64.02 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 CA-C-O 118.052 -0.975 . . . . 61.22 109.206 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -54.72 -44.41 73.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 119.716 1.144 . . . . 71.31 113.838 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -59.88 -43.77 94.57 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.931 1.293 . . . . 45.53 108.64 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.9 mt -81.59 -26.82 34.62 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.049 0.759 . . . . 54.34 113.049 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.93 73.39 35.27 Favored Pre-proline 0 N--CA 1.447 -0.578 0 C-N-CA 127.655 2.382 . . . . 72.53 111.498 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.81 -3.6 13.48 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.522 2.148 . . . . 64.22 111.312 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.11 18.68 10.35 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 128.345 2.658 . . . . 61.12 111.094 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.7 mt -133.83 154.82 50.75 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.351 1.461 . . . . 74.05 111.001 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -80.53 142.32 53.58 Favored Pre-proline 0 C--O 1.236 0.383 0 N-CA-C 107.416 -1.327 . . . . 72.32 107.416 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HA ' HD12 ' A' ' 85' ' ' ILE . 37.0 Cg_endo -66.33 -29.02 46.63 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.642 2.228 . . . . 64.41 113.022 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -75.43 -41.1 56.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.756 -0.59 . . . . 74.12 110.809 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -59.73 -41.92 91.97 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.634 -0.506 . . . . 63.52 109.634 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 82' ' ' PRO . 86.3 mt -51.36 -58.51 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 124.066 0.946 . . . . 72.13 108.984 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.05 -47.01 11.76 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.548 0.739 . . . . 73.54 111.619 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -64.53 -48.49 74.89 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.419 0.628 . . . . 73.11 111.489 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.4 m -56.92 -47.7 79.99 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 108.173 -1.047 . . . . 70.25 108.173 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.52 -39.74 77.23 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 124.584 1.154 . . . . 74.45 111.095 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -66.94 -31.64 72.35 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.168 0.44 . . . . 75.42 110.784 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -77.66 -50.59 12.15 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.209 0.448 . . . . 72.35 112.209 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -74.58 -41.94 59.62 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.952 1.701 . . . . 43.13 112.794 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.14 -12.02 69.11 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 126.671 2.081 . . . . 71.4 116.507 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 t -145.32 123.1 11.9 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 121.467 2.633 . . . . 64.41 111.706 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.475 HG11 ' CG2' ' A' ' 72' ' ' THR . 84.6 t -41.88 -41.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 120.366 1.439 . . . . 72.05 112.819 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -49.89 -43.61 49.55 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 124.694 1.246 . . . . 73.54 111.67 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -67.63 -42.83 81.68 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 121.092 -1.005 . . . . 71.13 109.489 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.8 m -60.45 -39.01 86.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.131 0.572 . . . . 74.21 111.114 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.36 -39.1 76.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.21 -0.663 . . . . 54.12 109.21 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -66.83 -41.02 88.13 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.622 0.769 . . . . 75.33 111.456 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -75.4 -35.36 61.04 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 121.104 -0.997 . . . . 63.31 109.619 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -57.4 -57.4 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.212 -0.93 . . . . 72.35 110.009 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.69 -22.16 56.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.951 0.722 . . . . 74.4 112.951 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -5.19 56.53 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.796 0.725 . . . . 64.24 110.953 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.15 36.81 50.28 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 118.519 0.6 . . . . 73.43 112.322 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -69.98 -178.46 1.6 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.211 1.006 . . . . 72.04 111.013 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.75 131.26 35.21 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.698 -1.251 . . . . 63.23 110.257 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -130.92 109.89 10.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.462 -1.681 . . . . 74.52 106.462 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.3 m -96.79 168.6 10.4 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.707 0.803 . . . . 54.22 110.084 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -91.23 155.91 44.16 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 107.326 -1.361 . . . . 73.44 107.326 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.57 168.51 21.1 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.759 2.306 . . . . 53.44 113.722 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.33 149.44 91.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.37 2.047 . . . . 72.13 108.921 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.12 -12.07 13.7 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.564 -1.131 . . . . 62.34 113.207 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -68.96 -24.41 64.25 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.715 1.758 . . . . 74.3 109.381 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 130.757 3.623 . . . . 71.15 105.212 178.183 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 119.188 -0.434 . . . . 61.44 110.605 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.79 143.7 21.26 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.884 3.056 . . . . 71.41 111.127 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.0 m -134.17 167.07 27.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-O 122.026 0.917 . . . . 55.14 109.943 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 p -125.36 161.15 27.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.119 1.768 . . . . 72.42 107.802 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.5 m -57.96 -38.01 75.22 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.124 0.57 . . . . 74.42 110.588 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -35.9 69.45 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 119.336 -0.364 . . . . 63.42 111.63 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.0 mtp -64.29 -38.88 92.62 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.044 0.838 . . . . 70.32 109.537 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.0 t -63.96 -57.41 11.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 124.552 1.141 . . . . 75.22 110.767 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -59.62 -40.23 86.86 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 118.444 -0.789 . . . . 75.23 110.73 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.2 m -58.62 -58.21 9.58 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.321 1.419 . . . . 71.53 108.57 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.533 HG23 HG13 ' A' ' 95' ' ' VAL . 53.0 t -52.52 -50.23 40.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 CA-C-O 118.249 -0.881 . . . . 74.22 109.469 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -54.08 -45.58 71.81 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.928 0.785 . . . . 53.51 111.375 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -59.49 -36.84 76.8 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.016 0.926 . . . . 74.1 110.688 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.0 mt -89.84 -14.92 33.35 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.034 0.753 . . . . 74.12 113.034 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.27 71.12 61.21 Favored Pre-proline 0 N--CA 1.448 -0.551 0 C-N-CA 126.927 2.091 . . . . 75.31 110.993 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.67 -15.41 49.19 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.286 1.99 . . . . 74.13 112.408 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.32 -13.86 59.85 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.072 1.349 . . . . 72.13 112.003 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.2 mt -92.05 156.48 17.37 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.315 0.961 . . . . 61.32 111.376 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.442 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 58.3 t-80 -80.42 146.11 60.94 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 106.474 -1.676 . . . . 74.13 106.474 178.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 36.4 Cg_endo -65.45 -30.16 52.97 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.092 1.862 . . . . 63.33 113.187 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.58 -34.92 46.51 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 121.77 -0.582 . . . . 72.41 110.863 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -64.47 -35.92 82.49 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.677 -0.86 . . . . 71.14 108.677 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.3 mt -54.94 -60.82 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 C-N-CA 124.583 1.153 . . . . 73.32 109.749 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -46.63 -48.64 19.85 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 118.558 0.617 . . . . 74.22 110.8 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.405 ' CE1' ' HD3' ' A' ' 112' ' ' PRO . 4.1 t80 -59.37 -44.9 92.67 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.812 0.815 . . . . 73.33 112.391 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 p -62.79 -43.4 98.89 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.165 -0.47 . . . . 73.22 110.01 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.431 HD21 ' CG2' ' A' ' 73' ' ' VAL . 52.0 mt -60.35 -38.47 83.91 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.816 -0.552 . . . . 72.22 111.678 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -70.57 -28.44 64.9 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.169 0.587 . . . . 73.2 109.834 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -85.33 -43.59 13.56 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 114.453 1.279 . . . . 75.4 114.453 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.7 p -79.57 -41.44 27.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.692 1.197 . . . . 63.43 111.411 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.51 0.86 88.02 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 118.745 -1.031 . . . . 64.25 112.379 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.27 129.5 18.74 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.393 1.477 . . . . 63.11 111.297 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.533 HG13 HG23 ' A' ' 73' ' ' VAL . 44.3 t -61.56 -46.51 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 105.551 -2.018 . . . . 74.45 105.551 177.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -55.89 -45.66 78.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.48 -0.772 . . . . 74.12 110.013 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -59.03 -43.8 91.67 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.74 0.7 . . . . 64.54 110.029 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.1 m -61.17 -42.41 98.51 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.297 1.839 . . . . 63.43 110.872 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.0 t -74.63 -38.27 45.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 121.672 -0.642 . . . . 75.02 109.966 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -66.62 -37.49 84.97 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 125.191 1.396 . . . . 72.02 111.056 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -77.81 -39.58 43.31 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.861 -1.162 . . . . 74.0 107.861 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -55.23 -52.07 64.56 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 120.564 -1.335 . . . . 71.43 111.908 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.5 -16.13 33.97 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 113.662 0.986 . . . . 73.22 113.662 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.58 -11.66 42.05 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.813 0.845 . . . . 73.3 109.569 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.72 28.45 32.14 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 118.707 -1.052 . . . . 62.11 111.375 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -64.33 -178.22 0.35 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.859 1.263 . . . . 74.23 112.987 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -87.08 137.91 31.94 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 126.449 1.9 . . . . 64.23 111.549 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -141.85 109.91 5.87 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.19 1.396 . . . . 75.21 111.93 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.2 m -83.11 176.95 8.82 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.843 0.857 . . . . 73.25 110.369 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -105.54 157.17 35.13 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 127.366 2.266 . . . . 62.11 107.308 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.42 154.5 73.64 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.125 1.883 . . . . 73.44 112.197 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.405 ' HD3' ' CE1' ' A' ' 87' ' ' TYR . 36.4 Cg_endo -60.98 123.34 12.73 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 124.457 3.438 . . . . 72.44 110.703 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.8 -4.22 53.13 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 124.842 1.21 . . . . 41.43 111.811 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -78.22 -34.37 49.32 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.83 1.815 . . . . 64.14 109.606 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 . . . . . 0 C--O 1.247 0.937 0 C-N-CA 125.452 1.501 . . . . 72.21 111.542 -178.526 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 107.291 -1.374 . . . . 74.43 107.291 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.28 142.44 27.05 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 121.99 1.793 . . . . 53.04 108.96 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.12 160.89 40.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.187 0.995 . . . . 70.2 108.323 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -124.62 159.11 31.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.296 -1.742 . . . . 65.14 106.296 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -59.73 -30.02 68.54 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 120.961 -1.087 . . . . 61.34 112.543 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -57.95 -33.57 68.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.465 1.029 . . . . 74.25 111.047 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.1 mtp -66.96 -43.37 83.28 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.229 -0.919 . . . . 72.51 108.61 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 t -57.1 -56.36 15.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 125.184 1.394 . . . . 74.41 110.827 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -59.09 -38.57 79.81 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 117.704 -1.141 . . . . 55.53 109.464 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.4 m -56.59 -58.97 5.77 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 120.278 1.399 . . . . 71.14 110.393 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.9 t -53.55 -45.77 59.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-N 119.384 0.993 . . . . 74.54 109.037 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.07 -50.14 67.43 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.209 0.913 . . . . 70.32 112.687 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -58.85 -40.87 85.54 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.693 0.797 . . . . 65.32 110.98 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.9 mt -83.9 -22.54 31.55 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.663 0.616 . . . . 63.41 112.663 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.17 72.54 81.35 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 127.104 2.162 . . . . 71.11 109.826 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.54 -6.26 18.06 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.007 3.138 . . . . 61.4 113.964 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.6 4.89 50.04 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.82 -1.175 . . . . 71.12 111.016 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.3 mt -109.93 161.02 15.89 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 120.678 -1.264 . . . . 51.55 110.419 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -81.89 144.9 52.45 Favored Pre-proline 0 N--CA 1.453 -0.317 0 C-N-CA 124.604 1.162 . . . . 63.34 108.551 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.539 ' HA ' HD12 ' A' ' 85' ' ' ILE . 56.7 Cg_endo -70.6 -25.32 24.85 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.009 2.473 . . . . 74.11 113.634 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.65 -39.17 32.04 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.665 0.666 . . . . 75.45 110.328 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -57.29 -44.2 83.84 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.034 0.534 . . . . 75.13 110.629 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 82' ' ' PRO . 59.9 mt -47.56 -54.75 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 C-N-CA 125.04 1.336 . . . . 70.23 112.471 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.43 -46.34 37.49 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.34 0.518 . . . . 73.4 111.475 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -65.29 -42.74 92.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.633 -0.667 . . . . 74.04 111.263 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 m -60.0 -47.01 87.6 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 122.922 0.489 . . . . 73.5 109.721 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.41 -37.41 85.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.826 0.85 . . . . 63.12 110.697 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -69.92 -34.31 73.32 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.594 0.633 . . . . 74.22 110.38 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -74.87 -46.99 32.53 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.575 0.75 . . . . 61.33 112.485 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.9 p -77.77 -41.03 38.87 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.321 1.049 . . . . 70.32 111.49 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.92 -14.01 64.43 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 127.413 2.435 . . . . 61.4 112.588 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.2 m -144.09 150.08 37.57 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 120.115 1.957 . . . . 45.52 112.658 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.68 -50.97 73.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 126.275 1.83 . . . . 74.02 107.148 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -49.99 -46.76 52.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.151 1.38 . . . . 73.33 109.987 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -65.07 -46.57 80.6 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.374 0.67 . . . . 75.25 109.936 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 89.0 m -59.05 -37.07 76.14 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.873 1.269 . . . . 75.45 111.729 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.2 t -77.55 -36.72 23.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 123.62 0.768 . . . . 74.05 109.583 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -66.16 -35.33 80.2 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 125.151 1.38 . . . . 72.1 110.873 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -81.4 -36.12 29.89 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.94 -1.1 . . . . 74.32 108.608 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -56.67 -55.36 35.05 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.614 -0.679 . . . . 74.33 110.366 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -59.87 -19.97 54.41 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.34 0.867 . . . . 74.11 113.34 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -13.22 41.43 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.105 0.562 . . . . 61.15 110.426 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.25 20.98 39.86 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 118.921 -0.933 . . . . 64.4 113.469 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -63.71 174.35 1.42 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.442 1.097 . . . . 74.53 111.221 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -83.12 141.54 31.9 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.673 1.189 . . . . 75.35 111.712 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -128.58 109.91 11.78 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.268 1.827 . . . . 70.33 108.433 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.2 m -93.78 173.9 7.45 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.205 1.002 . . . . 61.11 111.404 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -105.03 156.62 35.8 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.963 1.305 . . . . 73.13 108.873 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.65 158.59 56.47 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.75 2.3 . . . . 75.21 114.488 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.39 116.82 4.7 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 105.769 -2.435 . . . . 73.35 105.769 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.25 -17.62 7.47 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-O 117.683 -1.621 . . . . 75.2 111.83 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -66.09 -27.75 68.3 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.577 1.189 . . . . 74.5 111.803 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 . . . . . 0 C--O 1.248 1.018 0 N-CA-C 105.167 -2.16 . . . . 72.04 105.167 178.363 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 . . . . . 0 C--O 1.236 0.374 0 CA-C-O 119.353 -0.356 . . . . 64.21 110.409 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.67 133.89 16.12 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.701 2.934 . . . . 75.21 108.905 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 m -134.85 152.6 33.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.644 0.778 . . . . 65.42 109.942 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.35 164.04 21.26 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.706 1.203 . . . . 65.21 110.488 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -45.54 -47.46 14.34 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.154 2.181 . . . . 70.1 112.313 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -57.53 -34.59 69.29 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.715 0.806 . . . . 61.44 112.761 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 84.4 mtp -67.93 -39.78 83.43 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.968 -0.753 . . . . 74.53 108.968 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 t -58.88 -57.41 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.037 1.335 . . . . 71.2 110.485 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -58.6 -42.08 87.28 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-O 117.989 -1.005 . . . . 72.33 110.02 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -55.78 -60.13 3.89 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 120.057 1.299 . . . . 74.45 109.841 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.0 t -51.67 -49.49 34.65 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-O 118.836 -0.602 . . . . 75.55 109.969 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -51.26 -48.16 62.24 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.516 0.726 . . . . 73.13 112.211 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -59.49 -43.41 93.33 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.506 -0.553 . . . . 62.44 109.506 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mt -80.41 -13.07 59.44 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.972 0.73 . . . . 73.11 112.972 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.14 69.86 34.54 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.993 2.117 . . . . 71.33 110.861 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.28 -2.86 9.76 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.164 2.576 . . . . 72.53 113.254 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -86.69 -10.88 52.77 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.629 1.572 . . . . 53.5 110.465 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.69 158.52 15.46 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.494 -0.754 . . . . 63.42 112.277 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -81.93 147.14 57.38 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.971 -1.122 . . . . 73.23 107.971 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.94 -29.97 67.13 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.392 2.061 . . . . 72.42 112.837 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.28 -39.43 28.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.946 -0.471 . . . . 62.12 112.173 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -60.66 -41.42 94.98 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.62 -0.511 . . . . 60.12 109.62 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.1 mt -51.86 -59.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.556 0.742 . . . . 71.42 109.09 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.95 -44.75 30.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.425 0.69 . . . . 74.33 111.388 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -65.92 -43.42 88.18 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.145 -0.972 . . . . 72.44 112.817 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -66.99 -37.65 84.61 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.346 -0.983 . . . . 63.05 108.346 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.4 mt -61.25 -38.19 85.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.547 -1.279 . . . . 63.51 107.547 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -67.58 -34.44 77.03 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.949 0.795 . . . . 75.12 109.676 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -71.74 -51.85 20.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 119.008 -0.52 . . . . 61.0 112.364 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.9 p -74.77 -40.99 60.87 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.497 1.519 . . . . 54.13 112.708 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.66 -4.14 86.18 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.624 1.107 . . . . 71.42 111.447 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -144.48 135.03 24.67 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.806 1.803 . . . . 62.33 111.836 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.2 t -55.12 -52.43 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.9 1.68 . . . . 74.25 108.631 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -47.55 -47.45 28.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 126.571 1.949 . . . . 74.23 111.574 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -65.21 -44.65 87.65 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.17 -0.678 . . . . 73.43 109.17 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -56.92 -43.01 80.98 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.827 1.251 . . . . 71.22 111.319 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.0 t -73.89 -36.1 44.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 120.717 -1.239 . . . . 63.43 109.519 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -65.78 -45.09 83.76 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.584 1.154 . . . . 74.25 110.383 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -69.06 -36.43 77.64 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.748 -1.22 . . . . 72.2 108.681 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -58.25 -57.22 13.86 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.68 -0.489 . . . . 61.33 109.68 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.15 -23.3 63.8 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.912 -0.566 . . . . 73.12 111.927 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 ptm85 -82.83 -12.07 57.73 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.408 1.004 . . . . 65.42 110.598 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.11 22.91 39.76 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 125.83 1.681 . . . . 45.35 113.65 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.4 169.08 14.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.856 1.328 . . . . 70.44 110.742 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -80.32 146.85 31.37 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.698 0.999 . . . . 70.42 113.698 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -130.32 109.92 11.13 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.011 1.324 . . . . 73.24 107.826 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.7 m -87.66 176.54 7.38 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.213 -1.358 . . . . 64.11 108.802 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -108.27 156.18 38.94 Favored Pre-proline 0 N--CA 1.467 0.379 0 C-N-CA 124.462 1.105 . . . . 72.3 109.193 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.62 157.24 59.28 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.76 2.307 . . . . 74.12 112.661 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.7 149.82 88.32 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.748 1.632 . . . . 70.52 108.604 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.08 -16.41 59.67 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.575 -1.125 . . . . 65.44 111.733 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -77.9 -43.49 29.91 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.132 1.466 . . . . 71.14 108.708 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 C--O 1.246 0.871 0 CA-C-O 117.481 -1.247 . . . . 73.44 109.277 178.411 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 110.088 -0.338 . . . . 71.12 110.088 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.53 126.78 9.23 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.736 2.957 . . . . 61.43 109.12 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 m -122.83 162.16 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.156 0.583 . . . . 73.4 109.65 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.9 p -124.17 167.65 13.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.453 1.101 . . . . 62.52 110.178 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.62 -43.46 72.27 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.6 1.16 . . . . 64.25 111.296 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -32.8 67.19 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 125.528 1.531 . . . . 71.22 111.655 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 93.5 mtp -67.07 -45.31 77.71 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.462 -0.94 . . . . 63.2 108.462 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 t -57.58 -57.24 11.09 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 CA-C-O 119.061 -0.495 . . . . 73.0 110.477 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -57.64 -39.93 78.11 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 117.638 -1.172 . . . . 71.43 111.138 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.405 ' CG2' HG11 ' A' ' 95' ' ' VAL . 40.8 m -56.34 -61.81 2.15 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.222 1.374 . . . . 74.42 108.29 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.6 t -57.26 -45.1 84.86 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 CA-C-N 119.16 0.891 . . . . 74.23 110.055 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.66 -39.03 67.65 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.451 1.478 . . . . 51.11 113.757 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -69.61 -44.6 70.38 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.103 -1.073 . . . . 53.32 108.103 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 37.6 mt -71.45 -28.4 63.93 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.054 -0.521 . . . . 64.5 111.207 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.13 75.76 67.65 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 128.997 2.919 . . . . 74.24 111.001 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.61 -4.92 16.2 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.431 2.087 . . . . 63.22 111.148 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -91.19 5.57 48.55 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.939 1.695 . . . . 70.14 112.417 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.3 mt -118.41 162.79 17.74 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.81 1.244 . . . . 70.32 110.817 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.421 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 49.7 t-80 -87.85 146.22 38.37 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 107.386 -1.338 . . . . 71.43 107.386 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 33.7 Cg_endo -64.29 -23.76 65.58 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.667 2.245 . . . . 74.45 112.123 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -78.13 -43.58 28.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 121.327 -0.858 . . . . 64.45 112.385 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -58.35 -45.51 88.03 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.777 -0.823 . . . . 51.44 108.777 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 63.8 mt -51.89 -59.07 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.369 1.068 . . . . 73.51 108.491 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.33 -47.37 25.78 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.402 1.001 . . . . 75.42 112.161 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -65.85 -38.01 87.71 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 122.77 1.271 . . . . 70.14 111.675 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.5 t -62.48 -50.32 71.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.556 -1.276 . . . . 54.51 107.556 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.3 mt -57.91 -35.97 71.79 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 126.117 1.767 . . . . 71.43 109.333 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -67.86 -36.82 80.96 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.521 1.055 . . . . 74.3 109.526 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -76.87 -53.15 8.26 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.232 0.469 . . . . 61.43 111.992 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.7 p -67.01 -40.96 87.41 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.87 1.268 . . . . 53.14 110.897 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.92 -6.12 81.96 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.867 2.175 . . . . 63.14 113.247 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.5 m -144.28 143.75 31.16 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.163 1.482 . . . . 62.54 110.82 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.405 HG11 ' CG2' ' A' ' 72' ' ' THR . 42.2 t -61.96 -47.81 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 C-N-CA 126.184 1.793 . . . . 62.42 108.171 178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -50.38 -48.51 55.78 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.204 1.002 . . . . 52.51 111.717 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -63.78 -39.13 93.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.132 0.492 . . . . 73.31 109.939 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.5 m -63.77 -37.31 86.91 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.287 1.435 . . . . 75.42 110.498 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.09 -41.43 59.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.904 -1.147 . . . . 64.22 107.904 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -63.3 -35.17 79.48 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.76 1.224 . . . . 74.44 111.693 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -81.01 -39.0 26.55 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.254 -0.647 . . . . 74.42 109.254 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -56.55 -52.67 63.89 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.53 -0.731 . . . . 75.25 111.333 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.94 -19.97 61.55 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.744 0.646 . . . . 75.0 112.744 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -86.6 -12.57 48.21 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.167 -0.92 . . . . 74.35 110.334 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.81 37.06 13.98 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 108.63 -1.788 . . . . 74.23 108.63 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -74.84 172.36 12.34 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.582 -0.952 . . . . 72.42 110.999 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -78.99 131.61 36.37 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.423 1.089 . . . . 63.13 110.147 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -129.1 109.95 11.61 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.502 -1.296 . . . . 74.52 107.502 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.4 m -97.2 177.57 5.53 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.178 1.391 . . . . 64.15 108.954 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -104.84 158.64 31.58 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.42 1.088 . . . . 75.42 110.41 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.36 162.65 41.71 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.479 2.12 . . . . 52.43 112.97 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.68 133.98 45.03 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.383 2.055 . . . . 73.21 109.109 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.03 -11.52 64.02 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 118.811 -0.994 . . . . 73.03 112.641 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -77.17 -28.46 54.08 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.642 1.721 . . . . 71.32 111.717 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.021 -0.99 . . . . 61.44 110.334 -179.166 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 . . . . . 0 CA--C 1.534 0.347 0 N-CA-C 108.193 -1.04 . . . . 73.12 108.193 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.86 140.51 32.02 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.038 1.825 . . . . 74.43 110.245 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.81 165.65 30.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 124.725 1.21 . . . . 64.12 108.707 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -124.31 163.62 21.3 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.541 1.537 . . . . 74.21 108.247 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -55.06 -42.35 72.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.406 1.482 . . . . 73.43 110.409 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -33.31 65.44 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.345 1.458 . . . . 73.4 112.197 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.4 mtp -68.55 -41.42 79.81 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.939 1.245 . . . . 65.01 109.518 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.8 t -59.23 -54.86 28.49 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 123.988 0.915 . . . . 65.5 109.286 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -60.08 -37.17 79.13 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 117.562 -1.209 . . . . 62.23 110.59 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.5 m -55.15 -64.41 0.85 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.748 1.613 . . . . 70.22 108.555 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.7 t -53.52 -45.94 59.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.375 0 CA-C-O 118.184 -0.912 . . . . 63.42 110.313 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.1 tp60 -55.69 -48.63 74.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.342 0.974 . . . . 74.14 112.29 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -57.97 -43.33 86.44 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.164 0.586 . . . . 71.31 109.446 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 17.9 mt -80.54 -18.6 47.92 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.868 0.692 . . . . 62.2 112.868 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.14 76.44 77.94 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 127.428 2.291 . . . . 51.45 110.118 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.05 -15.1 42.67 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 121.695 1.596 . . . . 53.24 111.698 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.66 -22.74 53.61 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.324 2.249 . . . . 72.12 112.907 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.5 mt -85.14 156.36 21.07 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 114.008 1.114 . . . . 73.43 114.008 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -74.54 145.66 82.56 Favored Pre-proline 0 C--O 1.236 0.355 0 N-CA-C 107.192 -1.41 . . . . 73.41 107.192 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.52 -26.8 46.77 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.482 2.121 . . . . 74.13 114.096 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.33 -37.66 18.25 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.888 -0.412 . . . . 73.14 109.888 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -58.99 -36.97 75.79 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 109.499 -0.556 . . . . 75.12 109.499 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.0 mt -58.07 -61.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.092 -1.077 . . . . 52.02 108.092 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -48.27 -50.22 30.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 119.155 0.888 . . . . 75.42 110.876 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -60.39 -41.39 93.74 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 119.401 -0.92 . . . . 74.45 112.513 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.6 t -63.01 -48.66 77.86 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 107.495 -1.298 . . . . 74.32 107.495 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.8 mt -55.09 -42.12 72.45 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.514 1.126 . . . . 74.33 111.176 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -66.67 -33.74 76.32 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.848 0.459 . . . . 73.23 110.177 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -82.21 -46.25 13.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 118.139 -0.934 . . . . 42.24 113.366 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p -73.21 -41.3 63.95 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.361 1.464 . . . . 75.11 110.487 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.86 5.64 89.94 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 126.387 1.946 . . . . 23.51 112.357 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.8 m -142.63 127.13 17.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.913 1.357 . . . . 33.11 110.182 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.0 t -58.95 -49.35 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 105.846 -1.909 . . . . 64.33 105.846 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -52.99 -42.82 65.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.77 0.828 . . . . 74.35 111.209 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -61.14 -43.64 98.57 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 108.779 -0.823 . . . . 71.43 108.779 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.3 m -61.59 -40.38 94.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.849 2.06 . . . . 71.42 111.48 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.3 -37.07 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 O-C-N 121.29 -0.881 . . . . 74.32 108.856 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.36 -31.82 70.49 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 125.077 1.351 . . . . 65.1 112.225 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -83.12 -36.04 25.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.219 -1.03 . . . . 71.32 108.219 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -58.16 -56.09 26.48 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.39 -0.819 . . . . 75.21 109.805 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -57.5 -25.55 59.96 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-O 119.071 -0.49 . . . . 62.31 111.32 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.76 -8.2 59.3 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.742 0.701 . . . . 74.31 111.682 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.17 28.54 53.31 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 123.804 0.716 . . . . 53.41 111.704 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -67.14 173.81 3.56 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 117.207 0.503 . . . . 70.31 112.092 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -80.98 140.57 35.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.895 1.278 . . . . 72.13 109.253 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -132.63 109.42 9.72 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.813 -1.551 . . . . 73.3 106.813 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 t -83.79 169.95 14.66 Favored 'General case' 0 C--O 1.24 0.574 0 O-C-N 121.638 -0.664 . . . . 63.42 110.386 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -100.38 150.26 36.78 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 125.069 1.347 . . . . 74.33 108.321 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.48 166.99 19.95 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.922 3.081 . . . . 62.34 113.97 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -63.32 139.91 74.12 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.064 2.509 . . . . 52.05 111.804 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.2 -0.29 68.34 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 118.457 -1.191 . . . . 43.21 113.878 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -70.58 -34.43 72.18 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.289 1.545 . . . . 70.32 109.027 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 126.857 2.063 . . . . 60.12 111.866 179.642 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.238 0.448 0 N-CA-C 109.004 -0.739 . . . . 63.51 109.004 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.04 136.98 15.15 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.468 2.779 . . . . 63.32 109.874 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.4 m -128.26 158.2 40.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 O-C-N 121.4 -0.812 . . . . 64.2 110.436 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -125.43 163.39 22.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.039 1.336 . . . . 74.13 110.104 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.1 m -49.52 -45.8 47.75 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.743 1.617 . . . . 53.31 110.634 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -35.96 65.79 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.434 1.894 . . . . 74.32 112.75 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.7 mtp -68.48 -44.74 74.12 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.985 -1.072 . . . . 71.41 109.231 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.1 t -60.98 -51.61 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.012 0.925 . . . . 72.02 110.815 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -61.48 -43.42 98.9 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 117.247 -1.358 . . . . 64.51 110.335 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.404 ' CG2' HG11 ' A' ' 95' ' ' VAL . 85.2 m -57.8 -55.87 29.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.949 1.704 . . . . 72.0 109.803 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.1 t -55.0 -46.85 77.29 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 CA-C-N 119.865 1.211 . . . . 74.01 109.084 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -56.08 -43.54 78.12 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.543 1.065 . . . . 75.53 112.205 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -61.91 -35.74 79.27 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.027 1.331 . . . . 73.31 111.838 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.6 mt -94.06 -12.78 27.82 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.969 1.308 . . . . 54.43 112.454 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.95 67.44 56.53 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 127.828 2.451 . . . . 71.42 108.468 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.76 -9.4 22.75 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.385 2.056 . . . . 62.22 112.763 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.17 -12.01 48.2 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.887 0.875 . . . . 71.45 111.73 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.1 mt -88.32 152.93 21.59 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.345 0.975 . . . . 74.22 111.902 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -72.94 140.07 80.45 Favored Pre-proline 0 N--CA 1.448 -0.565 0 N-CA-C 106.617 -1.623 . . . . 72.4 106.617 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.29 -23.44 44.87 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.985 2.457 . . . . 65.44 113.765 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -40.09 17.76 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.42 0.554 . . . . 74.34 109.594 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -60.92 -40.32 92.71 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-O 118.141 -0.933 . . . . 54.1 109.658 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.78 -56.49 7.2 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 C-N-CA 124.265 1.026 . . . . 33.41 109.42 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -45.67 -54.35 7.91 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.128 0.422 . . . . 55.43 110.867 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -61.64 -36.19 80.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.826 0.306 . . . . 73.41 111.826 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.2 m -61.42 -49.65 76.02 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.368 -0.975 . . . . 60.14 108.368 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.8 mt -59.69 -35.5 74.6 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.197 0.999 . . . . 75.41 110.478 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -67.75 -33.82 75.61 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.666 -0.494 . . . . 72.04 109.666 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -79.46 -50.2 11.14 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.862 1.265 . . . . 71.15 114.093 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.6 p -74.56 -41.77 59.97 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.53 1.532 . . . . 73.54 110.872 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.28 -18.1 58.0 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 127.947 2.689 . . . . 61.43 112.551 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -139.35 151.15 46.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 123.718 1.723 . . . . 54.21 112.235 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.404 HG11 ' CG2' ' A' ' 72' ' ' THR . 96.1 t -64.33 -47.44 89.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 113.008 -1.905 . . . . 72.33 107.989 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -50.91 -51.03 56.01 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.367 1.467 . . . . 70.51 110.204 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -62.82 -42.36 99.69 Favored 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 109.863 -0.421 . . . . 74.44 109.863 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.1 m -60.36 -39.8 88.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.287 1.035 . . . . 70.15 111.833 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.59 -37.67 44.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 121.399 -0.813 . . . . 73.22 109.436 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -66.7 -38.13 86.14 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.483 1.113 . . . . 65.42 111.251 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -78.6 -33.87 47.14 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.493 -0.754 . . . . 75.11 109.216 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -59.62 -59.6 5.18 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.674 -1.266 . . . . 63.24 111.349 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -56.54 -28.95 61.33 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.509 0.724 . . . . 71.41 111.93 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -18.7 56.4 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.757 -0.64 . . . . 74.22 110.936 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.9 28.05 14.92 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.581 -1.122 . . . . 71.35 112.357 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -68.34 -179.25 1.26 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.939 1.296 . . . . 75.2 111.83 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -82.6 144.06 30.59 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.78 1.232 . . . . 75.51 111.564 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -138.84 109.18 6.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.628 -0.878 . . . . 64.52 108.628 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.2 m -84.96 177.13 8.06 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.773 1.229 . . . . 62.33 110.903 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -111.66 153.9 44.14 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 105.683 -1.969 . . . . 75.45 105.683 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.87 166.14 29.96 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.407 2.071 . . . . 53.44 111.641 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -63.03 156.17 56.37 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.404 2.069 . . . . 63.3 109.622 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.5 -28.53 3.43 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 118.312 -1.271 . . . . 74.22 111.587 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -66.81 -53.46 32.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 119.376 1.588 . . . . 74.31 111.024 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 . . . . . 0 C--O 1.249 1.062 0 C-N-CA 125.069 1.348 . . . . 72.41 107.513 -179.574 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 107.924 -1.139 . . . . 72.41 107.924 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.01 142.78 31.72 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.99 1.793 . . . . 72.34 110.979 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 m -128.75 164.85 29.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.291 1.036 . . . . 71.25 109.509 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.2 p -124.3 162.79 23.02 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.399 1.48 . . . . 73.02 109.163 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -53.02 -38.99 62.83 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.101 0.961 . . . . 71.42 110.777 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -60.23 -44.29 95.34 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 118.579 -0.724 . . . . 64.21 112.043 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 5.2 mtm -59.53 -35.2 73.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.421 -0.912 . . . . 73.24 110.703 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.7 t -65.44 -52.76 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.061 -0.718 . . . . 63.2 109.061 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -64.09 -35.52 81.01 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.708 -1.139 . . . . 75.51 110.718 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.3 m -57.18 -60.12 4.08 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 121.107 1.776 . . . . 65.51 108.082 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.5 t -54.5 -47.99 70.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 CA-C-O 117.571 -1.204 . . . . 74.24 108.596 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 tp60 -52.55 -45.48 66.38 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 120.153 1.342 . . . . 72.22 111.97 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -62.73 -36.4 82.88 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.402 -0.812 . . . . 72.13 110.469 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.7 mt -89.67 -14.65 34.36 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.85 -0.595 . . . . 75.53 112.54 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -138.33 73.55 43.16 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 129.111 2.965 . . . . 51.01 111.685 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -69.79 -5.67 16.77 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.904 3.069 . . . . 51.54 113.515 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.5 -15.69 36.87 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 120.745 -1.222 . . . . 73.1 111.981 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.8 mt -91.14 160.09 15.74 Favored 'General case' 0 N--CA 1.458 -0.074 0 C-N-CA 123.236 0.614 . . . . 61.11 111.571 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.475 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 56.0 t-80 -85.26 149.42 52.4 Favored Pre-proline 0 C--O 1.239 0.521 0 N-CA-C 106.171 -1.788 . . . . 65.14 106.171 178.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.475 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 33.2 Cg_endo -63.93 -30.07 67.25 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.548 2.165 . . . . 74.11 112.456 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.28 -34.22 55.65 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 112.717 0.636 . . . . 44.43 112.717 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -61.3 -46.1 91.69 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.609 -0.886 . . . . 63.12 108.609 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.0 mt -52.49 -59.63 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 125.002 1.321 . . . . 62.32 108.299 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -49.47 12.95 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.618 1.099 . . . . 75.11 111.888 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -64.41 -45.71 86.43 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.919 0.781 . . . . 75.05 113.085 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.7 p -65.7 -37.99 87.99 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.574 -0.704 . . . . 75.31 109.472 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.35 -38.16 88.43 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.105 -0.997 . . . . 72.31 109.062 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -68.39 -35.33 77.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.569 0.622 . . . . 71.14 110.062 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -72.51 -55.05 7.58 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.935 -0.478 . . . . 71.24 111.091 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.0 p -67.19 -41.36 85.98 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.911 1.284 . . . . 65.31 112.021 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.83 -11.85 67.61 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.87 1.224 . . . . 52.04 113.429 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -144.44 144.11 31.23 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 119.031 1.415 . . . . 74.31 109.336 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.1 t -59.63 -43.37 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 125.181 1.393 . . . . 74.24 109.025 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -46.93 -47.75 21.55 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.895 1.278 . . . . 72.14 111.011 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -69.82 -40.56 75.84 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.445 -0.784 . . . . 73.01 109.967 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.8 m -58.96 -37.12 76.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.161 0.584 . . . . 64.51 110.28 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 85.7 t -74.95 -36.96 40.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 123.919 0.888 . . . . 72.34 109.157 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -68.76 -39.61 80.2 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.352 1.061 . . . . 63.13 111.263 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -74.33 -37.11 63.66 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.122 -1.066 . . . . 71.33 108.122 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -58.03 -56.32 23.49 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.613 0.765 . . . . 73.13 109.935 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 pp -60.62 -22.49 63.85 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.284 -0.885 . . . . 73.15 112.055 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -16.72 48.7 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.846 0.748 . . . . 64.15 109.898 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.25 36.67 9.62 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 119.032 0.833 . . . . 61.1 112.168 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -76.76 173.38 11.72 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 117.986 0.893 . . . . 55.4 109.827 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -81.58 135.73 35.57 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.481 -1.303 . . . . 75.14 107.481 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -118.42 110.94 18.05 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.138 -2.542 . . . . 75.41 104.138 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.7 m -97.79 178.59 5.09 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 125.063 1.345 . . . . 64.14 110.086 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -110.88 158.79 34.72 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 125.371 1.469 . . . . 74.2 111.283 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.33 164.07 36.75 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.358 2.705 . . . . 74.13 113.898 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.09 139.53 84.72 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.967 2.444 . . . . 72.15 109.707 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.14 -18.41 56.88 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.508 1.052 . . . . 65.54 111.096 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -71.61 -45.29 62.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 119.243 1.522 . . . . 63.52 109.427 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.021 -0.99 . . . . 73.3 111.439 -178.962 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 . . . . . 0 CA--C 1.529 0.154 0 N-CA-C 109.127 -0.694 . . . . 73.44 109.127 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.27 138.12 38.57 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.033 1.822 . . . . 64.14 109.957 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 m -134.46 159.55 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.337 -0.986 . . . . 62.22 108.337 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.31 162.43 23.77 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.445 -0.946 . . . . 75.1 108.445 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 m -51.36 -39.1 56.4 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.607 1.963 . . . . 75.22 111.393 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.83 -38.05 77.81 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 124.561 1.144 . . . . 75.52 110.248 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.1 mtp -63.87 -38.14 89.98 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 120.407 -1.433 . . . . 62.31 109.377 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 t -61.08 -54.26 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.308 -0.627 . . . . 65.1 109.308 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -62.95 -38.24 90.28 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-O 117.294 -1.336 . . . . 74.1 110.588 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.6 m -53.98 -61.1 2.52 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 121.138 1.79 . . . . 72.42 108.087 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.7 t -55.51 -48.52 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 118.138 -0.934 . . . . 75.23 110.411 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -56.37 -42.24 77.5 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.074 0.852 . . . . 64.14 111.839 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -62.64 -43.6 98.39 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.618 -0.882 . . . . 61.13 108.618 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 mt -75.85 -26.91 57.57 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.735 -0.603 . . . . 62.21 111.476 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.77 83.37 62.57 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 128.054 2.542 . . . . 62.53 111.848 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.8 -21.3 38.49 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.575 1.517 . . . . 71.23 112.802 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.07 -19.29 51.69 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.754 1.222 . . . . 61.24 113.523 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 mt -79.53 154.52 28.76 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.786 0.721 . . . . 73.03 109.756 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -79.6 144.19 60.46 Favored Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 107.352 -1.351 . . . . 70.03 107.352 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.53 -29.53 52.79 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.924 1.75 . . . . 64.51 112.228 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -75.39 -41.52 56.0 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 112.491 0.552 . . . . 75.03 112.491 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -63.14 -35.19 79.48 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.893 0.477 . . . . 73.32 110.05 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 75.2 mt -56.64 -60.37 2.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 109.297 -0.631 . . . . 72.32 109.297 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.89 -40.77 61.21 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.653 1.115 . . . . 73.54 112.271 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -61.93 -46.96 87.04 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.126 0.965 . . . . 74.23 111.092 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.8 p -63.49 -44.8 93.32 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.78 -1.1 . . . . 64.41 108.595 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.5 mt -56.86 -39.3 74.06 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.186 0.903 . . . . 74.52 109.814 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.39 -34.93 75.25 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.73 1.15 . . . . 73.14 110.071 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.54 -47.4 48.6 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.222 0.609 . . . . 71.23 111.5 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.5 p -79.07 -35.51 42.32 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 127.574 2.35 . . . . 64.23 113.547 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.39 -12.24 55.95 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 125.864 1.697 . . . . 65.41 113.135 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.0 m -143.91 146.17 32.79 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 118.854 1.327 . . . . 72.31 111.962 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.41 -47.53 89.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.127 -1.434 . . . . 65.42 107.127 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -45.86 -46.07 15.52 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.953 1.301 . . . . 73.42 111.481 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -65.45 -53.58 40.74 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.061 1.744 . . . . 72.1 108.358 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.9 m -54.75 -37.59 66.15 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.98 1.312 . . . . 75.24 111.392 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.56 -39.68 54.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 124.124 0.97 . . . . 73.33 109.444 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -64.04 -44.41 92.56 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.279 1.432 . . . . 61.54 109.772 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -74.32 -32.47 62.84 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.46 -0.775 . . . . 63.13 110.909 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -62.9 -54.51 37.56 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.464 -0.772 . . . . 62.54 110.451 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.79 -25.85 67.73 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 118.209 -0.901 . . . . 71.43 111.78 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -81.41 -11.61 59.21 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.757 0.661 . . . . 54.01 110.2 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.78 36.62 25.12 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-O 119.06 -0.856 . . . . 50.52 111.203 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -74.73 -175.89 2.63 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.14 0.97 . . . . 70.21 111.456 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -86.69 138.72 31.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.608 1.163 . . . . 72.1 111.221 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -138.51 110.3 7.16 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.022 1.329 . . . . 75.43 109.895 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.8 m -89.58 -179.78 5.87 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.534 1.534 . . . . 42.11 109.71 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -110.05 159.13 33.02 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 126.352 1.861 . . . . 74.33 110.032 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.64 166.92 27.49 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.584 2.856 . . . . 74.44 114.782 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.85 137.22 40.97 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.532 2.154 . . . . 75.43 107.139 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.2 -10.37 59.89 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.997 1.284 . . . . 65.11 111.065 -178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -77.33 -29.01 53.31 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.571 1.685 . . . . 71.02 109.986 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 . . . . . 0 C--O 1.25 1.112 0 C-N-CA 125.439 1.496 . . . . 63.12 108.936 179.508 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 107.772 -1.195 . . . . 61.33 107.772 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.0 127.38 15.1 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.7 2.933 . . . . 53.11 114.035 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.438 HG11 ' CB ' ' A' ' 89' ' ' LEU . 17.8 m -107.91 166.82 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.432 1.093 . . . . 71.12 109.934 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.2 p -124.26 157.68 34.3 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.931 -1.877 . . . . 73.13 105.931 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -56.12 -35.75 67.45 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 119.105 -0.474 . . . . 73.51 110.811 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -36.84 73.01 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.753 0.706 . . . . 73.15 111.756 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.1 mtp -66.36 -33.39 75.62 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.089 -1.007 . . . . 74.2 109.29 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.87 -53.95 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 123.93 0.892 . . . . 64.13 109.475 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -60.33 -40.99 92.61 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.56 -1.209 . . . . 74.24 109.367 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.405 ' CG2' HG11 ' A' ' 95' ' ' VAL . 85.9 m -56.22 -57.38 12.48 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.676 1.58 . . . . 75.1 108.624 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.464 HG23 HG13 ' A' ' 95' ' ' VAL . 47.5 t -55.43 -50.8 63.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-O 118.456 -0.783 . . . . 73.13 109.699 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -52.08 -44.12 64.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 118.893 0.77 . . . . 55.13 112.767 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -62.86 -42.52 99.78 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.891 0.876 . . . . 72.02 110.363 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.8 mt -86.34 -10.83 53.64 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.843 0.683 . . . . 64.15 112.843 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.68 70.7 58.83 Favored Pre-proline 0 N--CA 1.447 -0.597 0 C-N-CA 127.186 2.195 . . . . 73.33 108.673 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -68.54 0.23 5.05 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.279 3.32 . . . . 71.25 112.633 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.16 12.83 29.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.453 1.501 . . . . 72.34 112.071 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.9 mt -114.77 157.53 23.1 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.545 1.138 . . . . 73.51 109.25 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.423 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 57.3 t-80 -85.46 145.59 42.6 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 108.276 -1.009 . . . . 74.53 108.276 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 33.0 Cg_endo -62.67 -29.87 78.1 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.938 2.426 . . . . 73.43 113.232 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -77.41 -42.99 34.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.967 -0.458 . . . . 61.15 110.931 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.403 ' HG3' ' CE1' ' A' ' 110' ' ' PHE . 48.7 mt-30 -58.27 -42.63 86.91 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 122.028 -0.42 . . . . 72.52 110.075 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 76.2 mt -50.59 -58.86 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 124.786 1.234 . . . . 74.43 109.692 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.05 -50.29 10.98 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.568 0.622 . . . . 70.1 111.342 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -61.34 -45.37 94.72 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.702 -0.624 . . . . 74.01 112.33 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 p -63.35 -42.63 98.93 Favored 'General case' 0 C--O 1.218 -0.583 0 C-N-CA 120.216 -0.593 . . . . 62.11 110.153 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.438 ' CB ' HG11 ' A' ' 65' ' ' VAL . 74.2 mt -60.21 -34.76 74.1 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.618 0.767 . . . . 64.53 110.114 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.85 -36.54 78.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.356 -0.609 . . . . 44.11 109.356 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -78.26 -44.5 25.34 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.07 0.767 . . . . 74.13 113.07 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.9 p -76.25 -36.18 58.59 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.787 1.635 . . . . 61.22 111.423 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.49 -17.82 46.25 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.921 1.248 . . . . 53.14 113.298 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.5 t -145.11 150.1 36.2 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.657 1.228 . . . . 74.14 108.991 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.464 HG13 HG23 ' A' ' 73' ' ' VAL . 54.9 t -65.12 -41.8 92.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 126.373 1.869 . . . . 74.55 109.285 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -46.52 -48.01 19.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.389 1.476 . . . . 62.2 111.491 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -68.35 -44.85 74.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.378 1.471 . . . . 71.31 108.845 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.6 m -56.96 -39.16 74.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.945 0.898 . . . . 64.11 110.791 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.3 t -74.4 -37.72 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.273 -0.87 . . . . 71.42 110.074 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -66.69 -43.66 83.81 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.173 0.989 . . . . 55.33 110.126 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -72.59 -35.66 67.95 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.295 -0.878 . . . . 62.11 109.98 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -57.91 -57.39 13.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 121.133 -0.979 . . . . 72.15 110.482 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.22 -26.09 62.43 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.195 0.452 . . . . 72.13 111.269 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -12.17 59.96 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.599 -0.688 . . . . 73.4 110.364 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.65 37.35 40.34 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 125.054 1.312 . . . . 53.35 110.715 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.2 -171.17 0.88 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.207 1.004 . . . . 63.12 112.126 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.45 139.05 34.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 120.961 -1.087 . . . . 73.4 109.582 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -129.85 108.72 10.36 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 104.862 -2.273 . . . . 63.44 104.862 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.7 m -96.26 163.92 12.88 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.732 1.213 . . . . 63.31 111.786 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.403 ' CE1' ' HG3' ' A' ' 84' ' ' GLN . 35.8 m-85 -97.11 156.52 36.23 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 124.542 1.137 . . . . 64.23 108.835 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.94 164.74 30.59 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.803 2.335 . . . . 75.31 112.211 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.23 142.43 66.92 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.037 1.825 . . . . 63.31 110.324 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.22 -9.37 73.1 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 118.607 -1.107 . . . . 51.22 113.286 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -76.78 -22.8 53.19 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.897 1.349 . . . . 41.13 110.459 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 C--O 1.247 0.926 0 C-N-CA 126.351 1.86 . . . . 74.1 112.64 179.811 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 . . . . . 0 C--O 1.236 0.367 0 N-CA-C 109.671 -0.492 . . . . 63.25 109.671 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.75 141.08 21.42 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.201 1.934 . . . . 75.12 109.308 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 m -134.64 160.15 41.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.427 -0.953 . . . . 60.15 108.427 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.98 157.76 37.0 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.889 1.276 . . . . 71.11 108.768 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 m -42.75 -48.37 5.61 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.762 2.425 . . . . 60.32 111.522 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -53.97 -36.71 63.17 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 126.933 2.093 . . . . 54.12 112.324 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 87.3 mtp -66.81 -42.39 85.98 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.661 -0.866 . . . . 64.54 108.661 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.78 -57.93 9.01 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 CA-C-N 117.92 0.327 . . . . 42.24 110.601 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -58.04 -40.78 81.77 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 118.14 -0.933 . . . . 63.01 110.725 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.8 m -58.01 -62.0 2.13 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.09 1.314 . . . . 73.5 109.524 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.408 ' CG2' HG13 ' A' ' 95' ' ' VAL . 86.4 t -52.42 -46.42 46.95 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 CA-C-O 118.354 -0.832 . . . . 73.01 108.999 178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.19 -38.31 79.53 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.698 1.136 . . . . 62.35 113.336 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -65.41 -40.89 93.95 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.152 0.887 . . . . 72.43 108.846 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mt -78.98 -34.53 44.09 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 112.248 0.462 . . . . 74.31 112.248 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.11 75.46 4.15 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 127.33 2.252 . . . . 74.52 109.532 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.08 -13.69 40.72 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.267 1.978 . . . . 63.23 112.2 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -83.12 -6.63 59.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.872 1.269 . . . . 64.31 113.08 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.2 mt -98.06 155.24 17.22 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 120.92 -1.113 . . . . 65.21 109.355 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.432 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 53.7 t-80 -78.34 146.43 70.41 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 105.607 -1.997 . . . . 73.43 105.607 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 32.2 Cg_endo -63.88 -31.85 66.97 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.651 1.567 . . . . 64.21 112.281 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -74.88 -38.33 61.92 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.281 -0.887 . . . . 74.54 111.912 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -58.56 -45.12 89.65 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.81 -0.441 . . . . 53.15 109.81 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.1 mt -49.22 -56.31 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 117.812 -1.089 . . . . 73.13 110.123 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.409 HH21 ' CG ' ' A' ' 111' ' ' PRO . 4.6 tmm_? -48.7 -48.51 40.25 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.558 1.072 . . . . 63.12 111.712 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.496 ' CE1' ' HD3' ' A' ' 112' ' ' PRO . 9.2 t80 -62.25 -41.16 98.2 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.807 0.731 . . . . 73.33 111.704 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.2 m -63.6 -48.66 76.44 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.756 -0.831 . . . . 74.14 108.756 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -57.32 -37.34 72.35 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.021 1.328 . . . . 65.21 110.309 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -68.18 -38.0 81.57 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.042 -0.725 . . . . 72.35 109.042 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -76.68 -48.34 19.25 Favored 'General case' 0 C--N 1.334 -0.097 0 O-C-N 121.457 -0.777 . . . . 63.0 112.106 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.3 p -71.47 -38.33 71.27 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.567 1.147 . . . . 63.41 111.369 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.55 -2.94 87.57 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.906 2.193 . . . . 74.1 111.447 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -144.31 145.06 31.77 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.137 1.469 . . . . 43.25 112.608 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.408 HG13 ' CG2' ' A' ' 73' ' ' VAL . 55.1 t -64.93 -52.48 53.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.517 -1.66 . . . . 61.14 106.517 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -49.17 -51.99 29.25 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.316 1.847 . . . . 74.41 110.674 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.49 -43.49 93.31 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.852 0.861 . . . . 74.13 109.527 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.7 m -61.52 -39.42 90.95 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.969 0.908 . . . . 72.54 110.501 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.5 t -75.2 -34.62 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 121.247 -0.908 . . . . 65.02 110.131 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -68.18 -39.29 82.54 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 126.113 1.765 . . . . 75.22 111.23 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -79.02 -37.08 40.04 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.877 -0.786 . . . . 75.2 108.877 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -54.67 -54.36 42.7 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.943 0.897 . . . . 72.41 109.705 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.13 -18.06 56.02 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.168 0.803 . . . . 74.42 113.168 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -19.26 42.17 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.714 -1.217 . . . . 55.53 107.714 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 83.3 31.7 27.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 125.656 1.598 . . . . 70.03 109.658 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -62.59 176.79 0.6 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.866 1.666 . . . . 73.24 111.382 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -83.47 139.11 33.13 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 123.076 0.55 . . . . 64.33 110.284 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -135.88 109.04 7.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.284 1.033 . . . . 75.2 108.83 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.5 m -91.52 176.1 6.67 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.851 0.861 . . . . 72.04 109.033 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -103.14 155.71 36.3 Favored Pre-proline 0 N--CA 1.45 -0.457 0 C-N-CA 124.873 1.269 . . . . 73.3 108.779 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.409 ' CG ' HH21 ' A' ' 86' ' ' ARG . 29.7 Cg_endo -69.27 161.57 45.34 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.907 2.405 . . . . 54.14 113.628 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.496 ' HD3' ' CE1' ' A' ' 87' ' ' TYR . 37.2 Cg_endo -63.36 145.95 93.08 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 121.94 1.76 . . . . 54.23 107.992 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.47 -5.38 82.59 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.418 -1.212 . . . . 52.24 111.599 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -86.36 -28.32 23.71 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.632 1.716 . . . . 74.15 111.845 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 123.805 0.842 . . . . 74.24 111.236 179.114 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.16 0 N-CA-C 109.144 -1.582 . . . . 73.41 109.144 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.76 174.4 8.47 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 117.86 0.83 . . . . 44.03 109.248 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 24.2 ptp -155.26 166.65 32.89 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.713 1.605 . . . . 54.24 107.667 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.76 80.96 0.03 OUTLIER Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.345 -1.253 . . . . 55.53 110.232 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.21 -9.29 25.62 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.991 2.461 . . . . 63.54 115.124 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 26.91 73.53 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.749 2.82 . . . . 54.51 114.634 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.36 106.72 0.33 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.459 -1.457 . . . . 43.33 109.459 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.2 m -97.05 169.48 9.79 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.515 1.126 . . . . 72.41 109.412 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 p -77.47 95.99 4.61 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.748 -1.22 . . . . 53.04 107.765 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -70.99 29.34 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.555 1.542 . . . . 62.33 114.41 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -87.35 81.75 7.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.831 1.652 . . . . 74.33 108.921 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.28 -178.73 0.38 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.903 0.881 . . . . 72.33 110.964 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.4 tt -49.32 139.56 11.31 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.966 1.307 . . . . 64.42 110.881 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -45.88 134.82 7.6 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.251 1.42 . . . . 61.25 111.127 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -43.66 114.01 0.59 Allowed 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.482 1.513 . . . . 74.32 110.652 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.2 p -73.17 165.39 25.13 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.935 0.894 . . . . 64.52 109.876 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.69 -56.77 3.25 Favored Glycine 0 C--O 1.237 0.327 0 O-C-N 121.196 -0.94 . . . . 51.33 112.068 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -146.73 112.11 5.53 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.787 1.235 . . . . 53.22 109.138 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.2 m -82.14 103.11 8.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 105.584 -2.006 . . . . 71.43 105.584 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.59 -172.89 3.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.802 2.841 . . . . 75.11 107.766 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.37 34.78 6.22 Favored Glycine 0 CA--C 1.522 0.52 0 O-C-N 121.434 -0.791 . . . . 73.21 111.933 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.19 135.92 6.92 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.2 -1.56 . . . . 75.54 109.2 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -129.91 151.09 77.64 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 126.372 1.869 . . . . 74.44 108.26 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.2 126.3 9.75 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.712 2.275 . . . . 72.53 110.645 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 m -122.99 161.29 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 O-C-N 120.954 -1.091 . . . . 52.54 110.001 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 p -124.4 166.24 16.32 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.053 0.941 . . . . 52.12 110.036 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.1 m -52.73 -41.85 64.35 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.496 1.518 . . . . 64.41 110.95 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -34.04 67.57 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.194 0.997 . . . . 62.35 111.013 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.9 mtp -70.32 -43.37 70.45 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.962 -0.755 . . . . 73.55 108.962 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.2 t -59.5 -55.98 20.23 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 C-N-CA 124.168 0.987 . . . . 74.25 110.193 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.66 -41.5 90.72 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 117.784 -1.103 . . . . 62.22 111.103 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.3 m -55.01 -60.42 3.4 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.57 1.077 . . . . 52.34 109.051 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.57 -46.22 79.03 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 CA-C-N 119.16 0.891 . . . . 62.31 109.694 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -54.9 -44.29 74.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 119.131 0.878 . . . . 74.51 112.97 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -62.85 -44.19 96.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.172 -0.677 . . . . 72.13 109.172 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.9 mt -79.41 -14.72 58.75 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.43 1.092 . . . . 74.43 113.583 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -137.33 70.87 54.17 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 127.368 2.267 . . . . 61.33 108.566 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.9 -23.16 62.32 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.584 2.189 . . . . 61.42 112.916 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.29 -14.56 62.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.523 0.729 . . . . 62.31 111.938 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.4 mt -92.36 156.69 17.07 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 119.181 0.9 . . . . 72.22 112.74 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -79.92 143.2 57.28 Favored Pre-proline 0 C--O 1.238 0.46 0 N-CA-C 106.111 -1.811 . . . . 62.14 106.111 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.62 -29.12 52.29 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.782 2.322 . . . . 54.21 113.032 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -40.2 48.77 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.698 -0.626 . . . . 75.24 111.727 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -60.9 -35.34 76.39 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.29 -0.633 . . . . 72.33 109.29 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.9 mt -56.57 -56.5 13.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 CA-C-O 118.164 -0.922 . . . . 64.12 108.713 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.82 -46.65 20.91 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.488 1.04 . . . . 75.33 111.048 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -64.59 -43.54 93.5 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.418 0.554 . . . . 72.25 111.911 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.2 t -64.59 -41.37 96.29 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.174 -0.676 . . . . 63.23 109.174 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.24 -37.97 84.99 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.943 0.897 . . . . 74.31 110.475 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -72.05 -34.77 69.02 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.608 0.64 . . . . 71.53 110.877 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -72.51 -50.61 24.63 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.001 -0.437 . . . . 43.22 110.808 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.3 p -72.64 -41.59 65.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.26 1.024 . . . . 71.24 111.819 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.16 -6.12 75.63 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.249 1.881 . . . . 44.41 112.538 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -145.59 152.13 39.2 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 120.897 2.348 . . . . 73.22 112.394 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.63 -50.62 64.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 106.765 -1.568 . . . . 73.41 106.765 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -52.32 -47.03 66.25 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.453 1.501 . . . . 64.44 111.754 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -63.74 -43.24 97.07 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.458 -0.942 . . . . 74.23 108.458 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.9 m -61.68 -37.05 82.68 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.422 1.089 . . . . 40.34 110.559 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.6 t -73.8 -35.95 44.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.412 1.085 . . . . 74.12 109.103 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -70.16 -40.5 74.7 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.417 1.487 . . . . 71.23 110.31 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -76.35 -30.2 57.51 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 122.084 0.945 . . . . 73.25 109.88 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -64.31 -54.59 30.8 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 121.099 -1.0 . . . . 74.23 108.932 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.15 -20.94 60.81 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.43 0.9 . . . . 61.33 113.43 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -92.23 -6.26 50.87 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.742 0.701 . . . . 73.21 109.913 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.62 36.68 58.39 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 126.528 2.013 . . . . 62.44 113.322 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -70.38 -178.68 1.79 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 118.256 1.028 . . . . 63.13 110.148 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.2 134.77 36.16 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 126.137 1.775 . . . . 73.32 111.901 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -129.07 110.51 12.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.245 1.818 . . . . 72.41 106.168 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.1 m -96.0 174.29 7.0 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.736 1.214 . . . . 60.44 108.035 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -98.1 155.6 36.82 Favored Pre-proline 0 C--N 1.33 -0.243 0 O-C-N 121.585 -0.697 . . . . 73.41 110.197 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -69.44 163.66 37.19 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.899 1.732 . . . . 72.11 111.48 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -59.89 144.6 99.43 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.887 1.724 . . . . 53.03 109.313 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.24 -12.39 58.47 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.595 1.093 . . . . 73.33 113.026 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -75.59 -46.54 31.21 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.195 1.497 . . . . 65.53 108.268 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 . . . . . 0 C--O 1.24 0.58 0 C-N-CA 124.92 1.288 . . . . 74.31 109.225 179.252 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.175 0 N-CA-C 109.411 -1.476 . . . . 70.24 109.411 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 64.85 -12.85 0.12 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.18 2.192 . . . . 63.52 115.87 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.9 164.44 22.1 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.071 1.305 . . . . 64.3 108.477 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 141.55 -72.81 0.39 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.384 -2.287 . . . . 62.12 107.384 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.51 1.03 5.33 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.915 2.41 . . . . 75.31 112.296 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -142.52 137.0 29.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 103.628 -2.73 . . . . 74.14 103.628 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.3 -142.61 3.48 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.301 1.905 . . . . 75.43 108.878 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.8 t -148.92 170.46 18.25 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.209 1.004 . . . . 54.31 108.622 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.3 t -167.64 -171.43 1.64 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.859 1.664 . . . . 72.25 108.378 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -129.7 35.21 4.21 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.44 2.296 . . . . 64.14 109.327 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -63.35 99.46 0.2 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 125.706 1.602 . . . . 74.4 107.269 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.26 167.06 23.03 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.243 1.417 . . . . 63.54 110.146 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.53 -169.92 2.28 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.219 1.808 . . . . 54.43 110.372 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.95 168.16 5.48 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 122.02 0.914 . . . . 73.01 113.178 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -74.14 -177.56 3.0 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.805 0.842 . . . . 73.21 109.671 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 t -129.31 174.6 9.46 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.651 0.781 . . . . 74.22 110.191 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.58 -77.8 0.55 Allowed Glycine 0 C--O 1.225 -0.464 0 N-CA-C 109.463 -1.455 . . . . 74.24 109.463 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 2.51 81.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 129.486 3.114 . . . . 61.44 113.995 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -125.68 157.38 35.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.767 -1.197 . . . . 64.12 107.767 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -70.07 157.61 37.22 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.494 -0.928 . . . . 71.33 108.494 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.51 47.36 0.02 OUTLIER Glycine 0 CA--C 1.52 0.366 0 CA-C-O 118.797 -1.002 . . . . 60.45 112.127 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.94 -133.46 0.19 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.762 -1.335 . . . . 74.42 109.762 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -119.0 153.92 52.98 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 123.98 0.912 . . . . 63.55 111.6 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.88 150.12 30.01 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.39 2.727 . . . . 62.42 109.841 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 m -134.28 160.83 41.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 123.988 0.915 . . . . 44.31 110.844 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.3 p -125.76 163.64 22.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.879 0.871 . . . . 74.22 110.034 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.7 m -49.61 -45.86 48.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.779 2.031 . . . . 51.25 111.593 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -62.41 -34.05 75.98 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.893 1.277 . . . . 32.44 112.614 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 94.5 mtp -65.12 -42.5 93.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.098 -1.075 . . . . 74.42 108.098 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 t -60.01 -55.34 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.458 0.703 . . . . 72.44 110.728 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -61.01 -37.67 83.34 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 119.538 -0.865 . . . . 75.41 112.059 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.0 m -60.18 -57.36 13.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 120.308 1.413 . . . . 75.31 109.525 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 t -54.97 -44.13 72.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-N 119.891 1.223 . . . . 74.31 108.438 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.6 tp60 -51.47 -50.92 58.89 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.197 0.908 . . . . 50.21 112.726 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -59.11 -44.73 92.0 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 122.837 0.455 . . . . 64.45 110.202 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.7 mt -77.71 -22.48 50.37 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.734 0.642 . . . . 74.14 112.734 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.89 75.07 79.23 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 126.374 1.87 . . . . 44.23 109.192 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.49 -18.05 54.05 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 123.492 2.795 . . . . 73.22 114.14 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.05 10.12 8.77 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.408 -0.808 . . . . 71.44 112.935 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.6 mt -112.74 155.81 23.9 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.171 0.896 . . . . 70.53 112.488 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.444 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 51.4 t-80 -80.63 145.46 58.55 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 108.626 -0.879 . . . . 75.54 108.626 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 28.9 Cg_endo -62.91 -30.53 77.17 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.228 2.619 . . . . 74.54 113.144 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.68 -39.16 37.49 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.026 -0.361 . . . . 62.01 110.026 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -59.46 -48.52 81.32 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 118.502 0.592 . . . . 64.41 109.452 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 82' ' ' PRO . 67.9 mt -49.35 -58.74 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 N-CA-C 107.789 -1.189 . . . . 73.24 107.789 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.538 HH21 ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -47.3 -52.08 17.3 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.749 0.819 . . . . 75.34 112.18 179.198 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -65.43 -33.94 77.11 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.681 -1.262 . . . . 64.22 111.712 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 t -65.14 -46.12 82.21 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.204 -1.406 . . . . 45.44 107.204 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.4 -36.57 76.07 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.343 1.457 . . . . 74.43 109.095 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.538 ' CD ' HH21 ' A' ' 86' ' ' ARG . 48.5 mt-10 -70.13 -38.36 75.51 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 118.78 0.718 . . . . 71.11 111.65 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -75.78 -45.7 34.78 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.109 0.411 . . . . 71.4 112.109 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 79.6 p -74.25 -40.65 62.24 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.475 1.11 . . . . 75.31 111.044 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.98 -13.56 67.39 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 127.832 2.634 . . . . 74.43 114.226 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.8 m -143.64 148.4 35.75 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.88 1.84 . . . . 64.43 111.996 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.8 t -59.64 -48.42 87.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 126.096 1.759 . . . . 64.53 107.655 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -51.87 -47.98 64.25 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.611 1.565 . . . . 74.31 111.79 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -65.33 -43.47 90.84 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 108.257 -1.016 . . . . 75.2 108.257 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.5 m -59.26 -40.47 86.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.407 1.083 . . . . 74.31 111.638 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.9 t -74.64 -40.27 47.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 118.008 -0.996 . . . . 71.5 108.581 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -62.81 -35.2 79.13 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.016 1.726 . . . . 71.03 111.206 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -80.13 -40.69 26.92 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.203 -0.665 . . . . 73.35 109.203 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -58.74 -51.05 71.63 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.026 0.531 . . . . 74.53 110.242 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -65.48 -9.14 23.26 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 113.397 0.888 . . . . 75.34 113.397 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.09 -16.82 20.33 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.748 2.019 . . . . 73.4 109.141 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.0 26.59 21.48 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.664 1.126 . . . . 72.22 113.315 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -72.11 172.83 9.42 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.275 1.037 . . . . 33.4 113.294 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -81.85 147.59 29.27 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.401 1.481 . . . . 75.04 111.56 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -138.51 109.93 6.98 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.861 1.264 . . . . 73.51 109.873 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.1 m -91.9 165.78 13.05 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.214 1.406 . . . . 74.3 108.255 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -94.01 160.06 33.09 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 124.759 1.224 . . . . 73.44 111.708 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.11 164.01 29.32 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.357 3.371 . . . . 65.52 113.767 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.34 140.3 87.44 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.11 2.54 . . . . 75.1 111.152 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.85 -17.65 54.14 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 117.959 -1.467 . . . . 74.02 112.403 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -66.12 -51.9 53.6 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.348 1.574 . . . . 75.04 108.881 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 . . . . . 0 C--O 1.245 0.859 0 C-N-CA 125.475 1.51 . . . . 74.34 108.555 179.126 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.548 0 N-CA-C 109.248 -1.541 . . . . 74.02 109.248 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.64 161.89 37.22 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.573 1.949 . . . . 63.43 106.641 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 56.4 ttm -74.37 -79.45 0.09 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.377 -0.601 . . . . 62.21 109.377 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.16 -168.34 4.17 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.539 1.066 . . . . 65.11 113.82 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.48 169.98 21.29 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.502 2.802 . . . . 75.13 111.711 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.28 -5.49 12.36 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.038 1.335 . . . . 62.12 112.145 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 55.23 79.74 0.09 OUTLIER Glycine 0 CA--C 1.524 0.642 0 C-N-CA 126.177 1.846 . . . . 75.41 115.585 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.11 141.6 57.32 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.408 -0.96 . . . . 73.44 108.408 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.8 t -153.48 151.29 29.67 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.126 -1.064 . . . . 73.14 108.126 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -157.12 120.56 4.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.958 0.903 . . . . 71.24 108.771 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -75.84 -75.7 0.18 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 107.075 -1.454 . . . . 53.3 107.075 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.54 -178.81 7.62 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.638 1.575 . . . . 72.24 109.613 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.2 tp -169.73 163.45 9.91 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.022 2.129 . . . . 62.24 107.507 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -73.42 165.91 24.2 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 106.166 -1.791 . . . . 75.13 106.166 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -129.67 84.93 2.25 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 106.923 -1.51 . . . . 72.25 106.923 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.5 t -148.32 162.96 38.47 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.435 -1.321 . . . . 75.41 107.435 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.27 162.78 54.6 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.004 -1.238 . . . . 72.53 110.004 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -113.67 -178.23 3.33 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.381 1.872 . . . . 55.31 106.539 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.13 -35.8 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 108.159 -1.052 . . . . 73.13 108.159 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -74.31 169.92 16.66 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.993 1.317 . . . . 64.45 110.204 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.35 -165.47 27.53 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.403 1.002 . . . . 71.24 111.516 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.26 71.09 0.1 OUTLIER Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.337 0.97 . . . . 73.25 112.566 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -107.84 155.58 39.65 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.508 1.123 . . . . 64.5 108.798 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.28 142.64 30.58 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.217 2.612 . . . . 71.44 110.272 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.37 153.39 35.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 109.058 -0.719 . . . . 61.4 109.058 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -124.84 162.69 23.8 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 125.995 1.718 . . . . 64.32 108.06 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 m -56.23 -36.37 68.42 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.839 -0.538 . . . . 62.35 111.531 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.06 -33.84 65.37 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.357 1.063 . . . . 63.21 110.987 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.8 mtp -70.02 -41.89 73.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.684 -0.858 . . . . 51.13 108.684 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 t -61.03 -55.47 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.276 1.03 . . . . 61.41 110.51 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.63 -40.86 84.56 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 118.252 -0.88 . . . . 63.42 110.391 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.415 ' CG2' HG11 ' A' ' 95' ' ' VAL . 88.8 m -58.13 -60.97 2.92 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.372 0.987 . . . . 63.14 109.597 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.3 t -52.52 -47.66 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 119.384 0.993 . . . . 74.41 109.044 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -56.3 -45.23 80.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.11 0.868 . . . . 53.33 112.188 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -59.13 -39.32 81.95 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.187 0.995 . . . . 74.35 110.528 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.3 mt -88.81 -20.28 24.88 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.203 0.816 . . . . 73.41 113.203 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.89 75.35 79.68 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 127.304 2.242 . . . . 62.3 108.858 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.7 -17.84 52.85 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.438 2.092 . . . . 75.2 113.425 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.49 -17.23 56.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.536 0.607 . . . . 64.21 112.551 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 mt -80.85 155.74 26.44 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.85 0.833 . . . . 73.43 112.634 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.439 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 57.2 t-80 -75.56 144.07 76.73 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 124.44 1.096 . . . . 71.14 109.035 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 36.8 Cg_endo -65.8 -26.55 52.42 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.836 2.357 . . . . 74.04 113.704 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.02 -40.11 16.14 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.66 1.118 . . . . 72.42 111.892 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -60.45 -32.38 71.32 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 119.175 -0.44 . . . . 45.23 111.547 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 78.1 mt -55.24 -58.26 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 118.352 -0.832 . . . . 63.32 109.748 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -42.29 44.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.269 0.94 . . . . 74.42 112.685 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -63.9 -43.22 96.64 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.328 -0.857 . . . . 72.02 110.696 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 t -59.41 -51.27 70.63 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 108.393 -0.966 . . . . 73.41 108.393 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.4 mt -58.34 -35.65 72.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.066 0.947 . . . . 72.22 110.775 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -72.54 -30.28 64.32 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.823 1.192 . . . . 62.44 109.65 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -76.35 -46.71 26.29 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.343 0.52 . . . . 73.44 112.043 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.5 p -80.19 -39.69 28.73 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.668 1.187 . . . . 64.51 111.151 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.58 -6.17 66.17 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 127.24 2.352 . . . . 32.44 112.723 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.4 m -139.56 132.46 29.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.523 1.529 . . . . 64.23 110.323 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.415 HG11 ' CG2' ' A' ' 72' ' ' THR . 53.1 t -58.8 -44.77 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 125.394 1.477 . . . . 72.11 109.622 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -52.83 -47.74 67.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.822 0.849 . . . . 74.13 110.454 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -62.45 -43.09 99.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.903 -0.777 . . . . 64.41 108.903 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.9 m -58.85 -35.98 73.82 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.742 0.817 . . . . 65.2 110.477 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.5 t -75.75 -41.52 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.763 0.825 . . . . 63.14 109.91 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -63.47 -33.71 76.16 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.703 1.601 . . . . 73.43 111.349 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -83.71 -40.43 18.89 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.135 0.574 . . . . 63.15 110.286 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -53.94 -55.2 29.24 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.758 0.823 . . . . 64.31 110.563 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -59.67 -14.8 15.39 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.878 1.271 . . . . 65.12 114.135 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -9.26 39.74 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.44 1.896 . . . . 74.33 109.374 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.44 28.75 54.87 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.659 -0.977 . . . . 73.5 110.659 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -69.45 -179.75 1.78 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.28 1.04 . . . . 73.52 112.393 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -83.36 134.11 34.92 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.356 1.462 . . . . 72.25 113.251 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -134.4 110.04 9.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.357 -0.979 . . . . 61.04 108.357 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.86 179.42 4.81 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.422 -0.584 . . . . 72.42 109.422 178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -100.08 158.75 31.46 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.823 1.249 . . . . 64.14 111.136 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.15 164.09 36.2 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.211 2.607 . . . . 72.41 111.144 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.01 153.69 67.54 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.896 1.731 . . . . 54.4 107.815 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.1 -15.32 61.28 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 118.988 -0.895 . . . . 72.42 110.899 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -71.86 -44.39 63.88 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.126 0.963 . . . . 75.01 109.177 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 . . . . . 0 C--O 1.25 1.131 0 C-N-CA 124.587 1.155 . . . . 75.42 111.145 179.684 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.575 0 N-CA-C 110.234 -1.147 . . . . 70.14 110.234 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.42 155.41 40.5 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.319 -0.993 . . . . 62.51 108.319 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.9 ptp -126.37 173.02 9.66 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.003 0.921 . . . . 45.22 111.284 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.58 164.59 36.23 Favored Glycine 0 CA--C 1.536 1.365 0 N-CA-C 109.022 -1.631 . . . . 64.34 109.022 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.63 165.18 28.36 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.529 2.152 . . . . 61.21 111.936 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -111.84 -5.1 14.43 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.762 1.225 . . . . 62.42 110.868 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.37 172.07 18.62 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 124.501 1.048 . . . . 60.24 110.701 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.9 m -129.22 34.24 4.43 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.029 1.332 . . . . 75.43 111.181 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.29 146.06 50.85 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 104.135 -2.543 . . . . 70.11 104.135 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -148.58 168.73 22.0 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 118.737 0.699 . . . . 74.44 112.352 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -146.28 -13.51 0.46 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.79 1.636 . . . . 71.31 111.308 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.65 78.98 2.2 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.957 1.303 . . . . 73.24 111.054 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 tp -93.1 105.79 17.83 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.604 -0.685 . . . . 73.34 111.077 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.499 ' H ' ' HA2' ' A' ' 113' ' ' GLY . 2.8 mpt_? 50.15 35.85 11.08 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.892 1.677 . . . . 74.23 112.014 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -57.98 167.29 1.25 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.504 1.121 . . . . 74.44 111.421 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -75.17 135.27 41.09 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 107.142 -1.429 . . . . 75.34 107.142 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.05 -159.63 8.1 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 125.74 1.638 . . . . 40.3 110.329 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.95 75.18 1.68 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 117.417 0.608 . . . . 72.13 109.502 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -58.33 146.2 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.089 -1.448 . . . . 61.22 107.089 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.5 m120 60.59 6.45 1.11 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.426 1.49 . . . . 72.12 114.036 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.79 33.0 2.14 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.002 1.287 . . . . 53.12 111.613 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -148.88 -137.89 2.89 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 127.61 2.529 . . . . 73.3 107.163 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -129.58 148.87 71.15 Favored Pre-proline 0 C--N 1.321 -0.635 0 C-N-CA 125.623 1.569 . . . . 50.52 107.374 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.2 126.45 12.38 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.315 2.01 . . . . 42.33 108.547 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.3 m -126.8 157.98 37.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 121.75 0.786 . . . . 63.15 110.084 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 p -124.25 164.44 19.54 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.999 1.72 . . . . 71.52 109.911 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.3 m -54.7 -37.37 65.74 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.964 1.706 . . . . 65.22 111.4 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -59.21 -35.93 74.5 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.285 1.034 . . . . 65.12 111.349 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.0 mtp -68.31 -41.71 80.48 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.045 -1.034 . . . . 64.41 108.896 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.5 t -60.23 -54.89 28.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 C-N-CA 124.358 1.063 . . . . 63.12 110.94 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.17 -42.33 90.55 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.428 -0.796 . . . . 74.21 110.306 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.1 m -56.35 -61.07 2.65 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.871 1.214 . . . . 70.32 109.856 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 83.9 t -53.41 -46.87 59.08 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 CA-C-N 119.136 0.88 . . . . 55.22 109.535 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.99 -41.17 67.61 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.167 0.894 . . . . 63.32 113.184 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -65.65 -43.35 89.68 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.969 0.804 . . . . 73.03 109.25 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.57 -17.42 56.15 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.674 0.62 . . . . 74.42 112.674 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.89 74.8 56.66 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 126.982 2.113 . . . . 70.52 109.743 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.89 -16.11 36.89 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.576 2.184 . . . . 74.21 111.166 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -83.61 15.95 2.9 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.497 1.519 . . . . 73.33 112.016 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.0 mt -124.23 152.14 43.3 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.897 1.279 . . . . 52.44 109.134 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -76.97 143.88 71.33 Favored Pre-proline 0 N--CA 1.45 -0.454 0 N-CA-C 107.858 -1.164 . . . . 71.35 107.858 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.21 -18.95 56.69 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.898 2.398 . . . . 50.44 113.285 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -86.11 -38.51 17.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.455 0.702 . . . . 73.41 110.231 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -58.36 -47.87 82.42 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 122.679 0.392 . . . . 73.44 109.965 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 89.1 mt -48.93 -54.08 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.683 1.593 . . . . 75.1 111.053 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.58 HH21 ' CG ' ' A' ' 111' ' ' PRO . 1.7 tmm_? -50.43 -46.93 56.83 Favored 'General case' 0 C--O 1.228 -0.051 0 CA-C-N 118.707 0.685 . . . . 74.3 110.668 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -64.91 -37.71 88.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.768 0.258 . . . . 70.44 111.181 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 m -61.46 -47.25 86.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.975 -0.75 . . . . 61.4 108.975 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.4 mt -63.16 -35.25 79.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.892 1.277 . . . . 70.51 110.428 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -70.26 -33.25 71.38 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 118.666 0.666 . . . . 73.23 109.801 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -76.62 -55.64 5.33 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.482 0.713 . . . . 75.45 111.461 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.1 p -70.6 -40.91 72.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.957 1.703 . . . . 74.12 112.796 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.88 -6.1 83.97 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.616 2.055 . . . . 62.24 113.144 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.2 m -144.28 143.18 30.89 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 119.273 1.537 . . . . 73.22 111.474 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.6 t -63.04 -49.67 82.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 C-N-CA 125.945 1.698 . . . . 55.12 106.924 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.71 -46.79 64.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.367 1.067 . . . . 72.41 111.195 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -63.03 -45.42 92.4 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 108.29 -1.004 . . . . 74.41 108.29 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.5 m -56.52 -37.52 70.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.228 0.611 . . . . 61.45 111.017 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.6 t -76.06 -39.31 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 121.363 -0.836 . . . . 75.03 109.447 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -65.95 -32.82 74.53 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.695 1.198 . . . . 65.14 111.54 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -82.38 -38.78 23.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.367 -0.975 . . . . 75.21 108.367 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -55.33 -53.95 49.65 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.954 0.902 . . . . 75.43 110.282 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -59.36 -21.21 59.49 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.582 0.586 . . . . 74.43 112.582 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -16.41 49.92 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.946 1.298 . . . . 71.43 109.526 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.2 28.66 48.36 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.245 -1.542 . . . . 71.32 109.245 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -61.15 177.32 0.35 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.739 1.616 . . . . 73.02 112.073 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -77.56 138.52 39.21 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 120.806 -1.184 . . . . 73.21 109.029 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -134.57 108.66 8.2 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.014 -1.847 . . . . 75.45 106.014 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.4 m -91.1 177.07 6.37 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.503 0.721 . . . . 73.15 109.833 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -108.83 153.71 42.22 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 107.977 -1.12 . . . . 70.15 107.977 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.58 ' CG ' HH21 ' A' ' 86' ' ' ARG . 33.2 Cg_endo -71.11 163.28 39.74 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.505 2.136 . . . . 74.22 113.182 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.5 131.4 27.84 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.481 2.12 . . . . 63.25 107.003 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.499 ' HA2' ' H ' ' A' ' 54' ' ' ARG . . . 105.14 -9.7 46.64 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-O 117.738 -1.59 . . . . 71.44 112.097 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -86.79 -28.32 23.04 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.157 1.479 . . . . 63.23 109.49 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--O 1.255 1.354 0 N-CA-C 103.994 -2.595 . . . . 75.31 103.994 178.258 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.738 0 N-CA-C 110.522 -1.031 . . . . 74.23 110.522 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.68 -176.76 4.67 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.235 1.414 . . . . 63.15 108.598 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -136.99 172.8 12.47 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.19 1.396 . . . . 73.22 107.69 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.9 178.9 43.9 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.099 -1.2 . . . . 64.41 110.099 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.87 117.55 4.54 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.193 2.595 . . . . 53.42 109.579 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -67.19 104.97 1.58 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.929 -1.508 . . . . 63.22 106.929 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.08 -135.66 3.58 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 108.729 -1.748 . . . . 60.04 108.729 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 t -72.41 64.92 0.61 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.449 1.099 . . . . 61.23 111.427 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.1 t -66.48 -15.0 63.02 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.001 -1.062 . . . . 72.35 110.955 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -65.27 22.63 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.253 2.621 . . . . 71.22 116.625 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.14 -50.73 21.07 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 123.711 0.805 . . . . 60.42 110.735 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.27 73.46 1.81 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.128 0.971 . . . . 73.54 112.057 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.2 mt -119.29 153.83 34.44 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.554 1.142 . . . . 64.04 112.705 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 56.3 13.39 1.24 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 118.082 2.623 . . . . 70.13 118.082 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -66.54 -29.78 69.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.82 1.191 . . . . 74.12 111.052 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.4 p -64.31 157.59 25.71 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.243 0.929 . . . . 73.44 109.326 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.73 170.93 14.27 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.955 1.264 . . . . 53.4 110.582 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.63 90.02 0.55 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.825 0.85 . . . . 63.41 112.13 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.86 157.33 3.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.687 -1.227 . . . . 71.32 107.687 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.1 m120 46.0 56.58 5.94 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.135 2.174 . . . . 72.41 112.539 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.73 -151.7 25.39 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.541 1.067 . . . . 42.34 112.702 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.61 58.08 0.09 OUTLIER Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.207 1.86 . . . . 73.34 111.849 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -72.01 141.72 84.45 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 118.042 0.921 . . . . 71.01 109.145 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.88 126.17 9.23 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 121.734 1.623 . . . . 71.43 108.198 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.6 m -111.94 170.15 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 120.814 -1.179 . . . . 72.33 109.807 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 p -125.37 157.0 37.86 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.691 1.596 . . . . 54.24 107.154 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 m -54.77 -38.89 67.79 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.533 1.133 . . . . 54.13 109.609 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -33.15 68.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.675 1.19 . . . . 72.15 112.445 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 93.0 mtp -68.5 -39.7 81.18 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.793 -1.192 . . . . 63.14 108.729 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 t -59.47 -53.78 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 124.86 1.264 . . . . 61.02 110.136 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -62.56 -41.82 99.16 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 117.209 -1.377 . . . . 65.03 110.845 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.3 m -54.58 -60.16 3.72 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 120.787 1.631 . . . . 62.23 108.93 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.0 t -53.32 -47.15 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 119.154 0.888 . . . . 63.22 110.674 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -57.21 -43.73 83.03 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.171 0.804 . . . . 72.32 113.171 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -59.14 -45.89 89.78 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.42 -0.956 . . . . 74.52 108.42 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.4 mt -71.47 -37.15 71.37 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.718 0.807 . . . . 74.31 111.879 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.82 80.99 11.46 Favored Pre-proline 0 C--O 1.241 0.642 0 C-N-CA 127.507 2.323 . . . . 72.11 112.043 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.37 -2.19 11.75 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 124.746 3.631 . . . . 70.12 112.306 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -90.26 -19.67 23.85 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.97 1.708 . . . . 74.01 110.584 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.8 mt -92.46 157.34 16.62 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.219 0.463 . . . . 73.22 112.146 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.4 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 41.7 t-80 -83.01 142.67 44.79 Favored Pre-proline 0 C--O 1.237 0.43 0 N-CA-C 106.229 -1.767 . . . . 75.14 106.229 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.5 ' HA ' HD12 ' A' ' 85' ' ' ILE . 20.1 Cg_endo -62.73 -28.98 76.74 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.751 2.3 . . . . 64.5 112.553 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HG2' ' CD1' ' A' ' 114' ' ' PHE . 2.2 tp10 -73.62 -41.61 62.59 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 122.112 -0.368 . . . . 63.03 111.466 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -61.24 -37.94 84.88 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.69 -0.631 . . . . 73.53 110.595 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 82' ' ' PRO . 97.5 mt -53.42 -58.3 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.47 1.108 . . . . 71.44 109.41 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.26 -47.76 18.09 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.971 0.805 . . . . 74.44 111.524 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -64.54 -42.76 95.51 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.179 0.9 . . . . 75.23 111.252 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.4 t -60.09 -46.24 90.25 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.03 -1.1 . . . . 45.3 108.03 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.28 -39.36 79.06 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.813 0.845 . . . . 62.14 111.025 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -69.42 -35.21 75.5 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.458 0.647 . . . . 74.45 111.395 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -72.39 -56.06 6.06 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.402 0.681 . . . . 73.3 110.454 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.8 p -68.73 -41.23 79.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.302 1.441 . . . . 73.02 113.341 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.86 -4.79 84.47 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.018 1.771 . . . . 74.3 113.439 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.4 m -142.23 134.58 27.83 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.507 1.153 . . . . 43.4 111.634 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.2 t -59.04 -48.48 86.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.173 0 N-CA-C 106.16 -1.792 . . . . 75.14 106.16 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.77 -42.23 64.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.904 0.882 . . . . 71.44 111.239 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -64.45 -45.04 89.17 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.53 -0.915 . . . . 70.52 108.53 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 58.3 m -59.51 -36.69 76.56 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.805 0.842 . . . . 74.12 110.315 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 65.9 t -74.67 -36.74 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.388 0.675 . . . . 72.23 110.138 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -71.47 -36.07 71.05 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.389 1.476 . . . . 71.13 111.192 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -79.34 -33.54 42.95 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.709 -0.848 . . . . 72.0 108.709 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -58.2 -55.73 31.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 118.925 -0.559 . . . . 74.53 109.59 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.41 -25.06 65.64 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.249 -0.881 . . . . 55.13 111.953 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -81.88 -8.02 59.65 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.238 0.926 . . . . 53.2 109.641 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.69 34.22 59.88 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 118.551 -1.139 . . . . 63.44 110.406 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -69.88 176.61 3.57 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 118.326 1.063 . . . . 74.3 110.127 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -75.7 147.25 39.53 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.844 -1.16 . . . . 73.55 109.33 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -138.9 109.08 6.41 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.325 -1.361 . . . . 75.44 107.325 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.4 m -94.66 164.95 12.74 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 124.237 1.015 . . . . 71.2 109.118 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -91.59 160.08 37.34 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.59 1.156 . . . . 74.43 109.7 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.39 165.35 29.23 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.213 1.942 . . . . 63.44 112.101 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.93 152.91 80.66 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.704 1.603 . . . . 73.41 108.528 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.73 -6.43 39.94 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.39 -1.228 . . . . 64.44 113.577 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . 0.415 ' CD1' ' HG2' ' A' ' 83' ' ' GLU . 85.9 t80 -77.49 -26.13 51.0 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.462 1.631 . . . . 73.22 110.547 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 116.964 -1.493 . . . . 74.3 109.841 179.789 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.782 0 CA-C-O 119.595 -0.558 . . . . 64.05 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.98 115.14 1.17 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.899 1.28 . . . . 63.5 111.879 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 31.1 mtt 51.34 17.11 0.47 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.881 1.673 . . . . 63.45 113.75 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -139.58 79.46 0.29 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 107.553 -2.219 . . . . 74.31 107.553 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -70.58 -179.25 3.14 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.17 1.914 . . . . 61.25 109.557 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.13 173.19 0.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.158 0.504 . . . . 75.23 110.625 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.96 48.58 0.86 Allowed Glycine 0 C--N 1.33 0.215 0 N-CA-C 109.234 -1.546 . . . . 24.42 109.234 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.6 t -79.65 100.03 7.65 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.346 -2.094 . . . . 75.22 105.346 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.1 t -61.14 -27.24 68.25 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.991 -0.744 . . . . 73.11 108.991 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 37.69 54.47 1.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.55 2.34 . . . . 71.31 111.377 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -65.17 171.96 3.38 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.183 0.993 . . . . 51.42 112.249 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.67 -176.72 4.26 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.651 2.38 . . . . 71.4 105.731 177.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.78 33.05 1.6 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.528 -0.733 . . . . 73.34 112.352 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -158.37 170.18 22.81 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.446 1.498 . . . . 74.14 109.517 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -133.13 104.52 6.55 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.396 -1.335 . . . . 74.45 107.396 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 m -76.67 -45.09 31.09 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.438 -0.949 . . . . 60.02 108.438 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.47 -177.07 17.89 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.748 -0.941 . . . . 71.54 110.748 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 65.3 mtt-85 -145.09 170.29 16.48 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 127.43 2.292 . . . . 73.44 106.203 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.7 t -111.15 -51.76 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.864 -1.532 . . . . 70.42 106.864 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -99.34 37.11 1.62 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.282 1.833 . . . . 74.02 110.361 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.02 -162.31 30.19 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.957 -1.257 . . . . 70.4 109.957 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.61 -110.22 0.06 OUTLIER Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.638 0.637 . . . . 70.4 111.978 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -129.63 154.87 80.97 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 118.39 1.095 . . . . 73.42 110.404 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.97 126.49 10.02 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.476 2.117 . . . . 61.34 109.3 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.3 m -125.13 162.52 27.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.932 0.893 . . . . 62.52 109.083 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p -120.34 172.89 7.48 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.687 1.995 . . . . 73.11 108.228 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.9 m -65.03 -40.23 94.52 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 121.423 -0.798 . . . . 62.1 110.304 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -38.38 62.91 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 124.402 1.081 . . . . 73.34 112.111 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.3 mtp -63.66 -41.52 98.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.385 -0.822 . . . . 70.43 109.413 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.93 -56.46 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 124.999 1.32 . . . . 74.44 110.464 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -59.69 -39.76 85.61 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.005 -0.998 . . . . 72.21 109.75 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.403 ' CG2' HG11 ' A' ' 95' ' ' VAL . 57.8 m -56.41 -60.42 3.55 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 120.356 1.435 . . . . 71.43 109.96 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.5 t -53.92 -45.5 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 119.374 0.988 . . . . 52.24 108.531 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -53.49 -43.15 68.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.717 1.144 . . . . 62.33 113.014 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -66.91 -35.33 79.77 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.715 0.406 . . . . 72.43 110.293 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 mt -88.22 -12.25 44.32 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.262 0.483 . . . . 62.53 112.278 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -143.78 76.77 15.37 Favored Pre-proline 0 C--O 1.241 0.607 0 C-N-CA 126.363 1.865 . . . . 52.34 108.85 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.5 -13.72 33.07 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.376 2.717 . . . . 73.13 112.405 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.6 -7.99 58.89 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.467 1.507 . . . . 75.13 112.395 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.2 mt -97.48 152.97 18.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.25 0.932 . . . . 63.13 112.005 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.42 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 58.0 t-80 -69.54 144.56 94.33 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.828 1.651 . . . . 74.52 109.394 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 41.0 Cg_endo -66.89 -24.94 45.64 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.85 2.367 . . . . 74.12 114.152 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.76 -41.33 14.21 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 120.054 1.297 . . . . 63.45 111.725 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -57.04 -35.8 69.73 Favored 'General case' 0 C--N 1.343 0.308 0 O-C-N 123.657 0.598 . . . . 74.2 110.478 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 66.8 mt -53.64 -58.16 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 118.485 -0.769 . . . . 62.42 110.035 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.72 -45.24 48.93 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.474 0.579 . . . . 65.32 111.815 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -63.32 -44.57 94.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.783 -0.573 . . . . 74.14 111.144 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 p -60.67 -44.4 96.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 118.567 -0.73 . . . . 73.3 109.998 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.4 mt -60.4 -37.07 79.66 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.82 0.848 . . . . 74.31 110.04 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.1 -33.55 74.74 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.296 0.498 . . . . 64.52 110.269 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -79.04 -42.24 26.93 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.258 1.023 . . . . 75.45 113.537 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -83.52 -34.6 25.25 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.713 1.605 . . . . 74.42 112.537 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.88 -11.12 63.09 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.418 1.961 . . . . 33.1 111.899 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 m -144.87 150.93 37.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.346 1.573 . . . . 71.41 112.106 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.403 HG11 ' CG2' ' A' ' 72' ' ' THR . 78.1 t -62.63 -49.78 82.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 126.281 1.832 . . . . 63.4 107.97 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -45.33 -53.24 8.76 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 128.092 2.557 . . . . 75.01 111.792 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -66.66 -41.59 87.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.638 -0.71 . . . . 73.21 109.43 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.9 m -59.26 -39.29 82.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.012 0.925 . . . . 73.53 110.463 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.8 t -74.39 -38.25 46.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 124.107 0.963 . . . . 73.42 109.924 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -68.07 -41.62 81.67 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.355 1.062 . . . . 60.13 110.495 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 108' ' ' PHE . 5.6 ptm180 -74.12 -35.35 64.11 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.351 -0.843 . . . . 72.01 108.816 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -57.57 -57.33 13.15 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 118.539 -0.743 . . . . 74.34 109.457 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.29 -24.9 65.32 Favored 'General case' 0 C--N 1.339 0.118 0 O-C-N 123.575 0.547 . . . . 53.54 111.402 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -15.39 59.51 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 118.457 -0.782 . . . . 53.04 109.684 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.27 28.82 32.36 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 118.748 -1.029 . . . . 34.44 110.545 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.25 174.46 4.7 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.664 1.232 . . . . 71.55 109.02 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -86.13 147.74 26.01 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 120.587 -1.32 . . . . 65.42 108.776 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 101' ' ' ARG . 34.9 m-85 -139.1 109.72 6.63 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.632 -1.167 . . . . 72.22 109.694 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.9 m -82.12 170.71 15.18 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.382 1.073 . . . . 63.13 108.876 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -94.4 161.98 27.51 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 126.442 1.897 . . . . 73.11 110.848 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.53 158.46 57.6 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.619 2.213 . . . . 61.25 111.766 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.42 128.88 23.63 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.838 2.359 . . . . 72.2 110.612 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.61 -3.95 66.0 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 118.734 -1.037 . . . . 72.04 113.16 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -67.93 -31.18 70.76 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.416 1.608 . . . . 74.11 107.661 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 128.223 2.609 . . . . 63.41 106.835 179.227 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.644 0 N-CA-C 110.524 -1.031 . . . . 43.32 110.524 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.69 51.51 0.11 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.309 2.244 . . . . 75.32 113.191 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -59.81 -18.23 42.18 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.849 -1.157 . . . . 74.4 113.001 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.24 74.79 0.71 Allowed Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.35 -1.9 . . . . 64.24 108.35 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -82.5 10.88 3.39 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 124.086 3.19 . . . . 74.33 112.161 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -145.55 38.62 1.14 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 127.583 2.353 . . . . 74.24 108.101 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.46 -169.88 38.74 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-O 123.055 1.364 . . . . 43.12 112.784 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.9 m -126.99 167.05 16.42 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.983 2.113 . . . . 74.0 107.756 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.7 t -156.72 -30.3 0.09 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.775 0.43 . . . . 71.43 111.552 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -59.12 133.28 55.96 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.802 0.841 . . . . 75.2 109.532 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -87.49 -5.12 58.94 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.555 0.742 . . . . 73.15 112.581 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.64 104.73 3.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.628 -1.99 . . . . 73.14 105.628 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -152.65 179.88 8.21 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 118.287 0.494 . . . . 64.0 111.171 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -57.3 118.2 4.86 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.886 -1.154 . . . . 72.2 107.886 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -61.86 99.52 0.12 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 118.819 -0.61 . . . . 72.11 110.677 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 t -167.49 169.32 12.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.854 -1.536 . . . . 41.12 106.854 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.53 175.03 36.77 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.422 -0.671 . . . . 55.53 111.422 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.62 149.58 45.36 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.609 -1.626 . . . . 74.35 106.609 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 p -159.64 161.47 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.92 -0.771 . . . . 74.33 108.92 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -145.14 164.11 32.27 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.698 1.999 . . . . 73.5 106.405 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.65 17.67 78.57 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 116.042 1.177 . . . . 72.31 116.042 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.15 80.81 0.09 OUTLIER Glycine 0 C--N 1.334 0.464 0 CA-C-N 120.485 2.142 . . . . 61.41 111.497 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -128.99 142.45 45.17 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.944 0.898 . . . . 75.01 110.545 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.99 140.2 22.58 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.898 3.065 . . . . 64.22 107.868 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.37 150.07 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.318 -0.864 . . . . 64.54 111.326 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.4 p -107.08 169.8 8.34 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.885 1.674 . . . . 73.24 111.952 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.8 m -58.22 -40.03 80.62 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.391 -0.814 . . . . 64.42 109.667 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -57.76 -35.12 70.31 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 118.81 0.732 . . . . 73.3 112.066 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 92.2 mtp -66.43 -42.84 87.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.216 -0.927 . . . . 62.42 109.171 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.38 -54.79 28.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 C-N-CA 124.625 1.17 . . . . 74.24 109.4 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -64.05 -35.75 81.75 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 118.127 -0.94 . . . . 44.45 111.78 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.415 ' CG2' HG11 ' A' ' 95' ' ' VAL . 27.4 m -57.59 -59.6 4.94 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.187 1.358 . . . . 72.24 109.037 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.4 t -55.91 -45.92 80.11 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 CA-C-O 117.749 -1.12 . . . . 53.12 109.225 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -54.27 -44.8 72.19 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 120.457 1.48 . . . . 74.22 112.771 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -61.07 -44.93 96.64 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.234 -1.024 . . . . 74.33 108.234 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.7 mt -76.34 -28.93 57.06 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.1 0.778 . . . . 63.53 113.1 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.31 78.4 71.44 Favored Pre-proline 0 C--O 1.242 0.666 0 C-N-CA 127.737 2.415 . . . . 73.24 110.153 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.43 -1.1 10.89 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.89 3.727 . . . . 74.44 113.309 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -95.71 2.8 54.16 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.331 1.453 . . . . 72.14 112.021 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.0 mt -108.43 156.22 19.7 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.68 1.192 . . . . 73.35 109.556 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.452 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 54.5 t-80 -79.49 147.53 68.14 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 107.539 -1.282 . . . . 74.34 107.539 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 37.7 Cg_endo -65.14 -22.88 61.0 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.873 2.382 . . . . 73.44 113.417 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.51 -37.08 28.42 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.567 -0.708 . . . . 71.22 110.12 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -58.54 -37.02 74.81 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 109.885 -0.413 . . . . 71.41 109.885 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 82' ' ' PRO . 47.2 mt -57.41 -60.8 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 117.471 -1.252 . . . . 70.43 109.813 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.45 -50.19 5.21 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.517 1.053 . . . . 75.05 110.918 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -63.2 -47.32 83.05 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.612 0.72 . . . . 75.45 111.998 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 m -57.1 -50.79 71.68 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.383 0.673 . . . . 54.12 109.23 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.0 mt -57.92 -39.83 78.93 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.3 1.04 . . . . 65.12 111.136 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -65.63 -32.0 73.33 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 122.478 0.311 . . . . 75.31 110.546 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -80.16 -51.32 9.11 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.646 -0.693 . . . . 50.45 111.094 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -71.41 -40.97 70.14 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.07 1.348 . . . . 65.31 113.145 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.52 -17.55 58.83 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.677 2.084 . . . . 21.14 113.102 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 t -143.33 147.87 35.39 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.426 1.613 . . . . 75.15 108.984 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.415 HG11 ' CG2' ' A' ' 72' ' ' THR . 31.1 t -59.8 -46.13 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 127.32 2.248 . . . . 75.31 109.27 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -47.62 -48.57 28.44 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.381 1.472 . . . . 64.53 110.48 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -67.84 -42.38 81.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.625 -0.509 . . . . 74.31 109.625 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.2 m -58.25 -36.64 73.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.066 0.547 . . . . 72.24 110.896 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 78.8 t -75.95 -38.71 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.402 1.081 . . . . 64.32 109.614 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -66.61 -38.7 87.52 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.03 1.332 . . . . 52.3 110.37 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -76.94 -37.52 55.16 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 121.057 -1.027 . . . . 73.43 108.649 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -56.29 -53.55 55.95 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.194 0.598 . . . . 74.24 109.743 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.79 -22.94 65.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 119.345 -0.36 . . . . 63.33 111.955 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -82.37 -10.15 59.18 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.796 0.726 . . . . 75.31 109.718 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.32 37.22 42.46 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.018 -1.233 . . . . 74.2 110.018 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.76 -171.72 0.43 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 117.645 0.723 . . . . 70.11 110.734 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -90.34 139.51 30.59 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 120.346 -1.471 . . . . 64.22 110.388 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -128.89 108.76 10.69 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.358 -1.349 . . . . 74.11 107.358 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.9 m -89.74 172.4 8.95 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.802 1.641 . . . . 75.21 110.349 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -107.49 152.87 41.52 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 125.747 1.619 . . . . 62.2 108.423 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.19 170.11 19.89 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 123.706 2.937 . . . . 71.13 112.874 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.01 152.52 82.1 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 N-CA-C 107.003 -1.96 . . . . 75.21 107.003 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.08 -18.96 13.86 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 118.045 -1.419 . . . . 62.42 112.495 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -72.42 -54.75 8.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 119.536 1.668 . . . . 73.25 107.316 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 C--O 1.253 1.264 0 N-CA-C 106.266 -1.753 . . . . 75.13 106.266 179.508 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.74 0 N-CA-C 109.106 -1.598 . . . . 54.32 109.106 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.03 156.63 46.52 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.296 1.438 . . . . 72.31 107.19 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 24.8 mmt -130.25 160.92 32.41 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.613 1.165 . . . . 70.43 108.459 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.65 82.03 0.2 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 105.711 -2.955 . . . . 60.23 105.711 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.21 162.34 38.85 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.021 1.814 . . . . 65.41 111.143 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -86.41 164.17 17.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.603 0.761 . . . . 73.14 109.212 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.64 -87.45 0.34 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 106.438 -2.665 . . . . 51.13 106.438 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.6 m -148.71 176.35 10.43 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.792 1.637 . . . . 31.11 107.994 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 t -57.77 132.13 52.39 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.382 -0.824 . . . . 75.31 109.61 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -130.0 146.9 51.7 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.573 -1.269 . . . . 62.33 107.573 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -87.42 60.24 5.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.05 -1.463 . . . . 71.43 107.05 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.05 172.0 1.99 Allowed 'General case' 0 C--O 1.237 0.447 0 O-C-N 121.6 -0.687 . . . . 70.53 110.564 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -148.37 38.02 0.86 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.924 0.89 . . . . 75.22 110.534 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.9 ttt-85 -131.39 28.48 4.67 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.843 0.857 . . . . 60.42 113.214 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 60.49 40.09 17.48 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.627 1.103 . . . . 72.23 108.449 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.8 p -129.06 15.61 6.25 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.524 1.93 . . . . 74.31 112.397 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -134.71 169.48 23.16 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.219 -1.152 . . . . 54.42 110.219 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -67.35 -0.26 3.46 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 116.228 1.936 . . . . 72.45 116.228 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.02 73.74 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 123.031 1.396 . . . . 75.5 110.794 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.05 126.99 47.78 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 103.757 -2.682 . . . . 71.52 103.757 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.44 60.24 0.49 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-N 119.054 0.843 . . . . 72.14 112.363 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.52 108.05 0.2 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-N 117.981 0.891 . . . . 71.12 111.68 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -130.92 155.96 80.74 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 126.851 2.06 . . . . 64.14 108.304 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.31 126.08 9.53 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.933 1.756 . . . . 71.03 109.084 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.2 m -126.48 161.16 33.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 O-C-N 121.306 -0.871 . . . . 43.12 109.836 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 p -125.09 164.18 20.78 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.96 2.104 . . . . 70.44 109.813 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.0 m -59.17 -39.39 82.36 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.757 0.708 . . . . 72.51 110.744 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.3 -33.66 67.9 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.398 0.679 . . . . 74.12 111.983 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.8 mtp -65.72 -46.84 77.44 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 120.638 -1.289 . . . . 71.02 107.696 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.7 t -50.77 -58.66 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.499 0 C-N-CA 126.703 2.001 . . . . 72.43 109.853 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -59.73 -37.18 78.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 118.283 -0.865 . . . . 73.42 110.559 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -54.82 -60.69 3.01 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 120.272 1.396 . . . . 63.05 109.071 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.8 t -54.91 -51.89 48.63 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-O 118.06 -0.972 . . . . 71.21 108.847 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.41 -42.89 54.41 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.044 0.838 . . . . 74.25 113.05 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -65.21 -40.1 93.69 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 118.961 0.801 . . . . 73.13 109.289 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.5 mt -82.98 -16.24 48.0 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.083 0.772 . . . . 53.45 113.083 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.37 72.36 65.35 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 129.208 3.003 . . . . 73.04 109.528 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.82 -12.38 30.8 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.225 1.95 . . . . 64.4 112.486 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -84.25 13.23 5.46 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.383 1.473 . . . . 74.31 112.618 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.1 mt -121.12 158.78 27.18 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.504 1.122 . . . . 55.5 110.663 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -81.86 141.91 48.14 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 107.7 -1.222 . . . . 75.22 107.7 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.464 ' HA ' HD12 ' A' ' 85' ' ' ILE . 38.7 Cg_endo -63.64 -26.35 69.05 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.654 2.236 . . . . 75.34 112.813 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.37 -39.5 53.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.748 -0.595 . . . . 54.13 111.942 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -60.25 -45.58 92.78 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.83 -0.433 . . . . 60.33 109.83 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 82' ' ' PRO . 95.2 mt -47.53 -55.58 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 126.272 1.829 . . . . 50.0 111.03 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -45.69 49.33 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.911 0.778 . . . . 73.51 111.447 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -64.1 -40.07 95.43 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.773 -1.204 . . . . 72.5 110.955 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.0 m -57.82 -55.77 30.6 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.042 1.337 . . . . 74.3 108.256 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.11 -39.99 76.15 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.704 1.202 . . . . 73.32 111.238 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.19 -33.93 77.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 119.553 -0.859 . . . . 70.14 110.698 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -76.96 -48.68 17.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 118.395 -0.812 . . . . 73.21 111.969 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.4 p -73.49 -40.98 63.67 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.627 1.571 . . . . 75.22 111.5 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.14 -4.14 84.12 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 127.363 2.411 . . . . 63.02 111.853 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 m -144.54 140.76 29.02 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.798 1.239 . . . . 61.43 110.704 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.22 -45.83 95.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 124.909 1.284 . . . . 51.21 108.439 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -47.8 -48.67 30.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.345 1.858 . . . . 62.32 111.362 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.72 -47.63 77.59 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 108.591 -0.892 . . . . 71.32 108.591 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 m -54.83 -41.7 71.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.548 1.539 . . . . 73.21 112.044 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.4 t -76.76 -34.5 23.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 121.503 -0.748 . . . . 53.04 110.364 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -73.19 -32.06 64.58 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.985 0.914 . . . . 71.14 111.197 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.464 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 3.9 ptm180 -82.19 -34.93 28.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.42 -0.956 . . . . 73.21 108.42 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -55.92 -55.1 36.67 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 108.298 -1.001 . . . . 62.12 108.298 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.32 -24.78 66.68 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 119.335 -0.364 . . . . 72.22 111.219 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 101' ' ' ARG . 0.1 OUTLIER -74.68 -17.23 60.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.153 0.888 . . . . 70.12 108.962 178.205 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.83 35.12 28.96 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.318 -1.513 . . . . 71.11 109.318 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -70.61 -173.0 0.69 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.129 0.964 . . . . 73.13 110.047 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -89.71 144.48 25.95 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 119.523 -1.986 . . . . 75.02 108.529 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -136.69 109.44 7.54 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.242 -1.344 . . . . 63.44 108.895 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.63 173.44 8.05 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.179 1.392 . . . . 73.22 110.932 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -103.8 158.75 31.23 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.096 1.758 . . . . 72.31 109.074 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.0 161.88 40.61 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.485 2.123 . . . . 70.51 112.867 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -67.9 136.05 37.18 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.067 1.845 . . . . 52.43 109.688 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.34 -2.55 71.2 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.488 1.042 . . . . 73.34 111.388 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -75.52 -35.98 60.62 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.03 0.915 . . . . 71.53 109.838 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 . . . . . 0 C--O 1.248 1.007 0 C-N-CA 125.847 1.659 . . . . 71.54 110.982 -179.26 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.302 0 N-CA-C 109.342 -1.503 . . . . 55.34 109.342 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.22 176.3 10.99 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.551 1.54 . . . . 65.41 107.614 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -156.55 -179.96 8.69 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.869 2.068 . . . . 74.22 107.428 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.18 172.84 29.98 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 110.565 -1.014 . . . . 74.34 110.565 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.85 138.98 35.46 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.046 2.498 . . . . 65.43 110.352 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -87.73 -7.17 57.7 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.019 0.748 . . . . 71.43 113.019 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.21 -167.05 54.72 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 110.758 -0.937 . . . . 42.23 110.758 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 p -160.52 171.99 17.99 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.124 1.37 . . . . 71.23 108.783 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.8 t -161.02 177.71 10.07 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.509 1.524 . . . . 71.23 107.368 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -146.0 176.35 9.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.138 1.775 . . . . 74.44 109.236 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -129.19 174.4 9.61 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.304 1.842 . . . . 73.33 110.741 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.52 72.04 0.33 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 127.723 2.409 . . . . 51.34 112.538 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -142.36 131.46 23.25 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.138 -0.69 . . . . 65.51 109.138 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -156.36 146.54 21.36 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.79 -1.189 . . . . 71.34 107.79 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -62.83 -17.61 61.61 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.542 1.137 . . . . 73.0 112.853 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.8 t -66.37 172.28 4.13 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.522 1.055 . . . . 70.42 109.826 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.62 -45.24 0.06 OUTLIER Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.107 -1.197 . . . . 54.32 110.107 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.5 52.87 7.33 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.387 1.075 . . . . 54.45 111.172 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.42 168.68 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.129 -0.941 . . . . 44.24 110.678 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -63.76 147.21 52.3 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.48 -0.782 . . . . 75.11 110.173 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.47 2.47 0.26 Allowed Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.08 -0.844 . . . . 52.34 114.057 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.8 84.46 0.09 OUTLIER Glycine 0 C--N 1.335 0.493 0 CA-C-N 119.595 1.697 . . . . 71.34 109.48 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -96.08 144.98 28.76 Favored Pre-proline 0 N--CA 1.447 -0.592 0 N-CA-C 107.529 -1.285 . . . . 75.04 107.529 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.84 148.84 36.62 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.819 2.346 . . . . 74.53 109.268 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.35 165.64 30.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-O 121.619 0.723 . . . . 75.22 110.201 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 p -125.36 157.24 37.26 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.152 1.781 . . . . 74.31 107.387 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.9 m -54.31 -36.7 64.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.354 0.662 . . . . 73.13 111.149 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -32.59 68.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.144 0.978 . . . . 73.42 111.948 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.7 mtp -69.9 -40.75 75.44 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.036 -1.098 . . . . 71.33 108.036 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 t -59.94 -58.02 9.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.971 1.308 . . . . 73.54 109.349 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -60.01 -36.05 76.37 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 118.341 -0.837 . . . . 64.14 110.877 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.436 ' CG2' HG11 ' A' ' 95' ' ' VAL . 82.2 m -58.03 -61.72 2.34 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.958 1.254 . . . . 61.44 108.863 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.411 HG21 HD21 ' A' ' 89' ' ' LEU . 61.3 t -54.9 -43.98 70.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 119.481 1.037 . . . . 71.22 109.39 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -55.2 -48.07 74.38 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 119.655 1.116 . . . . 43.52 111.525 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -59.03 -39.68 82.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.12 0.968 . . . . 65.23 110.324 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.2 mt -86.63 -19.75 28.86 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.109 0.781 . . . . 75.22 113.109 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.05 77.91 74.79 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.847 2.059 . . . . 43.42 109.032 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.49 -0.24 6.41 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.294 3.33 . . . . 64.1 113.602 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.45 20.51 18.12 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.287 1.035 . . . . 72.32 111.749 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.2 mt -123.37 154.5 38.89 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.905 1.282 . . . . 73.14 110.039 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.467 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 48.5 t-80 -86.27 147.72 45.47 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-O 118.495 -0.764 . . . . 71.54 109.104 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 40.3 Cg_endo -63.57 -32.1 70.17 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.315 2.677 . . . . 53.21 112.752 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 81' ' ' HIS . 0.1 OUTLIER -74.82 -44.65 48.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.884 -0.413 . . . . 75.35 109.884 -178.329 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -59.27 -39.81 84.08 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 108.834 -0.802 . . . . 71.24 108.834 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 82' ' ' PRO . 48.5 mt -57.52 -59.59 3.11 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 N-CA-C 107.84 -1.171 . . . . 75.5 107.84 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.08 -47.06 34.33 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.395 0.998 . . . . 70.12 111.596 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -62.01 -44.25 97.13 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.205 0.911 . . . . 71.43 111.494 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m -63.75 -41.29 98.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.414 -0.587 . . . . 75.34 109.414 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.411 HD21 HG21 ' A' ' 73' ' ' VAL . 87.9 mt -61.62 -37.77 85.18 Favored 'General case' 0 C--O 1.225 -0.236 0 O-C-N 121.229 -0.92 . . . . 72.34 110.38 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -69.9 -37.31 75.96 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 117.992 0.36 . . . . 62.02 111.078 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -74.77 -53.06 9.88 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 122.171 -0.331 . . . . 73.43 111.137 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.7 p -67.14 -41.88 85.35 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.068 0.947 . . . . 73.42 111.486 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.28 -15.0 64.19 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 128.335 2.874 . . . . 73.24 113.806 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.0 m -139.55 148.5 42.66 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.636 1.718 . . . . 71.23 111.763 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.436 HG11 ' CG2' ' A' ' 72' ' ' THR . 51.1 t -61.7 -50.99 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 106.342 -1.725 . . . . 65.03 106.342 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -50.86 -48.36 60.12 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.756 1.622 . . . . 71.22 111.101 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.71 -42.56 99.71 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.729 1.211 . . . . 73.42 109.179 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.5 m -65.0 -38.45 90.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.857 1.263 . . . . 52.42 110.807 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.9 t -73.35 -39.81 55.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 121.339 -0.85 . . . . 62.11 109.66 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -65.19 -38.97 92.18 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.474 1.51 . . . . 60.2 111.015 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -77.58 -35.53 52.92 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.592 -0.892 . . . . 61.53 108.592 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -57.17 -57.59 11.91 Favored 'General case' 0 C--O 1.233 0.226 0 O-C-N 121.255 -0.903 . . . . 74.31 110.53 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.47 -23.95 59.06 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.429 0.692 . . . . 74.54 111.179 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -12.11 59.24 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 117.845 -1.074 . . . . 50.51 111.464 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.06 22.7 51.67 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.786 -1.008 . . . . 73.51 112.317 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -67.25 172.99 4.19 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.635 1.217 . . . . 61.44 111.101 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -77.19 144.59 38.21 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.822 1.649 . . . . 74.02 109.985 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -137.43 110.11 7.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.895 1.278 . . . . 61.33 107.804 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -92.97 167.99 11.44 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.503 -1.226 . . . . 71.2 110.169 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -94.21 158.81 35.32 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 124.671 1.189 . . . . 74.22 109.221 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -67.99 166.99 22.87 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.473 2.782 . . . . 51.35 114.483 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.42 143.92 89.61 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.025 1.817 . . . . 63.12 108.147 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.12 3.45 88.33 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.094 -0.837 . . . . 45.32 112.915 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -84.36 -41.37 16.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.425 1.613 . . . . 74.33 110.981 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 C--O 1.254 1.302 0 CA-C-O 118.013 -0.994 . . . . 72.11 110.86 -179.091 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.169 0 N-CA-C 108.79 -1.724 . . . . 70.44 108.79 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.91 168.79 16.15 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.189 0.995 . . . . 72.25 109.031 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 55.1 mtt -147.91 169.52 19.65 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.952 2.101 . . . . 75.2 106.452 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.04 -82.06 0.35 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.239 -1.544 . . . . 71.34 109.239 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.82 127.81 22.56 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.77 2.314 . . . . 72.54 109.922 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -159.43 169.88 22.98 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.849 2.06 . . . . 73.24 107.141 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.34 -171.37 28.77 Favored Glycine 0 CA--C 1.521 0.469 0 N-CA-C 110.365 -1.094 . . . . 73.25 110.365 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.2 m -159.03 165.3 34.31 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.491 1.916 . . . . 55.41 107.094 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.0 t -160.75 -171.12 2.98 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.532 -1.285 . . . . 54.35 107.532 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -129.73 179.12 6.02 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.84 2.056 . . . . 74.13 107.369 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -136.25 156.15 49.08 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.343 -0.848 . . . . 70.02 109.45 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.98 92.93 3.02 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.052 -1.832 . . . . 42.33 106.052 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -134.71 159.54 40.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.843 1.657 . . . . 74.43 108.04 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? 51.15 19.54 0.73 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.633 1.173 . . . . 74.4 113.653 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -60.84 -66.58 0.51 Allowed 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 120.27 1.396 . . . . 73.14 110.766 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -61.89 148.12 44.52 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.19 -0.671 . . . . 73.52 109.19 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.69 157.65 20.51 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 123.648 0.642 . . . . 74.14 111.972 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.4 135.7 33.4 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.127 -1.064 . . . . 74.32 108.127 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.44 153.9 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 107.322 -1.362 . . . . 65.53 107.322 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -90.2 167.82 12.41 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.156 -0.965 . . . . 72.11 110.283 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.53 163.76 33.76 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 126.195 1.855 . . . . 54.32 111.638 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.18 36.24 81.44 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.808 -0.517 . . . . 75.3 111.808 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -82.82 149.02 58.95 Favored Pre-proline 0 CA--C 1.539 0.529 0 O-C-N 121.849 -0.795 . . . . 74.21 109.389 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.3 125.93 7.36 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.568 2.845 . . . . 74.1 110.321 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.92 143.61 29.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 122.747 1.26 . . . . 45.15 111.731 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p -112.04 161.02 16.93 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.579 1.951 . . . . 70.33 109.197 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.7 m -52.67 -38.96 61.38 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.82 1.248 . . . . 71.12 111.917 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -59.47 -31.67 69.54 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.483 1.113 . . . . 71.22 112.317 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 91.6 mtp -71.91 -45.87 59.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.455 -0.943 . . . . 63.24 108.455 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.4 t -59.98 -52.33 62.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.893 0.877 . . . . 73.42 109.883 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.53 -41.1 98.49 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-O 117.342 -1.313 . . . . 74.34 110.315 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.475 ' CG2' HG11 ' A' ' 95' ' ' VAL . 61.3 m -52.6 -60.38 3.32 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 120.602 1.546 . . . . 70.44 108.71 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.473 HG23 HG13 ' A' ' 95' ' ' VAL . 92.8 t -55.27 -50.53 64.02 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 CA-C-O 118.052 -0.975 . . . . 61.22 109.206 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -54.72 -44.41 73.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 119.716 1.144 . . . . 71.31 113.838 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -59.88 -43.77 94.57 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.931 1.293 . . . . 45.53 108.64 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.9 mt -81.59 -26.82 34.62 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.049 0.759 . . . . 54.34 113.049 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.93 73.39 35.27 Favored Pre-proline 0 N--CA 1.447 -0.578 0 C-N-CA 127.655 2.382 . . . . 72.53 111.498 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.81 -3.6 13.48 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.522 2.148 . . . . 64.22 111.312 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.11 18.68 10.35 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 128.345 2.658 . . . . 61.12 111.094 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.7 mt -133.83 154.82 50.75 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.351 1.461 . . . . 74.05 111.001 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -80.53 142.32 53.58 Favored Pre-proline 0 C--O 1.236 0.383 0 N-CA-C 107.416 -1.327 . . . . 72.32 107.416 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HA ' HD12 ' A' ' 85' ' ' ILE . 37.0 Cg_endo -66.33 -29.02 46.63 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.642 2.228 . . . . 64.41 113.022 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -75.43 -41.1 56.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.756 -0.59 . . . . 74.12 110.809 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -59.73 -41.92 91.97 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.634 -0.506 . . . . 63.52 109.634 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 82' ' ' PRO . 86.3 mt -51.36 -58.51 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 124.066 0.946 . . . . 72.13 108.984 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.05 -47.01 11.76 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.548 0.739 . . . . 73.54 111.619 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -64.53 -48.49 74.89 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.419 0.628 . . . . 73.11 111.489 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.4 m -56.92 -47.7 79.99 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 108.173 -1.047 . . . . 70.25 108.173 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.52 -39.74 77.23 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 124.584 1.154 . . . . 74.45 111.095 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -66.94 -31.64 72.35 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.168 0.44 . . . . 75.42 110.784 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -77.66 -50.59 12.15 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.209 0.448 . . . . 72.35 112.209 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -74.58 -41.94 59.62 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.952 1.701 . . . . 43.13 112.794 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.14 -12.02 69.11 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 126.671 2.081 . . . . 71.4 116.507 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 t -145.32 123.1 11.9 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 121.467 2.633 . . . . 64.41 111.706 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.475 HG11 ' CG2' ' A' ' 72' ' ' THR . 84.6 t -41.88 -41.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 120.366 1.439 . . . . 72.05 112.819 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -49.89 -43.61 49.55 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 124.694 1.246 . . . . 73.54 111.67 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -67.63 -42.83 81.68 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 121.092 -1.005 . . . . 71.13 109.489 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.8 m -60.45 -39.01 86.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.131 0.572 . . . . 74.21 111.114 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.36 -39.1 76.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.21 -0.663 . . . . 54.12 109.21 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -66.83 -41.02 88.13 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.622 0.769 . . . . 75.33 111.456 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -75.4 -35.36 61.04 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 121.104 -0.997 . . . . 63.31 109.619 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -57.4 -57.4 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.212 -0.93 . . . . 72.35 110.009 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.69 -22.16 56.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.951 0.722 . . . . 74.4 112.951 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -5.19 56.53 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.796 0.725 . . . . 64.24 110.953 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.15 36.81 50.28 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 118.519 0.6 . . . . 73.43 112.322 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -69.98 -178.46 1.6 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.211 1.006 . . . . 72.04 111.013 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.75 131.26 35.21 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.698 -1.251 . . . . 63.23 110.257 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -130.92 109.89 10.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.462 -1.681 . . . . 74.52 106.462 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.3 m -96.79 168.6 10.4 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.707 0.803 . . . . 54.22 110.084 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -91.23 155.91 44.16 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 107.326 -1.361 . . . . 73.44 107.326 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.57 168.51 21.1 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.759 2.306 . . . . 53.44 113.722 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.33 149.44 91.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.37 2.047 . . . . 72.13 108.921 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.12 -12.07 13.7 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.564 -1.131 . . . . 62.34 113.207 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -68.96 -24.41 64.25 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.715 1.758 . . . . 74.3 109.381 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 130.757 3.623 . . . . 71.15 105.212 178.183 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.264 0 N-CA-C 109.267 -1.533 . . . . 60.34 109.267 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.39 120.47 13.38 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.232 1.016 . . . . 73.02 108.347 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.1 tpp -164.63 153.35 12.73 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 105.951 -1.87 . . . . 64.24 105.951 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.48 175.27 34.26 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.615 -0.994 . . . . 51.44 110.615 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.15 166.71 28.92 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.06 2.507 . . . . 72.22 110.702 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.84 -172.31 2.54 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.421 1.888 . . . . 75.32 109.752 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.54 -178.13 44.02 Favored Glycine 0 CA--C 1.525 0.66 0 O-C-N 121.432 -0.792 . . . . 44.52 111.266 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.7 m -67.86 21.16 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 128.274 2.63 . . . . 62.52 113.951 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t 157.91 170.84 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 1 C-N-CA 132.681 4.392 . . . . 74.24 105.231 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -111.27 156.69 21.12 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 105.748 -1.945 . . . . 63.4 105.748 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -60.69 158.77 12.0 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.47 -0.567 . . . . 71.4 109.47 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -128.51 174.2 9.57 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.933 1.293 . . . . 71.11 110.946 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.6 tt -64.01 144.5 57.05 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.377 -1.342 . . . . 74.21 107.377 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.1 ttp85 -44.13 151.76 0.22 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.74 1.616 . . . . 64.12 111.818 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 55.77 46.56 22.15 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.606 1.162 . . . . 74.12 108.54 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 t -56.7 -30.42 63.43 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.108 1.363 . . . . 64.54 111.71 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.8 -173.77 40.93 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 119.309 0.959 . . . . 64.22 111.982 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -76.8 176.56 8.38 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.164 0.985 . . . . 74.44 110.898 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 p -144.19 156.51 15.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.629 -1.989 . . . . 75.21 105.629 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -65.68 152.02 45.19 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 122.921 0.488 . . . . 75.33 110.42 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.53 98.94 2.5 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 115.174 0.83 . . . . 72.14 115.174 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.92 82.7 0.66 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 124.917 1.246 . . . . 55.13 111.71 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -111.12 160.36 29.31 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 125.51 1.524 . . . . 61.44 110.605 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.79 143.7 21.26 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.884 3.056 . . . . 71.41 111.127 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.0 m -134.17 167.07 27.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-O 122.026 0.917 . . . . 55.14 109.943 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 p -125.36 161.15 27.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.119 1.768 . . . . 72.42 107.802 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.5 m -57.96 -38.01 75.22 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.124 0.57 . . . . 74.42 110.588 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -35.9 69.45 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 119.336 -0.364 . . . . 63.42 111.63 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.0 mtp -64.29 -38.88 92.62 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.044 0.838 . . . . 70.32 109.537 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.0 t -63.96 -57.41 11.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 124.552 1.141 . . . . 75.22 110.767 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -59.62 -40.23 86.86 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 118.444 -0.789 . . . . 75.23 110.73 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.2 m -58.62 -58.21 9.58 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.321 1.419 . . . . 71.53 108.57 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.533 HG23 HG13 ' A' ' 95' ' ' VAL . 53.0 t -52.52 -50.23 40.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 CA-C-O 118.249 -0.881 . . . . 74.22 109.469 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -54.08 -45.58 71.81 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.928 0.785 . . . . 53.51 111.375 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -59.49 -36.84 76.8 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.016 0.926 . . . . 74.1 110.688 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.0 mt -89.84 -14.92 33.35 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.034 0.753 . . . . 74.12 113.034 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.27 71.12 61.21 Favored Pre-proline 0 N--CA 1.448 -0.551 0 C-N-CA 126.927 2.091 . . . . 75.31 110.993 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.67 -15.41 49.19 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.286 1.99 . . . . 74.13 112.408 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.32 -13.86 59.85 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.072 1.349 . . . . 72.13 112.003 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.2 mt -92.05 156.48 17.37 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.315 0.961 . . . . 61.32 111.376 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.442 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 58.3 t-80 -80.42 146.11 60.94 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 106.474 -1.676 . . . . 74.13 106.474 178.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 36.4 Cg_endo -65.45 -30.16 52.97 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.092 1.862 . . . . 63.33 113.187 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.58 -34.92 46.51 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 121.77 -0.582 . . . . 72.41 110.863 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -64.47 -35.92 82.49 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.677 -0.86 . . . . 71.14 108.677 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.3 mt -54.94 -60.82 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 C-N-CA 124.583 1.153 . . . . 73.32 109.749 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -46.63 -48.64 19.85 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 118.558 0.617 . . . . 74.22 110.8 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.405 ' CE1' ' HD3' ' A' ' 112' ' ' PRO . 4.1 t80 -59.37 -44.9 92.67 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.812 0.815 . . . . 73.33 112.391 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 p -62.79 -43.4 98.89 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.165 -0.47 . . . . 73.22 110.01 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.431 HD21 ' CG2' ' A' ' 73' ' ' VAL . 52.0 mt -60.35 -38.47 83.91 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.816 -0.552 . . . . 72.22 111.678 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -70.57 -28.44 64.9 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.169 0.587 . . . . 73.2 109.834 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -85.33 -43.59 13.56 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 114.453 1.279 . . . . 75.4 114.453 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.7 p -79.57 -41.44 27.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.692 1.197 . . . . 63.43 111.411 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.51 0.86 88.02 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 118.745 -1.031 . . . . 64.25 112.379 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.27 129.5 18.74 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.393 1.477 . . . . 63.11 111.297 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.533 HG13 HG23 ' A' ' 73' ' ' VAL . 44.3 t -61.56 -46.51 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 105.551 -2.018 . . . . 74.45 105.551 177.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -55.89 -45.66 78.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.48 -0.772 . . . . 74.12 110.013 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -59.03 -43.8 91.67 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.74 0.7 . . . . 64.54 110.029 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.1 m -61.17 -42.41 98.51 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.297 1.839 . . . . 63.43 110.872 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.0 t -74.63 -38.27 45.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 121.672 -0.642 . . . . 75.02 109.966 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -66.62 -37.49 84.97 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 125.191 1.396 . . . . 72.02 111.056 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -77.81 -39.58 43.31 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.861 -1.162 . . . . 74.0 107.861 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -55.23 -52.07 64.56 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 120.564 -1.335 . . . . 71.43 111.908 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.5 -16.13 33.97 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 113.662 0.986 . . . . 73.22 113.662 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.58 -11.66 42.05 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.813 0.845 . . . . 73.3 109.569 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.72 28.45 32.14 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 118.707 -1.052 . . . . 62.11 111.375 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -64.33 -178.22 0.35 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.859 1.263 . . . . 74.23 112.987 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -87.08 137.91 31.94 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 126.449 1.9 . . . . 64.23 111.549 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -141.85 109.91 5.87 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.19 1.396 . . . . 75.21 111.93 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.2 m -83.11 176.95 8.82 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.843 0.857 . . . . 73.25 110.369 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -105.54 157.17 35.13 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 127.366 2.266 . . . . 62.11 107.308 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.42 154.5 73.64 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.125 1.883 . . . . 73.44 112.197 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.405 ' HD3' ' CE1' ' A' ' 87' ' ' TYR . 36.4 Cg_endo -60.98 123.34 12.73 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 124.457 3.438 . . . . 72.44 110.703 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.8 -4.22 53.13 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 124.842 1.21 . . . . 41.43 111.811 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -78.22 -34.37 49.32 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.83 1.815 . . . . 64.14 109.606 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 . . . . . 0 C--O 1.247 0.937 0 C-N-CA 125.452 1.501 . . . . 72.21 111.542 -178.526 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.732 0 N-CA-C 109.965 -1.254 . . . . 53.04 109.965 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.88 -178.39 7.19 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 128.027 2.531 . . . . 71.33 105.793 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.1 ttt -152.77 -48.45 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 118.822 0.737 . . . . 53.14 111.17 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.1 62.29 5.32 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.437 -1.201 . . . . 51.24 110.58 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.25 132.94 31.12 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 123.189 2.592 . . . . 64.35 111.995 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -76.48 162.97 27.39 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.193 -1.04 . . . . 74.23 108.193 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 167.68 68.47 0.03 OUTLIER Glycine 0 C--O 1.228 -0.245 0 N-CA-C 108.638 -1.785 . . . . 74.03 108.638 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.6 t -152.25 -172.19 4.16 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.503 1.921 . . . . 62.34 106.608 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.9 p -79.75 113.49 17.94 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.447 -1.316 . . . . 55.25 107.447 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -64.63 121.73 15.16 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.877 -1.157 . . . . 72.44 107.877 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.17 98.35 2.13 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 117.114 2.265 . . . . 70.44 117.114 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.37 133.44 48.72 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.071 -1.455 . . . . 22.42 107.071 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -136.08 0.38 2.6 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.11 1.364 . . . . 75.53 113.344 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -117.76 105.6 12.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.54 1.536 . . . . 75.5 110.34 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.51 157.36 34.47 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.539 1.536 . . . . 72.21 109.682 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.5 p -121.07 -92.22 0.54 Allowed 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.163 -1.421 . . . . 74.42 107.163 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.31 -54.38 0.36 Allowed Glycine 0 C--N 1.335 0.485 0 CA-C-N 118.886 0.766 . . . . 62.35 113.576 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -71.49 179.74 2.86 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 117.677 0.739 . . . . 73.12 109.322 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.3 p -121.59 -27.09 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.758 0.823 . . . . 73.54 112.858 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 53.97 -13.99 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 130.608 3.563 . . . . 65.02 117.766 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.23 114.59 0.64 Allowed Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 104.387 -3.485 . . . . 45.51 104.387 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -152.69 98.44 0.18 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 109.623 -1.391 . . . . 71.21 109.623 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -114.86 156.95 44.38 Favored Pre-proline 0 C--N 1.321 -0.664 0 C-N-CA 126.274 1.83 . . . . 74.43 107.291 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.28 142.44 27.05 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 121.99 1.793 . . . . 53.04 108.96 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.12 160.89 40.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.187 0.995 . . . . 70.2 108.323 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -124.62 159.11 31.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.296 -1.742 . . . . 65.14 106.296 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -59.73 -30.02 68.54 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 120.961 -1.087 . . . . 61.34 112.543 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -57.95 -33.57 68.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.465 1.029 . . . . 74.25 111.047 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.1 mtp -66.96 -43.37 83.28 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.229 -0.919 . . . . 72.51 108.61 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 t -57.1 -56.36 15.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 125.184 1.394 . . . . 74.41 110.827 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -59.09 -38.57 79.81 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 117.704 -1.141 . . . . 55.53 109.464 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.4 m -56.59 -58.97 5.77 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 120.278 1.399 . . . . 71.14 110.393 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.9 t -53.55 -45.77 59.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-N 119.384 0.993 . . . . 74.54 109.037 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.07 -50.14 67.43 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.209 0.913 . . . . 70.32 112.687 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -58.85 -40.87 85.54 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.693 0.797 . . . . 65.32 110.98 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.9 mt -83.9 -22.54 31.55 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.663 0.616 . . . . 63.41 112.663 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.17 72.54 81.35 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 127.104 2.162 . . . . 71.11 109.826 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.54 -6.26 18.06 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.007 3.138 . . . . 61.4 113.964 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.6 4.89 50.04 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.82 -1.175 . . . . 71.12 111.016 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.3 mt -109.93 161.02 15.89 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 120.678 -1.264 . . . . 51.55 110.419 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -81.89 144.9 52.45 Favored Pre-proline 0 N--CA 1.453 -0.317 0 C-N-CA 124.604 1.162 . . . . 63.34 108.551 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.539 ' HA ' HD12 ' A' ' 85' ' ' ILE . 56.7 Cg_endo -70.6 -25.32 24.85 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.009 2.473 . . . . 74.11 113.634 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.65 -39.17 32.04 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.665 0.666 . . . . 75.45 110.328 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -57.29 -44.2 83.84 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.034 0.534 . . . . 75.13 110.629 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 82' ' ' PRO . 59.9 mt -47.56 -54.75 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 C-N-CA 125.04 1.336 . . . . 70.23 112.471 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.43 -46.34 37.49 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.34 0.518 . . . . 73.4 111.475 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -65.29 -42.74 92.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.633 -0.667 . . . . 74.04 111.263 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 m -60.0 -47.01 87.6 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 122.922 0.489 . . . . 73.5 109.721 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.41 -37.41 85.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.826 0.85 . . . . 63.12 110.697 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -69.92 -34.31 73.32 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.594 0.633 . . . . 74.22 110.38 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -74.87 -46.99 32.53 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.575 0.75 . . . . 61.33 112.485 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.9 p -77.77 -41.03 38.87 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.321 1.049 . . . . 70.32 111.49 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.92 -14.01 64.43 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 127.413 2.435 . . . . 61.4 112.588 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.2 m -144.09 150.08 37.57 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 120.115 1.957 . . . . 45.52 112.658 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.68 -50.97 73.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 126.275 1.83 . . . . 74.02 107.148 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -49.99 -46.76 52.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.151 1.38 . . . . 73.33 109.987 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -65.07 -46.57 80.6 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.374 0.67 . . . . 75.25 109.936 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 89.0 m -59.05 -37.07 76.14 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.873 1.269 . . . . 75.45 111.729 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.2 t -77.55 -36.72 23.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 123.62 0.768 . . . . 74.05 109.583 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -66.16 -35.33 80.2 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 125.151 1.38 . . . . 72.1 110.873 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -81.4 -36.12 29.89 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.94 -1.1 . . . . 74.32 108.608 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -56.67 -55.36 35.05 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.614 -0.679 . . . . 74.33 110.366 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -59.87 -19.97 54.41 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.34 0.867 . . . . 74.11 113.34 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -13.22 41.43 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.105 0.562 . . . . 61.15 110.426 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.25 20.98 39.86 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 118.921 -0.933 . . . . 64.4 113.469 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -63.71 174.35 1.42 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.442 1.097 . . . . 74.53 111.221 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -83.12 141.54 31.9 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.673 1.189 . . . . 75.35 111.712 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -128.58 109.91 11.78 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.268 1.827 . . . . 70.33 108.433 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.2 m -93.78 173.9 7.45 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.205 1.002 . . . . 61.11 111.404 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -105.03 156.62 35.8 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.963 1.305 . . . . 73.13 108.873 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.65 158.59 56.47 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.75 2.3 . . . . 75.21 114.488 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.39 116.82 4.7 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 105.769 -2.435 . . . . 73.35 105.769 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.25 -17.62 7.47 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-O 117.683 -1.621 . . . . 75.2 111.83 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -66.09 -27.75 68.3 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.577 1.189 . . . . 74.5 111.803 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 . . . . . 0 C--O 1.248 1.018 0 N-CA-C 105.167 -2.16 . . . . 72.04 105.167 178.363 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.542 0 N-CA-C 110.737 -0.945 . . . . 71.45 110.737 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.14 171.38 13.67 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.195 -0.669 . . . . 55.21 109.195 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 21.1 ptp -130.25 -5.21 4.35 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.24 1.016 . . . . 73.34 111.564 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.33 -175.19 46.96 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.158 0.885 . . . . 61.53 111.437 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.61 166.41 17.8 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.828 2.352 . . . . 72.32 111.6 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -126.97 169.82 12.93 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 126.03 1.732 . . . . 72.44 109.992 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.36 -127.68 2.66 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 108.553 -1.819 . . . . 73.22 108.553 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.19 87.45 3.05 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.937 -1.134 . . . . 64.44 107.937 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.3 p -71.33 112.48 7.49 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.666 -1.235 . . . . 63.03 107.666 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -130.53 157.04 43.76 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.232 -0.917 . . . . 73.04 108.72 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -158.25 162.29 37.81 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.329 1.052 . . . . 71.01 110.1 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.96 101.08 0.35 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.869 1.268 . . . . 73.14 110.522 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.4 tp -150.31 173.14 14.32 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.451 0.7 . . . . 73.23 109.26 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -82.15 -34.05 29.3 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.753 0.649 . . . . 74.24 112.753 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -72.37 154.72 40.77 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 107.209 -1.404 . . . . 75.35 107.209 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.5 p -141.63 17.48 2.18 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.256 0.622 . . . . 65.41 112.061 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.94 -76.24 0.31 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 107.266 -2.334 . . . . 72.23 107.266 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.69 165.72 33.5 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.736 0.814 . . . . 73.41 108.82 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.9 t -131.58 96.95 2.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 104.157 -2.534 . . . . 73.22 104.157 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -140.13 -171.93 3.3 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.608 2.363 . . . . 71.13 107.457 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.01 -86.97 1.82 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.693 1.139 . . . . 62.54 110.827 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.66 -100.69 0.17 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.561 -1.016 . . . . 71.41 110.561 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -105.64 159.57 29.1 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 127.032 2.133 . . . . 64.21 110.409 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.67 133.89 16.12 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.701 2.934 . . . . 75.21 108.905 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 m -134.85 152.6 33.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.644 0.778 . . . . 65.42 109.942 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.35 164.04 21.26 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.706 1.203 . . . . 65.21 110.488 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -45.54 -47.46 14.34 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.154 2.181 . . . . 70.1 112.313 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -57.53 -34.59 69.29 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.715 0.806 . . . . 61.44 112.761 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 84.4 mtp -67.93 -39.78 83.43 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.968 -0.753 . . . . 74.53 108.968 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 t -58.88 -57.41 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.037 1.335 . . . . 71.2 110.485 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -58.6 -42.08 87.28 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-O 117.989 -1.005 . . . . 72.33 110.02 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -55.78 -60.13 3.89 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 120.057 1.299 . . . . 74.45 109.841 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.0 t -51.67 -49.49 34.65 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-O 118.836 -0.602 . . . . 75.55 109.969 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -51.26 -48.16 62.24 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.516 0.726 . . . . 73.13 112.211 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -59.49 -43.41 93.33 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.506 -0.553 . . . . 62.44 109.506 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mt -80.41 -13.07 59.44 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.972 0.73 . . . . 73.11 112.972 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.14 69.86 34.54 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.993 2.117 . . . . 71.33 110.861 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.28 -2.86 9.76 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.164 2.576 . . . . 72.53 113.254 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -86.69 -10.88 52.77 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.629 1.572 . . . . 53.5 110.465 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.69 158.52 15.46 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.494 -0.754 . . . . 63.42 112.277 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -81.93 147.14 57.38 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.971 -1.122 . . . . 73.23 107.971 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.94 -29.97 67.13 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.392 2.061 . . . . 72.42 112.837 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.28 -39.43 28.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.946 -0.471 . . . . 62.12 112.173 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -60.66 -41.42 94.98 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.62 -0.511 . . . . 60.12 109.62 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.1 mt -51.86 -59.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.556 0.742 . . . . 71.42 109.09 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.95 -44.75 30.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.425 0.69 . . . . 74.33 111.388 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -65.92 -43.42 88.18 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.145 -0.972 . . . . 72.44 112.817 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -66.99 -37.65 84.61 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.346 -0.983 . . . . 63.05 108.346 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.4 mt -61.25 -38.19 85.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.547 -1.279 . . . . 63.51 107.547 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -67.58 -34.44 77.03 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.949 0.795 . . . . 75.12 109.676 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -71.74 -51.85 20.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 119.008 -0.52 . . . . 61.0 112.364 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.9 p -74.77 -40.99 60.87 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.497 1.519 . . . . 54.13 112.708 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.66 -4.14 86.18 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.624 1.107 . . . . 71.42 111.447 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -144.48 135.03 24.67 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.806 1.803 . . . . 62.33 111.836 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.2 t -55.12 -52.43 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.9 1.68 . . . . 74.25 108.631 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -47.55 -47.45 28.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 126.571 1.949 . . . . 74.23 111.574 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -65.21 -44.65 87.65 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.17 -0.678 . . . . 73.43 109.17 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -56.92 -43.01 80.98 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.827 1.251 . . . . 71.22 111.319 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.0 t -73.89 -36.1 44.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 120.717 -1.239 . . . . 63.43 109.519 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -65.78 -45.09 83.76 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.584 1.154 . . . . 74.25 110.383 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -69.06 -36.43 77.64 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.748 -1.22 . . . . 72.2 108.681 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -58.25 -57.22 13.86 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.68 -0.489 . . . . 61.33 109.68 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.15 -23.3 63.8 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.912 -0.566 . . . . 73.12 111.927 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 ptm85 -82.83 -12.07 57.73 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.408 1.004 . . . . 65.42 110.598 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.11 22.91 39.76 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 125.83 1.681 . . . . 45.35 113.65 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.4 169.08 14.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.856 1.328 . . . . 70.44 110.742 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -80.32 146.85 31.37 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.698 0.999 . . . . 70.42 113.698 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -130.32 109.92 11.13 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.011 1.324 . . . . 73.24 107.826 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.7 m -87.66 176.54 7.38 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.213 -1.358 . . . . 64.11 108.802 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -108.27 156.18 38.94 Favored Pre-proline 0 N--CA 1.467 0.379 0 C-N-CA 124.462 1.105 . . . . 72.3 109.193 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.62 157.24 59.28 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.76 2.307 . . . . 74.12 112.661 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.7 149.82 88.32 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.748 1.632 . . . . 70.52 108.604 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.08 -16.41 59.67 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.575 -1.125 . . . . 65.44 111.733 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -77.9 -43.49 29.91 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.132 1.466 . . . . 71.14 108.708 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 C--O 1.246 0.871 0 CA-C-O 117.481 -1.247 . . . . 73.44 109.277 178.411 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.423 0 N-CA-C 109.812 -1.315 . . . . 62.24 109.812 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.33 75.06 9.27 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.463 -1.31 . . . . 52.21 107.463 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 81.4 mmm -58.55 -41.6 85.95 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.735 1.614 . . . . 74.23 110.643 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.49 71.23 0.94 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.912 -0.938 . . . . 23.33 111.474 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -70.74 -177.31 2.12 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.319 2.679 . . . . 62.4 111.246 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -87.97 -170.25 2.91 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.715 1.206 . . . . 74.22 108.421 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.17 -66.98 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 106.862 -2.495 . . . . 41.33 106.862 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -138.49 -170.87 2.92 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 126.459 1.904 . . . . 44.23 106.873 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.1 p -100.13 160.22 14.5 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 105.667 -1.975 . . . . 71.41 105.667 178.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -138.98 73.92 1.45 Allowed 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.261 -1.385 . . . . 62.21 107.261 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -93.06 146.73 23.42 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.046 -1.094 . . . . 74.2 108.046 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.36 160.04 42.99 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.958 1.303 . . . . 45.2 108.873 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -102.5 -5.53 23.91 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.784 1.031 . . . . 74.12 113.784 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -135.84 134.94 39.38 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.049 -1.032 . . . . 62.42 110.573 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.08 179.36 6.3 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.698 1.999 . . . . 72.24 109.779 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.6 p -128.75 99.5 5.35 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.964 1.706 . . . . 63.31 108.532 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.27 76.49 0.16 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 126.465 1.983 . . . . 64.33 111.803 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.89 132.4 11.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 115.609 1.707 . . . . 71.12 115.609 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.11 176.77 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 126.786 2.035 . . . . 71.22 110.009 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -139.62 -178.34 5.36 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.16 1.384 . . . . 74.13 109.859 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.1 -87.29 0.06 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 110.352 -1.099 . . . . 74.23 110.352 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -93.76 -148.54 23.89 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-O 122.8 1.222 . . . . 54.34 111.099 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -114.15 152.11 45.57 Favored Pre-proline 0 C--N 1.322 -0.594 0 C-N-CA 127.227 2.211 . . . . 71.12 110.088 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.53 126.78 9.23 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.736 2.957 . . . . 61.43 109.12 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 m -122.83 162.16 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.156 0.583 . . . . 73.4 109.65 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.9 p -124.17 167.65 13.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.453 1.101 . . . . 62.52 110.178 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.62 -43.46 72.27 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.6 1.16 . . . . 64.25 111.296 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -32.8 67.19 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 125.528 1.531 . . . . 71.22 111.655 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 93.5 mtp -67.07 -45.31 77.71 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.462 -0.94 . . . . 63.2 108.462 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 t -57.58 -57.24 11.09 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 CA-C-O 119.061 -0.495 . . . . 73.0 110.477 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -57.64 -39.93 78.11 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 117.638 -1.172 . . . . 71.43 111.138 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.405 ' CG2' HG11 ' A' ' 95' ' ' VAL . 40.8 m -56.34 -61.81 2.15 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.222 1.374 . . . . 74.42 108.29 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.6 t -57.26 -45.1 84.86 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 CA-C-N 119.16 0.891 . . . . 74.23 110.055 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.66 -39.03 67.65 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.451 1.478 . . . . 51.11 113.757 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -69.61 -44.6 70.38 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.103 -1.073 . . . . 53.32 108.103 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 37.6 mt -71.45 -28.4 63.93 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.054 -0.521 . . . . 64.5 111.207 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.13 75.76 67.65 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 128.997 2.919 . . . . 74.24 111.001 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.61 -4.92 16.2 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.431 2.087 . . . . 63.22 111.148 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -91.19 5.57 48.55 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.939 1.695 . . . . 70.14 112.417 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.3 mt -118.41 162.79 17.74 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.81 1.244 . . . . 70.32 110.817 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.421 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 49.7 t-80 -87.85 146.22 38.37 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 107.386 -1.338 . . . . 71.43 107.386 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 33.7 Cg_endo -64.29 -23.76 65.58 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.667 2.245 . . . . 74.45 112.123 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -78.13 -43.58 28.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 121.327 -0.858 . . . . 64.45 112.385 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -58.35 -45.51 88.03 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.777 -0.823 . . . . 51.44 108.777 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 63.8 mt -51.89 -59.07 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.369 1.068 . . . . 73.51 108.491 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.33 -47.37 25.78 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.402 1.001 . . . . 75.42 112.161 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -65.85 -38.01 87.71 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 122.77 1.271 . . . . 70.14 111.675 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.5 t -62.48 -50.32 71.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.556 -1.276 . . . . 54.51 107.556 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.3 mt -57.91 -35.97 71.79 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 126.117 1.767 . . . . 71.43 109.333 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -67.86 -36.82 80.96 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.521 1.055 . . . . 74.3 109.526 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -76.87 -53.15 8.26 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.232 0.469 . . . . 61.43 111.992 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.7 p -67.01 -40.96 87.41 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.87 1.268 . . . . 53.14 110.897 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.92 -6.12 81.96 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.867 2.175 . . . . 63.14 113.247 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.5 m -144.28 143.75 31.16 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.163 1.482 . . . . 62.54 110.82 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.405 HG11 ' CG2' ' A' ' 72' ' ' THR . 42.2 t -61.96 -47.81 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 C-N-CA 126.184 1.793 . . . . 62.42 108.171 178.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -50.38 -48.51 55.78 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.204 1.002 . . . . 52.51 111.717 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -63.78 -39.13 93.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.132 0.492 . . . . 73.31 109.939 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.5 m -63.77 -37.31 86.91 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.287 1.435 . . . . 75.42 110.498 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.09 -41.43 59.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.904 -1.147 . . . . 64.22 107.904 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -63.3 -35.17 79.48 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.76 1.224 . . . . 74.44 111.693 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -81.01 -39.0 26.55 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.254 -0.647 . . . . 74.42 109.254 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -56.55 -52.67 63.89 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.53 -0.731 . . . . 75.25 111.333 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.94 -19.97 61.55 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.744 0.646 . . . . 75.0 112.744 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -86.6 -12.57 48.21 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.167 -0.92 . . . . 74.35 110.334 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.81 37.06 13.98 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 108.63 -1.788 . . . . 74.23 108.63 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -74.84 172.36 12.34 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.582 -0.952 . . . . 72.42 110.999 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -78.99 131.61 36.37 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.423 1.089 . . . . 63.13 110.147 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -129.1 109.95 11.61 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.502 -1.296 . . . . 74.52 107.502 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.4 m -97.2 177.57 5.53 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.178 1.391 . . . . 64.15 108.954 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -104.84 158.64 31.58 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.42 1.088 . . . . 75.42 110.41 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.36 162.65 41.71 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.479 2.12 . . . . 52.43 112.97 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.68 133.98 45.03 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.383 2.055 . . . . 73.21 109.109 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.03 -11.52 64.02 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 118.811 -0.994 . . . . 73.03 112.641 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -77.17 -28.46 54.08 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.642 1.721 . . . . 71.32 111.717 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.021 -0.99 . . . . 61.44 110.334 -179.166 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.846 0 N-CA-C 108.845 -1.702 . . . . 71.15 108.845 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -31.4 72.55 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.647 1.224 . . . . 43.11 111.077 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 71.0 mtm -92.99 83.47 4.72 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.328 -2.471 . . . . 72.21 104.328 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.88 62.53 0.05 OUTLIER Glycine 0 CA--C 1.529 0.921 0 CA-C-O 118.71 -1.05 . . . . 74.05 112.814 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.93 161.12 44.42 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.363 2.042 . . . . 45.54 109.596 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -60.04 155.4 17.02 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.94 0.896 . . . . 73.32 111.379 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.26 -170.06 21.35 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 124.574 1.083 . . . . 71.42 111.154 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.0 m -148.29 179.48 7.74 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.373 1.469 . . . . 64.15 109.476 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 p -126.58 4.59 6.82 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.067 2.147 . . . . 64.33 111.707 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.0 77.76 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.004 2.521 . . . . 73.41 113.186 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -77.86 -21.16 51.82 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.418 1.487 . . . . 65.33 109.875 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -96.36 127.91 42.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.51 -1.663 . . . . 71.43 106.51 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.7 mt -135.64 165.55 25.29 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.791 0.836 . . . . 74.53 110.14 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -42.71 118.47 1.24 Allowed 'General case' 0 C--O 1.24 0.566 0 C-N-CA 126.483 1.913 . . . . 73.52 111.321 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -89.28 104.32 16.88 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 104.868 -2.271 . . . . 64.13 104.868 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -127.69 139.21 52.85 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.954 -1.498 . . . . 74.53 106.954 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.27 173.79 14.45 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.282 -0.727 . . . . 74.32 111.282 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -119.78 178.6 4.53 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.941 1.296 . . . . 65.03 109.82 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 m -115.44 46.85 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.034 1.734 . . . . 44.2 108.144 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -81.44 71.38 8.44 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.598 -0.89 . . . . 63.21 108.598 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.51 -14.12 1.96 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.699 1.142 . . . . 73.43 114.915 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.98 -156.27 13.29 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 107.568 -2.213 . . . . 70.45 107.568 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -104.55 153.71 38.97 Favored Pre-proline 0 C--N 1.319 -0.727 0 C-N-CA 129.044 2.938 . . . . 73.12 108.193 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.86 140.51 32.02 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.038 1.825 . . . . 74.43 110.245 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.81 165.65 30.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 124.725 1.21 . . . . 64.12 108.707 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -124.31 163.62 21.3 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.541 1.537 . . . . 74.21 108.247 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -55.06 -42.35 72.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.406 1.482 . . . . 73.43 110.409 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -33.31 65.44 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.345 1.458 . . . . 73.4 112.197 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.4 mtp -68.55 -41.42 79.81 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.939 1.245 . . . . 65.01 109.518 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.8 t -59.23 -54.86 28.49 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 123.988 0.915 . . . . 65.5 109.286 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -60.08 -37.17 79.13 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 117.562 -1.209 . . . . 62.23 110.59 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.5 m -55.15 -64.41 0.85 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.748 1.613 . . . . 70.22 108.555 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.7 t -53.52 -45.94 59.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.375 0 CA-C-O 118.184 -0.912 . . . . 63.42 110.313 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.1 tp60 -55.69 -48.63 74.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.342 0.974 . . . . 74.14 112.29 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -57.97 -43.33 86.44 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.164 0.586 . . . . 71.31 109.446 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 17.9 mt -80.54 -18.6 47.92 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.868 0.692 . . . . 62.2 112.868 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.14 76.44 77.94 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 127.428 2.291 . . . . 51.45 110.118 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.05 -15.1 42.67 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 121.695 1.596 . . . . 53.24 111.698 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.66 -22.74 53.61 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.324 2.249 . . . . 72.12 112.907 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.5 mt -85.14 156.36 21.07 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 114.008 1.114 . . . . 73.43 114.008 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -74.54 145.66 82.56 Favored Pre-proline 0 C--O 1.236 0.355 0 N-CA-C 107.192 -1.41 . . . . 73.41 107.192 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.52 -26.8 46.77 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.482 2.121 . . . . 74.13 114.096 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.33 -37.66 18.25 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.888 -0.412 . . . . 73.14 109.888 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -58.99 -36.97 75.79 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 109.499 -0.556 . . . . 75.12 109.499 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.0 mt -58.07 -61.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.092 -1.077 . . . . 52.02 108.092 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -48.27 -50.22 30.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 119.155 0.888 . . . . 75.42 110.876 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -60.39 -41.39 93.74 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 119.401 -0.92 . . . . 74.45 112.513 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.6 t -63.01 -48.66 77.86 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 107.495 -1.298 . . . . 74.32 107.495 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.8 mt -55.09 -42.12 72.45 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.514 1.126 . . . . 74.33 111.176 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -66.67 -33.74 76.32 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.848 0.459 . . . . 73.23 110.177 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -82.21 -46.25 13.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 118.139 -0.934 . . . . 42.24 113.366 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p -73.21 -41.3 63.95 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.361 1.464 . . . . 75.11 110.487 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.86 5.64 89.94 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 126.387 1.946 . . . . 23.51 112.357 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.8 m -142.63 127.13 17.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.913 1.357 . . . . 33.11 110.182 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.0 t -58.95 -49.35 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 105.846 -1.909 . . . . 64.33 105.846 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -52.99 -42.82 65.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.77 0.828 . . . . 74.35 111.209 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -61.14 -43.64 98.57 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 108.779 -0.823 . . . . 71.43 108.779 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.3 m -61.59 -40.38 94.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.849 2.06 . . . . 71.42 111.48 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.3 -37.07 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 O-C-N 121.29 -0.881 . . . . 74.32 108.856 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.36 -31.82 70.49 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 125.077 1.351 . . . . 65.1 112.225 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -83.12 -36.04 25.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.219 -1.03 . . . . 71.32 108.219 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -58.16 -56.09 26.48 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.39 -0.819 . . . . 75.21 109.805 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -57.5 -25.55 59.96 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-O 119.071 -0.49 . . . . 62.31 111.32 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.76 -8.2 59.3 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.742 0.701 . . . . 74.31 111.682 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.17 28.54 53.31 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 123.804 0.716 . . . . 53.41 111.704 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -67.14 173.81 3.56 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 117.207 0.503 . . . . 70.31 112.092 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -80.98 140.57 35.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.895 1.278 . . . . 72.13 109.253 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -132.63 109.42 9.72 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.813 -1.551 . . . . 73.3 106.813 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 t -83.79 169.95 14.66 Favored 'General case' 0 C--O 1.24 0.574 0 O-C-N 121.638 -0.664 . . . . 63.42 110.386 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -100.38 150.26 36.78 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 125.069 1.347 . . . . 74.33 108.321 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.48 166.99 19.95 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.922 3.081 . . . . 62.34 113.97 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -63.32 139.91 74.12 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.064 2.509 . . . . 52.05 111.804 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.2 -0.29 68.34 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 118.457 -1.191 . . . . 43.21 113.878 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -70.58 -34.43 72.18 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.289 1.545 . . . . 70.32 109.027 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 126.857 2.063 . . . . 60.12 111.866 179.642 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.597 0 N-CA-C 110.79 -0.924 . . . . 60.22 110.79 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 45.15 68.28 0.59 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.346 2.258 . . . . 52.14 111.793 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -114.76 0.32 13.79 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.56 0.744 . . . . 75.33 112.997 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 42.76 62.96 2.09 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.2 1.857 . . . . 52.44 115.292 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.03 -26.57 83.27 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.238 2.625 . . . . 74.22 114.043 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -82.28 -15.33 53.37 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.778 -0.576 . . . . 74.22 110.086 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.8 -103.12 1.3 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 106.357 -2.697 . . . . 64.15 106.357 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.1 t -116.54 161.21 19.49 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.413 1.085 . . . . 74.33 109.718 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.6 p -77.78 51.18 0.91 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.827 2.051 . . . . 63.44 109.844 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -73.31 159.53 33.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.57 1.948 . . . . 73.41 110.336 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -64.55 124.3 21.49 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.402 -0.962 . . . . 72.14 108.402 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.2 162.61 39.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.076 -1.453 . . . . 51.13 107.076 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.593 HD13 ' H ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -143.6 162.98 34.48 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.471 -0.937 . . . . 73.3 108.471 179.124 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.593 ' H ' HD13 ' A' ' 53' ' ' LEU . 48.8 ttp180 -71.44 122.09 19.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.307 -0.627 . . . . 72.35 109.307 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.69 151.58 46.21 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 106.283 -1.747 . . . . 52.32 106.283 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 m -129.37 109.97 11.53 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 106.966 -1.494 . . . . 74.02 106.966 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.76 41.45 0.07 OUTLIER Glycine 0 C--O 1.227 -0.307 0 N-CA-C 111.036 -0.826 . . . . 63.42 111.036 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.57 174.27 8.37 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.092 1.357 . . . . 71.14 109.094 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 t -46.35 155.94 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 128.554 2.742 . . . . 64.12 112.294 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -73.71 -172.27 1.22 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.817 1.247 . . . . 74.1 109.103 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.21 59.41 0.5 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 108.406 -1.878 . . . . 72.14 108.406 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -143.7 88.07 0.17 Allowed Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.333 -1.107 . . . . 61.03 110.333 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -122.13 155.59 61.1 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 125.391 1.476 . . . . 63.51 109.004 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.04 136.98 15.15 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.468 2.779 . . . . 63.32 109.874 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.4 m -128.26 158.2 40.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 O-C-N 121.4 -0.812 . . . . 64.2 110.436 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -125.43 163.39 22.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.039 1.336 . . . . 74.13 110.104 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.1 m -49.52 -45.8 47.75 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.743 1.617 . . . . 53.31 110.634 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -35.96 65.79 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.434 1.894 . . . . 74.32 112.75 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.7 mtp -68.48 -44.74 74.12 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.985 -1.072 . . . . 71.41 109.231 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.1 t -60.98 -51.61 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.012 0.925 . . . . 72.02 110.815 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -61.48 -43.42 98.9 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 117.247 -1.358 . . . . 64.51 110.335 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.404 ' CG2' HG11 ' A' ' 95' ' ' VAL . 85.2 m -57.8 -55.87 29.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.949 1.704 . . . . 72.0 109.803 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.1 t -55.0 -46.85 77.29 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 CA-C-N 119.865 1.211 . . . . 74.01 109.084 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -56.08 -43.54 78.12 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.543 1.065 . . . . 75.53 112.205 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -61.91 -35.74 79.27 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.027 1.331 . . . . 73.31 111.838 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.6 mt -94.06 -12.78 27.82 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.969 1.308 . . . . 54.43 112.454 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.95 67.44 56.53 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 127.828 2.451 . . . . 71.42 108.468 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.76 -9.4 22.75 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.385 2.056 . . . . 62.22 112.763 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.17 -12.01 48.2 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.887 0.875 . . . . 71.45 111.73 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.1 mt -88.32 152.93 21.59 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.345 0.975 . . . . 74.22 111.902 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -72.94 140.07 80.45 Favored Pre-proline 0 N--CA 1.448 -0.565 0 N-CA-C 106.617 -1.623 . . . . 72.4 106.617 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.29 -23.44 44.87 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.985 2.457 . . . . 65.44 113.765 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -40.09 17.76 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.42 0.554 . . . . 74.34 109.594 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -60.92 -40.32 92.71 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-O 118.141 -0.933 . . . . 54.1 109.658 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.78 -56.49 7.2 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 C-N-CA 124.265 1.026 . . . . 33.41 109.42 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -45.67 -54.35 7.91 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.128 0.422 . . . . 55.43 110.867 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -61.64 -36.19 80.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.826 0.306 . . . . 73.41 111.826 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.2 m -61.42 -49.65 76.02 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.368 -0.975 . . . . 60.14 108.368 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.8 mt -59.69 -35.5 74.6 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.197 0.999 . . . . 75.41 110.478 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -67.75 -33.82 75.61 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.666 -0.494 . . . . 72.04 109.666 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -79.46 -50.2 11.14 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.862 1.265 . . . . 71.15 114.093 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.6 p -74.56 -41.77 59.97 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.53 1.532 . . . . 73.54 110.872 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.28 -18.1 58.0 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 127.947 2.689 . . . . 61.43 112.551 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -139.35 151.15 46.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 123.718 1.723 . . . . 54.21 112.235 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.404 HG11 ' CG2' ' A' ' 72' ' ' THR . 96.1 t -64.33 -47.44 89.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 113.008 -1.905 . . . . 72.33 107.989 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -50.91 -51.03 56.01 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.367 1.467 . . . . 70.51 110.204 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -62.82 -42.36 99.69 Favored 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 109.863 -0.421 . . . . 74.44 109.863 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.1 m -60.36 -39.8 88.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.287 1.035 . . . . 70.15 111.833 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.59 -37.67 44.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 121.399 -0.813 . . . . 73.22 109.436 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -66.7 -38.13 86.14 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.483 1.113 . . . . 65.42 111.251 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -78.6 -33.87 47.14 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.493 -0.754 . . . . 75.11 109.216 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -59.62 -59.6 5.18 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.674 -1.266 . . . . 63.24 111.349 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -56.54 -28.95 61.33 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.509 0.724 . . . . 71.41 111.93 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -18.7 56.4 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.757 -0.64 . . . . 74.22 110.936 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.9 28.05 14.92 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.581 -1.122 . . . . 71.35 112.357 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -68.34 -179.25 1.26 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.939 1.296 . . . . 75.2 111.83 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -82.6 144.06 30.59 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.78 1.232 . . . . 75.51 111.564 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -138.84 109.18 6.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.628 -0.878 . . . . 64.52 108.628 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.2 m -84.96 177.13 8.06 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.773 1.229 . . . . 62.33 110.903 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -111.66 153.9 44.14 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 105.683 -1.969 . . . . 75.45 105.683 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.87 166.14 29.96 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.407 2.071 . . . . 53.44 111.641 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -63.03 156.17 56.37 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.404 2.069 . . . . 63.3 109.622 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.5 -28.53 3.43 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 118.312 -1.271 . . . . 74.22 111.587 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -66.81 -53.46 32.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 119.376 1.588 . . . . 74.31 111.024 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 . . . . . 0 C--O 1.249 1.062 0 C-N-CA 125.069 1.348 . . . . 72.41 107.513 -179.574 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.272 0 N-CA-C 109.284 -1.526 . . . . 60.21 109.284 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.26 155.28 42.56 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.061 -1.459 . . . . 75.33 107.061 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 90.0 mmm -79.43 73.93 6.07 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.435 0.694 . . . . 62.11 109.919 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.92 -100.99 0.51 Allowed Glycine 0 CA--C 1.525 0.684 0 CA-C-O 117.232 -1.871 . . . . 52.02 108.69 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.37 108.04 0.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.526 2.817 . . . . 70.34 111.057 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -145.58 123.32 11.89 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 103.025 -2.954 . . . . 71.55 103.025 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.79 94.13 0.14 Allowed Glycine 0 C--N 1.336 0.541 0 CA-C-N 120.324 1.42 . . . . 73.21 111.193 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.49 ' H ' ' HB3' ' A' ' 51' ' ' ASN . 7.2 m -149.4 -172.85 4.23 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.977 1.311 . . . . 64.31 109.764 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.2 p -59.19 126.63 28.46 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.336 1.054 . . . . 73.34 108.665 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 46.0 38.29 4.51 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.496 1.518 . . . . 71.43 113.607 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.49 ' HB3' ' H ' ' A' ' 48' ' ' SER . 9.9 p30 -60.4 123.42 17.24 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.549 1.14 . . . . 74.43 109.024 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.24 109.48 7.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.958 1.303 . . . . 63.13 110.797 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.664 ' CD1' ' H ' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -146.16 -174.63 4.49 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 106.57 -1.641 . . . . 63.3 106.57 178.444 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.664 ' H ' ' CD1' ' A' ' 53' ' ' LEU . 27.7 mmm180 -105.04 174.34 5.92 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 127.25 2.22 . . . . 72.54 107.181 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.78 85.82 2.26 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.373 -0.602 . . . . 63.21 109.373 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.1 t -69.29 155.39 40.49 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 105.038 -2.208 . . . . 52.34 105.038 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.83 -165.26 18.01 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.704 -0.958 . . . . 45.31 110.704 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.91 116.06 21.59 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 105.617 -1.994 . . . . 74.22 105.617 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.69 22.13 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 125.454 1.502 . . . . 73.13 113.635 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -52.76 -39.21 62.01 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.461 1.282 . . . . 71.45 114.461 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.0 -66.49 0.24 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 106.025 -2.83 . . . . 73.23 106.025 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -112.84 -149.49 10.64 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 107.78 -2.128 . . . . 73.44 107.78 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -70.85 150.46 95.16 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 125.02 1.328 . . . . 72.41 107.924 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.01 142.78 31.72 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.99 1.793 . . . . 72.34 110.979 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 m -128.75 164.85 29.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.291 1.036 . . . . 71.25 109.509 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.2 p -124.3 162.79 23.02 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.399 1.48 . . . . 73.02 109.163 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -53.02 -38.99 62.83 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.101 0.961 . . . . 71.42 110.777 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 10.8 pm0 -60.23 -44.29 95.34 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 118.579 -0.724 . . . . 64.21 112.043 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 5.2 mtm -59.53 -35.2 73.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.421 -0.912 . . . . 73.24 110.703 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.7 t -65.44 -52.76 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.061 -0.718 . . . . 63.2 109.061 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -64.09 -35.52 81.01 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.708 -1.139 . . . . 75.51 110.718 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.3 m -57.18 -60.12 4.08 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 121.107 1.776 . . . . 65.51 108.082 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.5 t -54.5 -47.99 70.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 CA-C-O 117.571 -1.204 . . . . 74.24 108.596 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 tp60 -52.55 -45.48 66.38 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 120.153 1.342 . . . . 72.22 111.97 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -62.73 -36.4 82.88 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.402 -0.812 . . . . 72.13 110.469 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.7 mt -89.67 -14.65 34.36 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.85 -0.595 . . . . 75.53 112.54 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -138.33 73.55 43.16 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 129.111 2.965 . . . . 51.01 111.685 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -69.79 -5.67 16.77 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.904 3.069 . . . . 51.54 113.515 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.5 -15.69 36.87 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 120.745 -1.222 . . . . 73.1 111.981 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.8 mt -91.14 160.09 15.74 Favored 'General case' 0 N--CA 1.458 -0.074 0 C-N-CA 123.236 0.614 . . . . 61.11 111.571 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.475 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 56.0 t-80 -85.26 149.42 52.4 Favored Pre-proline 0 C--O 1.239 0.521 0 N-CA-C 106.171 -1.788 . . . . 65.14 106.171 178.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.475 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 33.2 Cg_endo -63.93 -30.07 67.25 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.548 2.165 . . . . 74.11 112.456 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.28 -34.22 55.65 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 112.717 0.636 . . . . 44.43 112.717 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -61.3 -46.1 91.69 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.609 -0.886 . . . . 63.12 108.609 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.0 mt -52.49 -59.63 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 125.002 1.321 . . . . 62.32 108.299 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -49.47 12.95 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.618 1.099 . . . . 75.11 111.888 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -64.41 -45.71 86.43 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.919 0.781 . . . . 75.05 113.085 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.7 p -65.7 -37.99 87.99 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.574 -0.704 . . . . 75.31 109.472 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.35 -38.16 88.43 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.105 -0.997 . . . . 72.31 109.062 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -68.39 -35.33 77.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.569 0.622 . . . . 71.14 110.062 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -72.51 -55.05 7.58 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.935 -0.478 . . . . 71.24 111.091 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.0 p -67.19 -41.36 85.98 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.911 1.284 . . . . 65.31 112.021 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.83 -11.85 67.61 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.87 1.224 . . . . 52.04 113.429 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -144.44 144.11 31.23 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 119.031 1.415 . . . . 74.31 109.336 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.1 t -59.63 -43.37 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 125.181 1.393 . . . . 74.24 109.025 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -46.93 -47.75 21.55 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.895 1.278 . . . . 72.14 111.011 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -69.82 -40.56 75.84 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.445 -0.784 . . . . 73.01 109.967 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.8 m -58.96 -37.12 76.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.161 0.584 . . . . 64.51 110.28 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 85.7 t -74.95 -36.96 40.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 123.919 0.888 . . . . 72.34 109.157 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -68.76 -39.61 80.2 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.352 1.061 . . . . 63.13 111.263 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -74.33 -37.11 63.66 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.122 -1.066 . . . . 71.33 108.122 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -58.03 -56.32 23.49 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.613 0.765 . . . . 73.13 109.935 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 pp -60.62 -22.49 63.85 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.284 -0.885 . . . . 73.15 112.055 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -16.72 48.7 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.846 0.748 . . . . 64.15 109.898 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.25 36.67 9.62 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 119.032 0.833 . . . . 61.1 112.168 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -76.76 173.38 11.72 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 117.986 0.893 . . . . 55.4 109.827 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -81.58 135.73 35.57 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.481 -1.303 . . . . 75.14 107.481 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -118.42 110.94 18.05 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.138 -2.542 . . . . 75.41 104.138 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.7 m -97.79 178.59 5.09 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 125.063 1.345 . . . . 64.14 110.086 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -110.88 158.79 34.72 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 125.371 1.469 . . . . 74.2 111.283 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.33 164.07 36.75 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.358 2.705 . . . . 74.13 113.898 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.09 139.53 84.72 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.967 2.444 . . . . 72.15 109.707 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.14 -18.41 56.88 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.508 1.052 . . . . 65.54 111.096 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -71.61 -45.29 62.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 119.243 1.522 . . . . 63.52 109.427 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.021 -0.99 . . . . 73.3 111.439 -178.962 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.215 0 N-CA-C 109.227 -1.549 . . . . 74.42 109.227 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.34 175.39 8.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 117.822 0.811 . . . . 73.21 109.204 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.1 mtt -144.71 175.03 10.47 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.016 2.126 . . . . 60.24 106.845 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.06 173.94 37.58 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.772 -1.331 . . . . 52.24 109.772 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.76 102.05 0.84 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.44 2.76 . . . . 60.23 110.384 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -133.05 107.12 8.05 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.98 -1.118 . . . . 74.04 107.98 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.52 76.26 2.21 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 107.0 -2.44 . . . . 45.21 107.0 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 p -68.43 -32.11 71.9 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.395 0.678 . . . . 45.11 112.439 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.5 t -170.4 161.58 8.05 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.848 1.659 . . . . 61.34 106.996 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -148.57 161.47 41.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.725 1.21 . . . . 73.4 109.941 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -150.58 160.2 43.96 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.369 -1.345 . . . . 75.33 107.369 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.42 -159.4 0.79 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.759 1.624 . . . . 55.21 107.814 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.4 tp -59.44 158.13 10.09 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.586 0.754 . . . . 74.12 110.241 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -65.06 175.29 1.62 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.209 1.004 . . . . 73.13 109.055 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.59 158.72 27.95 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.183 1.393 . . . . 73.21 107.888 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 m -102.96 -54.49 2.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.859 0.864 . . . . 73.2 111.56 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.57 33.0 80.09 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 119.032 0.833 . . . . 51.44 111.655 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 66.01 13.65 9.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.417 1.487 . . . . 64.52 112.981 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 66.1 t -91.71 139.25 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 121.203 0.525 . . . . 73.23 111.683 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -143.65 172.5 12.73 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.379 2.272 . . . . 71.51 108.858 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.93 114.1 1.62 Allowed Glycine 0 C--O 1.237 0.29 0 N-CA-C 108.573 -1.811 . . . . 60.2 108.573 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.5 79.94 1.37 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 106.437 -2.665 . . . . 72.54 106.437 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -124.84 149.55 63.12 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 125.991 1.717 . . . . 73.44 109.127 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.27 138.12 38.57 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.033 1.822 . . . . 64.14 109.957 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 m -134.46 159.55 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.337 -0.986 . . . . 62.22 108.337 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.31 162.43 23.77 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.445 -0.946 . . . . 75.1 108.445 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 m -51.36 -39.1 56.4 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.607 1.963 . . . . 75.22 111.393 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.83 -38.05 77.81 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 124.561 1.144 . . . . 75.52 110.248 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.1 mtp -63.87 -38.14 89.98 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 120.407 -1.433 . . . . 62.31 109.377 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 t -61.08 -54.26 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.308 -0.627 . . . . 65.1 109.308 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -62.95 -38.24 90.28 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-O 117.294 -1.336 . . . . 74.1 110.588 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.6 m -53.98 -61.1 2.52 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 121.138 1.79 . . . . 72.42 108.087 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.7 t -55.51 -48.52 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 118.138 -0.934 . . . . 75.23 110.411 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -56.37 -42.24 77.5 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.074 0.852 . . . . 64.14 111.839 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -62.64 -43.6 98.39 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.618 -0.882 . . . . 61.13 108.618 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 mt -75.85 -26.91 57.57 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.735 -0.603 . . . . 62.21 111.476 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.77 83.37 62.57 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 128.054 2.542 . . . . 62.53 111.848 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.8 -21.3 38.49 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.575 1.517 . . . . 71.23 112.802 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.07 -19.29 51.69 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.754 1.222 . . . . 61.24 113.523 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 mt -79.53 154.52 28.76 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.786 0.721 . . . . 73.03 109.756 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -79.6 144.19 60.46 Favored Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 107.352 -1.351 . . . . 70.03 107.352 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.53 -29.53 52.79 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.924 1.75 . . . . 64.51 112.228 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -75.39 -41.52 56.0 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 112.491 0.552 . . . . 75.03 112.491 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -63.14 -35.19 79.48 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.893 0.477 . . . . 73.32 110.05 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 75.2 mt -56.64 -60.37 2.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 109.297 -0.631 . . . . 72.32 109.297 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.89 -40.77 61.21 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.653 1.115 . . . . 73.54 112.271 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -61.93 -46.96 87.04 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.126 0.965 . . . . 74.23 111.092 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.8 p -63.49 -44.8 93.32 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.78 -1.1 . . . . 64.41 108.595 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.5 mt -56.86 -39.3 74.06 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.186 0.903 . . . . 74.52 109.814 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.39 -34.93 75.25 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.73 1.15 . . . . 73.14 110.071 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.54 -47.4 48.6 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.222 0.609 . . . . 71.23 111.5 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.5 p -79.07 -35.51 42.32 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 127.574 2.35 . . . . 64.23 113.547 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.39 -12.24 55.95 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 125.864 1.697 . . . . 65.41 113.135 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.0 m -143.91 146.17 32.79 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 118.854 1.327 . . . . 72.31 111.962 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.41 -47.53 89.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.127 -1.434 . . . . 65.42 107.127 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -45.86 -46.07 15.52 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.953 1.301 . . . . 73.42 111.481 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -65.45 -53.58 40.74 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.061 1.744 . . . . 72.1 108.358 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.9 m -54.75 -37.59 66.15 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.98 1.312 . . . . 75.24 111.392 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.56 -39.68 54.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 124.124 0.97 . . . . 73.33 109.444 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -64.04 -44.41 92.56 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.279 1.432 . . . . 61.54 109.772 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -74.32 -32.47 62.84 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.46 -0.775 . . . . 63.13 110.909 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -62.9 -54.51 37.56 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.464 -0.772 . . . . 62.54 110.451 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.79 -25.85 67.73 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 118.209 -0.901 . . . . 71.43 111.78 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -81.41 -11.61 59.21 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.757 0.661 . . . . 54.01 110.2 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.78 36.62 25.12 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-O 119.06 -0.856 . . . . 50.52 111.203 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -74.73 -175.89 2.63 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.14 0.97 . . . . 70.21 111.456 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -86.69 138.72 31.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.608 1.163 . . . . 72.1 111.221 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -138.51 110.3 7.16 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.022 1.329 . . . . 75.43 109.895 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.8 m -89.58 -179.78 5.87 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.534 1.534 . . . . 42.11 109.71 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -110.05 159.13 33.02 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 126.352 1.861 . . . . 74.33 110.032 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.64 166.92 27.49 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.584 2.856 . . . . 74.44 114.782 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.85 137.22 40.97 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.532 2.154 . . . . 75.43 107.139 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.2 -10.37 59.89 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.997 1.284 . . . . 65.11 111.065 -178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -77.33 -29.01 53.31 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.571 1.685 . . . . 71.02 109.986 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 . . . . . 0 C--O 1.25 1.112 0 C-N-CA 125.439 1.496 . . . . 63.12 108.936 179.508 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.147 0 N-CA-C 106.836 -2.506 . . . . 64.34 106.836 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.45 162.97 21.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.279 -1.378 . . . . 74.05 107.279 177.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -113.63 -89.96 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 105.483 -2.043 . . . . 75.5 105.483 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.4 74.42 0.04 OUTLIER Glycine 0 CA--C 1.522 0.511 0 N-CA-C 107.063 -2.415 . . . . 52.12 107.063 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.85 -19.44 40.67 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.398 2.066 . . . . 32.52 113.978 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -162.83 176.2 10.48 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.406 1.083 . . . . 44.43 110.076 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.38 82.35 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 108.91 -1.676 . . . . 54.12 108.91 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.4 m -148.41 126.84 12.32 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.47 -1.678 . . . . 74.01 106.47 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 t -83.29 164.19 20.22 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.951 0.9 . . . . 74.44 108.991 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -119.71 109.59 15.81 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.816 0.846 . . . . 72.33 110.849 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.63 169.11 18.18 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.122 1.369 . . . . 62.53 108.739 178.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.06 162.45 14.14 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.753 -0.592 . . . . 72.25 110.144 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.28 148.96 47.02 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.652 1.581 . . . . 73.32 108.451 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -61.78 155.77 22.13 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 124.216 0.947 . . . . 73.13 110.13 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -74.88 141.37 44.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 106.752 -1.573 . . . . 71.34 106.752 177.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.03 -21.61 0.71 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 118.701 -0.666 . . . . 72.43 110.999 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.7 159.97 53.12 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.015 -1.234 . . . . 62.25 110.015 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -74.61 177.58 5.98 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 125.827 1.651 . . . . 75.14 110.348 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 p -59.67 -22.55 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 123.272 0.629 . . . . 53.41 111.687 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -70.86 147.85 48.42 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.45 1.1 . . . . 62.11 109.688 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.44 -61.58 7.31 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 124.587 1.089 . . . . 45.43 112.124 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -127.9 -168.16 12.41 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 107.99 -2.044 . . . . 75.23 107.99 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -90.96 138.39 26.15 Favored Pre-proline 0 C--N 1.316 -0.887 0 C-N-CA 127.618 2.367 . . . . 61.33 107.772 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.0 127.38 15.1 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.7 2.933 . . . . 53.11 114.035 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.438 HG11 ' CB ' ' A' ' 89' ' ' LEU . 17.8 m -107.91 166.82 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.432 1.093 . . . . 71.12 109.934 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.2 p -124.26 157.68 34.3 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.931 -1.877 . . . . 73.13 105.931 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -56.12 -35.75 67.45 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 119.105 -0.474 . . . . 73.51 110.811 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -36.84 73.01 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.753 0.706 . . . . 73.15 111.756 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.1 mtp -66.36 -33.39 75.62 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.089 -1.007 . . . . 74.2 109.29 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.87 -53.95 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 123.93 0.892 . . . . 64.13 109.475 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -60.33 -40.99 92.61 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.56 -1.209 . . . . 74.24 109.367 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.405 ' CG2' HG11 ' A' ' 95' ' ' VAL . 85.9 m -56.22 -57.38 12.48 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.676 1.58 . . . . 75.1 108.624 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.464 HG23 HG13 ' A' ' 95' ' ' VAL . 47.5 t -55.43 -50.8 63.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-O 118.456 -0.783 . . . . 73.13 109.699 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -52.08 -44.12 64.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 118.893 0.77 . . . . 55.13 112.767 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -62.86 -42.52 99.78 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.891 0.876 . . . . 72.02 110.363 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.8 mt -86.34 -10.83 53.64 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.843 0.683 . . . . 64.15 112.843 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.68 70.7 58.83 Favored Pre-proline 0 N--CA 1.447 -0.597 0 C-N-CA 127.186 2.195 . . . . 73.33 108.673 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -68.54 0.23 5.05 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.279 3.32 . . . . 71.25 112.633 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.16 12.83 29.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.453 1.501 . . . . 72.34 112.071 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.9 mt -114.77 157.53 23.1 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.545 1.138 . . . . 73.51 109.25 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.423 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 57.3 t-80 -85.46 145.59 42.6 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 108.276 -1.009 . . . . 74.53 108.276 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 33.0 Cg_endo -62.67 -29.87 78.1 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.938 2.426 . . . . 73.43 113.232 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -77.41 -42.99 34.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.967 -0.458 . . . . 61.15 110.931 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.403 ' HG3' ' CE1' ' A' ' 110' ' ' PHE . 48.7 mt-30 -58.27 -42.63 86.91 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 122.028 -0.42 . . . . 72.52 110.075 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 76.2 mt -50.59 -58.86 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 124.786 1.234 . . . . 74.43 109.692 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.05 -50.29 10.98 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.568 0.622 . . . . 70.1 111.342 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -61.34 -45.37 94.72 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.702 -0.624 . . . . 74.01 112.33 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 p -63.35 -42.63 98.93 Favored 'General case' 0 C--O 1.218 -0.583 0 C-N-CA 120.216 -0.593 . . . . 62.11 110.153 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.438 ' CB ' HG11 ' A' ' 65' ' ' VAL . 74.2 mt -60.21 -34.76 74.1 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.618 0.767 . . . . 64.53 110.114 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.85 -36.54 78.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.356 -0.609 . . . . 44.11 109.356 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -78.26 -44.5 25.34 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.07 0.767 . . . . 74.13 113.07 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.9 p -76.25 -36.18 58.59 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.787 1.635 . . . . 61.22 111.423 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.49 -17.82 46.25 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.921 1.248 . . . . 53.14 113.298 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.5 t -145.11 150.1 36.2 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.657 1.228 . . . . 74.14 108.991 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.464 HG13 HG23 ' A' ' 73' ' ' VAL . 54.9 t -65.12 -41.8 92.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 126.373 1.869 . . . . 74.55 109.285 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -46.52 -48.01 19.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.389 1.476 . . . . 62.2 111.491 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -68.35 -44.85 74.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.378 1.471 . . . . 71.31 108.845 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.6 m -56.96 -39.16 74.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.945 0.898 . . . . 64.11 110.791 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.3 t -74.4 -37.72 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.273 -0.87 . . . . 71.42 110.074 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -66.69 -43.66 83.81 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.173 0.989 . . . . 55.33 110.126 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -72.59 -35.66 67.95 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.295 -0.878 . . . . 62.11 109.98 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -57.91 -57.39 13.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 121.133 -0.979 . . . . 72.15 110.482 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.22 -26.09 62.43 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.195 0.452 . . . . 72.13 111.269 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -12.17 59.96 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.599 -0.688 . . . . 73.4 110.364 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.65 37.35 40.34 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 125.054 1.312 . . . . 53.35 110.715 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.2 -171.17 0.88 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.207 1.004 . . . . 63.12 112.126 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.45 139.05 34.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 120.961 -1.087 . . . . 73.4 109.582 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -129.85 108.72 10.36 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 104.862 -2.273 . . . . 63.44 104.862 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.7 m -96.26 163.92 12.88 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.732 1.213 . . . . 63.31 111.786 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.403 ' CE1' ' HG3' ' A' ' 84' ' ' GLN . 35.8 m-85 -97.11 156.52 36.23 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 124.542 1.137 . . . . 64.23 108.835 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.94 164.74 30.59 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.803 2.335 . . . . 75.31 112.211 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.23 142.43 66.92 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.037 1.825 . . . . 63.31 110.324 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.22 -9.37 73.1 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 118.607 -1.107 . . . . 51.22 113.286 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -76.78 -22.8 53.19 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.897 1.349 . . . . 41.13 110.459 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 C--O 1.247 0.926 0 C-N-CA 126.351 1.86 . . . . 74.1 112.64 179.811 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 N-CA-C 110.285 -1.126 . . . . 72.2 110.285 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.54 -23.32 14.32 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.742 0.771 . . . . 62.13 111.945 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 77.0 mtp 46.73 67.93 0.7 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.984 1.714 . . . . 65.33 113.286 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.87 -177.21 43.13 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.521 0.581 . . . . 74.51 112.801 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.93 157.62 34.69 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 125.243 3.962 . . . . 62.15 111.175 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -79.88 -16.54 55.17 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.271 1.028 . . . . 75.21 113.16 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.04 156.75 6.89 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 108.077 -2.009 . . . . 53.01 108.077 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.9 t -158.16 -164.35 1.48 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 118.441 1.121 . . . . 71.21 109.02 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 p 45.37 62.27 2.23 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.859 1.664 . . . . 72.13 110.267 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.01 163.75 9.34 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 122.27 1.033 . . . . 73.13 111.86 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -105.69 178.4 4.57 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.982 2.113 . . . . 74.44 108.731 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 49.8 28.63 2.83 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.919 1.288 . . . . 31.41 113.035 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -67.46 177.25 2.0 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.818 1.647 . . . . 55.32 112.654 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.43 137.54 52.81 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.543 1.137 . . . . 75.14 110.739 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -62.24 106.97 0.81 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.92 1.688 . . . . 72.31 111.401 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.6 p -145.29 -176.55 5.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.672 0.789 . . . . 74.53 109.077 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.94 -41.58 0.37 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 125.082 1.325 . . . . 45.34 111.76 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -146.69 136.81 23.52 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.248 -1.019 . . . . 74.13 108.248 -178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.04 159.43 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.661 1.184 . . . . 74.52 107.822 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.87 164.61 3.7 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.853 1.261 . . . . 75.14 111.618 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.14 -111.76 4.32 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 108.744 -1.742 . . . . 53.33 108.744 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.77 -152.78 6.81 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 117.908 0.854 . . . . 51.34 111.534 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -77.13 162.41 69.74 Favored Pre-proline 0 C--N 1.32 -0.679 0 C-N-CA 129.82 3.248 . . . . 63.25 109.671 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.75 141.08 21.42 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.201 1.934 . . . . 75.12 109.308 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 m -134.64 160.15 41.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.427 -0.953 . . . . 60.15 108.427 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.98 157.76 37.0 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.889 1.276 . . . . 71.11 108.768 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 m -42.75 -48.37 5.61 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.762 2.425 . . . . 60.32 111.522 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -53.97 -36.71 63.17 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 126.933 2.093 . . . . 54.12 112.324 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 87.3 mtp -66.81 -42.39 85.98 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.661 -0.866 . . . . 64.54 108.661 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.78 -57.93 9.01 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 CA-C-N 117.92 0.327 . . . . 42.24 110.601 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -58.04 -40.78 81.77 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 118.14 -0.933 . . . . 63.01 110.725 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.8 m -58.01 -62.0 2.13 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.09 1.314 . . . . 73.5 109.524 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.408 ' CG2' HG13 ' A' ' 95' ' ' VAL . 86.4 t -52.42 -46.42 46.95 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 CA-C-O 118.354 -0.832 . . . . 73.01 108.999 178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.19 -38.31 79.53 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.698 1.136 . . . . 62.35 113.336 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -65.41 -40.89 93.95 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.152 0.887 . . . . 72.43 108.846 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mt -78.98 -34.53 44.09 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 112.248 0.462 . . . . 74.31 112.248 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.11 75.46 4.15 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 127.33 2.252 . . . . 74.52 109.532 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.08 -13.69 40.72 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.267 1.978 . . . . 63.23 112.2 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -83.12 -6.63 59.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.872 1.269 . . . . 64.31 113.08 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.2 mt -98.06 155.24 17.22 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 120.92 -1.113 . . . . 65.21 109.355 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.432 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 53.7 t-80 -78.34 146.43 70.41 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 105.607 -1.997 . . . . 73.43 105.607 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 32.2 Cg_endo -63.88 -31.85 66.97 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.651 1.567 . . . . 64.21 112.281 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -74.88 -38.33 61.92 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.281 -0.887 . . . . 74.54 111.912 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -58.56 -45.12 89.65 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.81 -0.441 . . . . 53.15 109.81 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.1 mt -49.22 -56.31 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 117.812 -1.089 . . . . 73.13 110.123 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.409 HH21 ' CG ' ' A' ' 111' ' ' PRO . 4.6 tmm_? -48.7 -48.51 40.25 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.558 1.072 . . . . 63.12 111.712 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.496 ' CE1' ' HD3' ' A' ' 112' ' ' PRO . 9.2 t80 -62.25 -41.16 98.2 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.807 0.731 . . . . 73.33 111.704 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.2 m -63.6 -48.66 76.44 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.756 -0.831 . . . . 74.14 108.756 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -57.32 -37.34 72.35 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.021 1.328 . . . . 65.21 110.309 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -68.18 -38.0 81.57 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.042 -0.725 . . . . 72.35 109.042 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -76.68 -48.34 19.25 Favored 'General case' 0 C--N 1.334 -0.097 0 O-C-N 121.457 -0.777 . . . . 63.0 112.106 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.3 p -71.47 -38.33 71.27 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.567 1.147 . . . . 63.41 111.369 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.55 -2.94 87.57 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.906 2.193 . . . . 74.1 111.447 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -144.31 145.06 31.77 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.137 1.469 . . . . 43.25 112.608 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.408 HG13 ' CG2' ' A' ' 73' ' ' VAL . 55.1 t -64.93 -52.48 53.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.517 -1.66 . . . . 61.14 106.517 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -49.17 -51.99 29.25 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.316 1.847 . . . . 74.41 110.674 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.49 -43.49 93.31 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.852 0.861 . . . . 74.13 109.527 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.7 m -61.52 -39.42 90.95 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.969 0.908 . . . . 72.54 110.501 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.5 t -75.2 -34.62 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 121.247 -0.908 . . . . 65.02 110.131 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -68.18 -39.29 82.54 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 126.113 1.765 . . . . 75.22 111.23 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -79.02 -37.08 40.04 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.877 -0.786 . . . . 75.2 108.877 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -54.67 -54.36 42.7 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.943 0.897 . . . . 72.41 109.705 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.13 -18.06 56.02 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.168 0.803 . . . . 74.42 113.168 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -19.26 42.17 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.714 -1.217 . . . . 55.53 107.714 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 83.3 31.7 27.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 125.656 1.598 . . . . 70.03 109.658 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -62.59 176.79 0.6 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.866 1.666 . . . . 73.24 111.382 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -83.47 139.11 33.13 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 123.076 0.55 . . . . 64.33 110.284 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -135.88 109.04 7.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.284 1.033 . . . . 75.2 108.83 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.5 m -91.52 176.1 6.67 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.851 0.861 . . . . 72.04 109.033 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -103.14 155.71 36.3 Favored Pre-proline 0 N--CA 1.45 -0.457 0 C-N-CA 124.873 1.269 . . . . 73.3 108.779 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.409 ' CG ' HH21 ' A' ' 86' ' ' ARG . 29.7 Cg_endo -69.27 161.57 45.34 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.907 2.405 . . . . 54.14 113.628 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.496 ' HD3' ' CE1' ' A' ' 87' ' ' TYR . 37.2 Cg_endo -63.36 145.95 93.08 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 121.94 1.76 . . . . 54.23 107.992 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.47 -5.38 82.59 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.418 -1.212 . . . . 52.24 111.599 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -86.36 -28.32 23.71 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.632 1.716 . . . . 74.15 111.845 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 123.805 0.842 . . . . 74.24 111.236 179.114 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 108.26 -1.015 . . . . 74.44 108.26 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.2 126.3 9.75 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.712 2.275 . . . . 72.53 110.645 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 m -122.99 161.29 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 O-C-N 120.954 -1.091 . . . . 52.54 110.001 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 p -124.4 166.24 16.32 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.053 0.941 . . . . 52.12 110.036 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.1 m -52.73 -41.85 64.35 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.496 1.518 . . . . 64.41 110.95 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -34.04 67.57 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.194 0.997 . . . . 62.35 111.013 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.9 mtp -70.32 -43.37 70.45 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.962 -0.755 . . . . 73.55 108.962 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.2 t -59.5 -55.98 20.23 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 C-N-CA 124.168 0.987 . . . . 74.25 110.193 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.66 -41.5 90.72 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 117.784 -1.103 . . . . 62.22 111.103 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.3 m -55.01 -60.42 3.4 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.57 1.077 . . . . 52.34 109.051 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.57 -46.22 79.03 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 CA-C-N 119.16 0.891 . . . . 62.31 109.694 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -54.9 -44.29 74.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 119.131 0.878 . . . . 74.51 112.97 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -62.85 -44.19 96.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.172 -0.677 . . . . 72.13 109.172 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.9 mt -79.41 -14.72 58.75 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.43 1.092 . . . . 74.43 113.583 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -137.33 70.87 54.17 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 127.368 2.267 . . . . 61.33 108.566 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.9 -23.16 62.32 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.584 2.189 . . . . 61.42 112.916 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.29 -14.56 62.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.523 0.729 . . . . 62.31 111.938 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.4 mt -92.36 156.69 17.07 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 119.181 0.9 . . . . 72.22 112.74 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -79.92 143.2 57.28 Favored Pre-proline 0 C--O 1.238 0.46 0 N-CA-C 106.111 -1.811 . . . . 62.14 106.111 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.62 -29.12 52.29 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.782 2.322 . . . . 54.21 113.032 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -40.2 48.77 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.698 -0.626 . . . . 75.24 111.727 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -60.9 -35.34 76.39 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.29 -0.633 . . . . 72.33 109.29 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.9 mt -56.57 -56.5 13.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 CA-C-O 118.164 -0.922 . . . . 64.12 108.713 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.82 -46.65 20.91 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.488 1.04 . . . . 75.33 111.048 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -64.59 -43.54 93.5 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.418 0.554 . . . . 72.25 111.911 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.2 t -64.59 -41.37 96.29 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.174 -0.676 . . . . 63.23 109.174 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.24 -37.97 84.99 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.943 0.897 . . . . 74.31 110.475 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -72.05 -34.77 69.02 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.608 0.64 . . . . 71.53 110.877 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -72.51 -50.61 24.63 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.001 -0.437 . . . . 43.22 110.808 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.3 p -72.64 -41.59 65.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.26 1.024 . . . . 71.24 111.819 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.16 -6.12 75.63 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.249 1.881 . . . . 44.41 112.538 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -145.59 152.13 39.2 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 120.897 2.348 . . . . 73.22 112.394 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.63 -50.62 64.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 106.765 -1.568 . . . . 73.41 106.765 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -52.32 -47.03 66.25 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.453 1.501 . . . . 64.44 111.754 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -63.74 -43.24 97.07 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.458 -0.942 . . . . 74.23 108.458 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.9 m -61.68 -37.05 82.68 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.422 1.089 . . . . 40.34 110.559 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.6 t -73.8 -35.95 44.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.412 1.085 . . . . 74.12 109.103 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -70.16 -40.5 74.7 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.417 1.487 . . . . 71.23 110.31 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -76.35 -30.2 57.51 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 122.084 0.945 . . . . 73.25 109.88 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -64.31 -54.59 30.8 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 121.099 -1.0 . . . . 74.23 108.932 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.15 -20.94 60.81 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.43 0.9 . . . . 61.33 113.43 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -92.23 -6.26 50.87 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.742 0.701 . . . . 73.21 109.913 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.62 36.68 58.39 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 126.528 2.013 . . . . 62.44 113.322 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -70.38 -178.68 1.79 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 118.256 1.028 . . . . 63.13 110.148 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.2 134.77 36.16 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 126.137 1.775 . . . . 73.32 111.901 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -129.07 110.51 12.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.245 1.818 . . . . 72.41 106.168 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.1 m -96.0 174.29 7.0 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.736 1.214 . . . . 60.44 108.035 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -98.1 155.6 36.82 Favored Pre-proline 0 C--N 1.33 -0.243 0 O-C-N 121.585 -0.697 . . . . 73.41 110.197 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -69.44 163.66 37.19 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.899 1.732 . . . . 72.11 111.48 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -59.89 144.6 99.43 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.887 1.724 . . . . 53.03 109.313 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.24 -12.39 58.47 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.595 1.093 . . . . 73.33 113.026 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -75.59 -46.54 31.21 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.195 1.497 . . . . 65.53 108.268 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 . . . . . 0 C--O 1.24 0.58 0 C-N-CA 124.92 1.288 . . . . 74.31 109.225 179.252 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 . . . . . 0 C--O 1.235 0.321 0 N-CA-C 111.6 0.222 . . . . 63.55 111.6 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.88 150.12 30.01 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.39 2.727 . . . . 62.42 109.841 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 m -134.28 160.83 41.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 123.988 0.915 . . . . 44.31 110.844 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.3 p -125.76 163.64 22.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.879 0.871 . . . . 74.22 110.034 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.7 m -49.61 -45.86 48.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.779 2.031 . . . . 51.25 111.593 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -62.41 -34.05 75.98 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.893 1.277 . . . . 32.44 112.614 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 94.5 mtp -65.12 -42.5 93.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.098 -1.075 . . . . 74.42 108.098 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 t -60.01 -55.34 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.458 0.703 . . . . 72.44 110.728 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -61.01 -37.67 83.34 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 119.538 -0.865 . . . . 75.41 112.059 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.0 m -60.18 -57.36 13.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 120.308 1.413 . . . . 75.31 109.525 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 t -54.97 -44.13 72.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-N 119.891 1.223 . . . . 74.31 108.438 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.6 tp60 -51.47 -50.92 58.89 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.197 0.908 . . . . 50.21 112.726 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -59.11 -44.73 92.0 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 122.837 0.455 . . . . 64.45 110.202 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.7 mt -77.71 -22.48 50.37 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.734 0.642 . . . . 74.14 112.734 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.89 75.07 79.23 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 126.374 1.87 . . . . 44.23 109.192 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.49 -18.05 54.05 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 123.492 2.795 . . . . 73.22 114.14 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.05 10.12 8.77 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.408 -0.808 . . . . 71.44 112.935 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.6 mt -112.74 155.81 23.9 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.171 0.896 . . . . 70.53 112.488 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.444 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 51.4 t-80 -80.63 145.46 58.55 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 108.626 -0.879 . . . . 75.54 108.626 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 28.9 Cg_endo -62.91 -30.53 77.17 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.228 2.619 . . . . 74.54 113.144 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.68 -39.16 37.49 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.026 -0.361 . . . . 62.01 110.026 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -59.46 -48.52 81.32 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 118.502 0.592 . . . . 64.41 109.452 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 82' ' ' PRO . 67.9 mt -49.35 -58.74 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 N-CA-C 107.789 -1.189 . . . . 73.24 107.789 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.538 HH21 ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -47.3 -52.08 17.3 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.749 0.819 . . . . 75.34 112.18 179.198 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -65.43 -33.94 77.11 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.681 -1.262 . . . . 64.22 111.712 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 t -65.14 -46.12 82.21 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.204 -1.406 . . . . 45.44 107.204 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.4 -36.57 76.07 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.343 1.457 . . . . 74.43 109.095 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.538 ' CD ' HH21 ' A' ' 86' ' ' ARG . 48.5 mt-10 -70.13 -38.36 75.51 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 118.78 0.718 . . . . 71.11 111.65 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -75.78 -45.7 34.78 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.109 0.411 . . . . 71.4 112.109 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 79.6 p -74.25 -40.65 62.24 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.475 1.11 . . . . 75.31 111.044 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.98 -13.56 67.39 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 127.832 2.634 . . . . 74.43 114.226 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.8 m -143.64 148.4 35.75 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.88 1.84 . . . . 64.43 111.996 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.8 t -59.64 -48.42 87.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 126.096 1.759 . . . . 64.53 107.655 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -51.87 -47.98 64.25 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.611 1.565 . . . . 74.31 111.79 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -65.33 -43.47 90.84 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 108.257 -1.016 . . . . 75.2 108.257 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.5 m -59.26 -40.47 86.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.407 1.083 . . . . 74.31 111.638 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.9 t -74.64 -40.27 47.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 118.008 -0.996 . . . . 71.5 108.581 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -62.81 -35.2 79.13 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.016 1.726 . . . . 71.03 111.206 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -80.13 -40.69 26.92 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.203 -0.665 . . . . 73.35 109.203 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -58.74 -51.05 71.63 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.026 0.531 . . . . 74.53 110.242 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -65.48 -9.14 23.26 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 113.397 0.888 . . . . 75.34 113.397 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.09 -16.82 20.33 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.748 2.019 . . . . 73.4 109.141 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.0 26.59 21.48 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.664 1.126 . . . . 72.22 113.315 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -72.11 172.83 9.42 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.275 1.037 . . . . 33.4 113.294 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -81.85 147.59 29.27 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.401 1.481 . . . . 75.04 111.56 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -138.51 109.93 6.98 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.861 1.264 . . . . 73.51 109.873 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.1 m -91.9 165.78 13.05 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.214 1.406 . . . . 74.3 108.255 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -94.01 160.06 33.09 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 124.759 1.224 . . . . 73.44 111.708 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.11 164.01 29.32 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.357 3.371 . . . . 65.52 113.767 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.34 140.3 87.44 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.11 2.54 . . . . 75.1 111.152 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.85 -17.65 54.14 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 117.959 -1.467 . . . . 74.02 112.403 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -66.12 -51.9 53.6 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.348 1.574 . . . . 75.04 108.881 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 . . . . . 0 C--O 1.245 0.859 0 C-N-CA 125.475 1.51 . . . . 74.34 108.555 179.126 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 108.798 -0.816 . . . . 64.5 108.798 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.28 142.64 30.58 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.217 2.612 . . . . 71.44 110.272 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.37 153.39 35.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 109.058 -0.719 . . . . 61.4 109.058 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -124.84 162.69 23.8 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 125.995 1.718 . . . . 64.32 108.06 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 m -56.23 -36.37 68.42 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.839 -0.538 . . . . 62.35 111.531 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.06 -33.84 65.37 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.357 1.063 . . . . 63.21 110.987 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.8 mtp -70.02 -41.89 73.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.684 -0.858 . . . . 51.13 108.684 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 t -61.03 -55.47 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.276 1.03 . . . . 61.41 110.51 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.63 -40.86 84.56 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 118.252 -0.88 . . . . 63.42 110.391 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.415 ' CG2' HG11 ' A' ' 95' ' ' VAL . 88.8 m -58.13 -60.97 2.92 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.372 0.987 . . . . 63.14 109.597 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.3 t -52.52 -47.66 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 119.384 0.993 . . . . 74.41 109.044 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -56.3 -45.23 80.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.11 0.868 . . . . 53.33 112.188 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -59.13 -39.32 81.95 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.187 0.995 . . . . 74.35 110.528 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.3 mt -88.81 -20.28 24.88 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.203 0.816 . . . . 73.41 113.203 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.89 75.35 79.68 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 127.304 2.242 . . . . 62.3 108.858 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.7 -17.84 52.85 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.438 2.092 . . . . 75.2 113.425 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.49 -17.23 56.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.536 0.607 . . . . 64.21 112.551 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 mt -80.85 155.74 26.44 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.85 0.833 . . . . 73.43 112.634 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.439 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 57.2 t-80 -75.56 144.07 76.73 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 124.44 1.096 . . . . 71.14 109.035 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 36.8 Cg_endo -65.8 -26.55 52.42 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.836 2.357 . . . . 74.04 113.704 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.02 -40.11 16.14 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.66 1.118 . . . . 72.42 111.892 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -60.45 -32.38 71.32 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 119.175 -0.44 . . . . 45.23 111.547 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 78.1 mt -55.24 -58.26 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 118.352 -0.832 . . . . 63.32 109.748 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -42.29 44.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.269 0.94 . . . . 74.42 112.685 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -63.9 -43.22 96.64 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.328 -0.857 . . . . 72.02 110.696 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 t -59.41 -51.27 70.63 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 108.393 -0.966 . . . . 73.41 108.393 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.4 mt -58.34 -35.65 72.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.066 0.947 . . . . 72.22 110.775 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -72.54 -30.28 64.32 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.823 1.192 . . . . 62.44 109.65 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -76.35 -46.71 26.29 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.343 0.52 . . . . 73.44 112.043 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.5 p -80.19 -39.69 28.73 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.668 1.187 . . . . 64.51 111.151 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.58 -6.17 66.17 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 127.24 2.352 . . . . 32.44 112.723 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.4 m -139.56 132.46 29.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.523 1.529 . . . . 64.23 110.323 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.415 HG11 ' CG2' ' A' ' 72' ' ' THR . 53.1 t -58.8 -44.77 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 125.394 1.477 . . . . 72.11 109.622 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -52.83 -47.74 67.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.822 0.849 . . . . 74.13 110.454 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -62.45 -43.09 99.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.903 -0.777 . . . . 64.41 108.903 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.9 m -58.85 -35.98 73.82 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.742 0.817 . . . . 65.2 110.477 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.5 t -75.75 -41.52 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.763 0.825 . . . . 63.14 109.91 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -63.47 -33.71 76.16 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.703 1.601 . . . . 73.43 111.349 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -83.71 -40.43 18.89 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.135 0.574 . . . . 63.15 110.286 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -53.94 -55.2 29.24 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.758 0.823 . . . . 64.31 110.563 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -59.67 -14.8 15.39 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.878 1.271 . . . . 65.12 114.135 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -9.26 39.74 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.44 1.896 . . . . 74.33 109.374 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.44 28.75 54.87 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.659 -0.977 . . . . 73.5 110.659 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -69.45 -179.75 1.78 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.28 1.04 . . . . 73.52 112.393 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -83.36 134.11 34.92 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.356 1.462 . . . . 72.25 113.251 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -134.4 110.04 9.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.357 -0.979 . . . . 61.04 108.357 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.86 179.42 4.81 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.422 -0.584 . . . . 72.42 109.422 178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -100.08 158.75 31.46 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.823 1.249 . . . . 64.14 111.136 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.15 164.09 36.2 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.211 2.607 . . . . 72.41 111.144 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.01 153.69 67.54 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.896 1.731 . . . . 54.4 107.815 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.1 -15.32 61.28 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 118.988 -0.895 . . . . 72.42 110.899 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -71.86 -44.39 63.88 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.126 0.963 . . . . 75.01 109.177 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 . . . . . 0 C--O 1.25 1.131 0 C-N-CA 124.587 1.155 . . . . 75.42 111.145 179.684 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 107.374 -1.343 . . . . 50.52 107.374 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.2 126.45 12.38 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.315 2.01 . . . . 42.33 108.547 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.3 m -126.8 157.98 37.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 121.75 0.786 . . . . 63.15 110.084 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 p -124.25 164.44 19.54 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.999 1.72 . . . . 71.52 109.911 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.3 m -54.7 -37.37 65.74 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.964 1.706 . . . . 65.22 111.4 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -59.21 -35.93 74.5 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.285 1.034 . . . . 65.12 111.349 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.0 mtp -68.31 -41.71 80.48 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.045 -1.034 . . . . 64.41 108.896 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.5 t -60.23 -54.89 28.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 C-N-CA 124.358 1.063 . . . . 63.12 110.94 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.17 -42.33 90.55 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.428 -0.796 . . . . 74.21 110.306 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.1 m -56.35 -61.07 2.65 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.871 1.214 . . . . 70.32 109.856 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 83.9 t -53.41 -46.87 59.08 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 CA-C-N 119.136 0.88 . . . . 55.22 109.535 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.99 -41.17 67.61 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.167 0.894 . . . . 63.32 113.184 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -65.65 -43.35 89.68 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.969 0.804 . . . . 73.03 109.25 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.57 -17.42 56.15 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.674 0.62 . . . . 74.42 112.674 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.89 74.8 56.66 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 126.982 2.113 . . . . 70.52 109.743 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.89 -16.11 36.89 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.576 2.184 . . . . 74.21 111.166 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.61 15.95 2.9 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.497 1.519 . . . . 73.33 112.016 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.0 mt -124.23 152.14 43.3 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.897 1.279 . . . . 52.44 109.134 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -76.97 143.88 71.33 Favored Pre-proline 0 N--CA 1.45 -0.454 0 N-CA-C 107.858 -1.164 . . . . 71.35 107.858 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.21 -18.95 56.69 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.898 2.398 . . . . 50.44 113.285 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -86.11 -38.51 17.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.455 0.702 . . . . 73.41 110.231 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -58.36 -47.87 82.42 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 122.679 0.392 . . . . 73.44 109.965 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 89.1 mt -48.93 -54.08 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.683 1.593 . . . . 75.1 111.053 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.58 HH21 ' CG ' ' A' ' 111' ' ' PRO . 1.7 tmm_? -50.43 -46.93 56.83 Favored 'General case' 0 C--O 1.228 -0.051 0 CA-C-N 118.707 0.685 . . . . 74.3 110.668 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -64.91 -37.71 88.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.768 0.258 . . . . 70.44 111.181 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 m -61.46 -47.25 86.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.975 -0.75 . . . . 61.4 108.975 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.4 mt -63.16 -35.25 79.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.892 1.277 . . . . 70.51 110.428 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -70.26 -33.25 71.38 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 118.666 0.666 . . . . 73.23 109.801 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -76.62 -55.64 5.33 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.482 0.713 . . . . 75.45 111.461 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.1 p -70.6 -40.91 72.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.957 1.703 . . . . 74.12 112.796 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.88 -6.1 83.97 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.616 2.055 . . . . 62.24 113.144 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.2 m -144.28 143.18 30.89 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 119.273 1.537 . . . . 73.22 111.474 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.6 t -63.04 -49.67 82.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 C-N-CA 125.945 1.698 . . . . 55.12 106.924 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.71 -46.79 64.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.367 1.067 . . . . 72.41 111.195 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -63.03 -45.42 92.4 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 108.29 -1.004 . . . . 74.41 108.29 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.5 m -56.52 -37.52 70.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.228 0.611 . . . . 61.45 111.017 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.6 t -76.06 -39.31 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 121.363 -0.836 . . . . 75.03 109.447 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -65.95 -32.82 74.53 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.695 1.198 . . . . 65.14 111.54 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -82.38 -38.78 23.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.367 -0.975 . . . . 75.21 108.367 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -55.33 -53.95 49.65 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.954 0.902 . . . . 75.43 110.282 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -59.36 -21.21 59.49 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.582 0.586 . . . . 74.43 112.582 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -16.41 49.92 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.946 1.298 . . . . 71.43 109.526 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.2 28.66 48.36 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.245 -1.542 . . . . 71.32 109.245 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -61.15 177.32 0.35 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.739 1.616 . . . . 73.02 112.073 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -77.56 138.52 39.21 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 120.806 -1.184 . . . . 73.21 109.029 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -134.57 108.66 8.2 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.014 -1.847 . . . . 75.45 106.014 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.4 m -91.1 177.07 6.37 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.503 0.721 . . . . 73.15 109.833 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -108.83 153.71 42.22 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 107.977 -1.12 . . . . 70.15 107.977 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.58 ' CG ' HH21 ' A' ' 86' ' ' ARG . 33.2 Cg_endo -71.11 163.28 39.74 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.505 2.136 . . . . 74.22 113.182 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.5 131.4 27.84 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.481 2.12 . . . . 63.25 107.003 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.14 -9.7 46.64 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-O 117.738 -1.59 . . . . 71.44 112.097 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -86.79 -28.32 23.04 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.157 1.479 . . . . 63.23 109.49 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--O 1.255 1.354 0 N-CA-C 103.994 -2.595 . . . . 75.31 103.994 178.258 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 . . . . . 0 C--O 1.232 0.183 0 N-CA-C 109.145 -0.687 . . . . 71.01 109.145 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.88 126.17 9.23 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 121.734 1.623 . . . . 71.43 108.198 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.6 m -111.94 170.15 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 120.814 -1.179 . . . . 72.33 109.807 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 p -125.37 157.0 37.86 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.691 1.596 . . . . 54.24 107.154 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 m -54.77 -38.89 67.79 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.533 1.133 . . . . 54.13 109.609 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -33.15 68.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.675 1.19 . . . . 72.15 112.445 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 93.0 mtp -68.5 -39.7 81.18 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.793 -1.192 . . . . 63.14 108.729 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 t -59.47 -53.78 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 124.86 1.264 . . . . 61.02 110.136 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -62.56 -41.82 99.16 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 117.209 -1.377 . . . . 65.03 110.845 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.3 m -54.58 -60.16 3.72 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 120.787 1.631 . . . . 62.23 108.93 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.0 t -53.32 -47.15 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 119.154 0.888 . . . . 63.22 110.674 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -57.21 -43.73 83.03 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.171 0.804 . . . . 72.32 113.171 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -59.14 -45.89 89.78 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.42 -0.956 . . . . 74.52 108.42 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.4 mt -71.47 -37.15 71.37 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.718 0.807 . . . . 74.31 111.879 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.82 80.99 11.46 Favored Pre-proline 0 C--O 1.241 0.642 0 C-N-CA 127.507 2.323 . . . . 72.11 112.043 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.37 -2.19 11.75 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 124.746 3.631 . . . . 70.12 112.306 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -90.26 -19.67 23.85 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.97 1.708 . . . . 74.01 110.584 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.8 mt -92.46 157.34 16.62 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.219 0.463 . . . . 73.22 112.146 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.4 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 41.7 t-80 -83.01 142.67 44.79 Favored Pre-proline 0 C--O 1.237 0.43 0 N-CA-C 106.229 -1.767 . . . . 75.14 106.229 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.5 ' HA ' HD12 ' A' ' 85' ' ' ILE . 20.1 Cg_endo -62.73 -28.98 76.74 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.751 2.3 . . . . 64.5 112.553 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HG2' ' CD1' ' A' ' 114' ' ' PHE . 2.2 tp10 -73.62 -41.61 62.59 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 122.112 -0.368 . . . . 63.03 111.466 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -61.24 -37.94 84.88 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.69 -0.631 . . . . 73.53 110.595 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 82' ' ' PRO . 97.5 mt -53.42 -58.3 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.47 1.108 . . . . 71.44 109.41 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.26 -47.76 18.09 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.971 0.805 . . . . 74.44 111.524 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -64.54 -42.76 95.51 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.179 0.9 . . . . 75.23 111.252 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.4 t -60.09 -46.24 90.25 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.03 -1.1 . . . . 45.3 108.03 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.28 -39.36 79.06 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.813 0.845 . . . . 62.14 111.025 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -69.42 -35.21 75.5 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.458 0.647 . . . . 74.45 111.395 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -72.39 -56.06 6.06 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.402 0.681 . . . . 73.3 110.454 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.8 p -68.73 -41.23 79.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.302 1.441 . . . . 73.02 113.341 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.86 -4.79 84.47 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.018 1.771 . . . . 74.3 113.439 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.4 m -142.23 134.58 27.83 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.507 1.153 . . . . 43.4 111.634 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.2 t -59.04 -48.48 86.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.173 0 N-CA-C 106.16 -1.792 . . . . 75.14 106.16 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.77 -42.23 64.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.904 0.882 . . . . 71.44 111.239 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -64.45 -45.04 89.17 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.53 -0.915 . . . . 70.52 108.53 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 58.3 m -59.51 -36.69 76.56 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.805 0.842 . . . . 74.12 110.315 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 65.9 t -74.67 -36.74 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.388 0.675 . . . . 72.23 110.138 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -71.47 -36.07 71.05 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.389 1.476 . . . . 71.13 111.192 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -79.34 -33.54 42.95 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.709 -0.848 . . . . 72.0 108.709 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -58.2 -55.73 31.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 118.925 -0.559 . . . . 74.53 109.59 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.41 -25.06 65.64 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.249 -0.881 . . . . 55.13 111.953 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -81.88 -8.02 59.65 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.238 0.926 . . . . 53.2 109.641 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.69 34.22 59.88 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 118.551 -1.139 . . . . 63.44 110.406 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -69.88 176.61 3.57 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 118.326 1.063 . . . . 74.3 110.127 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -75.7 147.25 39.53 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.844 -1.16 . . . . 73.55 109.33 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -138.9 109.08 6.41 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.325 -1.361 . . . . 75.44 107.325 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.4 m -94.66 164.95 12.74 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 124.237 1.015 . . . . 71.2 109.118 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -91.59 160.08 37.34 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.59 1.156 . . . . 74.43 109.7 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.39 165.35 29.23 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.213 1.942 . . . . 63.44 112.101 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.93 152.91 80.66 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.704 1.603 . . . . 73.41 108.528 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.73 -6.43 39.94 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.39 -1.228 . . . . 64.44 113.577 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . 0.415 ' CD1' ' HG2' ' A' ' 83' ' ' GLU . 85.9 t80 -77.49 -26.13 51.0 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.462 1.631 . . . . 73.22 110.547 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 116.964 -1.493 . . . . 74.3 109.841 179.789 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 . . . . . 0 C--O 1.235 0.315 0 N-CA-C 110.404 -0.221 . . . . 73.42 110.404 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.97 126.49 10.02 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.476 2.117 . . . . 61.34 109.3 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.3 m -125.13 162.52 27.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.932 0.893 . . . . 62.52 109.083 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p -120.34 172.89 7.48 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.687 1.995 . . . . 73.11 108.228 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.9 m -65.03 -40.23 94.52 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 121.423 -0.798 . . . . 62.1 110.304 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -38.38 62.91 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 124.402 1.081 . . . . 73.34 112.111 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.3 mtp -63.66 -41.52 98.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.385 -0.822 . . . . 70.43 109.413 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.93 -56.46 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 124.999 1.32 . . . . 74.44 110.464 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -59.69 -39.76 85.61 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.005 -0.998 . . . . 72.21 109.75 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.403 ' CG2' HG11 ' A' ' 95' ' ' VAL . 57.8 m -56.41 -60.42 3.55 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 120.356 1.435 . . . . 71.43 109.96 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.5 t -53.92 -45.5 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 119.374 0.988 . . . . 52.24 108.531 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -53.49 -43.15 68.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.717 1.144 . . . . 62.33 113.014 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -66.91 -35.33 79.77 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.715 0.406 . . . . 72.43 110.293 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 mt -88.22 -12.25 44.32 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.262 0.483 . . . . 62.53 112.278 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -143.78 76.77 15.37 Favored Pre-proline 0 C--O 1.241 0.607 0 C-N-CA 126.363 1.865 . . . . 52.34 108.85 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.5 -13.72 33.07 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.376 2.717 . . . . 73.13 112.405 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.6 -7.99 58.89 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.467 1.507 . . . . 75.13 112.395 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.2 mt -97.48 152.97 18.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.25 0.932 . . . . 63.13 112.005 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.42 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 58.0 t-80 -69.54 144.56 94.33 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.828 1.651 . . . . 74.52 109.394 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 41.0 Cg_endo -66.89 -24.94 45.64 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.85 2.367 . . . . 74.12 114.152 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.76 -41.33 14.21 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 120.054 1.297 . . . . 63.45 111.725 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -57.04 -35.8 69.73 Favored 'General case' 0 C--N 1.343 0.308 0 O-C-N 123.657 0.598 . . . . 74.2 110.478 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 66.8 mt -53.64 -58.16 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 118.485 -0.769 . . . . 62.42 110.035 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.72 -45.24 48.93 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.474 0.579 . . . . 65.32 111.815 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -63.32 -44.57 94.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.783 -0.573 . . . . 74.14 111.144 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 p -60.67 -44.4 96.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 118.567 -0.73 . . . . 73.3 109.998 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.4 mt -60.4 -37.07 79.66 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.82 0.848 . . . . 74.31 110.04 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.1 -33.55 74.74 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.296 0.498 . . . . 64.52 110.269 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -79.04 -42.24 26.93 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.258 1.023 . . . . 75.45 113.537 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -83.52 -34.6 25.25 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.713 1.605 . . . . 74.42 112.537 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.88 -11.12 63.09 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.418 1.961 . . . . 33.1 111.899 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 m -144.87 150.93 37.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.346 1.573 . . . . 71.41 112.106 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.403 HG11 ' CG2' ' A' ' 72' ' ' THR . 78.1 t -62.63 -49.78 82.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 126.281 1.832 . . . . 63.4 107.97 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -45.33 -53.24 8.76 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 128.092 2.557 . . . . 75.01 111.792 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -66.66 -41.59 87.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.638 -0.71 . . . . 73.21 109.43 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.9 m -59.26 -39.29 82.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.012 0.925 . . . . 73.53 110.463 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.8 t -74.39 -38.25 46.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 124.107 0.963 . . . . 73.42 109.924 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -68.07 -41.62 81.67 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.355 1.062 . . . . 60.13 110.495 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 108' ' ' PHE . 5.6 ptm180 -74.12 -35.35 64.11 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.351 -0.843 . . . . 72.01 108.816 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -57.57 -57.33 13.15 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 118.539 -0.743 . . . . 74.34 109.457 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.29 -24.9 65.32 Favored 'General case' 0 C--N 1.339 0.118 0 O-C-N 123.575 0.547 . . . . 53.54 111.402 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -15.39 59.51 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 118.457 -0.782 . . . . 53.04 109.684 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.27 28.82 32.36 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 118.748 -1.029 . . . . 34.44 110.545 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.25 174.46 4.7 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.664 1.232 . . . . 71.55 109.02 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -86.13 147.74 26.01 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 120.587 -1.32 . . . . 65.42 108.776 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 101' ' ' ARG . 34.9 m-85 -139.1 109.72 6.63 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.632 -1.167 . . . . 72.22 109.694 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.9 m -82.12 170.71 15.18 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.382 1.073 . . . . 63.13 108.876 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -94.4 161.98 27.51 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 126.442 1.897 . . . . 73.11 110.848 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.53 158.46 57.6 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.619 2.213 . . . . 61.25 111.766 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.42 128.88 23.63 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.838 2.359 . . . . 72.2 110.612 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.61 -3.95 66.0 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 118.734 -1.037 . . . . 72.04 113.16 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -67.93 -31.18 70.76 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.416 1.608 . . . . 74.11 107.661 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 128.223 2.609 . . . . 63.41 106.835 179.227 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 118.741 -0.647 . . . . 75.01 110.545 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.99 140.2 22.58 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.898 3.065 . . . . 64.22 107.868 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.37 150.07 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.318 -0.864 . . . . 64.54 111.326 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.4 p -107.08 169.8 8.34 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.885 1.674 . . . . 73.24 111.952 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.8 m -58.22 -40.03 80.62 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.391 -0.814 . . . . 64.42 109.667 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -35.12 70.31 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 118.81 0.732 . . . . 73.3 112.066 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 92.2 mtp -66.43 -42.84 87.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.216 -0.927 . . . . 62.42 109.171 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.38 -54.79 28.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 C-N-CA 124.625 1.17 . . . . 74.24 109.4 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -64.05 -35.75 81.75 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 118.127 -0.94 . . . . 44.45 111.78 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.415 ' CG2' HG11 ' A' ' 95' ' ' VAL . 27.4 m -57.59 -59.6 4.94 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.187 1.358 . . . . 72.24 109.037 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.4 t -55.91 -45.92 80.11 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 CA-C-O 117.749 -1.12 . . . . 53.12 109.225 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -54.27 -44.8 72.19 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 120.457 1.48 . . . . 74.22 112.771 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -61.07 -44.93 96.64 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.234 -1.024 . . . . 74.33 108.234 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.7 mt -76.34 -28.93 57.06 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.1 0.778 . . . . 63.53 113.1 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.31 78.4 71.44 Favored Pre-proline 0 C--O 1.242 0.666 0 C-N-CA 127.737 2.415 . . . . 73.24 110.153 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.43 -1.1 10.89 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.89 3.727 . . . . 74.44 113.309 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -95.71 2.8 54.16 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.331 1.453 . . . . 72.14 112.021 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.0 mt -108.43 156.22 19.7 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.68 1.192 . . . . 73.35 109.556 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.452 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 54.5 t-80 -79.49 147.53 68.14 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 107.539 -1.282 . . . . 74.34 107.539 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 37.7 Cg_endo -65.14 -22.88 61.0 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.873 2.382 . . . . 73.44 113.417 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.51 -37.08 28.42 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.567 -0.708 . . . . 71.22 110.12 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -58.54 -37.02 74.81 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 109.885 -0.413 . . . . 71.41 109.885 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 82' ' ' PRO . 47.2 mt -57.41 -60.8 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 117.471 -1.252 . . . . 70.43 109.813 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.45 -50.19 5.21 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.517 1.053 . . . . 75.05 110.918 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -63.2 -47.32 83.05 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.612 0.72 . . . . 75.45 111.998 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 m -57.1 -50.79 71.68 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.383 0.673 . . . . 54.12 109.23 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.0 mt -57.92 -39.83 78.93 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.3 1.04 . . . . 65.12 111.136 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -65.63 -32.0 73.33 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 122.478 0.311 . . . . 75.31 110.546 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -80.16 -51.32 9.11 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.646 -0.693 . . . . 50.45 111.094 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -71.41 -40.97 70.14 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.07 1.348 . . . . 65.31 113.145 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.52 -17.55 58.83 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.677 2.084 . . . . 21.14 113.102 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 t -143.33 147.87 35.39 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.426 1.613 . . . . 75.15 108.984 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.415 HG11 ' CG2' ' A' ' 72' ' ' THR . 31.1 t -59.8 -46.13 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 127.32 2.248 . . . . 75.31 109.27 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -47.62 -48.57 28.44 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.381 1.472 . . . . 64.53 110.48 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -67.84 -42.38 81.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.625 -0.509 . . . . 74.31 109.625 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.2 m -58.25 -36.64 73.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.066 0.547 . . . . 72.24 110.896 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 78.8 t -75.95 -38.71 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.402 1.081 . . . . 64.32 109.614 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -66.61 -38.7 87.52 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.03 1.332 . . . . 52.3 110.37 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -76.94 -37.52 55.16 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 121.057 -1.027 . . . . 73.43 108.649 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -56.29 -53.55 55.95 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.194 0.598 . . . . 74.24 109.743 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.79 -22.94 65.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 119.345 -0.36 . . . . 63.33 111.955 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -82.37 -10.15 59.18 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.796 0.726 . . . . 75.31 109.718 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.32 37.22 42.46 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.018 -1.233 . . . . 74.2 110.018 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.76 -171.72 0.43 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 117.645 0.723 . . . . 70.11 110.734 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -90.34 139.51 30.59 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 120.346 -1.471 . . . . 64.22 110.388 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -128.89 108.76 10.69 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.358 -1.349 . . . . 74.11 107.358 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.9 m -89.74 172.4 8.95 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.802 1.641 . . . . 75.21 110.349 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -107.49 152.87 41.52 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 125.747 1.619 . . . . 62.2 108.423 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.19 170.11 19.89 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 123.706 2.937 . . . . 71.13 112.874 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.01 152.52 82.1 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 N-CA-C 107.003 -1.96 . . . . 75.21 107.003 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.08 -18.96 13.86 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 118.045 -1.419 . . . . 62.42 112.495 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -72.42 -54.75 8.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 119.536 1.668 . . . . 73.25 107.316 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 C--O 1.253 1.264 0 N-CA-C 106.266 -1.753 . . . . 75.13 106.266 179.508 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 108.304 -0.998 . . . . 64.14 108.304 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.31 126.08 9.53 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.933 1.756 . . . . 71.03 109.084 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.2 m -126.48 161.16 33.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 O-C-N 121.306 -0.871 . . . . 43.12 109.836 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 p -125.09 164.18 20.78 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.96 2.104 . . . . 70.44 109.813 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.0 m -59.17 -39.39 82.36 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.757 0.708 . . . . 72.51 110.744 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.3 -33.66 67.9 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.398 0.679 . . . . 74.12 111.983 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.8 mtp -65.72 -46.84 77.44 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 120.638 -1.289 . . . . 71.02 107.696 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.7 t -50.77 -58.66 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.499 0 C-N-CA 126.703 2.001 . . . . 72.43 109.853 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -59.73 -37.18 78.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 118.283 -0.865 . . . . 73.42 110.559 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -54.82 -60.69 3.01 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 120.272 1.396 . . . . 63.05 109.071 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.8 t -54.91 -51.89 48.63 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-O 118.06 -0.972 . . . . 71.21 108.847 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.41 -42.89 54.41 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.044 0.838 . . . . 74.25 113.05 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -65.21 -40.1 93.69 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 118.961 0.801 . . . . 73.13 109.289 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.5 mt -82.98 -16.24 48.0 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.083 0.772 . . . . 53.45 113.083 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.37 72.36 65.35 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 129.208 3.003 . . . . 73.04 109.528 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.82 -12.38 30.8 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.225 1.95 . . . . 64.4 112.486 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -84.25 13.23 5.46 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.383 1.473 . . . . 74.31 112.618 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.1 mt -121.12 158.78 27.18 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.504 1.122 . . . . 55.5 110.663 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -81.86 141.91 48.14 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 107.7 -1.222 . . . . 75.22 107.7 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.464 ' HA ' HD12 ' A' ' 85' ' ' ILE . 38.7 Cg_endo -63.64 -26.35 69.05 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.654 2.236 . . . . 75.34 112.813 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.37 -39.5 53.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.748 -0.595 . . . . 54.13 111.942 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -60.25 -45.58 92.78 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.83 -0.433 . . . . 60.33 109.83 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 82' ' ' PRO . 95.2 mt -47.53 -55.58 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 126.272 1.829 . . . . 50.0 111.03 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -45.69 49.33 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.911 0.778 . . . . 73.51 111.447 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -64.1 -40.07 95.43 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.773 -1.204 . . . . 72.5 110.955 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.0 m -57.82 -55.77 30.6 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.042 1.337 . . . . 74.3 108.256 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.11 -39.99 76.15 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.704 1.202 . . . . 73.32 111.238 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.19 -33.93 77.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 119.553 -0.859 . . . . 70.14 110.698 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -76.96 -48.68 17.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 118.395 -0.812 . . . . 73.21 111.969 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.4 p -73.49 -40.98 63.67 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.627 1.571 . . . . 75.22 111.5 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.14 -4.14 84.12 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 127.363 2.411 . . . . 63.02 111.853 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 m -144.54 140.76 29.02 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.798 1.239 . . . . 61.43 110.704 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.22 -45.83 95.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 124.909 1.284 . . . . 51.21 108.439 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -47.8 -48.67 30.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.345 1.858 . . . . 62.32 111.362 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.72 -47.63 77.59 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 108.591 -0.892 . . . . 71.32 108.591 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 m -54.83 -41.7 71.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.548 1.539 . . . . 73.21 112.044 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.4 t -76.76 -34.5 23.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 121.503 -0.748 . . . . 53.04 110.364 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -73.19 -32.06 64.58 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.985 0.914 . . . . 71.14 111.197 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.464 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 3.9 ptm180 -82.19 -34.93 28.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.42 -0.956 . . . . 73.21 108.42 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -55.92 -55.1 36.67 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 108.298 -1.001 . . . . 62.12 108.298 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.32 -24.78 66.68 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 119.335 -0.364 . . . . 72.22 111.219 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 101' ' ' ARG . 0.1 OUTLIER -74.68 -17.23 60.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.153 0.888 . . . . 70.12 108.962 178.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.83 35.12 28.96 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.318 -1.513 . . . . 71.11 109.318 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -70.61 -173.0 0.69 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.129 0.964 . . . . 73.13 110.047 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -89.71 144.48 25.95 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 119.523 -1.986 . . . . 75.02 108.529 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -136.69 109.44 7.54 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.242 -1.344 . . . . 63.44 108.895 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.63 173.44 8.05 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.179 1.392 . . . . 73.22 110.932 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -103.8 158.75 31.23 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.096 1.758 . . . . 72.31 109.074 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.0 161.88 40.61 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.485 2.123 . . . . 70.51 112.867 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -67.9 136.05 37.18 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.067 1.845 . . . . 52.43 109.688 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.34 -2.55 71.2 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.488 1.042 . . . . 73.34 111.388 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -75.52 -35.98 60.62 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.03 0.915 . . . . 71.53 109.838 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 . . . . . 0 C--O 1.248 1.007 0 C-N-CA 125.847 1.659 . . . . 71.54 110.982 -179.26 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 107.529 -1.285 . . . . 75.04 107.529 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.84 148.84 36.62 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.819 2.346 . . . . 74.53 109.268 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.35 165.64 30.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-O 121.619 0.723 . . . . 75.22 110.201 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 p -125.36 157.24 37.26 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.152 1.781 . . . . 74.31 107.387 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.9 m -54.31 -36.7 64.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.354 0.662 . . . . 73.13 111.149 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -32.59 68.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.144 0.978 . . . . 73.42 111.948 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.7 mtp -69.9 -40.75 75.44 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.036 -1.098 . . . . 71.33 108.036 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 t -59.94 -58.02 9.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.971 1.308 . . . . 73.54 109.349 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -60.01 -36.05 76.37 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 118.341 -0.837 . . . . 64.14 110.877 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.436 ' CG2' HG11 ' A' ' 95' ' ' VAL . 82.2 m -58.03 -61.72 2.34 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.958 1.254 . . . . 61.44 108.863 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.411 HG21 HD21 ' A' ' 89' ' ' LEU . 61.3 t -54.9 -43.98 70.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 119.481 1.037 . . . . 71.22 109.39 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -55.2 -48.07 74.38 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 119.655 1.116 . . . . 43.52 111.525 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -59.03 -39.68 82.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.12 0.968 . . . . 65.23 110.324 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.2 mt -86.63 -19.75 28.86 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.109 0.781 . . . . 75.22 113.109 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.05 77.91 74.79 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.847 2.059 . . . . 43.42 109.032 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.49 -0.24 6.41 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.294 3.33 . . . . 64.1 113.602 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.45 20.51 18.12 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.287 1.035 . . . . 72.32 111.749 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.2 mt -123.37 154.5 38.89 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.905 1.282 . . . . 73.14 110.039 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.467 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 48.5 t-80 -86.27 147.72 45.47 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-O 118.495 -0.764 . . . . 71.54 109.104 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 40.3 Cg_endo -63.57 -32.1 70.17 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.315 2.677 . . . . 53.21 112.752 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 81' ' ' HIS . 0.1 OUTLIER -74.82 -44.65 48.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.884 -0.413 . . . . 75.35 109.884 -178.329 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -59.27 -39.81 84.08 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 108.834 -0.802 . . . . 71.24 108.834 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 82' ' ' PRO . 48.5 mt -57.52 -59.59 3.11 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 N-CA-C 107.84 -1.171 . . . . 75.5 107.84 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.08 -47.06 34.33 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.395 0.998 . . . . 70.12 111.596 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -62.01 -44.25 97.13 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.205 0.911 . . . . 71.43 111.494 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m -63.75 -41.29 98.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.414 -0.587 . . . . 75.34 109.414 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.411 HD21 HG21 ' A' ' 73' ' ' VAL . 87.9 mt -61.62 -37.77 85.18 Favored 'General case' 0 C--O 1.225 -0.236 0 O-C-N 121.229 -0.92 . . . . 72.34 110.38 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -69.9 -37.31 75.96 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 117.992 0.36 . . . . 62.02 111.078 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -74.77 -53.06 9.88 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 122.171 -0.331 . . . . 73.43 111.137 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.7 p -67.14 -41.88 85.35 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.068 0.947 . . . . 73.42 111.486 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.28 -15.0 64.19 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 128.335 2.874 . . . . 73.24 113.806 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.0 m -139.55 148.5 42.66 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.636 1.718 . . . . 71.23 111.763 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.436 HG11 ' CG2' ' A' ' 72' ' ' THR . 51.1 t -61.7 -50.99 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 106.342 -1.725 . . . . 65.03 106.342 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -50.86 -48.36 60.12 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.756 1.622 . . . . 71.22 111.101 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.71 -42.56 99.71 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.729 1.211 . . . . 73.42 109.179 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.5 m -65.0 -38.45 90.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.857 1.263 . . . . 52.42 110.807 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.9 t -73.35 -39.81 55.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 121.339 -0.85 . . . . 62.11 109.66 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -65.19 -38.97 92.18 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.474 1.51 . . . . 60.2 111.015 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -77.58 -35.53 52.92 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.592 -0.892 . . . . 61.53 108.592 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -57.17 -57.59 11.91 Favored 'General case' 0 C--O 1.233 0.226 0 O-C-N 121.255 -0.903 . . . . 74.31 110.53 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.47 -23.95 59.06 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.429 0.692 . . . . 74.54 111.179 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -12.11 59.24 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 117.845 -1.074 . . . . 50.51 111.464 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.06 22.7 51.67 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.786 -1.008 . . . . 73.51 112.317 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -67.25 172.99 4.19 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.635 1.217 . . . . 61.44 111.101 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -77.19 144.59 38.21 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.822 1.649 . . . . 74.02 109.985 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -137.43 110.11 7.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.895 1.278 . . . . 61.33 107.804 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -92.97 167.99 11.44 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.503 -1.226 . . . . 71.2 110.169 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -94.21 158.81 35.32 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 124.671 1.189 . . . . 74.22 109.221 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -67.99 166.99 22.87 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.473 2.782 . . . . 51.35 114.483 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.42 143.92 89.61 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.025 1.817 . . . . 63.12 108.147 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.12 3.45 88.33 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.094 -0.837 . . . . 45.32 112.915 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -84.36 -41.37 16.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.425 1.613 . . . . 74.33 110.981 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 C--O 1.254 1.302 0 CA-C-O 118.013 -0.994 . . . . 72.11 110.86 -179.091 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 . . . . . 0 CA--C 1.539 0.529 0 N-CA-C 109.389 -0.597 . . . . 74.21 109.389 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.3 125.93 7.36 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.568 2.845 . . . . 74.1 110.321 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.92 143.61 29.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 122.747 1.26 . . . . 45.15 111.731 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p -112.04 161.02 16.93 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.579 1.951 . . . . 70.33 109.197 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.7 m -52.67 -38.96 61.38 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.82 1.248 . . . . 71.12 111.917 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -59.47 -31.67 69.54 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.483 1.113 . . . . 71.22 112.317 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 91.6 mtp -71.91 -45.87 59.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.455 -0.943 . . . . 63.24 108.455 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.4 t -59.98 -52.33 62.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.893 0.877 . . . . 73.42 109.883 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.53 -41.1 98.49 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-O 117.342 -1.313 . . . . 74.34 110.315 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.475 ' CG2' HG11 ' A' ' 95' ' ' VAL . 61.3 m -52.6 -60.38 3.32 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 120.602 1.546 . . . . 70.44 108.71 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.473 HG23 HG13 ' A' ' 95' ' ' VAL . 92.8 t -55.27 -50.53 64.02 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 CA-C-O 118.052 -0.975 . . . . 61.22 109.206 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -54.72 -44.41 73.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 119.716 1.144 . . . . 71.31 113.838 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -59.88 -43.77 94.57 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.931 1.293 . . . . 45.53 108.64 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.9 mt -81.59 -26.82 34.62 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.049 0.759 . . . . 54.34 113.049 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.93 73.39 35.27 Favored Pre-proline 0 N--CA 1.447 -0.578 0 C-N-CA 127.655 2.382 . . . . 72.53 111.498 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.81 -3.6 13.48 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.522 2.148 . . . . 64.22 111.312 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.11 18.68 10.35 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 128.345 2.658 . . . . 61.12 111.094 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.7 mt -133.83 154.82 50.75 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.351 1.461 . . . . 74.05 111.001 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -80.53 142.32 53.58 Favored Pre-proline 0 C--O 1.236 0.383 0 N-CA-C 107.416 -1.327 . . . . 72.32 107.416 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HA ' HD12 ' A' ' 85' ' ' ILE . 37.0 Cg_endo -66.33 -29.02 46.63 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.642 2.228 . . . . 64.41 113.022 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -75.43 -41.1 56.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.756 -0.59 . . . . 74.12 110.809 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -59.73 -41.92 91.97 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.634 -0.506 . . . . 63.52 109.634 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 82' ' ' PRO . 86.3 mt -51.36 -58.51 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 124.066 0.946 . . . . 72.13 108.984 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.05 -47.01 11.76 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.548 0.739 . . . . 73.54 111.619 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -64.53 -48.49 74.89 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.419 0.628 . . . . 73.11 111.489 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.4 m -56.92 -47.7 79.99 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 108.173 -1.047 . . . . 70.25 108.173 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.52 -39.74 77.23 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 124.584 1.154 . . . . 74.45 111.095 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -66.94 -31.64 72.35 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.168 0.44 . . . . 75.42 110.784 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -77.66 -50.59 12.15 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.209 0.448 . . . . 72.35 112.209 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -74.58 -41.94 59.62 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.952 1.701 . . . . 43.13 112.794 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.14 -12.02 69.11 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 126.671 2.081 . . . . 71.4 116.507 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 t -145.32 123.1 11.9 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 121.467 2.633 . . . . 64.41 111.706 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.475 HG11 ' CG2' ' A' ' 72' ' ' THR . 84.6 t -41.88 -41.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 120.366 1.439 . . . . 72.05 112.819 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -49.89 -43.61 49.55 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 124.694 1.246 . . . . 73.54 111.67 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -67.63 -42.83 81.68 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 121.092 -1.005 . . . . 71.13 109.489 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.8 m -60.45 -39.01 86.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.131 0.572 . . . . 74.21 111.114 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.36 -39.1 76.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.21 -0.663 . . . . 54.12 109.21 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -66.83 -41.02 88.13 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.622 0.769 . . . . 75.33 111.456 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -75.4 -35.36 61.04 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 121.104 -0.997 . . . . 63.31 109.619 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -57.4 -57.4 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.212 -0.93 . . . . 72.35 110.009 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.69 -22.16 56.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.951 0.722 . . . . 74.4 112.951 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -5.19 56.53 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.796 0.725 . . . . 64.24 110.953 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.15 36.81 50.28 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 118.519 0.6 . . . . 73.43 112.322 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -69.98 -178.46 1.6 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.211 1.006 . . . . 72.04 111.013 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.75 131.26 35.21 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.698 -1.251 . . . . 63.23 110.257 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -130.92 109.89 10.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.462 -1.681 . . . . 74.52 106.462 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.3 m -96.79 168.6 10.4 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.707 0.803 . . . . 54.22 110.084 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -91.23 155.91 44.16 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 107.326 -1.361 . . . . 73.44 107.326 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.57 168.51 21.1 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.759 2.306 . . . . 53.44 113.722 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.33 149.44 91.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.37 2.047 . . . . 72.13 108.921 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.12 -12.07 13.7 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.564 -1.131 . . . . 62.34 113.207 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -68.96 -24.41 64.25 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.715 1.758 . . . . 74.3 109.381 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 130.757 3.623 . . . . 71.15 105.212 178.183 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 119.188 -0.434 . . . . 61.44 110.605 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.79 143.7 21.26 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.884 3.056 . . . . 71.41 111.127 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.0 m -134.17 167.07 27.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-O 122.026 0.917 . . . . 55.14 109.943 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 p -125.36 161.15 27.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.119 1.768 . . . . 72.42 107.802 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.5 m -57.96 -38.01 75.22 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.124 0.57 . . . . 74.42 110.588 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -35.9 69.45 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 119.336 -0.364 . . . . 63.42 111.63 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.0 mtp -64.29 -38.88 92.62 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.044 0.838 . . . . 70.32 109.537 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.0 t -63.96 -57.41 11.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 124.552 1.141 . . . . 75.22 110.767 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -59.62 -40.23 86.86 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 118.444 -0.789 . . . . 75.23 110.73 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.2 m -58.62 -58.21 9.58 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.321 1.419 . . . . 71.53 108.57 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.533 HG23 HG13 ' A' ' 95' ' ' VAL . 53.0 t -52.52 -50.23 40.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 CA-C-O 118.249 -0.881 . . . . 74.22 109.469 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -54.08 -45.58 71.81 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.928 0.785 . . . . 53.51 111.375 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -59.49 -36.84 76.8 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.016 0.926 . . . . 74.1 110.688 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.0 mt -89.84 -14.92 33.35 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.034 0.753 . . . . 74.12 113.034 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.27 71.12 61.21 Favored Pre-proline 0 N--CA 1.448 -0.551 0 C-N-CA 126.927 2.091 . . . . 75.31 110.993 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.67 -15.41 49.19 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.286 1.99 . . . . 74.13 112.408 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.32 -13.86 59.85 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.072 1.349 . . . . 72.13 112.003 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.2 mt -92.05 156.48 17.37 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.315 0.961 . . . . 61.32 111.376 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.442 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 58.3 t-80 -80.42 146.11 60.94 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 106.474 -1.676 . . . . 74.13 106.474 178.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 36.4 Cg_endo -65.45 -30.16 52.97 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.092 1.862 . . . . 63.33 113.187 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.58 -34.92 46.51 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 121.77 -0.582 . . . . 72.41 110.863 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -64.47 -35.92 82.49 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.677 -0.86 . . . . 71.14 108.677 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.3 mt -54.94 -60.82 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 C-N-CA 124.583 1.153 . . . . 73.32 109.749 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -46.63 -48.64 19.85 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 118.558 0.617 . . . . 74.22 110.8 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.405 ' CE1' ' HD3' ' A' ' 112' ' ' PRO . 4.1 t80 -59.37 -44.9 92.67 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.812 0.815 . . . . 73.33 112.391 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 p -62.79 -43.4 98.89 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.165 -0.47 . . . . 73.22 110.01 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.431 HD21 ' CG2' ' A' ' 73' ' ' VAL . 52.0 mt -60.35 -38.47 83.91 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.816 -0.552 . . . . 72.22 111.678 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -70.57 -28.44 64.9 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.169 0.587 . . . . 73.2 109.834 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -85.33 -43.59 13.56 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 114.453 1.279 . . . . 75.4 114.453 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.7 p -79.57 -41.44 27.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.692 1.197 . . . . 63.43 111.411 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.51 0.86 88.02 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 118.745 -1.031 . . . . 64.25 112.379 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.27 129.5 18.74 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.393 1.477 . . . . 63.11 111.297 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.533 HG13 HG23 ' A' ' 73' ' ' VAL . 44.3 t -61.56 -46.51 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 105.551 -2.018 . . . . 74.45 105.551 177.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -55.89 -45.66 78.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.48 -0.772 . . . . 74.12 110.013 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -59.03 -43.8 91.67 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.74 0.7 . . . . 64.54 110.029 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.1 m -61.17 -42.41 98.51 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.297 1.839 . . . . 63.43 110.872 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.0 t -74.63 -38.27 45.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 121.672 -0.642 . . . . 75.02 109.966 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -66.62 -37.49 84.97 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 125.191 1.396 . . . . 72.02 111.056 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -77.81 -39.58 43.31 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.861 -1.162 . . . . 74.0 107.861 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -55.23 -52.07 64.56 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 120.564 -1.335 . . . . 71.43 111.908 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.5 -16.13 33.97 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 113.662 0.986 . . . . 73.22 113.662 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.58 -11.66 42.05 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.813 0.845 . . . . 73.3 109.569 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.72 28.45 32.14 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 118.707 -1.052 . . . . 62.11 111.375 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -64.33 -178.22 0.35 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.859 1.263 . . . . 74.23 112.987 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -87.08 137.91 31.94 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 126.449 1.9 . . . . 64.23 111.549 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -141.85 109.91 5.87 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.19 1.396 . . . . 75.21 111.93 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.2 m -83.11 176.95 8.82 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.843 0.857 . . . . 73.25 110.369 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -105.54 157.17 35.13 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 127.366 2.266 . . . . 62.11 107.308 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.42 154.5 73.64 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.125 1.883 . . . . 73.44 112.197 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.405 ' HD3' ' CE1' ' A' ' 87' ' ' TYR . 36.4 Cg_endo -60.98 123.34 12.73 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 124.457 3.438 . . . . 72.44 110.703 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.8 -4.22 53.13 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 124.842 1.21 . . . . 41.43 111.811 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -78.22 -34.37 49.32 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.83 1.815 . . . . 64.14 109.606 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 . . . . . 0 C--O 1.247 0.937 0 C-N-CA 125.452 1.501 . . . . 72.21 111.542 -178.526 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 107.291 -1.374 . . . . 74.43 107.291 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.28 142.44 27.05 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 121.99 1.793 . . . . 53.04 108.96 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.12 160.89 40.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.187 0.995 . . . . 70.2 108.323 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -124.62 159.11 31.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.296 -1.742 . . . . 65.14 106.296 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -59.73 -30.02 68.54 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 120.961 -1.087 . . . . 61.34 112.543 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -33.57 68.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.465 1.029 . . . . 74.25 111.047 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.1 mtp -66.96 -43.37 83.28 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.229 -0.919 . . . . 72.51 108.61 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 t -57.1 -56.36 15.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 125.184 1.394 . . . . 74.41 110.827 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -59.09 -38.57 79.81 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 117.704 -1.141 . . . . 55.53 109.464 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.4 m -56.59 -58.97 5.77 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 120.278 1.399 . . . . 71.14 110.393 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.9 t -53.55 -45.77 59.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-N 119.384 0.993 . . . . 74.54 109.037 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.07 -50.14 67.43 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.209 0.913 . . . . 70.32 112.687 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -58.85 -40.87 85.54 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.693 0.797 . . . . 65.32 110.98 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.9 mt -83.9 -22.54 31.55 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.663 0.616 . . . . 63.41 112.663 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.17 72.54 81.35 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 127.104 2.162 . . . . 71.11 109.826 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.54 -6.26 18.06 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.007 3.138 . . . . 61.4 113.964 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.6 4.89 50.04 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.82 -1.175 . . . . 71.12 111.016 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.3 mt -109.93 161.02 15.89 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 120.678 -1.264 . . . . 51.55 110.419 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -81.89 144.9 52.45 Favored Pre-proline 0 N--CA 1.453 -0.317 0 C-N-CA 124.604 1.162 . . . . 63.34 108.551 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.539 ' HA ' HD12 ' A' ' 85' ' ' ILE . 56.7 Cg_endo -70.6 -25.32 24.85 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.009 2.473 . . . . 74.11 113.634 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.65 -39.17 32.04 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.665 0.666 . . . . 75.45 110.328 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -57.29 -44.2 83.84 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.034 0.534 . . . . 75.13 110.629 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 82' ' ' PRO . 59.9 mt -47.56 -54.75 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 C-N-CA 125.04 1.336 . . . . 70.23 112.471 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.43 -46.34 37.49 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.34 0.518 . . . . 73.4 111.475 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -65.29 -42.74 92.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.633 -0.667 . . . . 74.04 111.263 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 m -60.0 -47.01 87.6 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 122.922 0.489 . . . . 73.5 109.721 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.41 -37.41 85.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.826 0.85 . . . . 63.12 110.697 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -69.92 -34.31 73.32 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.594 0.633 . . . . 74.22 110.38 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -74.87 -46.99 32.53 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.575 0.75 . . . . 61.33 112.485 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.9 p -77.77 -41.03 38.87 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.321 1.049 . . . . 70.32 111.49 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.92 -14.01 64.43 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 127.413 2.435 . . . . 61.4 112.588 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.2 m -144.09 150.08 37.57 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 120.115 1.957 . . . . 45.52 112.658 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.68 -50.97 73.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 126.275 1.83 . . . . 74.02 107.148 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -49.99 -46.76 52.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.151 1.38 . . . . 73.33 109.987 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -65.07 -46.57 80.6 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.374 0.67 . . . . 75.25 109.936 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 89.0 m -59.05 -37.07 76.14 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.873 1.269 . . . . 75.45 111.729 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.2 t -77.55 -36.72 23.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 123.62 0.768 . . . . 74.05 109.583 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -66.16 -35.33 80.2 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 125.151 1.38 . . . . 72.1 110.873 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -81.4 -36.12 29.89 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.94 -1.1 . . . . 74.32 108.608 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -56.67 -55.36 35.05 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.614 -0.679 . . . . 74.33 110.366 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -59.87 -19.97 54.41 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.34 0.867 . . . . 74.11 113.34 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -13.22 41.43 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.105 0.562 . . . . 61.15 110.426 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.25 20.98 39.86 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 118.921 -0.933 . . . . 64.4 113.469 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -63.71 174.35 1.42 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.442 1.097 . . . . 74.53 111.221 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -83.12 141.54 31.9 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.673 1.189 . . . . 75.35 111.712 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -128.58 109.91 11.78 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.268 1.827 . . . . 70.33 108.433 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.2 m -93.78 173.9 7.45 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.205 1.002 . . . . 61.11 111.404 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -105.03 156.62 35.8 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.963 1.305 . . . . 73.13 108.873 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.65 158.59 56.47 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.75 2.3 . . . . 75.21 114.488 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.39 116.82 4.7 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 105.769 -2.435 . . . . 73.35 105.769 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.25 -17.62 7.47 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-O 117.683 -1.621 . . . . 75.2 111.83 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -66.09 -27.75 68.3 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.577 1.189 . . . . 74.5 111.803 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 . . . . . 0 C--O 1.248 1.018 0 N-CA-C 105.167 -2.16 . . . . 72.04 105.167 178.363 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 . . . . . 0 C--O 1.236 0.374 0 CA-C-O 119.353 -0.356 . . . . 64.21 110.409 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.67 133.89 16.12 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.701 2.934 . . . . 75.21 108.905 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 m -134.85 152.6 33.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.644 0.778 . . . . 65.42 109.942 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.35 164.04 21.26 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.706 1.203 . . . . 65.21 110.488 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -45.54 -47.46 14.34 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.154 2.181 . . . . 70.1 112.313 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -57.53 -34.59 69.29 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.715 0.806 . . . . 61.44 112.761 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 84.4 mtp -67.93 -39.78 83.43 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.968 -0.753 . . . . 74.53 108.968 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 t -58.88 -57.41 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.037 1.335 . . . . 71.2 110.485 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -58.6 -42.08 87.28 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-O 117.989 -1.005 . . . . 72.33 110.02 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -55.78 -60.13 3.89 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 120.057 1.299 . . . . 74.45 109.841 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.0 t -51.67 -49.49 34.65 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-O 118.836 -0.602 . . . . 75.55 109.969 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -51.26 -48.16 62.24 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.516 0.726 . . . . 73.13 112.211 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -59.49 -43.41 93.33 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.506 -0.553 . . . . 62.44 109.506 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mt -80.41 -13.07 59.44 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.972 0.73 . . . . 73.11 112.972 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.14 69.86 34.54 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.993 2.117 . . . . 71.33 110.861 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.28 -2.86 9.76 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.164 2.576 . . . . 72.53 113.254 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -86.69 -10.88 52.77 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.629 1.572 . . . . 53.5 110.465 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.69 158.52 15.46 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.494 -0.754 . . . . 63.42 112.277 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -81.93 147.14 57.38 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.971 -1.122 . . . . 73.23 107.971 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.94 -29.97 67.13 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.392 2.061 . . . . 72.42 112.837 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.28 -39.43 28.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.946 -0.471 . . . . 62.12 112.173 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -60.66 -41.42 94.98 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.62 -0.511 . . . . 60.12 109.62 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.1 mt -51.86 -59.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.556 0.742 . . . . 71.42 109.09 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.95 -44.75 30.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.425 0.69 . . . . 74.33 111.388 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -65.92 -43.42 88.18 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.145 -0.972 . . . . 72.44 112.817 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -66.99 -37.65 84.61 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.346 -0.983 . . . . 63.05 108.346 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.4 mt -61.25 -38.19 85.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.547 -1.279 . . . . 63.51 107.547 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -67.58 -34.44 77.03 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.949 0.795 . . . . 75.12 109.676 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -71.74 -51.85 20.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 119.008 -0.52 . . . . 61.0 112.364 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.9 p -74.77 -40.99 60.87 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.497 1.519 . . . . 54.13 112.708 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.66 -4.14 86.18 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.624 1.107 . . . . 71.42 111.447 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -144.48 135.03 24.67 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.806 1.803 . . . . 62.33 111.836 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.2 t -55.12 -52.43 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.9 1.68 . . . . 74.25 108.631 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -47.55 -47.45 28.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 126.571 1.949 . . . . 74.23 111.574 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -65.21 -44.65 87.65 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.17 -0.678 . . . . 73.43 109.17 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -56.92 -43.01 80.98 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.827 1.251 . . . . 71.22 111.319 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.0 t -73.89 -36.1 44.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 120.717 -1.239 . . . . 63.43 109.519 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -65.78 -45.09 83.76 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.584 1.154 . . . . 74.25 110.383 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -69.06 -36.43 77.64 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.748 -1.22 . . . . 72.2 108.681 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -58.25 -57.22 13.86 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.68 -0.489 . . . . 61.33 109.68 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.15 -23.3 63.8 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.912 -0.566 . . . . 73.12 111.927 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 ptm85 -82.83 -12.07 57.73 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.408 1.004 . . . . 65.42 110.598 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.11 22.91 39.76 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 125.83 1.681 . . . . 45.35 113.65 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.4 169.08 14.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.856 1.328 . . . . 70.44 110.742 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -80.32 146.85 31.37 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.698 0.999 . . . . 70.42 113.698 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -130.32 109.92 11.13 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.011 1.324 . . . . 73.24 107.826 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.7 m -87.66 176.54 7.38 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.213 -1.358 . . . . 64.11 108.802 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -108.27 156.18 38.94 Favored Pre-proline 0 N--CA 1.467 0.379 0 C-N-CA 124.462 1.105 . . . . 72.3 109.193 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.62 157.24 59.28 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.76 2.307 . . . . 74.12 112.661 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.7 149.82 88.32 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.748 1.632 . . . . 70.52 108.604 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.08 -16.41 59.67 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.575 -1.125 . . . . 65.44 111.733 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -77.9 -43.49 29.91 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.132 1.466 . . . . 71.14 108.708 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 C--O 1.246 0.871 0 CA-C-O 117.481 -1.247 . . . . 73.44 109.277 178.411 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 110.088 -0.338 . . . . 71.12 110.088 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.53 126.78 9.23 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.736 2.957 . . . . 61.43 109.12 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 m -122.83 162.16 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.156 0.583 . . . . 73.4 109.65 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.9 p -124.17 167.65 13.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.453 1.101 . . . . 62.52 110.178 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.62 -43.46 72.27 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.6 1.16 . . . . 64.25 111.296 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -32.8 67.19 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 125.528 1.531 . . . . 71.22 111.655 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 93.5 mtp -67.07 -45.31 77.71 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.462 -0.94 . . . . 63.2 108.462 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 t -57.58 -57.24 11.09 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 CA-C-O 119.061 -0.495 . . . . 73.0 110.477 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -57.64 -39.93 78.11 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 117.638 -1.172 . . . . 71.43 111.138 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.405 ' CG2' HG11 ' A' ' 95' ' ' VAL . 40.8 m -56.34 -61.81 2.15 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.222 1.374 . . . . 74.42 108.29 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.6 t -57.26 -45.1 84.86 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 CA-C-N 119.16 0.891 . . . . 74.23 110.055 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.66 -39.03 67.65 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.451 1.478 . . . . 51.11 113.757 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -69.61 -44.6 70.38 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.103 -1.073 . . . . 53.32 108.103 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 37.6 mt -71.45 -28.4 63.93 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.054 -0.521 . . . . 64.5 111.207 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.13 75.76 67.65 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 128.997 2.919 . . . . 74.24 111.001 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.61 -4.92 16.2 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.431 2.087 . . . . 63.22 111.148 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -91.19 5.57 48.55 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.939 1.695 . . . . 70.14 112.417 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.3 mt -118.41 162.79 17.74 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.81 1.244 . . . . 70.32 110.817 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.421 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 49.7 t-80 -87.85 146.22 38.37 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 107.386 -1.338 . . . . 71.43 107.386 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 33.7 Cg_endo -64.29 -23.76 65.58 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.667 2.245 . . . . 74.45 112.123 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -78.13 -43.58 28.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 121.327 -0.858 . . . . 64.45 112.385 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -58.35 -45.51 88.03 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.777 -0.823 . . . . 51.44 108.777 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 63.8 mt -51.89 -59.07 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.369 1.068 . . . . 73.51 108.491 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.33 -47.37 25.78 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.402 1.001 . . . . 75.42 112.161 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -65.85 -38.01 87.71 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 122.77 1.271 . . . . 70.14 111.675 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.5 t -62.48 -50.32 71.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.556 -1.276 . . . . 54.51 107.556 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.3 mt -57.91 -35.97 71.79 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 126.117 1.767 . . . . 71.43 109.333 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -67.86 -36.82 80.96 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.521 1.055 . . . . 74.3 109.526 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -76.87 -53.15 8.26 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.232 0.469 . . . . 61.43 111.992 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.7 p -67.01 -40.96 87.41 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.87 1.268 . . . . 53.14 110.897 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.92 -6.12 81.96 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.867 2.175 . . . . 63.14 113.247 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.5 m -144.28 143.75 31.16 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.163 1.482 . . . . 62.54 110.82 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.405 HG11 ' CG2' ' A' ' 72' ' ' THR . 42.2 t -61.96 -47.81 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 C-N-CA 126.184 1.793 . . . . 62.42 108.171 178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -50.38 -48.51 55.78 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.204 1.002 . . . . 52.51 111.717 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -63.78 -39.13 93.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.132 0.492 . . . . 73.31 109.939 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.5 m -63.77 -37.31 86.91 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.287 1.435 . . . . 75.42 110.498 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.09 -41.43 59.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.904 -1.147 . . . . 64.22 107.904 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -63.3 -35.17 79.48 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.76 1.224 . . . . 74.44 111.693 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -81.01 -39.0 26.55 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.254 -0.647 . . . . 74.42 109.254 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -56.55 -52.67 63.89 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.53 -0.731 . . . . 75.25 111.333 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.94 -19.97 61.55 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.744 0.646 . . . . 75.0 112.744 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -86.6 -12.57 48.21 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.167 -0.92 . . . . 74.35 110.334 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.81 37.06 13.98 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 108.63 -1.788 . . . . 74.23 108.63 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -74.84 172.36 12.34 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.582 -0.952 . . . . 72.42 110.999 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -78.99 131.61 36.37 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.423 1.089 . . . . 63.13 110.147 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -129.1 109.95 11.61 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.502 -1.296 . . . . 74.52 107.502 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.4 m -97.2 177.57 5.53 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.178 1.391 . . . . 64.15 108.954 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -104.84 158.64 31.58 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.42 1.088 . . . . 75.42 110.41 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.36 162.65 41.71 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.479 2.12 . . . . 52.43 112.97 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.68 133.98 45.03 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.383 2.055 . . . . 73.21 109.109 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.03 -11.52 64.02 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 118.811 -0.994 . . . . 73.03 112.641 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -77.17 -28.46 54.08 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.642 1.721 . . . . 71.32 111.717 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.021 -0.99 . . . . 61.44 110.334 -179.166 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 . . . . . 0 CA--C 1.534 0.347 0 N-CA-C 108.193 -1.04 . . . . 73.12 108.193 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.86 140.51 32.02 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.038 1.825 . . . . 74.43 110.245 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.81 165.65 30.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 124.725 1.21 . . . . 64.12 108.707 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -124.31 163.62 21.3 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.541 1.537 . . . . 74.21 108.247 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -55.06 -42.35 72.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.406 1.482 . . . . 73.43 110.409 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -33.31 65.44 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.345 1.458 . . . . 73.4 112.197 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.4 mtp -68.55 -41.42 79.81 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.939 1.245 . . . . 65.01 109.518 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.8 t -59.23 -54.86 28.49 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 123.988 0.915 . . . . 65.5 109.286 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -60.08 -37.17 79.13 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 117.562 -1.209 . . . . 62.23 110.59 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.5 m -55.15 -64.41 0.85 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.748 1.613 . . . . 70.22 108.555 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.7 t -53.52 -45.94 59.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.375 0 CA-C-O 118.184 -0.912 . . . . 63.42 110.313 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.1 tp60 -55.69 -48.63 74.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.342 0.974 . . . . 74.14 112.29 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -57.97 -43.33 86.44 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.164 0.586 . . . . 71.31 109.446 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 17.9 mt -80.54 -18.6 47.92 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.868 0.692 . . . . 62.2 112.868 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.14 76.44 77.94 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 127.428 2.291 . . . . 51.45 110.118 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.05 -15.1 42.67 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 121.695 1.596 . . . . 53.24 111.698 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.66 -22.74 53.61 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.324 2.249 . . . . 72.12 112.907 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.5 mt -85.14 156.36 21.07 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 114.008 1.114 . . . . 73.43 114.008 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -74.54 145.66 82.56 Favored Pre-proline 0 C--O 1.236 0.355 0 N-CA-C 107.192 -1.41 . . . . 73.41 107.192 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.52 -26.8 46.77 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.482 2.121 . . . . 74.13 114.096 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.33 -37.66 18.25 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.888 -0.412 . . . . 73.14 109.888 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -58.99 -36.97 75.79 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 109.499 -0.556 . . . . 75.12 109.499 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.0 mt -58.07 -61.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.092 -1.077 . . . . 52.02 108.092 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -48.27 -50.22 30.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 119.155 0.888 . . . . 75.42 110.876 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -60.39 -41.39 93.74 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 119.401 -0.92 . . . . 74.45 112.513 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.6 t -63.01 -48.66 77.86 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 107.495 -1.298 . . . . 74.32 107.495 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.8 mt -55.09 -42.12 72.45 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.514 1.126 . . . . 74.33 111.176 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -66.67 -33.74 76.32 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.848 0.459 . . . . 73.23 110.177 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -82.21 -46.25 13.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 118.139 -0.934 . . . . 42.24 113.366 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p -73.21 -41.3 63.95 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.361 1.464 . . . . 75.11 110.487 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.86 5.64 89.94 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 126.387 1.946 . . . . 23.51 112.357 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.8 m -142.63 127.13 17.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.913 1.357 . . . . 33.11 110.182 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.0 t -58.95 -49.35 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 105.846 -1.909 . . . . 64.33 105.846 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -52.99 -42.82 65.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.77 0.828 . . . . 74.35 111.209 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -61.14 -43.64 98.57 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 108.779 -0.823 . . . . 71.43 108.779 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.3 m -61.59 -40.38 94.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.849 2.06 . . . . 71.42 111.48 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.3 -37.07 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 O-C-N 121.29 -0.881 . . . . 74.32 108.856 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.36 -31.82 70.49 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 125.077 1.351 . . . . 65.1 112.225 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -83.12 -36.04 25.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.219 -1.03 . . . . 71.32 108.219 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -58.16 -56.09 26.48 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.39 -0.819 . . . . 75.21 109.805 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -57.5 -25.55 59.96 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-O 119.071 -0.49 . . . . 62.31 111.32 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.76 -8.2 59.3 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.742 0.701 . . . . 74.31 111.682 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.17 28.54 53.31 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 123.804 0.716 . . . . 53.41 111.704 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -67.14 173.81 3.56 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 117.207 0.503 . . . . 70.31 112.092 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -80.98 140.57 35.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.895 1.278 . . . . 72.13 109.253 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -132.63 109.42 9.72 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.813 -1.551 . . . . 73.3 106.813 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 t -83.79 169.95 14.66 Favored 'General case' 0 C--O 1.24 0.574 0 O-C-N 121.638 -0.664 . . . . 63.42 110.386 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -100.38 150.26 36.78 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 125.069 1.347 . . . . 74.33 108.321 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.48 166.99 19.95 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.922 3.081 . . . . 62.34 113.97 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -63.32 139.91 74.12 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.064 2.509 . . . . 52.05 111.804 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.2 -0.29 68.34 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 118.457 -1.191 . . . . 43.21 113.878 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -70.58 -34.43 72.18 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.289 1.545 . . . . 70.32 109.027 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 126.857 2.063 . . . . 60.12 111.866 179.642 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 . . . . . 0 C--O 1.238 0.448 0 N-CA-C 109.004 -0.739 . . . . 63.51 109.004 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.04 136.98 15.15 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.468 2.779 . . . . 63.32 109.874 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.4 m -128.26 158.2 40.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 O-C-N 121.4 -0.812 . . . . 64.2 110.436 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -125.43 163.39 22.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.039 1.336 . . . . 74.13 110.104 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.1 m -49.52 -45.8 47.75 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.743 1.617 . . . . 53.31 110.634 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -35.96 65.79 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.434 1.894 . . . . 74.32 112.75 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.7 mtp -68.48 -44.74 74.12 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.985 -1.072 . . . . 71.41 109.231 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.1 t -60.98 -51.61 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.012 0.925 . . . . 72.02 110.815 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -61.48 -43.42 98.9 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 117.247 -1.358 . . . . 64.51 110.335 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.404 ' CG2' HG11 ' A' ' 95' ' ' VAL . 85.2 m -57.8 -55.87 29.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.949 1.704 . . . . 72.0 109.803 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.1 t -55.0 -46.85 77.29 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 CA-C-N 119.865 1.211 . . . . 74.01 109.084 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -56.08 -43.54 78.12 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.543 1.065 . . . . 75.53 112.205 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -61.91 -35.74 79.27 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.027 1.331 . . . . 73.31 111.838 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.6 mt -94.06 -12.78 27.82 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.969 1.308 . . . . 54.43 112.454 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.95 67.44 56.53 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 127.828 2.451 . . . . 71.42 108.468 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.76 -9.4 22.75 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.385 2.056 . . . . 62.22 112.763 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.17 -12.01 48.2 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.887 0.875 . . . . 71.45 111.73 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.1 mt -88.32 152.93 21.59 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.345 0.975 . . . . 74.22 111.902 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -72.94 140.07 80.45 Favored Pre-proline 0 N--CA 1.448 -0.565 0 N-CA-C 106.617 -1.623 . . . . 72.4 106.617 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.29 -23.44 44.87 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.985 2.457 . . . . 65.44 113.765 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -40.09 17.76 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.42 0.554 . . . . 74.34 109.594 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -60.92 -40.32 92.71 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-O 118.141 -0.933 . . . . 54.1 109.658 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.78 -56.49 7.2 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 C-N-CA 124.265 1.026 . . . . 33.41 109.42 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -45.67 -54.35 7.91 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.128 0.422 . . . . 55.43 110.867 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -61.64 -36.19 80.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.826 0.306 . . . . 73.41 111.826 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.2 m -61.42 -49.65 76.02 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.368 -0.975 . . . . 60.14 108.368 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.8 mt -59.69 -35.5 74.6 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.197 0.999 . . . . 75.41 110.478 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -67.75 -33.82 75.61 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.666 -0.494 . . . . 72.04 109.666 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -79.46 -50.2 11.14 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.862 1.265 . . . . 71.15 114.093 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.6 p -74.56 -41.77 59.97 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.53 1.532 . . . . 73.54 110.872 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.28 -18.1 58.0 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 127.947 2.689 . . . . 61.43 112.551 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -139.35 151.15 46.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 123.718 1.723 . . . . 54.21 112.235 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.404 HG11 ' CG2' ' A' ' 72' ' ' THR . 96.1 t -64.33 -47.44 89.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 113.008 -1.905 . . . . 72.33 107.989 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -50.91 -51.03 56.01 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.367 1.467 . . . . 70.51 110.204 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -62.82 -42.36 99.69 Favored 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 109.863 -0.421 . . . . 74.44 109.863 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.1 m -60.36 -39.8 88.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.287 1.035 . . . . 70.15 111.833 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.59 -37.67 44.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 121.399 -0.813 . . . . 73.22 109.436 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -66.7 -38.13 86.14 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.483 1.113 . . . . 65.42 111.251 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -78.6 -33.87 47.14 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.493 -0.754 . . . . 75.11 109.216 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -59.62 -59.6 5.18 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.674 -1.266 . . . . 63.24 111.349 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -56.54 -28.95 61.33 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.509 0.724 . . . . 71.41 111.93 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -18.7 56.4 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.757 -0.64 . . . . 74.22 110.936 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.9 28.05 14.92 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.581 -1.122 . . . . 71.35 112.357 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -68.34 -179.25 1.26 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.939 1.296 . . . . 75.2 111.83 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -82.6 144.06 30.59 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.78 1.232 . . . . 75.51 111.564 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -138.84 109.18 6.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.628 -0.878 . . . . 64.52 108.628 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.2 m -84.96 177.13 8.06 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.773 1.229 . . . . 62.33 110.903 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -111.66 153.9 44.14 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 105.683 -1.969 . . . . 75.45 105.683 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.87 166.14 29.96 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.407 2.071 . . . . 53.44 111.641 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -63.03 156.17 56.37 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.404 2.069 . . . . 63.3 109.622 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.5 -28.53 3.43 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 118.312 -1.271 . . . . 74.22 111.587 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -66.81 -53.46 32.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 119.376 1.588 . . . . 74.31 111.024 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 . . . . . 0 C--O 1.249 1.062 0 C-N-CA 125.069 1.348 . . . . 72.41 107.513 -179.574 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 107.924 -1.139 . . . . 72.41 107.924 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.01 142.78 31.72 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.99 1.793 . . . . 72.34 110.979 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 m -128.75 164.85 29.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.291 1.036 . . . . 71.25 109.509 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.2 p -124.3 162.79 23.02 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.399 1.48 . . . . 73.02 109.163 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -53.02 -38.99 62.83 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.101 0.961 . . . . 71.42 110.777 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -44.29 95.34 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 118.579 -0.724 . . . . 64.21 112.043 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 5.2 mtm -59.53 -35.2 73.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.421 -0.912 . . . . 73.24 110.703 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.7 t -65.44 -52.76 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.061 -0.718 . . . . 63.2 109.061 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -64.09 -35.52 81.01 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.708 -1.139 . . . . 75.51 110.718 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.3 m -57.18 -60.12 4.08 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 121.107 1.776 . . . . 65.51 108.082 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.5 t -54.5 -47.99 70.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 CA-C-O 117.571 -1.204 . . . . 74.24 108.596 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 tp60 -52.55 -45.48 66.38 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 120.153 1.342 . . . . 72.22 111.97 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -62.73 -36.4 82.88 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.402 -0.812 . . . . 72.13 110.469 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.7 mt -89.67 -14.65 34.36 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.85 -0.595 . . . . 75.53 112.54 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -138.33 73.55 43.16 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 129.111 2.965 . . . . 51.01 111.685 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -69.79 -5.67 16.77 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.904 3.069 . . . . 51.54 113.515 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.5 -15.69 36.87 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 120.745 -1.222 . . . . 73.1 111.981 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.8 mt -91.14 160.09 15.74 Favored 'General case' 0 N--CA 1.458 -0.074 0 C-N-CA 123.236 0.614 . . . . 61.11 111.571 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.475 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 56.0 t-80 -85.26 149.42 52.4 Favored Pre-proline 0 C--O 1.239 0.521 0 N-CA-C 106.171 -1.788 . . . . 65.14 106.171 178.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.475 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 33.2 Cg_endo -63.93 -30.07 67.25 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.548 2.165 . . . . 74.11 112.456 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.28 -34.22 55.65 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 112.717 0.636 . . . . 44.43 112.717 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -61.3 -46.1 91.69 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.609 -0.886 . . . . 63.12 108.609 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.0 mt -52.49 -59.63 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 125.002 1.321 . . . . 62.32 108.299 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -49.47 12.95 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.618 1.099 . . . . 75.11 111.888 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -64.41 -45.71 86.43 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.919 0.781 . . . . 75.05 113.085 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.7 p -65.7 -37.99 87.99 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.574 -0.704 . . . . 75.31 109.472 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.35 -38.16 88.43 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.105 -0.997 . . . . 72.31 109.062 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -68.39 -35.33 77.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.569 0.622 . . . . 71.14 110.062 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -72.51 -55.05 7.58 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.935 -0.478 . . . . 71.24 111.091 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.0 p -67.19 -41.36 85.98 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.911 1.284 . . . . 65.31 112.021 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.83 -11.85 67.61 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.87 1.224 . . . . 52.04 113.429 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -144.44 144.11 31.23 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 119.031 1.415 . . . . 74.31 109.336 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.1 t -59.63 -43.37 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 125.181 1.393 . . . . 74.24 109.025 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -46.93 -47.75 21.55 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.895 1.278 . . . . 72.14 111.011 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -69.82 -40.56 75.84 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.445 -0.784 . . . . 73.01 109.967 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.8 m -58.96 -37.12 76.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.161 0.584 . . . . 64.51 110.28 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 85.7 t -74.95 -36.96 40.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 123.919 0.888 . . . . 72.34 109.157 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -68.76 -39.61 80.2 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.352 1.061 . . . . 63.13 111.263 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -74.33 -37.11 63.66 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.122 -1.066 . . . . 71.33 108.122 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -58.03 -56.32 23.49 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.613 0.765 . . . . 73.13 109.935 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 pp -60.62 -22.49 63.85 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.284 -0.885 . . . . 73.15 112.055 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -16.72 48.7 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.846 0.748 . . . . 64.15 109.898 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.25 36.67 9.62 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 119.032 0.833 . . . . 61.1 112.168 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -76.76 173.38 11.72 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 117.986 0.893 . . . . 55.4 109.827 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -81.58 135.73 35.57 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.481 -1.303 . . . . 75.14 107.481 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -118.42 110.94 18.05 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.138 -2.542 . . . . 75.41 104.138 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.7 m -97.79 178.59 5.09 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 125.063 1.345 . . . . 64.14 110.086 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -110.88 158.79 34.72 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 125.371 1.469 . . . . 74.2 111.283 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.33 164.07 36.75 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.358 2.705 . . . . 74.13 113.898 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.09 139.53 84.72 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.967 2.444 . . . . 72.15 109.707 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.14 -18.41 56.88 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.508 1.052 . . . . 65.54 111.096 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -71.61 -45.29 62.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 119.243 1.522 . . . . 63.52 109.427 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.021 -0.99 . . . . 73.3 111.439 -178.962 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 . . . . . 0 CA--C 1.529 0.154 0 N-CA-C 109.127 -0.694 . . . . 73.44 109.127 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.27 138.12 38.57 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.033 1.822 . . . . 64.14 109.957 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 m -134.46 159.55 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.337 -0.986 . . . . 62.22 108.337 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.31 162.43 23.77 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.445 -0.946 . . . . 75.1 108.445 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 m -51.36 -39.1 56.4 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.607 1.963 . . . . 75.22 111.393 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.83 -38.05 77.81 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 124.561 1.144 . . . . 75.52 110.248 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.1 mtp -63.87 -38.14 89.98 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 120.407 -1.433 . . . . 62.31 109.377 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 t -61.08 -54.26 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.308 -0.627 . . . . 65.1 109.308 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -62.95 -38.24 90.28 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-O 117.294 -1.336 . . . . 74.1 110.588 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.6 m -53.98 -61.1 2.52 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 121.138 1.79 . . . . 72.42 108.087 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.7 t -55.51 -48.52 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 118.138 -0.934 . . . . 75.23 110.411 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -56.37 -42.24 77.5 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.074 0.852 . . . . 64.14 111.839 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -62.64 -43.6 98.39 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.618 -0.882 . . . . 61.13 108.618 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 mt -75.85 -26.91 57.57 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.735 -0.603 . . . . 62.21 111.476 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.77 83.37 62.57 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 128.054 2.542 . . . . 62.53 111.848 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.8 -21.3 38.49 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.575 1.517 . . . . 71.23 112.802 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.07 -19.29 51.69 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.754 1.222 . . . . 61.24 113.523 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 mt -79.53 154.52 28.76 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.786 0.721 . . . . 73.03 109.756 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -79.6 144.19 60.46 Favored Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 107.352 -1.351 . . . . 70.03 107.352 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.53 -29.53 52.79 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.924 1.75 . . . . 64.51 112.228 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -75.39 -41.52 56.0 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 112.491 0.552 . . . . 75.03 112.491 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -63.14 -35.19 79.48 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.893 0.477 . . . . 73.32 110.05 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 75.2 mt -56.64 -60.37 2.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 109.297 -0.631 . . . . 72.32 109.297 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.89 -40.77 61.21 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.653 1.115 . . . . 73.54 112.271 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -61.93 -46.96 87.04 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.126 0.965 . . . . 74.23 111.092 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.8 p -63.49 -44.8 93.32 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.78 -1.1 . . . . 64.41 108.595 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.5 mt -56.86 -39.3 74.06 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.186 0.903 . . . . 74.52 109.814 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.39 -34.93 75.25 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.73 1.15 . . . . 73.14 110.071 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.54 -47.4 48.6 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.222 0.609 . . . . 71.23 111.5 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.5 p -79.07 -35.51 42.32 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 127.574 2.35 . . . . 64.23 113.547 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.39 -12.24 55.95 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 125.864 1.697 . . . . 65.41 113.135 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.0 m -143.91 146.17 32.79 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 118.854 1.327 . . . . 72.31 111.962 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.41 -47.53 89.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.127 -1.434 . . . . 65.42 107.127 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -45.86 -46.07 15.52 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.953 1.301 . . . . 73.42 111.481 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -65.45 -53.58 40.74 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.061 1.744 . . . . 72.1 108.358 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.9 m -54.75 -37.59 66.15 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.98 1.312 . . . . 75.24 111.392 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.56 -39.68 54.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 124.124 0.97 . . . . 73.33 109.444 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -64.04 -44.41 92.56 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.279 1.432 . . . . 61.54 109.772 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -74.32 -32.47 62.84 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.46 -0.775 . . . . 63.13 110.909 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -62.9 -54.51 37.56 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.464 -0.772 . . . . 62.54 110.451 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.79 -25.85 67.73 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 118.209 -0.901 . . . . 71.43 111.78 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -81.41 -11.61 59.21 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.757 0.661 . . . . 54.01 110.2 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.78 36.62 25.12 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-O 119.06 -0.856 . . . . 50.52 111.203 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -74.73 -175.89 2.63 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.14 0.97 . . . . 70.21 111.456 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -86.69 138.72 31.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.608 1.163 . . . . 72.1 111.221 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -138.51 110.3 7.16 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.022 1.329 . . . . 75.43 109.895 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.8 m -89.58 -179.78 5.87 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.534 1.534 . . . . 42.11 109.71 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -110.05 159.13 33.02 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 126.352 1.861 . . . . 74.33 110.032 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.64 166.92 27.49 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.584 2.856 . . . . 74.44 114.782 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.85 137.22 40.97 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.532 2.154 . . . . 75.43 107.139 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.2 -10.37 59.89 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.997 1.284 . . . . 65.11 111.065 -178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -77.33 -29.01 53.31 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.571 1.685 . . . . 71.02 109.986 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 . . . . . 0 C--O 1.25 1.112 0 C-N-CA 125.439 1.496 . . . . 63.12 108.936 179.508 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 107.772 -1.195 . . . . 61.33 107.772 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.0 127.38 15.1 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.7 2.933 . . . . 53.11 114.035 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.438 HG11 ' CB ' ' A' ' 89' ' ' LEU . 17.8 m -107.91 166.82 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.432 1.093 . . . . 71.12 109.934 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.2 p -124.26 157.68 34.3 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.931 -1.877 . . . . 73.13 105.931 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -56.12 -35.75 67.45 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 119.105 -0.474 . . . . 73.51 110.811 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -36.84 73.01 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.753 0.706 . . . . 73.15 111.756 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.1 mtp -66.36 -33.39 75.62 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.089 -1.007 . . . . 74.2 109.29 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.87 -53.95 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 123.93 0.892 . . . . 64.13 109.475 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -60.33 -40.99 92.61 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.56 -1.209 . . . . 74.24 109.367 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.405 ' CG2' HG11 ' A' ' 95' ' ' VAL . 85.9 m -56.22 -57.38 12.48 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.676 1.58 . . . . 75.1 108.624 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.464 HG23 HG13 ' A' ' 95' ' ' VAL . 47.5 t -55.43 -50.8 63.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-O 118.456 -0.783 . . . . 73.13 109.699 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -52.08 -44.12 64.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 118.893 0.77 . . . . 55.13 112.767 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -62.86 -42.52 99.78 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.891 0.876 . . . . 72.02 110.363 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.8 mt -86.34 -10.83 53.64 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.843 0.683 . . . . 64.15 112.843 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.68 70.7 58.83 Favored Pre-proline 0 N--CA 1.447 -0.597 0 C-N-CA 127.186 2.195 . . . . 73.33 108.673 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -68.54 0.23 5.05 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.279 3.32 . . . . 71.25 112.633 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.16 12.83 29.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.453 1.501 . . . . 72.34 112.071 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.9 mt -114.77 157.53 23.1 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.545 1.138 . . . . 73.51 109.25 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.423 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 57.3 t-80 -85.46 145.59 42.6 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 108.276 -1.009 . . . . 74.53 108.276 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 33.0 Cg_endo -62.67 -29.87 78.1 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.938 2.426 . . . . 73.43 113.232 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -77.41 -42.99 34.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.967 -0.458 . . . . 61.15 110.931 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.403 ' HG3' ' CE1' ' A' ' 110' ' ' PHE . 48.7 mt-30 -58.27 -42.63 86.91 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 122.028 -0.42 . . . . 72.52 110.075 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 76.2 mt -50.59 -58.86 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 124.786 1.234 . . . . 74.43 109.692 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.05 -50.29 10.98 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.568 0.622 . . . . 70.1 111.342 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -61.34 -45.37 94.72 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.702 -0.624 . . . . 74.01 112.33 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 p -63.35 -42.63 98.93 Favored 'General case' 0 C--O 1.218 -0.583 0 C-N-CA 120.216 -0.593 . . . . 62.11 110.153 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.438 ' CB ' HG11 ' A' ' 65' ' ' VAL . 74.2 mt -60.21 -34.76 74.1 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.618 0.767 . . . . 64.53 110.114 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.85 -36.54 78.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.356 -0.609 . . . . 44.11 109.356 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -78.26 -44.5 25.34 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.07 0.767 . . . . 74.13 113.07 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.9 p -76.25 -36.18 58.59 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.787 1.635 . . . . 61.22 111.423 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.49 -17.82 46.25 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.921 1.248 . . . . 53.14 113.298 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.5 t -145.11 150.1 36.2 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.657 1.228 . . . . 74.14 108.991 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.464 HG13 HG23 ' A' ' 73' ' ' VAL . 54.9 t -65.12 -41.8 92.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 126.373 1.869 . . . . 74.55 109.285 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -46.52 -48.01 19.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.389 1.476 . . . . 62.2 111.491 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -68.35 -44.85 74.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.378 1.471 . . . . 71.31 108.845 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.6 m -56.96 -39.16 74.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.945 0.898 . . . . 64.11 110.791 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.3 t -74.4 -37.72 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.273 -0.87 . . . . 71.42 110.074 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -66.69 -43.66 83.81 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.173 0.989 . . . . 55.33 110.126 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -72.59 -35.66 67.95 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.295 -0.878 . . . . 62.11 109.98 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -57.91 -57.39 13.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 121.133 -0.979 . . . . 72.15 110.482 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.22 -26.09 62.43 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.195 0.452 . . . . 72.13 111.269 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -12.17 59.96 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.599 -0.688 . . . . 73.4 110.364 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.65 37.35 40.34 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 125.054 1.312 . . . . 53.35 110.715 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.2 -171.17 0.88 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.207 1.004 . . . . 63.12 112.126 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.45 139.05 34.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 120.961 -1.087 . . . . 73.4 109.582 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -129.85 108.72 10.36 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 104.862 -2.273 . . . . 63.44 104.862 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.7 m -96.26 163.92 12.88 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.732 1.213 . . . . 63.31 111.786 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.403 ' CE1' ' HG3' ' A' ' 84' ' ' GLN . 35.8 m-85 -97.11 156.52 36.23 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 124.542 1.137 . . . . 64.23 108.835 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.94 164.74 30.59 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.803 2.335 . . . . 75.31 112.211 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.23 142.43 66.92 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.037 1.825 . . . . 63.31 110.324 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.22 -9.37 73.1 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 118.607 -1.107 . . . . 51.22 113.286 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -76.78 -22.8 53.19 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.897 1.349 . . . . 41.13 110.459 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 C--O 1.247 0.926 0 C-N-CA 126.351 1.86 . . . . 74.1 112.64 179.811 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 . . . . . 0 C--O 1.236 0.367 0 N-CA-C 109.671 -0.492 . . . . 63.25 109.671 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.75 141.08 21.42 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.201 1.934 . . . . 75.12 109.308 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 m -134.64 160.15 41.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.427 -0.953 . . . . 60.15 108.427 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.98 157.76 37.0 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.889 1.276 . . . . 71.11 108.768 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 m -42.75 -48.37 5.61 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.762 2.425 . . . . 60.32 111.522 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -53.97 -36.71 63.17 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 126.933 2.093 . . . . 54.12 112.324 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 87.3 mtp -66.81 -42.39 85.98 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.661 -0.866 . . . . 64.54 108.661 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.78 -57.93 9.01 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 CA-C-N 117.92 0.327 . . . . 42.24 110.601 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -58.04 -40.78 81.77 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 118.14 -0.933 . . . . 63.01 110.725 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.8 m -58.01 -62.0 2.13 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.09 1.314 . . . . 73.5 109.524 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.408 ' CG2' HG13 ' A' ' 95' ' ' VAL . 86.4 t -52.42 -46.42 46.95 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 CA-C-O 118.354 -0.832 . . . . 73.01 108.999 178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.19 -38.31 79.53 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.698 1.136 . . . . 62.35 113.336 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -65.41 -40.89 93.95 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.152 0.887 . . . . 72.43 108.846 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mt -78.98 -34.53 44.09 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 112.248 0.462 . . . . 74.31 112.248 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.11 75.46 4.15 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 127.33 2.252 . . . . 74.52 109.532 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.08 -13.69 40.72 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.267 1.978 . . . . 63.23 112.2 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -83.12 -6.63 59.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.872 1.269 . . . . 64.31 113.08 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.2 mt -98.06 155.24 17.22 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 120.92 -1.113 . . . . 65.21 109.355 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.432 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 53.7 t-80 -78.34 146.43 70.41 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 105.607 -1.997 . . . . 73.43 105.607 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 32.2 Cg_endo -63.88 -31.85 66.97 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.651 1.567 . . . . 64.21 112.281 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -74.88 -38.33 61.92 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.281 -0.887 . . . . 74.54 111.912 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -58.56 -45.12 89.65 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.81 -0.441 . . . . 53.15 109.81 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.1 mt -49.22 -56.31 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 117.812 -1.089 . . . . 73.13 110.123 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.409 HH21 ' CG ' ' A' ' 111' ' ' PRO . 4.6 tmm_? -48.7 -48.51 40.25 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.558 1.072 . . . . 63.12 111.712 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.496 ' CE1' ' HD3' ' A' ' 112' ' ' PRO . 9.2 t80 -62.25 -41.16 98.2 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.807 0.731 . . . . 73.33 111.704 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.2 m -63.6 -48.66 76.44 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.756 -0.831 . . . . 74.14 108.756 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -57.32 -37.34 72.35 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.021 1.328 . . . . 65.21 110.309 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -68.18 -38.0 81.57 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.042 -0.725 . . . . 72.35 109.042 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -76.68 -48.34 19.25 Favored 'General case' 0 C--N 1.334 -0.097 0 O-C-N 121.457 -0.777 . . . . 63.0 112.106 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.3 p -71.47 -38.33 71.27 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.567 1.147 . . . . 63.41 111.369 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.55 -2.94 87.57 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.906 2.193 . . . . 74.1 111.447 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -144.31 145.06 31.77 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.137 1.469 . . . . 43.25 112.608 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.408 HG13 ' CG2' ' A' ' 73' ' ' VAL . 55.1 t -64.93 -52.48 53.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.517 -1.66 . . . . 61.14 106.517 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -49.17 -51.99 29.25 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.316 1.847 . . . . 74.41 110.674 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.49 -43.49 93.31 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.852 0.861 . . . . 74.13 109.527 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.7 m -61.52 -39.42 90.95 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.969 0.908 . . . . 72.54 110.501 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.5 t -75.2 -34.62 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 121.247 -0.908 . . . . 65.02 110.131 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -68.18 -39.29 82.54 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 126.113 1.765 . . . . 75.22 111.23 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -79.02 -37.08 40.04 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.877 -0.786 . . . . 75.2 108.877 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -54.67 -54.36 42.7 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.943 0.897 . . . . 72.41 109.705 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.13 -18.06 56.02 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.168 0.803 . . . . 74.42 113.168 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -19.26 42.17 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.714 -1.217 . . . . 55.53 107.714 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 83.3 31.7 27.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 125.656 1.598 . . . . 70.03 109.658 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -62.59 176.79 0.6 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.866 1.666 . . . . 73.24 111.382 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -83.47 139.11 33.13 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 123.076 0.55 . . . . 64.33 110.284 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -135.88 109.04 7.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.284 1.033 . . . . 75.2 108.83 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.5 m -91.52 176.1 6.67 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.851 0.861 . . . . 72.04 109.033 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -103.14 155.71 36.3 Favored Pre-proline 0 N--CA 1.45 -0.457 0 C-N-CA 124.873 1.269 . . . . 73.3 108.779 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.409 ' CG ' HH21 ' A' ' 86' ' ' ARG . 29.7 Cg_endo -69.27 161.57 45.34 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.907 2.405 . . . . 54.14 113.628 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.496 ' HD3' ' CE1' ' A' ' 87' ' ' TYR . 37.2 Cg_endo -63.36 145.95 93.08 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 121.94 1.76 . . . . 54.23 107.992 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.47 -5.38 82.59 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.418 -1.212 . . . . 52.24 111.599 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -86.36 -28.32 23.71 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.632 1.716 . . . . 74.15 111.845 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 123.805 0.842 . . . . 74.24 111.236 179.114 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.16 0 N-CA-C 109.144 -1.582 . . . . 73.41 109.144 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.76 174.4 8.47 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 117.86 0.83 . . . . 44.03 109.248 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 24.2 ptp -155.26 166.65 32.89 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.713 1.605 . . . . 54.24 107.667 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 157.76 80.96 0.03 OUTLIER Glycine 0 CA--C 1.527 0.807 0 CA-C-O 118.345 -1.253 . . . . 55.53 110.232 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.21 -9.29 25.62 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 122.991 2.461 . . . . 63.54 115.124 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 26.91 73.53 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.749 2.82 . . . . 54.51 114.634 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.36 106.72 0.33 Allowed Glycine 0 C--N 1.336 0.553 0 N-CA-C 109.459 -1.457 . . . . 43.33 109.459 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.2 m -97.05 169.48 9.79 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.515 1.126 . . . . 72.41 109.412 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 p -77.47 95.99 4.61 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.748 -1.22 . . . . 53.04 107.765 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -70.99 29.34 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.555 1.542 . . . . 62.33 114.41 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -87.35 81.75 7.78 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.831 1.652 . . . . 74.33 108.921 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.28 -178.73 0.38 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.903 0.881 . . . . 72.33 110.964 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.4 tt -49.32 139.56 11.31 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.966 1.307 . . . . 64.42 110.881 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -45.88 134.82 7.6 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.251 1.42 . . . . 61.25 111.127 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -43.66 114.01 0.59 Allowed 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.482 1.513 . . . . 74.32 110.652 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.2 p -73.17 165.39 25.13 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.935 0.894 . . . . 64.52 109.876 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.69 -56.77 3.25 Favored Glycine 0 C--O 1.237 0.327 0 O-C-N 121.196 -0.94 . . . . 51.33 112.068 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -146.73 112.11 5.53 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.787 1.235 . . . . 53.22 109.138 -179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.2 m -82.14 103.11 8.86 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 105.584 -2.006 . . . . 71.43 105.584 178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.59 -172.89 3.55 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.802 2.841 . . . . 75.11 107.766 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 94.37 34.78 6.22 Favored Glycine 0 CA--C 1.522 0.52 0 O-C-N 121.434 -0.791 . . . . 73.21 111.933 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.19 135.92 6.92 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 109.2 -1.56 . . . . 75.54 109.2 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -129.91 151.09 77.64 Favored Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 126.372 1.869 . . . . 74.44 108.26 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.2 126.3 9.75 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.712 2.275 . . . . 72.53 110.645 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 m -122.99 161.29 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 O-C-N 120.954 -1.091 . . . . 52.54 110.001 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 p -124.4 166.24 16.32 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.053 0.941 . . . . 52.12 110.036 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.1 m -52.73 -41.85 64.35 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.496 1.518 . . . . 64.41 110.95 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -56.92 -34.04 67.57 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.194 0.997 . . . . 62.35 111.013 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.9 mtp -70.32 -43.37 70.45 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.962 -0.755 . . . . 73.55 108.962 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.2 t -59.5 -55.98 20.23 Favored 'Isoleucine or valine' 0 C--N 1.339 0.138 0 C-N-CA 124.168 0.987 . . . . 74.25 110.193 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.66 -41.5 90.72 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-O 117.784 -1.103 . . . . 62.22 111.103 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 89.3 m -55.01 -60.42 3.4 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 119.57 1.077 . . . . 52.34 109.051 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.9 t -55.57 -46.22 79.03 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.534 0 CA-C-N 119.16 0.891 . . . . 62.31 109.694 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -54.9 -44.29 74.03 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 119.131 0.878 . . . . 74.51 112.97 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -62.85 -44.19 96.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.172 -0.677 . . . . 72.13 109.172 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 32.9 mt -79.41 -14.72 58.75 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.43 1.092 . . . . 74.43 113.583 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -137.33 70.87 54.17 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 127.368 2.267 . . . . 61.33 108.566 -179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -64.9 -23.16 62.32 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.584 2.189 . . . . 61.42 112.916 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.29 -14.56 62.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.523 0.729 . . . . 62.31 111.938 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.4 mt -92.36 156.69 17.07 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 119.181 0.9 . . . . 72.22 112.74 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -79.92 143.2 57.28 Favored Pre-proline 0 C--O 1.238 0.46 0 N-CA-C 106.111 -1.811 . . . . 62.14 106.111 178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.62 -29.12 52.29 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.782 2.322 . . . . 54.21 113.032 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -40.2 48.77 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.698 -0.626 . . . . 75.24 111.727 -178.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -60.9 -35.34 76.39 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.29 -0.633 . . . . 72.33 109.29 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 84.9 mt -56.57 -56.5 13.58 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.285 0 CA-C-O 118.164 -0.922 . . . . 64.12 108.713 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.82 -46.65 20.91 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 119.488 1.04 . . . . 75.33 111.048 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -64.59 -43.54 93.5 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 118.418 0.554 . . . . 72.25 111.911 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 6.2 t -64.59 -41.37 96.29 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.174 -0.676 . . . . 63.23 109.174 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.24 -37.97 84.99 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 123.943 0.897 . . . . 74.31 110.475 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -72.05 -34.77 69.02 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.608 0.64 . . . . 71.53 110.877 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -72.51 -50.61 24.63 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 122.001 -0.437 . . . . 43.22 110.808 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.3 p -72.64 -41.59 65.31 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.26 1.024 . . . . 71.24 111.819 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.16 -6.12 75.63 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.249 1.881 . . . . 44.41 112.538 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -145.59 152.13 39.2 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 120.897 2.348 . . . . 73.22 112.394 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.8 t -66.63 -50.62 64.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.456 0 N-CA-C 106.765 -1.568 . . . . 73.41 106.765 178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -52.32 -47.03 66.25 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.453 1.501 . . . . 64.44 111.754 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -63.74 -43.24 97.07 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 108.458 -0.942 . . . . 74.23 108.458 179.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.9 m -61.68 -37.05 82.68 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.422 1.089 . . . . 40.34 110.559 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.6 t -73.8 -35.95 44.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 124.412 1.085 . . . . 74.12 109.103 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -70.16 -40.5 74.7 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 125.417 1.487 . . . . 71.23 110.31 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -76.35 -30.2 57.51 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 122.084 0.945 . . . . 73.25 109.88 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -64.31 -54.59 30.8 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 121.099 -1.0 . . . . 74.23 108.932 177.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.15 -20.94 60.81 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.43 0.9 . . . . 61.33 113.43 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -92.23 -6.26 50.87 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 118.742 0.701 . . . . 73.21 109.913 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.62 36.68 58.39 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 126.528 2.013 . . . . 62.44 113.322 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -70.38 -178.68 1.79 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 118.256 1.028 . . . . 63.13 110.148 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.2 134.77 36.16 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 126.137 1.775 . . . . 73.32 111.901 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -129.07 110.51 12.1 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 126.245 1.818 . . . . 72.41 106.168 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 21.1 m -96.0 174.29 7.0 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.736 1.214 . . . . 60.44 108.035 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -98.1 155.6 36.82 Favored Pre-proline 0 C--N 1.33 -0.243 0 O-C-N 121.585 -0.697 . . . . 73.41 110.197 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -69.44 163.66 37.19 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.899 1.732 . . . . 72.11 111.48 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -59.89 144.6 99.43 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 121.887 1.724 . . . . 53.03 109.313 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.24 -12.39 58.47 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.595 1.093 . . . . 73.33 113.026 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -75.59 -46.54 31.21 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 119.195 1.497 . . . . 65.53 108.268 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 . . . . . 0 C--O 1.24 0.58 0 C-N-CA 124.92 1.288 . . . . 74.31 109.225 179.252 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.175 0 N-CA-C 109.411 -1.476 . . . . 70.24 109.411 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 64.85 -12.85 0.12 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.18 2.192 . . . . 63.52 115.87 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -68.9 164.44 22.1 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.071 1.305 . . . . 64.3 108.477 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 141.55 -72.81 0.39 Allowed Glycine 0 CA--C 1.523 0.563 0 N-CA-C 107.384 -2.287 . . . . 62.12 107.384 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.51 1.03 5.33 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.915 2.41 . . . . 75.31 112.296 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -142.52 137.0 29.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 103.628 -2.73 . . . . 74.14 103.628 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -166.3 -142.61 3.48 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.301 1.905 . . . . 75.43 108.878 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.8 t -148.92 170.46 18.25 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 118.209 1.004 . . . . 54.31 108.622 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.3 t -167.64 -171.43 1.64 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.859 1.664 . . . . 72.25 108.378 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -129.7 35.21 4.21 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.44 2.296 . . . . 64.14 109.327 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -63.35 99.46 0.2 Allowed 'General case' 0 C--O 1.24 0.569 0 C-N-CA 125.706 1.602 . . . . 74.4 107.269 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.26 167.06 23.03 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 125.243 1.417 . . . . 63.54 110.146 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.53 -169.92 2.28 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.219 1.808 . . . . 54.43 110.372 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.95 168.16 5.48 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 122.02 0.914 . . . . 73.01 113.178 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -74.14 -177.56 3.0 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.805 0.842 . . . . 73.21 109.671 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.5 t -129.31 174.6 9.46 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.651 0.781 . . . . 74.22 110.191 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.58 -77.8 0.55 Allowed Glycine 0 C--O 1.225 -0.464 0 N-CA-C 109.463 -1.455 . . . . 74.24 109.463 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 2.51 81.88 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 129.486 3.114 . . . . 61.44 113.995 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.9 p -125.68 157.38 35.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 N-CA-C 107.767 -1.197 . . . . 64.12 107.767 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -70.07 157.61 37.22 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 108.494 -0.928 . . . . 71.33 108.494 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 153.51 47.36 0.02 OUTLIER Glycine 0 CA--C 1.52 0.366 0 CA-C-O 118.797 -1.002 . . . . 60.45 112.127 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.94 -133.46 0.19 Allowed Glycine 0 CA--C 1.528 0.844 0 N-CA-C 109.762 -1.335 . . . . 74.42 109.762 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -119.0 153.92 52.98 Favored Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 123.98 0.912 . . . . 63.55 111.6 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.88 150.12 30.01 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 123.39 2.727 . . . . 62.42 109.841 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.7 m -134.28 160.83 41.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 C-N-CA 123.988 0.915 . . . . 44.31 110.844 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.3 p -125.76 163.64 22.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.879 0.871 . . . . 74.22 110.034 179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.7 m -49.61 -45.86 48.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.779 2.031 . . . . 51.25 111.593 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -62.41 -34.05 75.98 Favored 'General case' 0 C--O 1.226 -0.14 0 C-N-CA 124.893 1.277 . . . . 32.44 112.614 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 94.5 mtp -65.12 -42.5 93.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.098 -1.075 . . . . 74.42 108.098 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 t -60.01 -55.34 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 C-N-CA 123.458 0.703 . . . . 72.44 110.728 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -61.01 -37.67 83.34 Favored 'General case' 0 C--O 1.225 -0.219 0 C-N-CA 119.538 -0.865 . . . . 75.41 112.059 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.0 m -60.18 -57.36 13.17 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 120.308 1.413 . . . . 75.31 109.525 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 36.0 t -54.97 -44.13 72.29 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.553 0 CA-C-N 119.891 1.223 . . . . 74.31 108.438 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.6 tp60 -51.47 -50.92 58.89 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 119.197 0.908 . . . . 50.21 112.726 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -59.11 -44.73 92.0 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 122.837 0.455 . . . . 64.45 110.202 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 20.7 mt -77.71 -22.48 50.37 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.734 0.642 . . . . 74.14 112.734 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.89 75.07 79.23 Favored Pre-proline 0 C--O 1.238 0.457 0 C-N-CA 126.374 1.87 . . . . 44.23 109.192 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.49 -18.05 54.05 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 123.492 2.795 . . . . 73.22 114.14 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.05 10.12 8.77 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.408 -0.808 . . . . 71.44 112.935 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.6 mt -112.74 155.81 23.9 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 119.171 0.896 . . . . 70.53 112.488 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.444 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 51.4 t-80 -80.63 145.46 58.55 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 108.626 -0.879 . . . . 75.54 108.626 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.444 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 28.9 Cg_endo -62.91 -30.53 77.17 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.228 2.619 . . . . 74.54 113.144 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.68 -39.16 37.49 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 110.026 -0.361 . . . . 62.01 110.026 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -59.46 -48.52 81.32 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 118.502 0.592 . . . . 64.41 109.452 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 82' ' ' PRO . 67.9 mt -49.35 -58.74 1.18 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 N-CA-C 107.789 -1.189 . . . . 73.24 107.789 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.538 HH21 ' CD ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -47.3 -52.08 17.3 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.749 0.819 . . . . 75.34 112.18 179.198 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -65.43 -33.94 77.11 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.681 -1.262 . . . . 64.22 111.712 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.8 t -65.14 -46.12 82.21 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.204 -1.406 . . . . 45.44 107.204 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.5 mt -59.4 -36.57 76.07 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.343 1.457 . . . . 74.43 109.095 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.538 ' CD ' HH21 ' A' ' 86' ' ' ARG . 48.5 mt-10 -70.13 -38.36 75.51 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 118.78 0.718 . . . . 71.11 111.65 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -75.78 -45.7 34.78 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 112.109 0.411 . . . . 71.4 112.109 -178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 79.6 p -74.25 -40.65 62.24 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.475 1.11 . . . . 75.31 111.044 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.98 -13.56 67.39 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 127.832 2.634 . . . . 74.43 114.226 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.8 m -143.64 148.4 35.75 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 119.88 1.84 . . . . 64.43 111.996 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.8 t -59.64 -48.42 87.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 126.096 1.759 . . . . 64.53 107.655 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -51.87 -47.98 64.25 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 125.611 1.565 . . . . 74.31 111.79 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -65.33 -43.47 90.84 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 108.257 -1.016 . . . . 75.2 108.257 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.5 m -59.26 -40.47 86.12 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.407 1.083 . . . . 74.31 111.638 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.9 t -74.64 -40.27 47.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 118.008 -0.996 . . . . 71.5 108.581 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -62.81 -35.2 79.13 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.016 1.726 . . . . 71.03 111.206 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -80.13 -40.69 26.92 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 109.203 -0.665 . . . . 73.35 109.203 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -58.74 -51.05 71.63 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.026 0.531 . . . . 74.53 110.242 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -65.48 -9.14 23.26 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 113.397 0.888 . . . . 75.34 113.397 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.09 -16.82 20.33 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.748 2.019 . . . . 73.4 109.141 178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.0 26.59 21.48 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.664 1.126 . . . . 72.22 113.315 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -72.11 172.83 9.42 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.275 1.037 . . . . 33.4 113.294 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -81.85 147.59 29.27 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.401 1.481 . . . . 75.04 111.56 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -138.51 109.93 6.98 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.861 1.264 . . . . 73.51 109.873 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 30.1 m -91.9 165.78 13.05 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 125.214 1.406 . . . . 74.3 108.255 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -94.01 160.06 33.09 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 124.759 1.224 . . . . 73.44 111.708 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.11 164.01 29.32 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 124.357 3.371 . . . . 65.52 113.767 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -61.34 140.3 87.44 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.11 2.54 . . . . 75.1 111.152 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.85 -17.65 54.14 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 117.959 -1.467 . . . . 74.02 112.403 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -66.12 -51.9 53.6 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.348 1.574 . . . . 75.04 108.881 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 . . . . . 0 C--O 1.245 0.859 0 C-N-CA 125.475 1.51 . . . . 74.34 108.555 179.126 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.548 0 N-CA-C 109.248 -1.541 . . . . 74.02 109.248 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.64 161.89 37.22 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 126.573 1.949 . . . . 63.43 106.641 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 56.4 ttm -74.37 -79.45 0.09 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.377 -0.601 . . . . 62.21 109.377 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.16 -168.34 4.17 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.539 1.066 . . . . 65.11 113.82 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.48 169.98 21.29 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.502 2.802 . . . . 75.13 111.711 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.28 -5.49 12.36 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.038 1.335 . . . . 62.12 112.145 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 55.23 79.74 0.09 OUTLIER Glycine 0 CA--C 1.524 0.642 0 C-N-CA 126.177 1.846 . . . . 75.41 115.585 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.11 141.6 57.32 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.408 -0.96 . . . . 73.44 108.408 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.8 t -153.48 151.29 29.67 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.126 -1.064 . . . . 73.14 108.126 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -157.12 120.56 4.14 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.958 0.903 . . . . 71.24 108.771 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -75.84 -75.7 0.18 Allowed 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 107.075 -1.454 . . . . 53.3 107.075 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.54 -178.81 7.62 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.638 1.575 . . . . 72.24 109.613 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.2 tp -169.73 163.45 9.91 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.022 2.129 . . . . 62.24 107.507 178.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -73.42 165.91 24.2 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 106.166 -1.791 . . . . 75.13 106.166 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -129.67 84.93 2.25 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 106.923 -1.51 . . . . 72.25 106.923 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.5 t -148.32 162.96 38.47 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.435 -1.321 . . . . 75.41 107.435 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -72.27 162.78 54.6 Favored Glycine 0 CA--C 1.521 0.453 0 N-CA-C 110.004 -1.238 . . . . 72.53 110.004 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -113.67 -178.23 3.33 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 126.381 1.872 . . . . 55.31 106.539 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.2 t -66.13 -35.8 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 N-CA-C 108.159 -1.052 . . . . 73.13 108.159 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -74.31 169.92 16.66 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.993 1.317 . . . . 64.45 110.204 179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -101.35 -165.47 27.53 Favored Glycine 0 CA--C 1.525 0.665 0 C-N-CA 124.403 1.002 . . . . 71.24 111.516 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.26 71.09 0.1 OUTLIER Glycine 0 CA--C 1.53 1.022 0 C-N-CA 124.337 0.97 . . . . 73.25 112.566 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -107.84 155.58 39.65 Favored Pre-proline 0 CA--C 1.534 0.331 0 C-N-CA 124.508 1.123 . . . . 64.5 108.798 178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -74.28 142.64 30.58 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.217 2.612 . . . . 71.44 110.272 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.4 m -134.37 153.39 35.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 109.058 -0.719 . . . . 61.4 109.058 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -124.84 162.69 23.8 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 125.995 1.718 . . . . 64.32 108.06 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.0 m -56.23 -36.37 68.42 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.839 -0.538 . . . . 62.35 111.531 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.06 -33.84 65.37 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.357 1.063 . . . . 63.21 110.987 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.8 mtp -70.02 -41.89 73.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.684 -0.858 . . . . 51.13 108.684 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 t -61.03 -55.47 24.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.276 1.03 . . . . 61.41 110.51 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.63 -40.86 84.56 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 118.252 -0.88 . . . . 63.42 110.391 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.415 ' CG2' HG11 ' A' ' 95' ' ' VAL . 88.8 m -58.13 -60.97 2.92 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.372 0.987 . . . . 63.14 109.597 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 74.3 t -52.52 -47.66 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 119.384 0.993 . . . . 74.41 109.044 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -56.3 -45.23 80.31 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 119.11 0.868 . . . . 53.33 112.188 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -59.13 -39.32 81.95 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.187 0.995 . . . . 74.35 110.528 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.3 mt -88.81 -20.28 24.88 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.203 0.816 . . . . 73.41 113.203 -178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.89 75.35 79.68 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 127.304 2.242 . . . . 62.3 108.858 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -66.7 -17.84 52.85 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.438 2.092 . . . . 75.2 113.425 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.49 -17.23 56.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.536 0.607 . . . . 64.21 112.551 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.3 mt -80.85 155.74 26.44 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 121.85 0.833 . . . . 73.43 112.634 -178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.439 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 57.2 t-80 -75.56 144.07 76.73 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 124.44 1.096 . . . . 71.14 109.035 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 36.8 Cg_endo -65.8 -26.55 52.42 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.836 2.357 . . . . 74.04 113.704 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.02 -40.11 16.14 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.66 1.118 . . . . 72.42 111.892 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -60.45 -32.38 71.32 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 119.175 -0.44 . . . . 45.23 111.547 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 78.1 mt -55.24 -58.26 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-O 118.352 -0.832 . . . . 63.32 109.748 -178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -42.29 44.12 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.269 0.94 . . . . 74.42 112.685 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -63.9 -43.22 96.64 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 121.328 -0.857 . . . . 72.02 110.696 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 t -59.41 -51.27 70.63 Favored 'General case' 0 C--O 1.224 -0.244 0 N-CA-C 108.393 -0.966 . . . . 73.41 108.393 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 63.4 mt -58.34 -35.65 72.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.066 0.947 . . . . 72.22 110.775 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -72.54 -30.28 64.32 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 119.823 1.192 . . . . 62.44 109.65 179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -76.35 -46.71 26.29 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.343 0.52 . . . . 73.44 112.043 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.5 p -80.19 -39.69 28.73 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.668 1.187 . . . . 64.51 111.151 -178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.58 -6.17 66.17 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 127.24 2.352 . . . . 32.44 112.723 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.4 m -139.56 132.46 29.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.523 1.529 . . . . 64.23 110.323 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.415 HG11 ' CG2' ' A' ' 72' ' ' THR . 53.1 t -58.8 -44.77 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 C-N-CA 125.394 1.477 . . . . 72.11 109.622 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -52.83 -47.74 67.48 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.822 0.849 . . . . 74.13 110.454 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -62.45 -43.09 99.66 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.903 -0.777 . . . . 64.41 108.903 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.9 m -58.85 -35.98 73.82 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.742 0.817 . . . . 65.2 110.477 178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.5 t -75.75 -41.52 40.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 123.763 0.825 . . . . 63.14 109.91 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -63.47 -33.71 76.16 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.703 1.601 . . . . 73.43 111.349 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -83.71 -40.43 18.89 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 123.135 0.574 . . . . 63.15 110.286 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -53.94 -55.2 29.24 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.758 0.823 . . . . 64.31 110.563 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -59.67 -14.8 15.39 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.878 1.271 . . . . 65.12 114.135 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.25 -9.26 39.74 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.44 1.896 . . . . 74.33 109.374 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.44 28.75 54.87 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.659 -0.977 . . . . 73.5 110.659 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -69.45 -179.75 1.78 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.28 1.04 . . . . 73.52 112.393 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -83.36 134.11 34.92 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 125.356 1.462 . . . . 72.25 113.251 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -134.4 110.04 9.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.357 -0.979 . . . . 61.04 108.357 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.86 179.42 4.81 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 109.422 -0.584 . . . . 72.42 109.422 178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -100.08 158.75 31.46 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.823 1.249 . . . . 64.14 111.136 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.15 164.09 36.2 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 123.211 2.607 . . . . 72.41 111.144 179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -70.01 153.69 67.54 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 121.896 1.731 . . . . 54.4 107.815 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 91.1 -15.32 61.28 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 118.988 -0.895 . . . . 72.42 110.899 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -71.86 -44.39 63.88 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.126 0.963 . . . . 75.01 109.177 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 . . . . . 0 C--O 1.25 1.131 0 C-N-CA 124.587 1.155 . . . . 75.42 111.145 179.684 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.575 0 N-CA-C 110.234 -1.147 . . . . 70.14 110.234 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.42 155.41 40.5 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.319 -0.993 . . . . 62.51 108.319 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 15.9 ptp -126.37 173.02 9.66 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 124.003 0.921 . . . . 45.22 111.284 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -86.58 164.59 36.23 Favored Glycine 0 CA--C 1.536 1.365 0 N-CA-C 109.022 -1.631 . . . . 64.34 109.022 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.63 165.18 28.36 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.529 2.152 . . . . 61.21 111.936 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -111.84 -5.1 14.43 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.762 1.225 . . . . 62.42 110.868 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.37 172.07 18.62 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 124.501 1.048 . . . . 60.24 110.701 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.9 m -129.22 34.24 4.43 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 125.029 1.332 . . . . 75.43 111.181 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -70.29 146.06 50.85 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 104.135 -2.543 . . . . 70.11 104.135 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 pp0? -148.58 168.73 22.0 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 118.737 0.699 . . . . 74.44 112.352 -178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.5 p30 -146.28 -13.51 0.46 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.79 1.636 . . . . 71.31 111.308 178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -99.65 78.98 2.2 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.957 1.303 . . . . 73.24 111.054 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 tp -93.1 105.79 17.83 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 121.604 -0.685 . . . . 73.34 111.077 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.499 ' H ' ' HA2' ' A' ' 113' ' ' GLY . 2.8 mpt_? 50.15 35.85 11.08 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.892 1.677 . . . . 74.23 112.014 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -57.98 167.29 1.25 Allowed 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.504 1.121 . . . . 74.44 111.421 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -75.17 135.27 41.09 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 107.142 -1.429 . . . . 75.34 107.142 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -144.05 -159.63 8.1 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 125.74 1.638 . . . . 40.3 110.329 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.95 75.18 1.68 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 117.417 0.608 . . . . 72.13 109.502 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -58.33 146.2 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.089 -1.448 . . . . 61.22 107.089 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.5 m120 60.59 6.45 1.11 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 125.426 1.49 . . . . 72.12 114.036 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.79 33.0 2.14 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.002 1.287 . . . . 53.12 111.613 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -148.88 -137.89 2.89 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 127.61 2.529 . . . . 73.3 107.163 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -129.58 148.87 71.15 Favored Pre-proline 0 C--N 1.321 -0.635 0 C-N-CA 125.623 1.569 . . . . 50.52 107.374 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.2 126.45 12.38 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.315 2.01 . . . . 42.33 108.547 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.3 m -126.8 157.98 37.63 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 121.75 0.786 . . . . 63.15 110.084 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.3 p -124.25 164.44 19.54 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.999 1.72 . . . . 71.52 109.911 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 90.3 m -54.7 -37.37 65.74 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.964 1.706 . . . . 65.22 111.4 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -59.21 -35.93 74.5 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.285 1.034 . . . . 65.12 111.349 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.0 mtp -68.31 -41.71 80.48 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.045 -1.034 . . . . 64.41 108.896 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.5 t -60.23 -54.89 28.62 Favored 'Isoleucine or valine' 0 C--N 1.34 0.19 0 C-N-CA 124.358 1.063 . . . . 63.12 110.94 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.17 -42.33 90.55 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 118.428 -0.796 . . . . 74.21 110.306 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 94.1 m -56.35 -61.07 2.65 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.871 1.214 . . . . 70.32 109.856 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 83.9 t -53.41 -46.87 59.08 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.556 0 CA-C-N 119.136 0.88 . . . . 55.22 109.535 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -53.99 -41.17 67.61 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.167 0.894 . . . . 63.32 113.184 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -65.65 -43.35 89.68 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.969 0.804 . . . . 73.03 109.25 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 19.4 mt -78.57 -17.42 56.15 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.674 0.62 . . . . 74.42 112.674 -178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.89 74.8 56.66 Favored Pre-proline 0 N--CA 1.45 -0.459 0 C-N-CA 126.982 2.113 . . . . 70.52 109.743 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.89 -16.11 36.89 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.576 2.184 . . . . 74.21 111.166 179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.61 15.95 2.9 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.497 1.519 . . . . 73.33 112.016 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.0 mt -124.23 152.14 43.3 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.897 1.279 . . . . 52.44 109.134 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -76.97 143.88 71.33 Favored Pre-proline 0 N--CA 1.45 -0.454 0 N-CA-C 107.858 -1.164 . . . . 71.35 107.858 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.21 -18.95 56.69 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.898 2.398 . . . . 50.44 113.285 -179.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -86.11 -38.51 17.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 123.455 0.702 . . . . 73.41 110.231 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -58.36 -47.87 82.42 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 122.679 0.392 . . . . 73.44 109.965 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 89.1 mt -48.93 -54.08 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 C-N-CA 125.683 1.593 . . . . 75.1 111.053 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.58 HH21 ' CG ' ' A' ' 111' ' ' PRO . 1.7 tmm_? -50.43 -46.93 56.83 Favored 'General case' 0 C--O 1.228 -0.051 0 CA-C-N 118.707 0.685 . . . . 74.3 110.668 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -64.91 -37.71 88.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.768 0.258 . . . . 70.44 111.181 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.8 m -61.46 -47.25 86.53 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 108.975 -0.75 . . . . 61.4 108.975 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 47.4 mt -63.16 -35.25 79.67 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.892 1.277 . . . . 70.51 110.428 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -70.26 -33.25 71.38 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 118.666 0.666 . . . . 73.23 109.801 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -76.62 -55.64 5.33 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 123.482 0.713 . . . . 75.45 111.461 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 68.1 p -70.6 -40.91 72.94 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.957 1.703 . . . . 74.12 112.796 -178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.88 -6.1 83.97 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 126.616 2.055 . . . . 62.24 113.144 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.2 m -144.28 143.18 30.89 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 119.273 1.537 . . . . 73.22 111.474 -178.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 51.6 t -63.04 -49.67 82.55 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.342 0 C-N-CA 125.945 1.698 . . . . 55.12 106.924 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -51.71 -46.79 64.05 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.367 1.067 . . . . 72.41 111.195 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -63.03 -45.42 92.4 Favored 'General case' 0 C--O 1.223 -0.298 0 N-CA-C 108.29 -1.004 . . . . 74.41 108.29 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.5 m -56.52 -37.52 70.56 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.228 0.611 . . . . 61.45 111.017 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.6 t -76.06 -39.31 36.32 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 121.363 -0.836 . . . . 75.03 109.447 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -65.95 -32.82 74.53 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.695 1.198 . . . . 65.14 111.54 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -82.38 -38.78 23.64 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.367 -0.975 . . . . 75.21 108.367 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -55.33 -53.95 49.65 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.954 0.902 . . . . 75.43 110.282 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -59.36 -21.21 59.49 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.582 0.586 . . . . 74.43 112.582 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.15 -16.41 49.92 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.946 1.298 . . . . 71.43 109.526 178.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.2 28.66 48.36 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 109.245 -1.542 . . . . 71.32 109.245 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -61.15 177.32 0.35 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.739 1.616 . . . . 73.02 112.073 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -77.56 138.52 39.21 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 120.806 -1.184 . . . . 73.21 109.029 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -134.57 108.66 8.2 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.014 -1.847 . . . . 75.45 106.014 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.4 m -91.1 177.07 6.37 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 123.503 0.721 . . . . 73.15 109.833 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -108.83 153.71 42.22 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 107.977 -1.12 . . . . 70.15 107.977 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.58 ' CG ' HH21 ' A' ' 86' ' ' ARG . 33.2 Cg_endo -71.11 163.28 39.74 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.505 2.136 . . . . 74.22 113.182 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -65.5 131.4 27.84 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.481 2.12 . . . . 63.25 107.003 178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.499 ' HA2' ' H ' ' A' ' 54' ' ' ARG . . . 105.14 -9.7 46.64 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-O 117.738 -1.59 . . . . 71.44 112.097 -178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -86.79 -28.32 23.04 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 119.157 1.479 . . . . 63.23 109.49 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 C--O 1.255 1.354 0 N-CA-C 103.994 -2.595 . . . . 75.31 103.994 178.258 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.738 0 N-CA-C 110.522 -1.031 . . . . 74.23 110.522 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.68 -176.76 4.67 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.235 1.414 . . . . 63.15 108.598 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -136.99 172.8 12.47 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.19 1.396 . . . . 73.22 107.69 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -171.9 178.9 43.9 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.099 -1.2 . . . . 64.41 110.099 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -63.87 117.55 4.54 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.193 2.595 . . . . 53.42 109.579 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 71.8 mm-40 -67.19 104.97 1.58 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.929 -1.508 . . . . 63.22 106.929 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.08 -135.66 3.58 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 108.729 -1.748 . . . . 60.04 108.729 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.3 t -72.41 64.92 0.61 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.449 1.099 . . . . 61.23 111.427 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.1 t -66.48 -15.0 63.02 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.001 -1.062 . . . . 72.35 110.955 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -65.27 22.63 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 128.253 2.621 . . . . 71.22 116.625 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -73.14 -50.73 21.07 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 123.711 0.805 . . . . 60.42 110.735 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.27 73.46 1.81 Allowed 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.128 0.971 . . . . 73.54 112.057 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 33.2 mt -119.29 153.83 34.44 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.554 1.142 . . . . 64.04 112.705 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 56.3 13.39 1.24 Allowed 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 118.082 2.623 . . . . 70.13 118.082 178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -66.54 -29.78 69.95 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.82 1.191 . . . . 74.12 111.052 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 28.4 p -64.31 157.59 25.71 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.243 0.929 . . . . 73.44 109.326 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 120.73 170.93 14.27 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 124.955 1.264 . . . . 53.4 110.582 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.63 90.02 0.55 Allowed 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.825 0.85 . . . . 63.41 112.13 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.86 157.33 3.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 107.687 -1.227 . . . . 71.32 107.687 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.1 m120 46.0 56.58 5.94 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 127.135 2.174 . . . . 72.41 112.539 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -89.73 -151.7 25.39 Favored Glycine 0 CA--C 1.524 0.627 0 C-N-CA 124.541 1.067 . . . . 42.34 112.702 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 131.61 58.08 0.09 OUTLIER Glycine 0 CA--C 1.527 0.824 0 C-N-CA 126.207 1.86 . . . . 73.34 111.849 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -72.01 141.72 84.45 Favored Pre-proline 0 C--O 1.232 0.183 0 CA-C-N 118.042 0.921 . . . . 71.01 109.145 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.88 126.17 9.23 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 121.734 1.623 . . . . 71.43 108.198 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 32.6 m -111.94 170.15 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 120.814 -1.179 . . . . 72.33 109.807 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 p -125.37 157.0 37.86 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.691 1.596 . . . . 54.24 107.154 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 m -54.77 -38.89 67.79 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.533 1.133 . . . . 54.13 109.609 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.1 -33.15 68.8 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.675 1.19 . . . . 72.15 112.445 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 93.0 mtp -68.5 -39.7 81.18 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.793 -1.192 . . . . 63.14 108.729 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 t -59.47 -53.78 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.19 0 C-N-CA 124.86 1.264 . . . . 61.02 110.136 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -62.56 -41.82 99.16 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 117.209 -1.377 . . . . 65.03 110.845 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 97.3 m -54.58 -60.16 3.72 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 120.787 1.631 . . . . 62.23 108.93 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.0 t -53.32 -47.15 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 119.154 0.888 . . . . 63.22 110.674 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -57.21 -43.73 83.03 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.171 0.804 . . . . 72.32 113.171 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.0 m-80 -59.14 -45.89 89.78 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 108.42 -0.956 . . . . 74.52 108.42 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.4 mt -71.47 -37.15 71.37 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 123.718 0.807 . . . . 74.31 111.879 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -116.82 80.99 11.46 Favored Pre-proline 0 C--O 1.241 0.642 0 C-N-CA 127.507 2.323 . . . . 72.11 112.043 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.37 -2.19 11.75 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 124.746 3.631 . . . . 70.12 112.306 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -90.26 -19.67 23.85 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.97 1.708 . . . . 74.01 110.584 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.8 mt -92.46 157.34 16.62 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 118.219 0.463 . . . . 73.22 112.146 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.4 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 41.7 t-80 -83.01 142.67 44.79 Favored Pre-proline 0 C--O 1.237 0.43 0 N-CA-C 106.229 -1.767 . . . . 75.14 106.229 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.5 ' HA ' HD12 ' A' ' 85' ' ' ILE . 20.1 Cg_endo -62.73 -28.98 76.74 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.751 2.3 . . . . 64.5 112.553 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.415 ' HG2' ' CD1' ' A' ' 114' ' ' PHE . 2.2 tp10 -73.62 -41.61 62.59 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 122.112 -0.368 . . . . 63.03 111.466 -178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -61.24 -37.94 84.88 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.69 -0.631 . . . . 73.53 110.595 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 82' ' ' PRO . 97.5 mt -53.42 -58.3 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.47 1.108 . . . . 71.44 109.41 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.26 -47.76 18.09 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.971 0.805 . . . . 74.44 111.524 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -64.54 -42.76 95.51 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 119.179 0.9 . . . . 75.23 111.252 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.4 t -60.09 -46.24 90.25 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.03 -1.1 . . . . 45.3 108.03 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.6 mt -58.28 -39.36 79.06 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 123.813 0.845 . . . . 62.14 111.025 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -69.42 -35.21 75.5 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.458 0.647 . . . . 74.45 111.395 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -72.39 -56.06 6.06 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.402 0.681 . . . . 73.3 110.454 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.8 p -68.73 -41.23 79.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.302 1.441 . . . . 73.02 113.341 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.86 -4.79 84.47 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 126.018 1.771 . . . . 74.3 113.439 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.4 m -142.23 134.58 27.83 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 118.507 1.153 . . . . 43.4 111.634 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.2 t -59.04 -48.48 86.56 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.173 0 N-CA-C 106.16 -1.792 . . . . 75.14 106.16 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -52.77 -42.23 64.81 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.904 0.882 . . . . 71.44 111.239 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -64.45 -45.04 89.17 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 108.53 -0.915 . . . . 70.52 108.53 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 58.3 m -59.51 -36.69 76.56 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.805 0.842 . . . . 74.12 110.315 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 65.9 t -74.67 -36.74 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.388 0.675 . . . . 72.23 110.138 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -71.47 -36.07 71.05 Favored 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.389 1.476 . . . . 71.13 111.192 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -79.34 -33.54 42.95 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.709 -0.848 . . . . 72.0 108.709 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -58.2 -55.73 31.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 118.925 -0.559 . . . . 74.53 109.59 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.41 -25.06 65.64 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 118.249 -0.881 . . . . 55.13 111.953 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -81.88 -8.02 59.65 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 119.238 0.926 . . . . 53.2 109.641 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 72.69 34.22 59.88 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-O 118.551 -1.139 . . . . 63.44 110.406 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -69.88 176.61 3.57 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 118.326 1.063 . . . . 74.3 110.127 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -75.7 147.25 39.53 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 120.844 -1.16 . . . . 73.55 109.33 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -138.9 109.08 6.41 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 107.325 -1.361 . . . . 75.44 107.325 178.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.4 m -94.66 164.95 12.74 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 124.237 1.015 . . . . 71.2 109.118 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -91.59 160.08 37.34 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.59 1.156 . . . . 74.43 109.7 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.39 165.35 29.23 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.213 1.942 . . . . 63.44 112.101 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -64.93 152.91 80.66 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 121.704 1.603 . . . . 73.41 108.528 178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.73 -6.43 39.94 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-O 118.39 -1.228 . . . . 64.44 113.577 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . 0.415 ' CD1' ' HG2' ' A' ' 83' ' ' GLU . 85.9 t80 -77.49 -26.13 51.0 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.462 1.631 . . . . 73.22 110.547 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 C--O 1.247 0.934 0 CA-C-O 116.964 -1.493 . . . . 74.3 109.841 179.789 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.782 0 CA-C-O 119.595 -0.558 . . . . 64.05 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -48.98 115.14 1.17 Allowed 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 124.899 1.28 . . . . 63.5 111.879 -179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 31.1 mtt 51.34 17.11 0.47 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.881 1.673 . . . . 63.45 113.75 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -139.58 79.46 0.29 Allowed Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 107.553 -2.219 . . . . 74.31 107.553 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -70.58 -179.25 3.14 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.17 1.914 . . . . 61.25 109.557 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.13 173.19 0.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.158 0.504 . . . . 75.23 110.625 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.96 48.58 0.86 Allowed Glycine 0 C--N 1.33 0.215 0 N-CA-C 109.234 -1.546 . . . . 24.42 109.234 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 21.6 t -79.65 100.03 7.65 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.346 -2.094 . . . . 75.22 105.346 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.1 t -61.14 -27.24 68.25 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 108.991 -0.744 . . . . 73.11 108.991 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 37.69 54.47 1.5 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 127.55 2.34 . . . . 71.31 111.377 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -65.17 171.96 3.38 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.183 0.993 . . . . 51.42 112.249 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.67 -176.72 4.26 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.651 2.38 . . . . 71.4 105.731 177.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.78 33.05 1.6 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.528 -0.733 . . . . 73.34 112.352 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -158.37 170.18 22.81 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.446 1.498 . . . . 74.14 109.517 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -133.13 104.52 6.55 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 107.396 -1.335 . . . . 74.45 107.396 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.3 m -76.67 -45.09 31.09 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 108.438 -0.949 . . . . 60.02 108.438 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.47 -177.07 17.89 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.748 -0.941 . . . . 71.54 110.748 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 65.3 mtt-85 -145.09 170.29 16.48 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 127.43 2.292 . . . . 73.44 106.203 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.7 t -111.15 -51.76 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 106.864 -1.532 . . . . 70.42 106.864 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -99.34 37.11 1.62 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.282 1.833 . . . . 74.02 110.361 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -82.02 -162.31 30.19 Favored Glycine 0 CA--C 1.529 0.968 0 N-CA-C 109.957 -1.257 . . . . 70.4 109.957 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -72.61 -110.22 0.06 OUTLIER Glycine 0 CA--C 1.526 0.756 0 C-N-CA 123.638 0.637 . . . . 70.4 111.978 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -129.63 154.87 80.97 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 118.39 1.095 . . . . 73.42 110.404 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.97 126.49 10.02 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.476 2.117 . . . . 61.34 109.3 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 13.3 m -125.13 162.52 27.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 123.932 0.893 . . . . 62.52 109.083 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p -120.34 172.89 7.48 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.687 1.995 . . . . 73.11 108.228 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.9 m -65.03 -40.23 94.52 Favored 'General case' 0 C--N 1.332 -0.191 0 O-C-N 121.423 -0.798 . . . . 62.1 110.304 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.24 -38.38 62.91 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 124.402 1.081 . . . . 73.34 112.111 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.3 mtp -63.66 -41.52 98.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 121.385 -0.822 . . . . 70.43 109.413 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 t -62.93 -56.46 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 C-N-CA 124.999 1.32 . . . . 74.44 110.464 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -59.69 -39.76 85.61 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-O 118.005 -0.998 . . . . 72.21 109.75 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.403 ' CG2' HG11 ' A' ' 95' ' ' VAL . 57.8 m -56.41 -60.42 3.55 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 120.356 1.435 . . . . 71.43 109.96 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.5 t -53.92 -45.5 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 119.374 0.988 . . . . 52.24 108.531 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -53.49 -43.15 68.0 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.717 1.144 . . . . 62.33 113.014 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -66.91 -35.33 79.77 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 122.715 0.406 . . . . 72.43 110.293 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.2 mt -88.22 -12.25 44.32 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.262 0.483 . . . . 62.53 112.278 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -143.78 76.77 15.37 Favored Pre-proline 0 C--O 1.241 0.607 0 C-N-CA 126.363 1.865 . . . . 52.34 108.85 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.5 -13.72 33.07 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.376 2.717 . . . . 73.13 112.405 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.6 -7.99 58.89 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.467 1.507 . . . . 75.13 112.395 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.2 mt -97.48 152.97 18.44 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.25 0.932 . . . . 63.13 112.005 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.42 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 58.0 t-80 -69.54 144.56 94.33 Favored Pre-proline 0 CA--C 1.532 0.286 0 C-N-CA 125.828 1.651 . . . . 74.52 109.394 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 41.0 Cg_endo -66.89 -24.94 45.64 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 122.85 2.367 . . . . 74.12 114.152 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.76 -41.33 14.21 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 120.054 1.297 . . . . 63.45 111.725 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -57.04 -35.8 69.73 Favored 'General case' 0 C--N 1.343 0.308 0 O-C-N 123.657 0.598 . . . . 74.2 110.478 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 66.8 mt -53.64 -58.16 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-O 118.485 -0.769 . . . . 62.42 110.035 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.72 -45.24 48.93 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.474 0.579 . . . . 65.32 111.815 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -63.32 -44.57 94.58 Favored 'General case' 0 N--CA 1.455 -0.186 0 O-C-N 121.783 -0.573 . . . . 74.14 111.144 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.3 p -60.67 -44.4 96.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 118.567 -0.73 . . . . 73.3 109.998 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 73.4 mt -60.4 -37.07 79.66 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 123.82 0.848 . . . . 74.31 110.04 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.1 -33.55 74.74 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 118.296 0.498 . . . . 64.52 110.269 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -79.04 -42.24 26.93 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.258 1.023 . . . . 75.45 113.537 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.9 p -83.52 -34.6 25.25 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.713 1.605 . . . . 74.42 112.537 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.88 -11.12 63.09 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 126.418 1.961 . . . . 33.1 111.899 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 m -144.87 150.93 37.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 119.346 1.573 . . . . 71.41 112.106 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.403 HG11 ' CG2' ' A' ' 72' ' ' THR . 78.1 t -62.63 -49.78 82.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 126.281 1.832 . . . . 63.4 107.97 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -45.33 -53.24 8.76 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 128.092 2.557 . . . . 75.01 111.792 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -66.66 -41.59 87.95 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.638 -0.71 . . . . 73.21 109.43 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.9 m -59.26 -39.29 82.41 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.012 0.925 . . . . 73.53 110.463 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 71.8 t -74.39 -38.25 46.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 124.107 0.963 . . . . 73.42 109.924 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -68.07 -41.62 81.67 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.355 1.062 . . . . 60.13 110.495 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.405 ' HG3' ' CZ ' ' A' ' 108' ' ' PHE . 5.6 ptm180 -74.12 -35.35 64.11 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 121.351 -0.843 . . . . 72.01 108.816 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -57.57 -57.33 13.15 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 118.539 -0.743 . . . . 74.34 109.457 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.29 -24.9 65.32 Favored 'General case' 0 C--N 1.339 0.118 0 O-C-N 123.575 0.547 . . . . 53.54 111.402 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.21 -15.39 59.51 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 118.457 -0.782 . . . . 53.04 109.684 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.27 28.82 32.36 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-O 118.748 -1.029 . . . . 34.44 110.545 -179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -69.25 174.46 4.7 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 118.664 1.232 . . . . 71.55 109.02 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -86.13 147.74 26.01 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 120.587 -1.32 . . . . 65.42 108.776 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.405 ' CZ ' ' HG3' ' A' ' 101' ' ' ARG . 34.9 m-85 -139.1 109.72 6.63 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.632 -1.167 . . . . 72.22 109.694 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.9 m -82.12 170.71 15.18 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.382 1.073 . . . . 63.13 108.876 176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -94.4 161.98 27.51 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 126.442 1.897 . . . . 73.11 110.848 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.53 158.46 57.6 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.619 2.213 . . . . 61.25 111.766 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.42 128.88 23.63 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.838 2.359 . . . . 72.2 110.612 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.61 -3.95 66.0 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-O 118.734 -1.037 . . . . 72.04 113.16 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -67.93 -31.18 70.76 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.416 1.608 . . . . 74.11 107.661 177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 128.223 2.609 . . . . 63.41 106.835 179.227 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.644 0 N-CA-C 110.524 -1.031 . . . . 43.32 110.524 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -69.69 51.51 0.11 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 127.309 2.244 . . . . 75.32 113.191 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.5 ppp? -59.81 -18.23 42.18 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 120.849 -1.157 . . . . 74.4 113.001 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.24 74.79 0.71 Allowed Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.35 -1.9 . . . . 64.24 108.35 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -82.5 10.88 3.39 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 124.086 3.19 . . . . 74.33 112.161 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -145.55 38.62 1.14 Allowed 'General case' 0 C--O 1.238 0.472 0 C-N-CA 127.583 2.353 . . . . 74.24 108.101 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.46 -169.88 38.74 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-O 123.055 1.364 . . . . 43.12 112.784 -178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.9 m -126.99 167.05 16.42 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 126.983 2.113 . . . . 74.0 107.756 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.7 t -156.72 -30.3 0.09 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.775 0.43 . . . . 71.43 111.552 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -59.12 133.28 55.96 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.802 0.841 . . . . 75.2 109.532 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.9 p30 -87.49 -5.12 58.94 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.555 0.742 . . . . 73.15 112.581 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.64 104.73 3.77 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.628 -1.99 . . . . 73.14 105.628 179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -152.65 179.88 8.21 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 118.287 0.494 . . . . 64.0 111.171 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -57.3 118.2 4.86 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 107.886 -1.154 . . . . 72.2 107.886 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.8 mtp180 -61.86 99.52 0.12 Allowed 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 118.819 -0.61 . . . . 72.11 110.677 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.4 t -167.49 169.32 12.23 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 106.854 -1.536 . . . . 41.12 106.854 178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 75.53 175.03 36.77 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 111.422 -0.671 . . . . 55.53 111.422 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.62 149.58 45.36 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 106.609 -1.626 . . . . 74.35 106.609 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.0 p -159.64 161.47 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 108.92 -0.771 . . . . 74.33 108.92 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -145.14 164.11 32.27 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.698 1.999 . . . . 73.5 106.405 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 77.65 17.67 78.57 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 116.042 1.177 . . . . 72.31 116.042 178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -170.15 80.81 0.09 OUTLIER Glycine 0 C--N 1.334 0.464 0 CA-C-N 120.485 2.142 . . . . 61.41 111.497 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -128.99 142.45 45.17 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.944 0.898 . . . . 75.01 110.545 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.99 140.2 22.58 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.898 3.065 . . . . 64.22 107.868 178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.37 150.07 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.318 -0.864 . . . . 64.54 111.326 -179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.4 p -107.08 169.8 8.34 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 125.885 1.674 . . . . 73.24 111.952 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 94.8 m -58.22 -40.03 80.62 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.391 -0.814 . . . . 64.42 109.667 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.76 -35.12 70.31 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 118.81 0.732 . . . . 73.3 112.066 -179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 92.2 mtp -66.43 -42.84 87.14 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.216 -0.927 . . . . 62.42 109.171 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.38 -54.79 28.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 C-N-CA 124.625 1.17 . . . . 74.24 109.4 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -64.05 -35.75 81.75 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 118.127 -0.94 . . . . 44.45 111.78 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.415 ' CG2' HG11 ' A' ' 95' ' ' VAL . 27.4 m -57.59 -59.6 4.94 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.187 1.358 . . . . 72.24 109.037 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.4 t -55.91 -45.92 80.11 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 CA-C-O 117.749 -1.12 . . . . 53.12 109.225 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -54.27 -44.8 72.19 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 120.457 1.48 . . . . 74.22 112.771 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -61.07 -44.93 96.64 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 108.234 -1.024 . . . . 74.33 108.234 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.7 mt -76.34 -28.93 57.06 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.1 0.778 . . . . 63.53 113.1 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.31 78.4 71.44 Favored Pre-proline 0 C--O 1.242 0.666 0 C-N-CA 127.737 2.415 . . . . 73.24 110.153 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -75.43 -1.1 10.89 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.89 3.727 . . . . 74.44 113.309 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -95.71 2.8 54.16 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.331 1.453 . . . . 72.14 112.021 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.0 mt -108.43 156.22 19.7 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 124.68 1.192 . . . . 73.35 109.556 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.452 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 54.5 t-80 -79.49 147.53 68.14 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 107.539 -1.282 . . . . 74.34 107.539 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 37.7 Cg_endo -65.14 -22.88 61.0 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.873 2.382 . . . . 73.44 113.417 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -81.51 -37.08 28.42 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.567 -0.708 . . . . 71.22 110.12 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -58.54 -37.02 74.81 Favored 'General case' 0 C--N 1.347 0.476 0 N-CA-C 109.885 -0.413 . . . . 71.41 109.885 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.449 HD12 ' HA ' ' A' ' 82' ' ' PRO . 47.2 mt -57.41 -60.8 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-O 117.471 -1.252 . . . . 70.43 109.813 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.45 -50.19 5.21 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 119.517 1.053 . . . . 75.05 110.918 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -63.2 -47.32 83.05 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.612 0.72 . . . . 75.45 111.998 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 m -57.1 -50.79 71.68 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 123.383 0.673 . . . . 54.12 109.23 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.0 mt -57.92 -39.83 78.93 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.3 1.04 . . . . 65.12 111.136 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -65.63 -32.0 73.33 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 122.478 0.311 . . . . 75.31 110.546 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -80.16 -51.32 9.11 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 118.646 -0.693 . . . . 50.45 111.094 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.2 p -71.41 -40.97 70.14 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 125.07 1.348 . . . . 65.31 113.145 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.52 -17.55 58.83 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 126.677 2.084 . . . . 21.14 113.102 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.3 t -143.33 147.87 35.39 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.426 1.613 . . . . 75.15 108.984 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.415 HG11 ' CG2' ' A' ' 72' ' ' THR . 31.1 t -59.8 -46.13 94.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 C-N-CA 127.32 2.248 . . . . 75.31 109.27 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -47.62 -48.57 28.44 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.381 1.472 . . . . 64.53 110.48 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -67.84 -42.38 81.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.625 -0.509 . . . . 74.31 109.625 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.2 m -58.25 -36.64 73.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.066 0.547 . . . . 72.24 110.896 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 78.8 t -75.95 -38.71 36.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.402 1.081 . . . . 64.32 109.614 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -66.61 -38.7 87.52 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.03 1.332 . . . . 52.3 110.37 -178.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -76.94 -37.52 55.16 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 121.057 -1.027 . . . . 73.43 108.649 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -56.29 -53.55 55.95 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.194 0.598 . . . . 74.24 109.743 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.79 -22.94 65.87 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 119.345 -0.36 . . . . 63.33 111.955 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -82.37 -10.15 59.18 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 118.796 0.726 . . . . 75.31 109.718 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.32 37.22 42.46 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.018 -1.233 . . . . 74.2 110.018 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -69.76 -171.72 0.43 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 117.645 0.723 . . . . 70.11 110.734 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -90.34 139.51 30.59 Favored 'General case' 0 C--O 1.236 0.383 0 O-C-N 120.346 -1.471 . . . . 64.22 110.388 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -128.89 108.76 10.69 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 107.358 -1.349 . . . . 74.11 107.358 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 8.9 m -89.74 172.4 8.95 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.802 1.641 . . . . 75.21 110.349 179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -107.49 152.87 41.52 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 125.747 1.619 . . . . 62.2 108.423 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.19 170.11 19.89 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 123.706 2.937 . . . . 71.13 112.874 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.01 152.52 82.1 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 N-CA-C 107.003 -1.96 . . . . 75.21 107.003 177.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 83.08 -18.96 13.86 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 118.045 -1.419 . . . . 62.42 112.495 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -72.42 -54.75 8.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 119.536 1.668 . . . . 73.25 107.316 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 . . . . . 0 C--O 1.253 1.264 0 N-CA-C 106.266 -1.753 . . . . 75.13 106.266 179.508 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.74 0 N-CA-C 109.106 -1.598 . . . . 54.32 109.106 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.03 156.63 46.52 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.296 1.438 . . . . 72.31 107.19 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 24.8 mmt -130.25 160.92 32.41 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.613 1.165 . . . . 70.43 108.459 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.65 82.03 0.2 Allowed Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 105.711 -2.955 . . . . 60.23 105.711 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.21 162.34 38.85 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.021 1.814 . . . . 65.41 111.143 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -86.41 164.17 17.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.603 0.761 . . . . 73.14 109.212 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.64 -87.45 0.34 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 106.438 -2.665 . . . . 51.13 106.438 178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.6 m -148.71 176.35 10.43 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 125.792 1.637 . . . . 31.11 107.994 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.9 t -57.77 132.13 52.39 Favored 'General case' 0 C--O 1.238 0.448 0 O-C-N 121.382 -0.824 . . . . 75.31 109.61 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -130.0 146.9 51.7 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.573 -1.269 . . . . 62.33 107.573 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -87.42 60.24 5.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.05 -1.463 . . . . 71.43 107.05 178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.05 172.0 1.99 Allowed 'General case' 0 C--O 1.237 0.447 0 O-C-N 121.6 -0.687 . . . . 70.53 110.564 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -148.37 38.02 0.86 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.924 0.89 . . . . 75.22 110.534 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.9 ttt-85 -131.39 28.48 4.67 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.843 0.857 . . . . 60.42 113.214 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 60.49 40.09 17.48 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.627 1.103 . . . . 72.23 108.449 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.8 p -129.06 15.61 6.25 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.524 1.93 . . . . 74.31 112.397 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -134.71 169.48 23.16 Favored Glycine 0 C--N 1.337 0.614 0 N-CA-C 110.219 -1.152 . . . . 54.42 110.219 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -67.35 -0.26 3.46 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 116.228 1.936 . . . . 72.45 116.228 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.7 m -75.02 73.74 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 123.031 1.396 . . . . 75.5 110.794 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.05 126.99 47.78 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 103.757 -2.682 . . . . 71.52 103.757 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -145.44 60.24 0.49 Allowed Glycine 0 CA--C 1.523 0.557 0 CA-C-N 119.054 0.843 . . . . 72.14 112.363 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 167.52 108.05 0.2 Allowed Glycine 0 CA--C 1.524 0.622 0 CA-C-N 117.981 0.891 . . . . 71.12 111.68 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -130.92 155.96 80.74 Favored Pre-proline 0 CA--C 1.531 0.224 0 C-N-CA 126.851 2.06 . . . . 64.14 108.304 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.31 126.08 9.53 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.933 1.756 . . . . 71.03 109.084 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.2 m -126.48 161.16 33.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 O-C-N 121.306 -0.871 . . . . 43.12 109.836 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 p -125.09 164.18 20.78 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.96 2.104 . . . . 70.44 109.813 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 89.0 m -59.17 -39.39 82.36 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.757 0.708 . . . . 72.51 110.744 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.3 -33.66 67.9 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 123.398 0.679 . . . . 74.12 111.983 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.8 mtp -65.72 -46.84 77.44 Favored 'General case' 0 C--O 1.239 0.502 0 O-C-N 120.638 -1.289 . . . . 71.02 107.696 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.7 t -50.77 -58.66 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.499 0 C-N-CA 126.703 2.001 . . . . 72.43 109.853 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -59.73 -37.18 78.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 118.283 -0.865 . . . . 73.42 110.559 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 33.3 m -54.82 -60.69 3.01 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 120.272 1.396 . . . . 63.05 109.071 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.8 t -54.91 -51.89 48.63 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.61 0 CA-C-O 118.06 -0.972 . . . . 71.21 108.847 178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -50.41 -42.89 54.41 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 119.044 0.838 . . . . 74.25 113.05 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 -65.21 -40.1 93.69 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 118.961 0.801 . . . . 73.13 109.289 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.5 mt -82.98 -16.24 48.0 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 113.083 0.772 . . . . 53.45 113.083 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -135.37 72.36 65.35 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 129.208 3.003 . . . . 73.04 109.528 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.82 -12.38 30.8 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 122.225 1.95 . . . . 64.4 112.486 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -84.25 13.23 5.46 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.383 1.473 . . . . 74.31 112.618 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.1 mt -121.12 158.78 27.18 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.504 1.122 . . . . 55.5 110.663 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -81.86 141.91 48.14 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 107.7 -1.222 . . . . 75.22 107.7 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.464 ' HA ' HD12 ' A' ' 85' ' ' ILE . 38.7 Cg_endo -63.64 -26.35 69.05 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.654 2.236 . . . . 75.34 112.813 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.37 -39.5 53.64 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 121.748 -0.595 . . . . 54.13 111.942 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -60.25 -45.58 92.78 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 109.83 -0.433 . . . . 60.33 109.83 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 82' ' ' PRO . 95.2 mt -47.53 -55.58 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 126.272 1.829 . . . . 50.0 111.03 -178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.71 -45.69 49.33 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.911 0.778 . . . . 73.51 111.447 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -64.1 -40.07 95.43 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 120.773 -1.204 . . . . 72.5 110.955 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.0 m -57.82 -55.77 30.6 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.042 1.337 . . . . 74.3 108.256 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.11 -39.99 76.15 Favored 'General case' 0 CA--C 1.509 -0.6 0 C-N-CA 124.704 1.202 . . . . 73.32 111.238 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -65.19 -33.93 77.18 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 119.553 -0.859 . . . . 70.14 110.698 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -76.96 -48.68 17.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 118.395 -0.812 . . . . 73.21 111.969 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 74.4 p -73.49 -40.98 63.67 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.627 1.571 . . . . 75.22 111.5 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.14 -4.14 84.12 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 127.363 2.411 . . . . 63.02 111.853 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.8 m -144.54 140.76 29.02 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.798 1.239 . . . . 61.43 110.704 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.22 -45.83 95.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 124.909 1.284 . . . . 51.21 108.439 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -47.8 -48.67 30.33 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 126.345 1.858 . . . . 62.32 111.362 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -64.72 -47.63 77.59 Favored 'General case' 0 C--O 1.225 -0.223 0 N-CA-C 108.591 -0.892 . . . . 71.32 108.591 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.7 m -54.83 -41.7 71.01 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.548 1.539 . . . . 73.21 112.044 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.4 t -76.76 -34.5 23.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 121.503 -0.748 . . . . 53.04 110.364 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -73.19 -32.06 64.58 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 123.985 0.914 . . . . 71.14 111.197 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.464 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 3.9 ptm180 -82.19 -34.93 28.79 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.42 -0.956 . . . . 73.21 108.42 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -55.92 -55.1 36.67 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 108.298 -1.001 . . . . 62.12 108.298 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.32 -24.78 66.68 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 119.335 -0.364 . . . . 72.22 111.219 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.464 ' HD2' ' HA ' ' A' ' 101' ' ' ARG . 0.1 OUTLIER -74.68 -17.23 60.71 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 119.153 0.888 . . . . 70.12 108.962 178.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.83 35.12 28.96 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.318 -1.513 . . . . 71.11 109.318 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -70.61 -173.0 0.69 Allowed 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.129 0.964 . . . . 73.13 110.047 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -89.71 144.48 25.95 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 119.523 -1.986 . . . . 75.02 108.529 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -136.69 109.44 7.54 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.242 -1.344 . . . . 63.44 108.895 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.63 173.44 8.05 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.179 1.392 . . . . 73.22 110.932 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -103.8 158.75 31.23 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 126.096 1.758 . . . . 72.31 109.074 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -67.0 161.88 40.61 Favored 'Trans proline' 0 CA--C 1.536 0.593 0 C-N-CA 122.485 2.123 . . . . 70.51 112.867 -179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -67.9 136.05 37.18 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.067 1.845 . . . . 52.43 109.688 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.34 -2.55 71.2 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.488 1.042 . . . . 73.34 111.388 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -75.52 -35.98 60.62 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.03 0.915 . . . . 71.53 109.838 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 . . . . . 0 C--O 1.248 1.007 0 C-N-CA 125.847 1.659 . . . . 71.54 110.982 -179.26 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.302 0 N-CA-C 109.342 -1.503 . . . . 55.34 109.342 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -150.22 176.3 10.99 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.551 1.54 . . . . 65.41 107.614 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.2 pmm? -156.55 -179.96 8.69 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.869 2.068 . . . . 74.22 107.428 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.18 172.84 29.98 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 110.565 -1.014 . . . . 74.34 110.565 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.85 138.98 35.46 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.046 2.498 . . . . 65.43 110.352 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -87.73 -7.17 57.7 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.019 0.748 . . . . 71.43 113.019 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.21 -167.05 54.72 Favored Glycine 0 CA--C 1.533 1.194 0 N-CA-C 110.758 -0.937 . . . . 42.23 110.758 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.0 p -160.52 171.99 17.99 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.124 1.37 . . . . 71.23 108.783 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.8 t -161.02 177.71 10.07 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.509 1.524 . . . . 71.23 107.368 179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -146.0 176.35 9.77 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.138 1.775 . . . . 74.44 109.236 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -129.19 174.4 9.61 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 126.304 1.842 . . . . 73.33 110.741 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.52 72.04 0.33 Allowed 'General case' 0 C--O 1.233 0.223 0 C-N-CA 127.723 2.409 . . . . 51.34 112.538 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -142.36 131.46 23.25 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.138 -0.69 . . . . 65.51 109.138 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -156.36 146.54 21.36 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.79 -1.189 . . . . 71.34 107.79 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -62.83 -17.61 61.61 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.542 1.137 . . . . 73.0 112.853 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.8 t -66.37 172.28 4.13 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.522 1.055 . . . . 70.42 109.826 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.62 -45.24 0.06 OUTLIER Glycine 0 CA--C 1.52 0.367 0 N-CA-C 110.107 -1.197 . . . . 54.32 110.107 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.5 52.87 7.33 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.387 1.075 . . . . 54.45 111.172 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.42 168.68 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.129 -0.941 . . . . 44.24 110.678 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -63.76 147.21 52.3 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.48 -0.782 . . . . 75.11 110.173 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 150.47 2.47 0.26 Allowed Glycine 0 CA--C 1.53 0.979 0 CA-C-O 119.08 -0.844 . . . . 52.34 114.057 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 140.8 84.46 0.09 OUTLIER Glycine 0 C--N 1.335 0.493 0 CA-C-N 119.595 1.697 . . . . 71.34 109.48 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -96.08 144.98 28.76 Favored Pre-proline 0 N--CA 1.447 -0.592 0 N-CA-C 107.529 -1.285 . . . . 75.04 107.529 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.84 148.84 36.62 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 122.819 2.346 . . . . 74.53 109.268 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.35 165.64 30.96 Favored 'Isoleucine or valine' 0 C--O 1.241 0.647 0 CA-C-O 121.619 0.723 . . . . 75.22 110.201 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 p -125.36 157.24 37.26 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 126.152 1.781 . . . . 74.31 107.387 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.9 m -54.31 -36.7 64.01 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.354 0.662 . . . . 73.13 111.149 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -32.59 68.39 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.144 0.978 . . . . 73.42 111.948 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.7 mtp -69.9 -40.75 75.44 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.036 -1.098 . . . . 71.33 108.036 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 t -59.94 -58.02 9.1 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 C-N-CA 124.971 1.308 . . . . 73.54 109.349 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -60.01 -36.05 76.37 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 118.341 -0.837 . . . . 64.14 110.877 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.436 ' CG2' HG11 ' A' ' 95' ' ' VAL . 82.2 m -58.03 -61.72 2.34 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.958 1.254 . . . . 61.44 108.863 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.411 HG21 HD21 ' A' ' 89' ' ' LEU . 61.3 t -54.9 -43.98 70.8 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.554 0 CA-C-N 119.481 1.037 . . . . 71.22 109.39 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -55.2 -48.07 74.38 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 119.655 1.116 . . . . 43.52 111.525 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -59.03 -39.68 82.68 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.12 0.968 . . . . 65.23 110.324 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.2 mt -86.63 -19.75 28.86 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.109 0.781 . . . . 75.22 113.109 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -127.05 77.91 74.79 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.847 2.059 . . . . 43.42 109.032 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.49 -0.24 6.41 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 124.294 3.33 . . . . 64.1 113.602 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.45 20.51 18.12 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.287 1.035 . . . . 72.32 111.749 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 24.2 mt -123.37 154.5 38.89 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.905 1.282 . . . . 73.14 110.039 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.467 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 48.5 t-80 -86.27 147.72 45.47 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-O 118.495 -0.764 . . . . 71.54 109.104 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 40.3 Cg_endo -63.57 -32.1 70.17 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.315 2.677 . . . . 53.21 112.752 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 81' ' ' HIS . 0.1 OUTLIER -74.82 -44.65 48.19 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.884 -0.413 . . . . 75.35 109.884 -178.329 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -59.27 -39.81 84.08 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 108.834 -0.802 . . . . 71.24 108.834 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 82' ' ' PRO . 48.5 mt -57.52 -59.59 3.11 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 N-CA-C 107.84 -1.171 . . . . 75.5 107.84 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.08 -47.06 34.33 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.395 0.998 . . . . 70.12 111.596 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -62.01 -44.25 97.13 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.205 0.911 . . . . 71.43 111.494 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.8 m -63.75 -41.29 98.04 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.414 -0.587 . . . . 75.34 109.414 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.411 HD21 HG21 ' A' ' 73' ' ' VAL . 87.9 mt -61.62 -37.77 85.18 Favored 'General case' 0 C--O 1.225 -0.236 0 O-C-N 121.229 -0.92 . . . . 72.34 110.38 179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -69.9 -37.31 75.96 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 117.992 0.36 . . . . 62.02 111.078 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -74.77 -53.06 9.88 Favored 'General case' 0 C--O 1.232 0.145 0 O-C-N 122.171 -0.331 . . . . 73.43 111.137 -179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.7 p -67.14 -41.88 85.35 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.068 0.947 . . . . 73.42 111.486 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.28 -15.0 64.19 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 128.335 2.874 . . . . 73.24 113.806 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.0 m -139.55 148.5 42.66 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.636 1.718 . . . . 71.23 111.763 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.436 HG11 ' CG2' ' A' ' 72' ' ' THR . 51.1 t -61.7 -50.99 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 106.342 -1.725 . . . . 65.03 106.342 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -50.86 -48.36 60.12 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.756 1.622 . . . . 71.22 111.101 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.71 -42.56 99.71 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.729 1.211 . . . . 73.42 109.179 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 81.5 m -65.0 -38.45 90.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.857 1.263 . . . . 52.42 110.807 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.9 t -73.35 -39.81 55.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 121.339 -0.85 . . . . 62.11 109.66 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -65.19 -38.97 92.18 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.474 1.51 . . . . 60.2 111.015 -178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.7 ptm180 -77.58 -35.53 52.92 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.592 -0.892 . . . . 61.53 108.592 177.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -57.17 -57.59 11.91 Favored 'General case' 0 C--O 1.233 0.226 0 O-C-N 121.255 -0.903 . . . . 74.31 110.53 178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.47 -23.95 59.06 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.429 0.692 . . . . 74.54 111.179 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.21 -12.11 59.24 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 117.845 -1.074 . . . . 50.51 111.464 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.06 22.7 51.67 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 118.786 -1.008 . . . . 73.51 112.317 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -67.25 172.99 4.19 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 118.635 1.217 . . . . 61.44 111.101 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 65.4 mt-10 -77.19 144.59 38.21 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.822 1.649 . . . . 74.02 109.985 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -137.43 110.11 7.56 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.895 1.278 . . . . 61.33 107.804 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.5 m -92.97 167.99 11.44 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.503 -1.226 . . . . 71.2 110.169 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -94.21 158.81 35.32 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 124.671 1.189 . . . . 74.22 109.221 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -67.99 166.99 22.87 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 123.473 2.782 . . . . 51.35 114.483 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.42 143.92 89.61 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.025 1.817 . . . . 63.12 108.147 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.12 3.45 88.33 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.094 -0.837 . . . . 45.32 112.915 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -84.36 -41.37 16.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 119.425 1.613 . . . . 74.33 110.981 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 C--O 1.254 1.302 0 CA-C-O 118.013 -0.994 . . . . 72.11 110.86 -179.091 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.169 0 N-CA-C 108.79 -1.724 . . . . 70.44 108.79 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -70.91 168.79 16.15 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.189 0.995 . . . . 72.25 109.031 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 55.1 mtt -147.91 169.52 19.65 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 126.952 2.101 . . . . 75.2 106.452 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 127.04 -82.06 0.35 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 109.239 -1.544 . . . . 71.34 109.239 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -61.82 127.81 22.56 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.77 2.314 . . . . 72.54 109.922 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -159.43 169.88 22.98 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.849 2.06 . . . . 73.24 107.141 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.34 -171.37 28.77 Favored Glycine 0 CA--C 1.521 0.469 0 N-CA-C 110.365 -1.094 . . . . 73.25 110.365 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.2 m -159.03 165.3 34.31 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.491 1.916 . . . . 55.41 107.094 179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 14.0 t -160.75 -171.12 2.98 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.532 -1.285 . . . . 54.35 107.532 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -129.73 179.12 6.02 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.84 2.056 . . . . 74.13 107.369 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -136.25 156.15 49.08 Favored 'General case' 0 N--CA 1.464 0.267 0 O-C-N 121.343 -0.848 . . . . 70.02 109.45 179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.98 92.93 3.02 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.052 -1.832 . . . . 42.33 106.052 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -134.71 159.54 40.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.843 1.657 . . . . 74.43 108.04 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.8 mmp_? 51.15 19.54 0.73 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.633 1.173 . . . . 74.4 113.653 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -60.84 -66.58 0.51 Allowed 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 120.27 1.396 . . . . 73.14 110.766 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -61.89 148.12 44.52 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.19 -0.671 . . . . 73.52 109.19 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -58.69 157.65 20.51 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 123.648 0.642 . . . . 74.14 111.972 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.4 135.7 33.4 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.127 -1.064 . . . . 74.32 108.127 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -66.44 153.9 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 107.322 -1.362 . . . . 65.53 107.322 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -90.2 167.82 12.41 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.156 -0.965 . . . . 72.11 110.283 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 82.53 163.76 33.76 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 126.195 1.855 . . . . 54.32 111.638 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 58.18 36.24 81.44 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.808 -0.517 . . . . 75.3 111.808 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -82.82 149.02 58.95 Favored Pre-proline 0 CA--C 1.539 0.529 0 O-C-N 121.849 -0.795 . . . . 74.21 109.389 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -78.3 125.93 7.36 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.568 2.845 . . . . 74.1 110.321 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.1 m -118.92 143.61 29.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-O 122.747 1.26 . . . . 45.15 111.731 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p -112.04 161.02 16.93 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.579 1.951 . . . . 70.33 109.197 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.7 m -52.67 -38.96 61.38 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.82 1.248 . . . . 71.12 111.917 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -59.47 -31.67 69.54 Favored 'General case' 0 C--O 1.226 -0.183 0 C-N-CA 124.483 1.113 . . . . 71.22 112.317 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 91.6 mtp -71.91 -45.87 59.68 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 108.455 -0.943 . . . . 63.24 108.455 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.4 t -59.98 -52.33 62.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.893 0.877 . . . . 73.42 109.883 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.53 -41.1 98.49 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-O 117.342 -1.313 . . . . 74.34 110.315 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.475 ' CG2' HG11 ' A' ' 95' ' ' VAL . 61.3 m -52.6 -60.38 3.32 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 120.602 1.546 . . . . 70.44 108.71 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.473 HG23 HG13 ' A' ' 95' ' ' VAL . 92.8 t -55.27 -50.53 64.02 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.739 0 CA-C-O 118.052 -0.975 . . . . 61.22 109.206 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -54.72 -44.41 73.48 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 119.716 1.144 . . . . 71.31 113.838 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -59.88 -43.77 94.57 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.931 1.293 . . . . 45.53 108.64 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 34.9 mt -81.59 -26.82 34.62 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.049 0.759 . . . . 54.34 113.049 -179.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -121.93 73.39 35.27 Favored Pre-proline 0 N--CA 1.447 -0.578 0 C-N-CA 127.655 2.382 . . . . 72.53 111.498 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.81 -3.6 13.48 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.522 2.148 . . . . 64.22 111.312 178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.11 18.68 10.35 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 128.345 2.658 . . . . 61.12 111.094 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.7 mt -133.83 154.82 50.75 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.351 1.461 . . . . 74.05 111.001 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 39.7 t-80 -80.53 142.32 53.58 Favored Pre-proline 0 C--O 1.236 0.383 0 N-CA-C 107.416 -1.327 . . . . 72.32 107.416 178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HA ' HD12 ' A' ' 85' ' ' ILE . 37.0 Cg_endo -66.33 -29.02 46.63 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.642 2.228 . . . . 64.41 113.022 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -75.43 -41.1 56.74 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.756 -0.59 . . . . 74.12 110.809 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -59.73 -41.92 91.97 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.634 -0.506 . . . . 63.52 109.634 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 82' ' ' PRO . 86.3 mt -51.36 -58.51 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 124.066 0.946 . . . . 72.13 108.984 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.05 -47.01 11.76 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.548 0.739 . . . . 73.54 111.619 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -64.53 -48.49 74.89 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.419 0.628 . . . . 73.11 111.489 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 66.4 m -56.92 -47.7 79.99 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 108.173 -1.047 . . . . 70.25 108.173 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 81.2 mt -57.52 -39.74 77.23 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 124.584 1.154 . . . . 74.45 111.095 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -66.94 -31.64 72.35 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.168 0.44 . . . . 75.42 110.784 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -77.66 -50.59 12.15 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 112.209 0.448 . . . . 72.35 112.209 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.2 p -74.58 -41.94 59.62 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.952 1.701 . . . . 43.13 112.794 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 90.14 -12.02 69.11 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 126.671 2.081 . . . . 71.4 116.507 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 t -145.32 123.1 11.9 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 121.467 2.633 . . . . 64.41 111.706 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.475 HG11 ' CG2' ' A' ' 72' ' ' THR . 84.6 t -41.88 -41.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 120.366 1.439 . . . . 72.05 112.819 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -49.89 -43.61 49.55 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 124.694 1.246 . . . . 73.54 111.67 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 21.0 tp10 -67.63 -42.83 81.68 Favored 'General case' 0 C--O 1.223 -0.302 0 O-C-N 121.092 -1.005 . . . . 71.13 109.489 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.8 m -60.45 -39.01 86.0 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.131 0.572 . . . . 74.21 111.114 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 57.5 t -70.36 -39.1 76.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.21 -0.663 . . . . 54.12 109.21 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -66.83 -41.02 88.13 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.622 0.769 . . . . 75.33 111.456 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -75.4 -35.36 61.04 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 121.104 -0.997 . . . . 63.31 109.619 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -57.4 -57.4 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.212 -0.93 . . . . 72.35 110.009 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.69 -22.16 56.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.951 0.722 . . . . 74.4 112.951 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.32 -5.19 56.53 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.796 0.725 . . . . 64.24 110.953 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.15 36.81 50.28 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 118.519 0.6 . . . . 73.43 112.322 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -69.98 -178.46 1.6 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.211 1.006 . . . . 72.04 111.013 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.75 131.26 35.21 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.698 -1.251 . . . . 63.23 110.257 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -130.92 109.89 10.87 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 106.462 -1.681 . . . . 74.52 106.462 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.3 m -96.79 168.6 10.4 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.707 0.803 . . . . 54.22 110.084 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -91.23 155.91 44.16 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 107.326 -1.361 . . . . 73.44 107.326 177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -69.57 168.51 21.1 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 122.759 2.306 . . . . 53.44 113.722 -179.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.33 149.44 91.23 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.37 2.047 . . . . 72.13 108.921 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.12 -12.07 13.7 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.564 -1.131 . . . . 62.34 113.207 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -68.96 -24.41 64.25 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.715 1.758 . . . . 74.3 109.381 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 . . . . . 0 C--O 1.254 1.32 0 C-N-CA 130.757 3.623 . . . . 71.15 105.212 178.183 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.264 0 N-CA-C 109.267 -1.533 . . . . 60.34 109.267 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.39 120.47 13.38 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.232 1.016 . . . . 73.02 108.347 179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.1 tpp -164.63 153.35 12.73 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 105.951 -1.87 . . . . 64.24 105.951 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 163.48 175.27 34.26 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.615 -0.994 . . . . 51.44 110.615 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.15 166.71 28.92 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.06 2.507 . . . . 72.22 110.702 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.84 -172.31 2.54 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 126.421 1.888 . . . . 75.32 109.752 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 171.54 -178.13 44.02 Favored Glycine 0 CA--C 1.525 0.66 0 O-C-N 121.432 -0.792 . . . . 44.52 111.266 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 12.7 m -67.86 21.16 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 128.274 2.63 . . . . 62.52 113.951 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.9 t 157.91 170.84 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.504 1 C-N-CA 132.681 4.392 . . . . 74.24 105.231 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 40.8 tp60 -111.27 156.69 21.12 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 105.748 -1.945 . . . . 63.4 105.748 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -60.69 158.77 12.0 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 109.47 -0.567 . . . . 71.4 109.47 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -128.51 174.2 9.57 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.933 1.293 . . . . 71.11 110.946 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.6 tt -64.01 144.5 57.05 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 107.377 -1.342 . . . . 74.21 107.377 178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.1 ttp85 -44.13 151.76 0.22 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.74 1.616 . . . . 64.12 111.818 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 55.77 46.56 22.15 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.606 1.162 . . . . 74.12 108.54 -178.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 t -56.7 -30.42 63.43 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.108 1.363 . . . . 64.54 111.71 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.8 -173.77 40.93 Favored Glycine 0 C--N 1.339 0.698 0 CA-C-N 119.309 0.959 . . . . 64.22 111.982 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -76.8 176.56 8.38 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.164 0.985 . . . . 74.44 110.898 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 p -144.19 156.51 15.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 105.629 -1.989 . . . . 75.21 105.629 178.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -65.68 152.02 45.19 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 122.921 0.488 . . . . 75.33 110.42 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 103.53 98.94 2.5 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 115.174 0.83 . . . . 72.14 115.174 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.92 82.7 0.66 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 124.917 1.246 . . . . 55.13 111.71 178.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 69.4 m-70 -111.12 160.36 29.31 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 125.51 1.524 . . . . 61.44 110.605 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.79 143.7 21.26 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.884 3.056 . . . . 71.41 111.127 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.0 m -134.17 167.07 27.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-O 122.026 0.917 . . . . 55.14 109.943 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 p -125.36 161.15 27.66 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.119 1.768 . . . . 72.42 107.802 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.5 m -57.96 -38.01 75.22 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.124 0.57 . . . . 74.42 110.588 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -35.9 69.45 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 119.336 -0.364 . . . . 63.42 111.63 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.0 mtp -64.29 -38.88 92.62 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.044 0.838 . . . . 70.32 109.537 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.0 t -63.96 -57.41 11.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 C-N-CA 124.552 1.141 . . . . 75.22 110.767 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -59.62 -40.23 86.86 Favored 'General case' 0 C--O 1.222 -0.377 0 CA-C-O 118.444 -0.789 . . . . 75.23 110.73 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.2 m -58.62 -58.21 9.58 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 120.321 1.419 . . . . 71.53 108.57 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.533 HG23 HG13 ' A' ' 95' ' ' VAL . 53.0 t -52.52 -50.23 40.66 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.384 0 CA-C-O 118.249 -0.881 . . . . 74.22 109.469 177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -54.08 -45.58 71.81 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.928 0.785 . . . . 53.51 111.375 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -59.49 -36.84 76.8 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.016 0.926 . . . . 74.1 110.688 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.0 mt -89.84 -14.92 33.35 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.034 0.753 . . . . 74.12 113.034 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.27 71.12 61.21 Favored Pre-proline 0 N--CA 1.448 -0.551 0 C-N-CA 126.927 2.091 . . . . 75.31 110.993 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.67 -15.41 49.19 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.286 1.99 . . . . 74.13 112.408 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.32 -13.86 59.85 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.072 1.349 . . . . 72.13 112.003 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.2 mt -92.05 156.48 17.37 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.315 0.961 . . . . 61.32 111.376 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.442 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 58.3 t-80 -80.42 146.11 60.94 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 106.474 -1.676 . . . . 74.13 106.474 178.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.442 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 36.4 Cg_endo -65.45 -30.16 52.97 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.092 1.862 . . . . 63.33 113.187 -178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.58 -34.92 46.51 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 121.77 -0.582 . . . . 72.41 110.863 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -64.47 -35.92 82.49 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.677 -0.86 . . . . 71.14 108.677 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 81.3 mt -54.94 -60.82 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 C-N-CA 124.583 1.153 . . . . 73.32 109.749 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -46.63 -48.64 19.85 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 118.558 0.617 . . . . 74.22 110.8 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.405 ' CE1' ' HD3' ' A' ' 112' ' ' PRO . 4.1 t80 -59.37 -44.9 92.67 Favored 'General case' 0 C--O 1.245 0.862 0 CA-C-O 121.812 0.815 . . . . 73.33 112.391 -178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.7 p -62.79 -43.4 98.89 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 116.165 -0.47 . . . . 73.22 110.01 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.431 HD21 ' CG2' ' A' ' 73' ' ' VAL . 52.0 mt -60.35 -38.47 83.91 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 121.816 -0.552 . . . . 72.22 111.678 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -70.57 -28.44 64.9 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.169 0.587 . . . . 73.2 109.834 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -85.33 -43.59 13.56 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 114.453 1.279 . . . . 75.4 114.453 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.7 p -79.57 -41.44 27.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.692 1.197 . . . . 63.43 111.411 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.51 0.86 88.02 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-O 118.745 -1.031 . . . . 64.25 112.379 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.27 129.5 18.74 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.393 1.477 . . . . 63.11 111.297 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.533 HG13 HG23 ' A' ' 73' ' ' VAL . 44.3 t -61.56 -46.51 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 105.551 -2.018 . . . . 74.45 105.551 177.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -55.89 -45.66 78.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.48 -0.772 . . . . 74.12 110.013 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -59.03 -43.8 91.67 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.74 0.7 . . . . 64.54 110.029 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.1 m -61.17 -42.41 98.51 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.297 1.839 . . . . 63.43 110.872 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 86.0 t -74.63 -38.27 45.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 121.672 -0.642 . . . . 75.02 109.966 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -66.62 -37.49 84.97 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 125.191 1.396 . . . . 72.02 111.056 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -77.81 -39.58 43.31 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 107.861 -1.162 . . . . 74.0 107.861 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -55.23 -52.07 64.56 Favored 'General case' 0 CA--C 1.518 -0.27 0 O-C-N 120.564 -1.335 . . . . 71.43 111.908 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.5 -16.13 33.97 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 113.662 0.986 . . . . 73.22 113.662 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.58 -11.66 42.05 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.813 0.845 . . . . 73.3 109.569 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.72 28.45 32.14 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 118.707 -1.052 . . . . 62.11 111.375 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -64.33 -178.22 0.35 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.859 1.263 . . . . 74.23 112.987 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -87.08 137.91 31.94 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 126.449 1.9 . . . . 64.23 111.549 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -141.85 109.91 5.87 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.19 1.396 . . . . 75.21 111.93 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 25.2 m -83.11 176.95 8.82 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.843 0.857 . . . . 73.25 110.369 177.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -105.54 157.17 35.13 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 127.366 2.266 . . . . 62.11 107.308 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.42 154.5 73.64 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.125 1.883 . . . . 73.44 112.197 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.405 ' HD3' ' CE1' ' A' ' 87' ' ' TYR . 36.4 Cg_endo -60.98 123.34 12.73 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 124.457 3.438 . . . . 72.44 110.703 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 101.8 -4.22 53.13 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 124.842 1.21 . . . . 41.43 111.811 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -78.22 -34.37 49.32 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 119.83 1.815 . . . . 64.14 109.606 178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 . . . . . 0 C--O 1.247 0.937 0 C-N-CA 125.452 1.501 . . . . 72.21 111.542 -178.526 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.732 0 N-CA-C 109.965 -1.254 . . . . 53.04 109.965 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -154.88 -178.39 7.19 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 128.027 2.531 . . . . 71.33 105.793 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 26.1 ttt -152.77 -48.45 0.1 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 118.822 0.737 . . . . 53.14 111.17 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 64.1 62.29 5.32 Favored Glycine 0 CA--C 1.533 1.162 0 CA-C-O 118.437 -1.201 . . . . 51.24 110.58 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.25 132.94 31.12 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 123.189 2.592 . . . . 64.35 111.995 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.0 mm-40 -76.48 162.97 27.39 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 108.193 -1.04 . . . . 74.23 108.193 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 167.68 68.47 0.03 OUTLIER Glycine 0 C--O 1.228 -0.245 0 N-CA-C 108.638 -1.785 . . . . 74.03 108.638 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 9.6 t -152.25 -172.19 4.16 Favored 'General case' 0 C--O 1.241 0.624 0 C-N-CA 126.503 1.921 . . . . 62.34 106.608 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.9 p -79.75 113.49 17.94 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.447 -1.316 . . . . 55.25 107.447 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -64.63 121.73 15.16 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.877 -1.157 . . . . 72.44 107.877 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.17 98.35 2.13 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 117.114 2.265 . . . . 70.44 117.114 -177.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.37 133.44 48.72 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.071 -1.455 . . . . 22.42 107.071 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -136.08 0.38 2.6 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.11 1.364 . . . . 75.53 113.344 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -117.76 105.6 12.16 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.54 1.536 . . . . 75.5 110.34 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -67.51 157.36 34.47 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.539 1.536 . . . . 72.21 109.682 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.5 p -121.07 -92.22 0.54 Allowed 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.163 -1.421 . . . . 74.42 107.163 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 159.31 -54.38 0.36 Allowed Glycine 0 C--N 1.335 0.485 0 CA-C-N 118.886 0.766 . . . . 62.35 113.576 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -71.49 179.74 2.86 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 117.677 0.739 . . . . 73.12 109.322 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.3 p -121.59 -27.09 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 C-N-CA 123.758 0.823 . . . . 73.54 112.858 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 53.97 -13.99 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 130.608 3.563 . . . . 65.02 117.766 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 151.23 114.59 0.64 Allowed Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 104.387 -3.485 . . . . 45.51 104.387 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -152.69 98.44 0.18 Allowed Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 109.623 -1.391 . . . . 71.21 109.623 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -114.86 156.95 44.38 Favored Pre-proline 0 C--N 1.321 -0.664 0 C-N-CA 126.274 1.83 . . . . 74.43 107.291 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.28 142.44 27.05 Favored 'Trans proline' 0 N--CA 1.449 -1.136 0 C-N-CA 121.99 1.793 . . . . 53.04 108.96 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.12 160.89 40.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.187 0.995 . . . . 70.2 108.323 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -124.62 159.11 31.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.296 -1.742 . . . . 65.14 106.296 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 24.6 m -59.73 -30.02 68.54 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 120.961 -1.087 . . . . 61.34 112.543 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -33.57 68.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.465 1.029 . . . . 74.25 111.047 179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 97.1 mtp -66.96 -43.37 83.28 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 121.229 -0.919 . . . . 72.51 108.61 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 t -57.1 -56.36 15.3 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 125.184 1.394 . . . . 74.41 110.827 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -59.09 -38.57 79.81 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 117.704 -1.141 . . . . 55.53 109.464 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.4 m -56.59 -58.97 5.77 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 120.278 1.399 . . . . 71.14 110.393 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.9 t -53.55 -45.77 59.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.452 0 CA-C-N 119.384 0.993 . . . . 74.54 109.037 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.07 -50.14 67.43 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.209 0.913 . . . . 70.32 112.687 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -58.85 -40.87 85.54 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.693 0.797 . . . . 65.32 110.98 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 26.9 mt -83.9 -22.54 31.55 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.663 0.616 . . . . 63.41 112.663 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -131.17 72.54 81.35 Favored Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 127.104 2.162 . . . . 71.11 109.826 -178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -69.54 -6.26 18.06 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 124.007 3.138 . . . . 61.4 113.964 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.6 4.89 50.04 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 120.82 -1.175 . . . . 71.12 111.016 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.3 mt -109.93 161.02 15.89 Favored 'General case' 0 C--O 1.232 0.169 0 O-C-N 120.678 -1.264 . . . . 51.55 110.419 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -81.89 144.9 52.45 Favored Pre-proline 0 N--CA 1.453 -0.317 0 C-N-CA 124.604 1.162 . . . . 63.34 108.551 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.539 ' HA ' HD12 ' A' ' 85' ' ' ILE . 56.7 Cg_endo -70.6 -25.32 24.85 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 123.009 2.473 . . . . 74.11 113.634 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.65 -39.17 32.04 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.665 0.666 . . . . 75.45 110.328 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -57.29 -44.2 83.84 Favored 'General case' 0 C--N 1.343 0.312 0 C-N-CA 123.034 0.534 . . . . 75.13 110.629 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 82' ' ' PRO . 59.9 mt -47.56 -54.75 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 C-N-CA 125.04 1.336 . . . . 70.23 112.471 -177.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.43 -46.34 37.49 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.34 0.518 . . . . 73.4 111.475 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -65.29 -42.74 92.8 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.633 -0.667 . . . . 74.04 111.263 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 14.5 m -60.0 -47.01 87.6 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 122.922 0.489 . . . . 73.5 109.721 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.41 -37.41 85.7 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 123.826 0.85 . . . . 63.12 110.697 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -69.92 -34.31 73.32 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.594 0.633 . . . . 74.22 110.38 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -74.87 -46.99 32.53 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 123.575 0.75 . . . . 61.33 112.485 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.9 p -77.77 -41.03 38.87 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.321 1.049 . . . . 70.32 111.49 -179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.92 -14.01 64.43 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 127.413 2.435 . . . . 61.4 112.588 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.2 m -144.09 150.08 37.57 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 120.115 1.957 . . . . 45.52 112.658 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.9 t -64.68 -50.97 73.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 126.275 1.83 . . . . 74.02 107.148 178.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -49.99 -46.76 52.9 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.151 1.38 . . . . 73.33 109.987 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -65.07 -46.57 80.6 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.374 0.67 . . . . 75.25 109.936 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 89.0 m -59.05 -37.07 76.14 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.873 1.269 . . . . 75.45 111.729 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.2 t -77.55 -36.72 23.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 123.62 0.768 . . . . 74.05 109.583 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -66.16 -35.33 80.2 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 125.151 1.38 . . . . 72.1 110.873 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -81.4 -36.12 29.89 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.94 -1.1 . . . . 74.32 108.608 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -56.67 -55.36 35.05 Favored 'General case' 0 C--N 1.331 -0.227 0 O-C-N 121.614 -0.679 . . . . 74.33 110.366 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -59.87 -19.97 54.41 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 113.34 0.867 . . . . 74.11 113.34 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.27 -13.22 41.43 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.105 0.562 . . . . 61.15 110.426 179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.25 20.98 39.86 Favored Glycine 0 C--N 1.34 0.789 0 CA-C-O 118.921 -0.933 . . . . 64.4 113.469 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -63.71 174.35 1.42 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.442 1.097 . . . . 74.53 111.221 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -83.12 141.54 31.9 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.673 1.189 . . . . 75.35 111.712 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -128.58 109.91 11.78 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.268 1.827 . . . . 70.33 108.433 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.2 m -93.78 173.9 7.45 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 124.205 1.002 . . . . 61.11 111.404 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -105.03 156.62 35.8 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.963 1.305 . . . . 73.13 108.873 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.65 158.59 56.47 Favored 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.75 2.3 . . . . 75.21 114.488 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.39 116.82 4.7 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 105.769 -2.435 . . . . 73.35 105.769 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 124.25 -17.62 7.47 Favored Glycine 0 CA--C 1.522 0.502 0 CA-C-O 117.683 -1.621 . . . . 75.2 111.83 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -66.09 -27.75 68.3 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 118.577 1.189 . . . . 74.5 111.803 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 . . . . . 0 C--O 1.248 1.018 0 N-CA-C 105.167 -2.16 . . . . 72.04 105.167 178.363 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.542 0 N-CA-C 110.737 -0.945 . . . . 71.45 110.737 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.14 171.38 13.67 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 109.195 -0.669 . . . . 55.21 109.195 178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 21.1 ptp -130.25 -5.21 4.35 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.24 1.016 . . . . 73.34 111.564 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.33 -175.19 46.96 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.158 0.885 . . . . 61.53 111.437 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -64.61 166.41 17.8 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.828 2.352 . . . . 72.32 111.6 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -126.97 169.82 12.93 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 126.03 1.732 . . . . 72.44 109.992 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.36 -127.68 2.66 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 108.553 -1.819 . . . . 73.22 108.553 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.19 87.45 3.05 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.937 -1.134 . . . . 64.44 107.937 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.3 p -71.33 112.48 7.49 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.666 -1.235 . . . . 63.03 107.666 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -130.53 157.04 43.76 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 121.232 -0.917 . . . . 73.04 108.72 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -158.25 162.29 37.81 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.329 1.052 . . . . 71.01 110.1 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.96 101.08 0.35 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.869 1.268 . . . . 73.14 110.522 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.4 tp -150.31 173.14 14.32 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.451 0.7 . . . . 73.23 109.26 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -82.15 -34.05 29.3 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.753 0.649 . . . . 74.24 112.753 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -72.37 154.72 40.77 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 107.209 -1.404 . . . . 75.35 107.209 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 34.5 p -141.63 17.48 2.18 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.256 0.622 . . . . 65.41 112.061 -178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.94 -76.24 0.31 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 107.266 -2.334 . . . . 72.23 107.266 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.69 165.72 33.5 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 123.736 0.814 . . . . 73.41 108.82 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.9 t -131.58 96.95 2.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 104.157 -2.534 . . . . 73.22 104.157 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -140.13 -171.93 3.3 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 127.608 2.363 . . . . 71.13 107.457 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -97.01 -86.97 1.82 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 124.693 1.139 . . . . 62.54 110.827 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -158.66 -100.69 0.17 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.561 -1.016 . . . . 71.41 110.561 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -105.64 159.57 29.1 Favored Pre-proline 0 C--N 1.326 -0.438 0 C-N-CA 127.032 2.133 . . . . 64.21 110.409 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.67 133.89 16.12 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.701 2.934 . . . . 75.21 108.905 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 m -134.85 152.6 33.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 123.644 0.778 . . . . 65.42 109.942 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -125.35 164.04 21.26 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.706 1.203 . . . . 65.21 110.488 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 22.6 m -45.54 -47.46 14.34 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 127.154 2.181 . . . . 70.1 112.313 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -57.53 -34.59 69.29 Favored 'General case' 0 C--O 1.226 -0.173 0 C-N-CA 123.715 0.806 . . . . 61.44 112.761 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 84.4 mtp -67.93 -39.78 83.43 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.968 -0.753 . . . . 74.53 108.968 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 t -58.88 -57.41 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 125.037 1.335 . . . . 71.2 110.485 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -58.6 -42.08 87.28 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-O 117.989 -1.005 . . . . 72.33 110.02 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -55.78 -60.13 3.89 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 120.057 1.299 . . . . 74.45 109.841 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.0 t -51.67 -49.49 34.65 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-O 118.836 -0.602 . . . . 75.55 109.969 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -51.26 -48.16 62.24 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 123.516 0.726 . . . . 73.13 112.211 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 56.4 m-80 -59.49 -43.41 93.33 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.506 -0.553 . . . . 62.44 109.506 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.7 mt -80.41 -13.07 59.44 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 112.972 0.73 . . . . 73.11 112.972 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -140.14 69.86 34.54 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.993 2.117 . . . . 71.33 110.861 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.28 -2.86 9.76 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.164 2.576 . . . . 72.53 113.254 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -86.69 -10.88 52.77 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.629 1.572 . . . . 53.5 110.465 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.69 158.52 15.46 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 121.494 -0.754 . . . . 63.42 112.277 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -81.93 147.14 57.38 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.971 -1.122 . . . . 73.23 107.971 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.94 -29.97 67.13 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.392 2.061 . . . . 72.42 112.837 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.28 -39.43 28.87 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 121.946 -0.471 . . . . 62.12 112.173 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -60.66 -41.42 94.98 Favored 'General case' 0 C--N 1.341 0.236 0 N-CA-C 109.62 -0.511 . . . . 60.12 109.62 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.1 mt -51.86 -59.43 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 C-N-CA 123.556 0.742 . . . . 71.42 109.09 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.95 -44.75 30.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.425 0.69 . . . . 74.33 111.388 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -65.92 -43.42 88.18 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.145 -0.972 . . . . 72.44 112.817 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 50.7 m -66.99 -37.65 84.61 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.346 -0.983 . . . . 63.05 108.346 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 74.4 mt -61.25 -38.19 85.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.547 -1.279 . . . . 63.51 107.547 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -67.58 -34.44 77.03 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 118.949 0.795 . . . . 75.12 109.676 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -71.74 -51.85 20.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 119.008 -0.52 . . . . 61.0 112.364 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.9 p -74.77 -40.99 60.87 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.497 1.519 . . . . 54.13 112.708 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.66 -4.14 86.18 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.624 1.107 . . . . 71.42 111.447 -178.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -144.48 135.03 24.67 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.806 1.803 . . . . 62.33 111.836 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 23.2 t -55.12 -52.43 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.9 1.68 . . . . 74.25 108.631 178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -47.55 -47.45 28.15 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 126.571 1.949 . . . . 74.23 111.574 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -65.21 -44.65 87.65 Favored 'General case' 0 C--O 1.223 -0.302 0 N-CA-C 109.17 -0.678 . . . . 73.43 109.17 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.3 m -56.92 -43.01 80.98 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.827 1.251 . . . . 71.22 111.319 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 32.0 t -73.89 -36.1 44.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 120.717 -1.239 . . . . 63.43 109.519 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -65.78 -45.09 83.76 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.584 1.154 . . . . 74.25 110.383 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -69.06 -36.43 77.64 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 120.748 -1.22 . . . . 72.2 108.681 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -58.25 -57.22 13.86 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.68 -0.489 . . . . 61.33 109.68 177.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.15 -23.3 63.8 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 118.912 -0.566 . . . . 73.12 111.927 178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 ptm85 -82.83 -12.07 57.73 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 119.408 1.004 . . . . 65.42 110.598 178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.11 22.91 39.76 Favored Glycine 0 C--N 1.339 0.695 0 C-N-CA 125.83 1.681 . . . . 45.35 113.65 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.4 169.08 14.71 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.856 1.328 . . . . 70.44 110.742 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -80.32 146.85 31.37 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 113.698 0.999 . . . . 70.42 113.698 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -130.32 109.92 11.13 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 125.011 1.324 . . . . 73.24 107.826 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 14.7 m -87.66 176.54 7.38 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.213 -1.358 . . . . 64.11 108.802 178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -108.27 156.18 38.94 Favored Pre-proline 0 N--CA 1.467 0.379 0 C-N-CA 124.462 1.105 . . . . 72.3 109.193 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.62 157.24 59.28 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.76 2.307 . . . . 74.12 112.661 -179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -61.7 149.82 88.32 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.748 1.632 . . . . 70.52 108.604 178.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 92.08 -16.41 59.67 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 118.575 -1.125 . . . . 65.44 111.733 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -77.9 -43.49 29.91 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 119.132 1.466 . . . . 71.14 108.708 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 . . . . . 0 C--O 1.246 0.871 0 CA-C-O 117.481 -1.247 . . . . 73.44 109.277 178.411 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.423 0 N-CA-C 109.812 -1.315 . . . . 62.24 109.812 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.33 75.06 9.27 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.463 -1.31 . . . . 52.21 107.463 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 81.4 mmm -58.55 -41.6 85.95 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.735 1.614 . . . . 74.23 110.643 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.49 71.23 0.94 Allowed Glycine 0 CA--C 1.53 1.009 0 CA-C-O 118.912 -0.938 . . . . 23.33 111.474 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -70.74 -177.31 2.12 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.319 2.679 . . . . 62.4 111.246 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -87.97 -170.25 2.91 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.715 1.206 . . . . 74.22 108.421 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.17 -66.98 0.01 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 106.862 -2.495 . . . . 41.33 106.862 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -138.49 -170.87 2.92 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 126.459 1.904 . . . . 44.23 106.873 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.1 p -100.13 160.22 14.5 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 105.667 -1.975 . . . . 71.41 105.667 178.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -138.98 73.92 1.45 Allowed 'General case' 0 C--O 1.232 0.154 0 N-CA-C 107.261 -1.385 . . . . 62.21 107.261 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -93.06 146.73 23.42 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.046 -1.094 . . . . 74.2 108.046 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.36 160.04 42.99 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.958 1.303 . . . . 45.2 108.873 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -102.5 -5.53 23.91 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 113.784 1.031 . . . . 74.12 113.784 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -135.84 134.94 39.38 Favored 'General case' 0 C--O 1.234 0.254 0 O-C-N 121.049 -1.032 . . . . 62.42 110.573 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.08 179.36 6.3 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.698 1.999 . . . . 72.24 109.779 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.6 p -128.75 99.5 5.35 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.964 1.706 . . . . 63.31 108.532 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 50.27 76.49 0.16 Allowed Glycine 0 C--N 1.34 0.795 0 C-N-CA 126.465 1.983 . . . . 64.33 111.803 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.89 132.4 11.59 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 115.609 1.707 . . . . 71.12 115.609 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.2 p -69.11 176.77 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 C-N-CA 126.786 2.035 . . . . 71.22 110.009 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -139.62 -178.34 5.36 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.16 1.384 . . . . 74.13 109.859 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -155.1 -87.29 0.06 OUTLIER Glycine 0 C--N 1.333 0.37 0 N-CA-C 110.352 -1.099 . . . . 74.23 110.352 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -93.76 -148.54 23.89 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-O 122.8 1.222 . . . . 54.34 111.099 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -114.15 152.11 45.57 Favored Pre-proline 0 C--N 1.322 -0.594 0 C-N-CA 127.227 2.211 . . . . 71.12 110.088 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.53 126.78 9.23 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.736 2.957 . . . . 61.43 109.12 179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 m -122.83 162.16 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 C-N-CA 123.156 0.583 . . . . 73.4 109.65 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.9 p -124.17 167.65 13.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.453 1.101 . . . . 62.52 110.178 -178.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.62 -43.46 72.27 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.6 1.16 . . . . 64.25 111.296 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -32.8 67.19 Favored 'General case' 0 N--CA 1.457 -0.097 0 C-N-CA 125.528 1.531 . . . . 71.22 111.655 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 93.5 mtp -67.07 -45.31 77.71 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.462 -0.94 . . . . 63.2 108.462 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 t -57.58 -57.24 11.09 Favored 'Isoleucine or valine' 0 C--N 1.344 0.327 0 CA-C-O 119.061 -0.495 . . . . 73.0 110.477 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -57.64 -39.93 78.11 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-O 117.638 -1.172 . . . . 71.43 111.138 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.405 ' CG2' HG11 ' A' ' 95' ' ' VAL . 40.8 m -56.34 -61.81 2.15 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 120.222 1.374 . . . . 74.42 108.29 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.6 t -57.26 -45.1 84.86 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 CA-C-N 119.16 0.891 . . . . 74.23 110.055 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -54.66 -39.03 67.65 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 120.451 1.478 . . . . 51.11 113.757 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -69.61 -44.6 70.38 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 108.103 -1.073 . . . . 53.32 108.103 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 37.6 mt -71.45 -28.4 63.93 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.054 -0.521 . . . . 64.5 111.207 -178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.13 75.76 67.65 Favored Pre-proline 0 C--O 1.238 0.475 0 C-N-CA 128.997 2.919 . . . . 74.24 111.001 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -72.61 -4.92 16.2 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.431 2.087 . . . . 63.22 111.148 178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -91.19 5.57 48.55 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.939 1.695 . . . . 70.14 112.417 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 64.3 mt -118.41 162.79 17.74 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.81 1.244 . . . . 70.32 110.817 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.421 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 49.7 t-80 -87.85 146.22 38.37 Favored Pre-proline 0 C--O 1.238 0.489 0 N-CA-C 107.386 -1.338 . . . . 71.43 107.386 178.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 33.7 Cg_endo -64.29 -23.76 65.58 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.667 2.245 . . . . 74.45 112.123 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -78.13 -43.58 28.46 Favored 'General case' 0 N--CA 1.444 -0.736 0 O-C-N 121.327 -0.858 . . . . 64.45 112.385 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -58.35 -45.51 88.03 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 108.777 -0.823 . . . . 51.44 108.777 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 63.8 mt -51.89 -59.07 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 C-N-CA 124.369 1.068 . . . . 73.51 108.491 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.33 -47.37 25.78 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.402 1.001 . . . . 75.42 112.161 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -65.85 -38.01 87.71 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 122.77 1.271 . . . . 70.14 111.675 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.5 t -62.48 -50.32 71.91 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.556 -1.276 . . . . 54.51 107.556 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 71.3 mt -57.91 -35.97 71.79 Favored 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 126.117 1.767 . . . . 71.43 109.333 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -67.86 -36.82 80.96 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-N 119.521 1.055 . . . . 74.3 109.526 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -76.87 -53.15 8.26 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.232 0.469 . . . . 61.43 111.992 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 67.7 p -67.01 -40.96 87.41 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.87 1.268 . . . . 53.14 110.897 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.92 -6.12 81.96 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.867 2.175 . . . . 63.14 113.247 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.5 m -144.28 143.75 31.16 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 119.163 1.482 . . . . 62.54 110.82 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.405 HG11 ' CG2' ' A' ' 72' ' ' THR . 42.2 t -61.96 -47.81 91.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 C-N-CA 126.184 1.793 . . . . 62.42 108.171 178.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -50.38 -48.51 55.78 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.204 1.002 . . . . 52.51 111.717 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.7 tp10 -63.78 -39.13 93.51 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.132 0.492 . . . . 73.31 109.939 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.5 m -63.77 -37.31 86.91 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.287 1.435 . . . . 75.42 110.498 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.8 t -73.09 -41.43 59.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 107.904 -1.147 . . . . 64.22 107.904 178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -63.3 -35.17 79.48 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.76 1.224 . . . . 74.44 111.693 -178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -81.01 -39.0 26.55 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.254 -0.647 . . . . 74.42 109.254 178.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -56.55 -52.67 63.89 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 121.53 -0.731 . . . . 75.25 111.333 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -60.94 -19.97 61.55 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.744 0.646 . . . . 75.0 112.744 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -86.6 -12.57 48.21 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 118.167 -0.92 . . . . 74.35 110.334 178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.81 37.06 13.98 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 108.63 -1.788 . . . . 74.23 108.63 -178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -74.84 172.36 12.34 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.582 -0.952 . . . . 72.42 110.999 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -78.99 131.61 36.37 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.423 1.089 . . . . 63.13 110.147 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -129.1 109.95 11.61 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.502 -1.296 . . . . 74.52 107.502 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.4 m -97.2 177.57 5.53 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 125.178 1.391 . . . . 64.15 108.954 178.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -104.84 158.64 31.58 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.42 1.088 . . . . 75.42 110.41 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.36 162.65 41.71 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.479 2.12 . . . . 52.43 112.97 -179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.68 133.98 45.03 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 122.383 2.055 . . . . 73.21 109.109 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.03 -11.52 64.02 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 118.811 -0.994 . . . . 73.03 112.641 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -77.17 -28.46 54.08 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.642 1.721 . . . . 71.32 111.717 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.021 -0.99 . . . . 61.44 110.334 -179.166 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.846 0 N-CA-C 108.845 -1.702 . . . . 71.15 108.845 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.47 -31.4 72.55 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.647 1.224 . . . . 43.11 111.077 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 71.0 mtm -92.99 83.47 4.72 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.328 -2.471 . . . . 72.21 104.328 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 174.88 62.53 0.05 OUTLIER Glycine 0 CA--C 1.529 0.921 0 CA-C-O 118.71 -1.05 . . . . 74.05 112.814 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.93 161.12 44.42 Favored 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.363 2.042 . . . . 45.54 109.596 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -60.04 155.4 17.02 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.94 0.896 . . . . 73.32 111.379 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.26 -170.06 21.35 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 124.574 1.083 . . . . 71.42 111.154 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.0 m -148.29 179.48 7.74 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.373 1.469 . . . . 64.15 109.476 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 p -126.58 4.59 6.82 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.067 2.147 . . . . 64.33 111.707 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.0 77.76 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 128.004 2.521 . . . . 73.41 113.186 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -77.86 -21.16 51.82 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 125.418 1.487 . . . . 65.33 109.875 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -96.36 127.91 42.79 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.51 -1.663 . . . . 71.43 106.51 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 31.7 mt -135.64 165.55 25.29 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 123.791 0.836 . . . . 74.53 110.14 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -42.71 118.47 1.24 Allowed 'General case' 0 C--O 1.24 0.566 0 C-N-CA 126.483 1.913 . . . . 73.52 111.321 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.5 mtp180 -89.28 104.32 16.88 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 104.868 -2.271 . . . . 64.13 104.868 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.2 m -127.69 139.21 52.85 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.954 -1.498 . . . . 74.53 106.954 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.27 173.79 14.45 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.282 -0.727 . . . . 74.32 111.282 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 20.8 mmm180 -119.78 178.6 4.53 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.941 1.296 . . . . 65.03 109.82 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.9 m -115.44 46.85 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 126.034 1.734 . . . . 44.2 108.144 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -81.44 71.38 8.44 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.598 -0.89 . . . . 63.21 108.598 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.51 -14.12 1.96 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 124.699 1.142 . . . . 73.43 114.915 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -173.98 -156.27 13.29 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 107.568 -2.213 . . . . 70.45 107.568 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -104.55 153.71 38.97 Favored Pre-proline 0 C--N 1.319 -0.727 0 C-N-CA 129.044 2.938 . . . . 73.12 108.193 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.86 140.51 32.02 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 122.038 1.825 . . . . 74.43 110.245 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.4 m -134.81 165.65 30.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 124.725 1.21 . . . . 64.12 108.707 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -124.31 163.62 21.3 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.541 1.537 . . . . 74.21 108.247 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.4 m -55.06 -42.35 72.64 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.406 1.482 . . . . 73.43 110.409 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -56.31 -33.31 65.44 Favored 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 125.345 1.458 . . . . 73.4 112.197 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.4 mtp -68.55 -41.42 79.81 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.939 1.245 . . . . 65.01 109.518 179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.8 t -59.23 -54.86 28.49 Favored 'Isoleucine or valine' 0 C--N 1.342 0.262 0 C-N-CA 123.988 0.915 . . . . 65.5 109.286 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -60.08 -37.17 79.13 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 117.562 -1.209 . . . . 62.23 110.59 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 39.5 m -55.15 -64.41 0.85 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 120.748 1.613 . . . . 70.22 108.555 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 63.7 t -53.52 -45.94 59.21 Favored 'Isoleucine or valine' 0 C--N 1.345 0.375 0 CA-C-O 118.184 -0.912 . . . . 63.42 110.313 178.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.1 tp60 -55.69 -48.63 74.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 119.342 0.974 . . . . 74.14 112.29 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -57.97 -43.33 86.44 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.164 0.586 . . . . 71.31 109.446 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 17.9 mt -80.54 -18.6 47.92 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.868 0.692 . . . . 62.2 112.868 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.14 76.44 77.94 Favored Pre-proline 0 C--O 1.239 0.508 0 C-N-CA 127.428 2.291 . . . . 51.45 110.118 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.05 -15.1 42.67 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 121.695 1.596 . . . . 53.24 111.698 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.66 -22.74 53.61 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 127.324 2.249 . . . . 72.12 112.907 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.5 mt -85.14 156.36 21.07 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 114.008 1.114 . . . . 73.43 114.008 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -74.54 145.66 82.56 Favored Pre-proline 0 C--O 1.236 0.355 0 N-CA-C 107.192 -1.41 . . . . 73.41 107.192 178.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.52 -26.8 46.77 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.482 2.121 . . . . 74.13 114.096 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.33 -37.66 18.25 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 109.888 -0.412 . . . . 73.14 109.888 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -58.99 -36.97 75.79 Favored 'General case' 0 C--N 1.346 0.45 0 N-CA-C 109.499 -0.556 . . . . 75.12 109.499 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 74.0 mt -58.07 -61.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 108.092 -1.077 . . . . 52.02 108.092 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.6 tmm_? -48.27 -50.22 30.62 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 119.155 0.888 . . . . 75.42 110.876 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -60.39 -41.39 93.74 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 119.401 -0.92 . . . . 74.45 112.513 -178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.6 t -63.01 -48.66 77.86 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 107.495 -1.298 . . . . 74.32 107.495 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.8 mt -55.09 -42.12 72.45 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.514 1.126 . . . . 74.33 111.176 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -66.67 -33.74 76.32 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.848 0.459 . . . . 73.23 110.177 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -82.21 -46.25 13.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 118.139 -0.934 . . . . 42.24 113.366 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.8 p -73.21 -41.3 63.95 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.361 1.464 . . . . 75.11 110.487 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 80.86 5.64 89.94 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 126.387 1.946 . . . . 23.51 112.357 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.8 m -142.63 127.13 17.85 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.913 1.357 . . . . 33.11 110.182 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.0 t -58.95 -49.35 83.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 105.846 -1.909 . . . . 64.33 105.846 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -52.99 -42.82 65.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.77 0.828 . . . . 74.35 111.209 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -61.14 -43.64 98.57 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 108.779 -0.823 . . . . 71.43 108.779 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 19.3 m -61.59 -40.38 94.56 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.849 2.06 . . . . 71.42 111.48 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.0 t -74.3 -37.07 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 O-C-N 121.29 -0.881 . . . . 74.32 108.856 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -69.36 -31.82 70.49 Favored 'General case' 0 C--O 1.231 0.11 0 C-N-CA 125.077 1.351 . . . . 65.1 112.225 -178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -83.12 -36.04 25.11 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.219 -1.03 . . . . 71.32 108.219 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -58.16 -56.09 26.48 Favored 'General case' 0 C--N 1.331 -0.198 0 O-C-N 121.39 -0.819 . . . . 75.21 109.805 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -57.5 -25.55 59.96 Favored 'General case' 0 C--N 1.338 0.108 0 CA-C-O 119.071 -0.49 . . . . 62.31 111.32 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.76 -8.2 59.3 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.742 0.701 . . . . 74.31 111.682 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.17 28.54 53.31 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 123.804 0.716 . . . . 53.41 111.704 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -67.14 173.81 3.56 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 117.207 0.503 . . . . 70.31 112.092 -179.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -80.98 140.57 35.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.895 1.278 . . . . 72.13 109.253 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -132.63 109.42 9.72 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.813 -1.551 . . . . 73.3 106.813 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 t -83.79 169.95 14.66 Favored 'General case' 0 C--O 1.24 0.574 0 O-C-N 121.638 -0.664 . . . . 63.42 110.386 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -100.38 150.26 36.78 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 125.069 1.347 . . . . 74.33 108.321 179.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.48 166.99 19.95 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.922 3.081 . . . . 62.34 113.97 -178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -63.32 139.91 74.12 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.064 2.509 . . . . 52.05 111.804 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 77.2 -0.29 68.34 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-O 118.457 -1.191 . . . . 43.21 113.878 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -70.58 -34.43 72.18 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 119.289 1.545 . . . . 70.32 109.027 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 126.857 2.063 . . . . 60.12 111.866 179.642 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.597 0 N-CA-C 110.79 -0.924 . . . . 60.22 110.79 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 45.15 68.28 0.59 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.346 2.258 . . . . 52.14 111.793 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.8 ptt? -114.76 0.32 13.79 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.56 0.744 . . . . 75.33 112.997 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 42.76 62.96 2.09 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 126.2 1.857 . . . . 52.44 115.292 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -61.03 -26.57 83.27 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.238 2.625 . . . . 74.22 114.043 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.9 tp60 -82.28 -15.33 53.37 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.778 -0.576 . . . . 74.22 110.086 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.8 -103.12 1.3 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 106.357 -2.697 . . . . 64.15 106.357 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.1 t -116.54 161.21 19.49 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.413 1.085 . . . . 74.33 109.718 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.6 p -77.78 51.18 0.91 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.827 2.051 . . . . 63.44 109.844 179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -73.31 159.53 33.24 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.57 1.948 . . . . 73.41 110.336 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -64.55 124.3 21.49 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.402 -0.962 . . . . 72.14 108.402 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.2 162.61 39.66 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.076 -1.453 . . . . 51.13 107.076 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.593 HD13 ' H ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -143.6 162.98 34.48 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 108.471 -0.937 . . . . 73.3 108.471 179.124 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.593 ' H ' HD13 ' A' ' 53' ' ' LEU . 48.8 ttp180 -71.44 122.09 19.76 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.307 -0.627 . . . . 72.35 109.307 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.69 151.58 46.21 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 106.283 -1.747 . . . . 52.32 106.283 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 m -129.37 109.97 11.53 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 106.966 -1.494 . . . . 74.02 106.966 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 179.76 41.45 0.07 OUTLIER Glycine 0 C--O 1.227 -0.307 0 N-CA-C 111.036 -0.826 . . . . 63.42 111.036 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.57 174.27 8.37 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.092 1.357 . . . . 71.14 109.094 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.7 t -46.35 155.94 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 128.554 2.742 . . . . 64.12 112.294 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -73.71 -172.27 1.22 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.817 1.247 . . . . 74.1 109.103 178.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.21 59.41 0.5 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 108.406 -1.878 . . . . 72.14 108.406 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -143.7 88.07 0.17 Allowed Glycine 0 C--N 1.334 0.47 0 N-CA-C 110.333 -1.107 . . . . 61.03 110.333 -179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -122.13 155.59 61.1 Favored Pre-proline 0 C--O 1.238 0.448 0 C-N-CA 125.391 1.476 . . . . 63.51 109.004 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.04 136.98 15.15 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.468 2.779 . . . . 63.32 109.874 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.4 m -128.26 158.2 40.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 O-C-N 121.4 -0.812 . . . . 64.2 110.436 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 p -125.43 163.39 22.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.039 1.336 . . . . 74.13 110.104 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 91.1 m -49.52 -45.8 47.75 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.743 1.617 . . . . 53.31 110.634 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -35.96 65.79 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.434 1.894 . . . . 74.32 112.75 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 95.7 mtp -68.48 -44.74 74.12 Favored 'General case' 0 N--CA 1.453 -0.297 0 O-C-N 120.985 -1.072 . . . . 71.41 109.231 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.1 t -60.98 -51.61 71.24 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.012 0.925 . . . . 72.02 110.815 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -61.48 -43.42 98.9 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-O 117.247 -1.358 . . . . 64.51 110.335 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.404 ' CG2' HG11 ' A' ' 95' ' ' VAL . 85.2 m -57.8 -55.87 29.33 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 120.949 1.704 . . . . 72.0 109.803 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.1 t -55.0 -46.85 77.29 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.55 0 CA-C-N 119.865 1.211 . . . . 74.01 109.084 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -56.08 -43.54 78.12 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 119.543 1.065 . . . . 75.53 112.205 -179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -61.91 -35.74 79.27 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.027 1.331 . . . . 73.31 111.838 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.6 mt -94.06 -12.78 27.82 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.969 1.308 . . . . 54.43 112.454 -179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.95 67.44 56.53 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 127.828 2.451 . . . . 71.42 108.468 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.76 -9.4 22.75 Favored 'Trans proline' 0 CA--C 1.536 0.613 0 C-N-CA 122.385 2.056 . . . . 62.22 112.763 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.17 -12.01 48.2 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.887 0.875 . . . . 71.45 111.73 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.1 mt -88.32 152.93 21.59 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 119.345 0.975 . . . . 74.22 111.902 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -72.94 140.07 80.45 Favored Pre-proline 0 N--CA 1.448 -0.565 0 N-CA-C 106.617 -1.623 . . . . 72.4 106.617 178.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.29 -23.44 44.87 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.985 2.457 . . . . 65.44 113.765 -178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.71 -40.09 17.76 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 118.42 0.554 . . . . 74.34 109.594 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -60.92 -40.32 92.71 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-O 118.141 -0.933 . . . . 54.1 109.658 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.9 mt -52.78 -56.49 7.2 Favored 'Isoleucine or valine' 0 C--N 1.344 0.346 0 C-N-CA 124.265 1.026 . . . . 33.41 109.42 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 5.1 tmm_? -45.67 -54.35 7.91 Favored 'General case' 0 N--CA 1.456 -0.156 0 CA-C-N 118.128 0.422 . . . . 55.43 110.867 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -61.64 -36.19 80.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.826 0.306 . . . . 73.41 111.826 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.2 m -61.42 -49.65 76.02 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.368 -0.975 . . . . 60.14 108.368 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 29.8 mt -59.69 -35.5 74.6 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.197 0.999 . . . . 75.41 110.478 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -67.75 -33.82 75.61 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.666 -0.494 . . . . 72.04 109.666 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -79.46 -50.2 11.14 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.862 1.265 . . . . 71.15 114.093 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.6 p -74.56 -41.77 59.97 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.53 1.532 . . . . 73.54 110.872 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.28 -18.1 58.0 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 127.947 2.689 . . . . 61.43 112.551 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.2 m -139.35 151.15 46.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 123.718 1.723 . . . . 54.21 112.235 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.404 HG11 ' CG2' ' A' ' 72' ' ' THR . 96.1 t -64.33 -47.44 89.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 113.008 -1.905 . . . . 72.33 107.989 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -50.91 -51.03 56.01 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.367 1.467 . . . . 70.51 110.204 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -62.82 -42.36 99.69 Favored 'General case' 0 C--O 1.227 -0.098 0 N-CA-C 109.863 -0.421 . . . . 74.44 109.863 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.1 m -60.36 -39.8 88.48 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.287 1.035 . . . . 70.15 111.833 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 70.8 t -74.59 -37.67 44.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 121.399 -0.813 . . . . 73.22 109.436 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -66.7 -38.13 86.14 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.483 1.113 . . . . 65.42 111.251 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 6.8 ptm180 -78.6 -33.87 47.14 Favored 'General case' 0 CA--C 1.531 0.25 0 O-C-N 121.493 -0.754 . . . . 75.11 109.216 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -59.62 -59.6 5.18 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 120.674 -1.266 . . . . 63.24 111.349 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.5 pp -56.54 -28.95 61.33 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.509 0.724 . . . . 71.41 111.93 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -18.7 56.4 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.757 -0.64 . . . . 74.22 110.936 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.9 28.05 14.92 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.581 -1.122 . . . . 71.35 112.357 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -68.34 -179.25 1.26 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.939 1.296 . . . . 75.2 111.83 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -82.6 144.06 30.59 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.78 1.232 . . . . 75.51 111.564 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -138.84 109.18 6.48 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.628 -0.878 . . . . 64.52 108.628 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.2 m -84.96 177.13 8.06 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.773 1.229 . . . . 62.33 110.903 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -111.66 153.9 44.14 Favored Pre-proline 0 CA--C 1.534 0.329 0 N-CA-C 105.683 -1.969 . . . . 75.45 105.683 176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -70.87 166.14 29.96 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.407 2.071 . . . . 53.44 111.641 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -63.03 156.17 56.37 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.404 2.069 . . . . 63.3 109.622 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 82.5 -28.53 3.43 Favored Glycine 0 CA--C 1.525 0.67 0 CA-C-O 118.312 -1.271 . . . . 74.22 111.587 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -66.81 -53.46 32.57 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 119.376 1.588 . . . . 74.31 111.024 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 . . . . . 0 C--O 1.249 1.062 0 C-N-CA 125.069 1.348 . . . . 72.41 107.513 -179.574 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.272 0 N-CA-C 109.284 -1.526 . . . . 60.21 109.284 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.26 155.28 42.56 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.061 -1.459 . . . . 75.33 107.061 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 90.0 mmm -79.43 73.93 6.07 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.435 0.694 . . . . 62.11 109.919 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.92 -100.99 0.51 Allowed Glycine 0 CA--C 1.525 0.684 0 CA-C-O 117.232 -1.871 . . . . 52.02 108.69 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.37 108.04 0.65 Allowed 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 123.526 2.817 . . . . 70.34 111.057 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -145.58 123.32 11.89 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 103.025 -2.954 . . . . 71.55 103.025 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.79 94.13 0.14 Allowed Glycine 0 C--N 1.336 0.541 0 CA-C-N 120.324 1.42 . . . . 73.21 111.193 -178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.49 ' H ' ' HB3' ' A' ' 51' ' ' ASN . 7.2 m -149.4 -172.85 4.23 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.977 1.311 . . . . 64.31 109.764 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.2 p -59.19 126.63 28.46 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.336 1.054 . . . . 73.34 108.665 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 46.0 38.29 4.51 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.496 1.518 . . . . 71.43 113.607 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.49 ' HB3' ' H ' ' A' ' 48' ' ' SER . 9.9 p30 -60.4 123.42 17.24 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 124.549 1.14 . . . . 74.43 109.024 179.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -74.24 109.48 7.76 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.958 1.303 . . . . 63.13 110.797 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.664 ' CD1' ' H ' ' A' ' 54' ' ' ARG . 0.1 OUTLIER -146.16 -174.63 4.49 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 106.57 -1.641 . . . . 63.3 106.57 178.444 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.664 ' H ' ' CD1' ' A' ' 53' ' ' LEU . 27.7 mmm180 -105.04 174.34 5.92 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 127.25 2.22 . . . . 72.54 107.181 178.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.78 85.82 2.26 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.373 -0.602 . . . . 63.21 109.373 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.1 t -69.29 155.39 40.49 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 105.038 -2.208 . . . . 52.34 105.038 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.83 -165.26 18.01 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.704 -0.958 . . . . 45.31 110.704 -179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.91 116.06 21.59 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 105.617 -1.994 . . . . 74.22 105.617 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.6 m -80.69 22.13 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 125.454 1.502 . . . . 73.13 113.635 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -52.76 -39.21 62.01 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.461 1.282 . . . . 71.45 114.461 -178.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.0 -66.49 0.24 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 106.025 -2.83 . . . . 73.23 106.025 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -112.84 -149.49 10.64 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 107.78 -2.128 . . . . 73.44 107.78 178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -70.85 150.46 95.16 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 125.02 1.328 . . . . 72.41 107.924 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.01 142.78 31.72 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 121.99 1.793 . . . . 72.34 110.979 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.6 m -128.75 164.85 29.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 124.291 1.036 . . . . 71.25 109.509 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.2 p -124.3 162.79 23.02 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.399 1.48 . . . . 73.02 109.163 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.6 m -53.02 -38.99 62.83 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.101 0.961 . . . . 71.42 110.777 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.23 -44.29 95.34 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 118.579 -0.724 . . . . 64.21 112.043 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 5.2 mtm -59.53 -35.2 73.72 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.421 -0.912 . . . . 73.24 110.703 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.7 t -65.44 -52.76 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 109.061 -0.718 . . . . 63.2 109.061 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -64.09 -35.52 81.01 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-O 117.708 -1.139 . . . . 75.51 110.718 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.3 m -57.18 -60.12 4.08 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 121.107 1.776 . . . . 65.51 108.082 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.5 t -54.5 -47.99 70.42 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.676 0 CA-C-O 117.571 -1.204 . . . . 74.24 108.596 178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 tp60 -52.55 -45.48 66.38 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 120.153 1.342 . . . . 72.22 111.97 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 -62.73 -36.4 82.88 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 121.402 -0.812 . . . . 72.13 110.469 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.7 mt -89.67 -14.65 34.36 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 118.85 -0.595 . . . . 75.53 112.54 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -138.33 73.55 43.16 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 129.111 2.965 . . . . 51.01 111.685 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -69.79 -5.67 16.77 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.904 3.069 . . . . 51.54 113.515 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.5 -15.69 36.87 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 120.745 -1.222 . . . . 73.1 111.981 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.8 mt -91.14 160.09 15.74 Favored 'General case' 0 N--CA 1.458 -0.074 0 C-N-CA 123.236 0.614 . . . . 61.11 111.571 -179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.475 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 56.0 t-80 -85.26 149.42 52.4 Favored Pre-proline 0 C--O 1.239 0.521 0 N-CA-C 106.171 -1.788 . . . . 65.14 106.171 178.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.475 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 33.2 Cg_endo -63.93 -30.07 67.25 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.548 2.165 . . . . 74.11 112.456 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -77.28 -34.22 55.65 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 112.717 0.636 . . . . 44.43 112.717 -179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -61.3 -46.1 91.69 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.609 -0.886 . . . . 63.12 108.609 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 90.0 mt -52.49 -59.63 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 125.002 1.321 . . . . 62.32 108.299 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -49.47 12.95 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.618 1.099 . . . . 75.11 111.888 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -64.41 -45.71 86.43 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 118.919 0.781 . . . . 75.05 113.085 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.7 p -65.7 -37.99 87.99 Favored 'General case' 0 C--N 1.328 -0.346 0 O-C-N 121.574 -0.704 . . . . 75.31 109.472 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 82.9 mt -62.35 -38.16 88.43 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.105 -0.997 . . . . 72.31 109.062 177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -68.39 -35.33 77.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.569 0.622 . . . . 71.14 110.062 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -72.51 -55.05 7.58 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.935 -0.478 . . . . 71.24 111.091 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.0 p -67.19 -41.36 85.98 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 124.911 1.284 . . . . 65.31 112.021 -178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.83 -11.85 67.61 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.87 1.224 . . . . 52.04 113.429 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -144.44 144.11 31.23 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 119.031 1.415 . . . . 74.31 109.336 177.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.1 t -59.63 -43.37 91.01 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 125.181 1.393 . . . . 74.24 109.025 178.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -46.93 -47.75 21.55 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.895 1.278 . . . . 72.14 111.011 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -69.82 -40.56 75.84 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.445 -0.784 . . . . 73.01 109.967 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.8 m -58.96 -37.12 76.04 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.161 0.584 . . . . 64.51 110.28 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 85.7 t -74.95 -36.96 40.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 123.919 0.888 . . . . 72.34 109.157 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -68.76 -39.61 80.2 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.352 1.061 . . . . 63.13 111.263 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -74.33 -37.11 63.66 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.122 -1.066 . . . . 71.33 108.122 178.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -58.03 -56.32 23.49 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.613 0.765 . . . . 73.13 109.935 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 pp -60.62 -22.49 63.85 Favored 'General case' 0 CA--C 1.53 0.211 0 O-C-N 121.284 -0.885 . . . . 73.15 112.055 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -16.72 48.7 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 118.846 0.748 . . . . 64.15 109.898 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.25 36.67 9.62 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 119.032 0.833 . . . . 61.1 112.168 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -76.76 173.38 11.72 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 117.986 0.893 . . . . 55.4 109.827 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -81.58 135.73 35.57 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.481 -1.303 . . . . 75.14 107.481 178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -118.42 110.94 18.05 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.138 -2.542 . . . . 75.41 104.138 178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.7 m -97.79 178.59 5.09 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 125.063 1.345 . . . . 64.14 110.086 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -110.88 158.79 34.72 Favored Pre-proline 0 C--O 1.238 0.451 0 C-N-CA 125.371 1.469 . . . . 74.2 111.283 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -72.33 164.07 36.75 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.358 2.705 . . . . 74.13 113.898 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.09 139.53 84.72 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.967 2.444 . . . . 72.15 109.707 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 94.14 -18.41 56.88 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.508 1.052 . . . . 65.54 111.096 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -71.61 -45.29 62.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 119.243 1.522 . . . . 63.52 109.427 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.021 -0.99 . . . . 73.3 111.439 -178.962 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.215 0 N-CA-C 109.227 -1.549 . . . . 74.42 109.227 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -75.34 175.39 8.43 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 117.822 0.811 . . . . 73.21 109.204 178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 57.1 mtt -144.71 175.03 10.47 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 127.016 2.126 . . . . 60.24 106.845 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.06 173.94 37.58 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 109.772 -1.331 . . . . 52.24 109.772 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -68.76 102.05 0.84 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.44 2.76 . . . . 60.23 110.384 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -133.05 107.12 8.05 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.98 -1.118 . . . . 74.04 107.98 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.52 76.26 2.21 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 107.0 -2.44 . . . . 45.21 107.0 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.4 p -68.43 -32.11 71.9 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.395 0.678 . . . . 45.11 112.439 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.5 t -170.4 161.58 8.05 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.848 1.659 . . . . 61.34 106.996 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -148.57 161.47 41.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.725 1.21 . . . . 73.4 109.941 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -150.58 160.2 43.96 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 107.369 -1.345 . . . . 75.33 107.369 178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -120.42 -159.4 0.79 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.759 1.624 . . . . 55.21 107.814 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.4 tp -59.44 158.13 10.09 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.586 0.754 . . . . 74.12 110.241 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -65.06 175.29 1.62 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.209 1.004 . . . . 73.13 109.055 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.59 158.72 27.95 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.183 1.393 . . . . 73.21 107.888 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.9 m -102.96 -54.49 2.61 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 123.859 0.864 . . . . 73.2 111.56 -178.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.57 33.0 80.09 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-N 119.032 0.833 . . . . 51.44 111.655 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 66.01 13.65 9.19 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.417 1.487 . . . . 64.52 112.981 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 66.1 t -91.71 139.25 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 CA-C-O 121.203 0.525 . . . . 73.23 111.683 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -143.65 172.5 12.73 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.379 2.272 . . . . 71.51 108.858 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.93 114.1 1.62 Allowed Glycine 0 C--O 1.237 0.29 0 N-CA-C 108.573 -1.811 . . . . 60.2 108.573 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 90.5 79.94 1.37 Allowed Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 106.437 -2.665 . . . . 72.54 106.437 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -124.84 149.55 63.12 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 125.991 1.717 . . . . 73.44 109.127 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -69.27 138.12 38.57 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.033 1.822 . . . . 64.14 109.957 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 m -134.46 159.55 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.337 -0.986 . . . . 62.22 108.337 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.31 162.43 23.77 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.445 -0.946 . . . . 75.1 108.445 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 11.6 m -51.36 -39.1 56.4 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.607 1.963 . . . . 75.22 111.393 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.83 -38.05 77.81 Favored 'General case' 0 C--O 1.216 -0.696 0 C-N-CA 124.561 1.144 . . . . 75.52 110.248 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 96.1 mtp -63.87 -38.14 89.98 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 120.407 -1.433 . . . . 62.31 109.377 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 t -61.08 -54.26 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.308 -0.627 . . . . 65.1 109.308 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -62.95 -38.24 90.28 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-O 117.294 -1.336 . . . . 74.1 110.588 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.6 m -53.98 -61.1 2.52 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 121.138 1.79 . . . . 72.42 108.087 178.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.7 t -55.51 -48.52 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 118.138 -0.934 . . . . 75.23 110.411 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -56.37 -42.24 77.5 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 119.074 0.852 . . . . 64.14 111.839 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -62.64 -43.6 98.39 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.618 -0.882 . . . . 61.13 108.618 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 mt -75.85 -26.91 57.57 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.735 -0.603 . . . . 62.21 111.476 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -125.77 83.37 62.57 Favored Pre-proline 0 C--O 1.237 0.442 0 C-N-CA 128.054 2.542 . . . . 62.53 111.848 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.8 -21.3 38.49 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 121.575 1.517 . . . . 71.23 112.802 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.07 -19.29 51.69 Favored 'General case' 0 C--N 1.339 0.151 0 C-N-CA 124.754 1.222 . . . . 61.24 113.523 -178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 mt -79.53 154.52 28.76 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 118.786 0.721 . . . . 73.03 109.756 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -79.6 144.19 60.46 Favored Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 107.352 -1.351 . . . . 70.03 107.352 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.53 -29.53 52.79 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.924 1.75 . . . . 64.51 112.228 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -75.39 -41.52 56.0 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 112.491 0.552 . . . . 75.03 112.491 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -63.14 -35.19 79.48 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.893 0.477 . . . . 73.32 110.05 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 75.2 mt -56.64 -60.37 2.02 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 109.297 -0.631 . . . . 72.32 109.297 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.89 -40.77 61.21 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 119.653 1.115 . . . . 73.54 112.271 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -61.93 -46.96 87.04 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 122.126 0.965 . . . . 74.23 111.092 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.8 p -63.49 -44.8 93.32 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.78 -1.1 . . . . 64.41 108.595 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.5 mt -56.86 -39.3 74.06 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 119.186 0.903 . . . . 74.52 109.814 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.39 -34.93 75.25 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 119.73 1.15 . . . . 73.14 110.071 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -72.54 -47.4 48.6 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.222 0.609 . . . . 71.23 111.5 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.5 p -79.07 -35.51 42.32 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 127.574 2.35 . . . . 64.23 113.547 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.39 -12.24 55.95 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 125.864 1.697 . . . . 65.41 113.135 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.0 m -143.91 146.17 32.79 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 118.854 1.327 . . . . 72.31 111.962 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.5 t -64.41 -47.53 89.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 107.127 -1.434 . . . . 65.42 107.127 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -45.86 -46.07 15.52 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.953 1.301 . . . . 73.42 111.481 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -65.45 -53.58 40.74 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.061 1.744 . . . . 72.1 108.358 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.9 m -54.75 -37.59 66.15 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.98 1.312 . . . . 75.24 111.392 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.56 -39.68 54.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 124.124 0.97 . . . . 73.33 109.444 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -64.04 -44.41 92.56 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 125.279 1.432 . . . . 61.54 109.772 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -74.32 -32.47 62.84 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.46 -0.775 . . . . 63.13 110.909 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -62.9 -54.51 37.56 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.464 -0.772 . . . . 62.54 110.451 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.79 -25.85 67.73 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 118.209 -0.901 . . . . 71.43 111.78 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -81.41 -11.61 59.21 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 123.757 0.661 . . . . 54.01 110.2 179.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 79.78 36.62 25.12 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-O 119.06 -0.856 . . . . 50.52 111.203 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -74.73 -175.89 2.63 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.14 0.97 . . . . 70.21 111.456 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -86.69 138.72 31.41 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.608 1.163 . . . . 72.1 111.221 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -138.51 110.3 7.16 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 125.022 1.329 . . . . 75.43 109.895 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.8 m -89.58 -179.78 5.87 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.534 1.534 . . . . 42.11 109.71 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -110.05 159.13 33.02 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 126.352 1.861 . . . . 74.33 110.032 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.64 166.92 27.49 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.584 2.856 . . . . 74.44 114.782 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.85 137.22 40.97 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.532 2.154 . . . . 75.43 107.139 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.2 -10.37 59.89 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.997 1.284 . . . . 65.11 111.065 -178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -77.33 -29.01 53.31 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 119.571 1.685 . . . . 71.02 109.986 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 . . . . . 0 C--O 1.25 1.112 0 C-N-CA 125.439 1.496 . . . . 63.12 108.936 179.508 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.147 0 N-CA-C 106.836 -2.506 . . . . 64.34 106.836 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.45 162.97 21.95 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 107.279 -1.378 . . . . 74.05 107.279 177.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -113.63 -89.96 0.53 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 105.483 -2.043 . . . . 75.5 105.483 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 170.4 74.42 0.04 OUTLIER Glycine 0 CA--C 1.522 0.511 0 N-CA-C 107.063 -2.415 . . . . 52.12 107.063 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -68.85 -19.44 40.67 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.398 2.066 . . . . 32.52 113.978 -179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -162.83 176.2 10.48 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.406 1.083 . . . . 44.43 110.076 -178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.38 82.35 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 108.91 -1.676 . . . . 54.12 108.91 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.4 m -148.41 126.84 12.32 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 106.47 -1.678 . . . . 74.01 106.47 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.2 t -83.29 164.19 20.22 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.951 0.9 . . . . 74.44 108.991 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -119.71 109.59 15.81 Favored 'General case' 0 C--O 1.232 0.134 0 C-N-CA 123.816 0.846 . . . . 72.33 110.849 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -142.63 169.11 18.18 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.122 1.369 . . . . 62.53 108.739 178.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.06 162.45 14.14 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 121.753 -0.592 . . . . 72.25 110.144 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.28 148.96 47.02 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.652 1.581 . . . . 73.32 108.451 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -61.78 155.77 22.13 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 124.216 0.947 . . . . 73.13 110.13 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -74.88 141.37 44.19 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 106.752 -1.573 . . . . 71.34 106.752 177.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.03 -21.61 0.71 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 118.701 -0.666 . . . . 72.43 110.999 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -69.7 159.97 53.12 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.015 -1.234 . . . . 62.25 110.015 178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -74.61 177.58 5.98 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 125.827 1.651 . . . . 75.14 110.348 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 p -59.67 -22.55 23.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 123.272 0.629 . . . . 53.41 111.687 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -70.86 147.85 48.42 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.45 1.1 . . . . 62.11 109.688 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.44 -61.58 7.31 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 124.587 1.089 . . . . 45.43 112.124 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -127.9 -168.16 12.41 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 107.99 -2.044 . . . . 75.23 107.99 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -90.96 138.39 26.15 Favored Pre-proline 0 C--N 1.316 -0.887 0 C-N-CA 127.618 2.367 . . . . 61.33 107.772 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -69.0 127.38 15.1 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.7 2.933 . . . . 53.11 114.035 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.438 HG11 ' CB ' ' A' ' 89' ' ' LEU . 17.8 m -107.91 166.82 4.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 C-N-CA 124.432 1.093 . . . . 71.12 109.934 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.2 p -124.26 157.68 34.3 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.931 -1.877 . . . . 73.13 105.931 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 30.2 m -56.12 -35.75 67.45 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 119.105 -0.474 . . . . 73.51 110.811 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -36.84 73.01 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 118.753 0.706 . . . . 73.15 111.756 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 98.1 mtp -66.36 -33.39 75.62 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.089 -1.007 . . . . 74.2 109.29 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.87 -53.95 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 123.93 0.892 . . . . 64.13 109.475 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -60.33 -40.99 92.61 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 117.56 -1.209 . . . . 74.24 109.367 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.405 ' CG2' HG11 ' A' ' 95' ' ' VAL . 85.9 m -56.22 -57.38 12.48 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 120.676 1.58 . . . . 75.1 108.624 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.464 HG23 HG13 ' A' ' 95' ' ' VAL . 47.5 t -55.43 -50.8 63.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.609 0 CA-C-O 118.456 -0.783 . . . . 73.13 109.699 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -52.08 -44.12 64.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 118.893 0.77 . . . . 55.13 112.767 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -62.86 -42.52 99.78 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.891 0.876 . . . . 72.02 110.363 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 21.8 mt -86.34 -10.83 53.64 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.843 0.683 . . . . 64.15 112.843 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -136.68 70.7 58.83 Favored Pre-proline 0 N--CA 1.447 -0.597 0 C-N-CA 127.186 2.195 . . . . 73.33 108.673 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -68.54 0.23 5.05 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.279 3.32 . . . . 71.25 112.633 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.16 12.83 29.75 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.453 1.501 . . . . 72.34 112.071 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.9 mt -114.77 157.53 23.1 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.545 1.138 . . . . 73.51 109.25 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.423 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 57.3 t-80 -85.46 145.59 42.6 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 108.276 -1.009 . . . . 74.53 108.276 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 33.0 Cg_endo -62.67 -29.87 78.1 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.938 2.426 . . . . 73.43 113.232 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -77.41 -42.99 34.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 121.967 -0.458 . . . . 61.15 110.931 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.403 ' HG3' ' CE1' ' A' ' 110' ' ' PHE . 48.7 mt-30 -58.27 -42.63 86.91 Favored 'General case' 0 C--N 1.341 0.208 0 O-C-N 122.028 -0.42 . . . . 72.52 110.075 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 76.2 mt -50.59 -58.86 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 C-N-CA 124.786 1.234 . . . . 74.43 109.692 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.05 -50.29 10.98 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.568 0.622 . . . . 70.1 111.342 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -61.34 -45.37 94.72 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 121.702 -0.624 . . . . 74.01 112.33 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 p -63.35 -42.63 98.93 Favored 'General case' 0 C--O 1.218 -0.583 0 C-N-CA 120.216 -0.593 . . . . 62.11 110.153 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.438 ' CB ' HG11 ' A' ' 65' ' ' VAL . 74.2 mt -60.21 -34.76 74.1 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.618 0.767 . . . . 64.53 110.114 178.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.85 -36.54 78.26 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.356 -0.609 . . . . 44.11 109.356 178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -78.26 -44.5 25.34 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 113.07 0.767 . . . . 74.13 113.07 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 72.9 p -76.25 -36.18 58.59 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 125.787 1.635 . . . . 61.22 111.423 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.49 -17.82 46.25 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 124.921 1.248 . . . . 53.14 113.298 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.5 t -145.11 150.1 36.2 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.657 1.228 . . . . 74.14 108.991 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.464 HG13 HG23 ' A' ' 73' ' ' VAL . 54.9 t -65.12 -41.8 92.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 C-N-CA 126.373 1.869 . . . . 74.55 109.285 178.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -46.52 -48.01 19.4 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.389 1.476 . . . . 62.2 111.491 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -68.35 -44.85 74.34 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.378 1.471 . . . . 71.31 108.845 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.6 m -56.96 -39.16 74.06 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.945 0.898 . . . . 64.11 110.791 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.3 t -74.4 -37.72 45.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 118.273 -0.87 . . . . 71.42 110.074 179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -66.69 -43.66 83.81 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 124.173 0.989 . . . . 55.33 110.126 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -72.59 -35.66 67.95 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 121.295 -0.878 . . . . 62.11 109.98 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -57.91 -57.39 13.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 121.133 -0.979 . . . . 72.15 110.482 178.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -58.22 -26.09 62.43 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 118.195 0.452 . . . . 72.13 111.269 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -12.17 59.96 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 121.599 -0.688 . . . . 73.4 110.364 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.65 37.35 40.34 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 125.054 1.312 . . . . 53.35 110.715 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.2 -171.17 0.88 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.207 1.004 . . . . 63.12 112.126 -179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.45 139.05 34.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 O-C-N 120.961 -1.087 . . . . 73.4 109.582 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -129.85 108.72 10.36 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 104.862 -2.273 . . . . 63.44 104.862 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.7 m -96.26 163.92 12.88 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 124.732 1.213 . . . . 63.31 111.786 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.403 ' CE1' ' HG3' ' A' ' 84' ' ' GLN . 35.8 m-85 -97.11 156.52 36.23 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 124.542 1.137 . . . . 64.23 108.835 178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.94 164.74 30.59 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.803 2.335 . . . . 75.31 112.211 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -66.23 142.43 66.92 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 122.037 1.825 . . . . 63.31 110.324 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 87.22 -9.37 73.1 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 118.607 -1.107 . . . . 51.22 113.286 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -76.78 -22.8 53.19 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 118.897 1.349 . . . . 41.13 110.459 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 . . . . . 0 C--O 1.247 0.926 0 C-N-CA 126.351 1.86 . . . . 74.1 112.64 179.811 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 N-CA-C 110.285 -1.126 . . . . 72.2 110.285 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -101.54 -23.32 14.32 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 117.742 0.771 . . . . 62.13 111.945 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 77.0 mtp 46.73 67.93 0.7 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.984 1.714 . . . . 65.33 113.286 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.87 -177.21 43.13 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.521 0.581 . . . . 74.51 112.801 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -76.93 157.62 34.69 Favored 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 125.243 3.962 . . . . 62.15 111.175 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -79.88 -16.54 55.17 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.271 1.028 . . . . 75.21 113.16 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.04 156.75 6.89 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 108.077 -2.009 . . . . 53.01 108.077 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.9 t -158.16 -164.35 1.48 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 118.441 1.121 . . . . 71.21 109.02 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.1 p 45.37 62.27 2.23 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.859 1.664 . . . . 72.13 110.267 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.01 163.75 9.34 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 122.27 1.033 . . . . 73.13 111.86 -179.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -105.69 178.4 4.57 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.982 2.113 . . . . 74.44 108.731 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 49.8 28.63 2.83 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.919 1.288 . . . . 31.41 113.035 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -67.46 177.25 2.0 Allowed 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 125.818 1.647 . . . . 55.32 112.654 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -56.43 137.54 52.81 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.543 1.137 . . . . 75.14 110.739 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -62.24 106.97 0.81 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.92 1.688 . . . . 72.31 111.401 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 59.6 p -145.29 -176.55 5.15 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.672 0.789 . . . . 74.53 109.077 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -124.94 -41.58 0.37 Allowed Glycine 0 C--N 1.336 0.572 0 C-N-CA 125.082 1.325 . . . . 45.34 111.76 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -146.69 136.81 23.52 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 108.248 -1.019 . . . . 74.13 108.248 -178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.5 t -145.04 159.43 13.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 C-N-CA 124.661 1.184 . . . . 74.52 107.822 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.87 164.61 3.7 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.853 1.261 . . . . 75.14 111.618 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 97.14 -111.76 4.32 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 108.744 -1.742 . . . . 53.33 108.744 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -161.77 -152.78 6.81 Favored Glycine 0 N--CA 1.44 -1.07 0 CA-C-N 117.908 0.854 . . . . 51.34 111.534 -178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -77.13 162.41 69.74 Favored Pre-proline 0 C--N 1.32 -0.679 0 C-N-CA 129.82 3.248 . . . . 63.25 109.671 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.75 141.08 21.42 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.201 1.934 . . . . 75.12 109.308 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 m -134.64 160.15 41.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.427 -0.953 . . . . 60.15 108.427 178.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -125.98 157.76 37.0 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.889 1.276 . . . . 71.11 108.768 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.9 m -42.75 -48.37 5.61 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.762 2.425 . . . . 60.32 111.522 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -53.97 -36.71 63.17 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 126.933 2.093 . . . . 54.12 112.324 -179.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 87.3 mtp -66.81 -42.39 85.98 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.661 -0.866 . . . . 64.54 108.661 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 t -58.78 -57.93 9.01 Favored 'Isoleucine or valine' 0 C--N 1.346 0.429 0 CA-C-N 117.92 0.327 . . . . 42.24 110.601 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -58.04 -40.78 81.77 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-O 118.14 -0.933 . . . . 63.01 110.725 -178.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 99.8 m -58.01 -62.0 2.13 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.09 1.314 . . . . 73.5 109.524 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.408 ' CG2' HG13 ' A' ' 95' ' ' VAL . 86.4 t -52.42 -46.42 46.95 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 CA-C-O 118.354 -0.832 . . . . 73.01 108.999 178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.19 -38.31 79.53 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 119.698 1.136 . . . . 62.35 113.336 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -65.41 -40.89 93.95 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 119.152 0.887 . . . . 72.43 108.846 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mt -78.98 -34.53 44.09 Favored 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 112.248 0.462 . . . . 74.31 112.248 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -115.11 75.46 4.15 Favored Pre-proline 0 N--CA 1.449 -0.508 0 C-N-CA 127.33 2.252 . . . . 74.52 109.532 -178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.08 -13.69 40.72 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.267 1.978 . . . . 63.23 112.2 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -83.12 -6.63 59.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.872 1.269 . . . . 64.31 113.08 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.2 mt -98.06 155.24 17.22 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 120.92 -1.113 . . . . 65.21 109.355 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.432 ' CG ' ' HD2' ' A' ' 82' ' ' PRO . 53.7 t-80 -78.34 146.43 70.41 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 105.607 -1.997 . . . . 73.43 105.607 177.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 81' ' ' HIS . 32.2 Cg_endo -63.88 -31.85 66.97 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.651 1.567 . . . . 64.21 112.281 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -74.88 -38.33 61.92 Favored 'General case' 0 C--O 1.235 0.301 0 O-C-N 121.281 -0.887 . . . . 74.54 111.912 -178.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -58.56 -45.12 89.65 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.81 -0.441 . . . . 53.15 109.81 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 91.1 mt -49.22 -56.31 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 117.812 -1.089 . . . . 73.13 110.123 -178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.409 HH21 ' CG ' ' A' ' 111' ' ' PRO . 4.6 tmm_? -48.7 -48.51 40.25 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 119.558 1.072 . . . . 63.12 111.712 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.496 ' CE1' ' HD3' ' A' ' 112' ' ' PRO . 9.2 t80 -62.25 -41.16 98.2 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.807 0.731 . . . . 73.33 111.704 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 69.2 m -63.6 -48.66 76.44 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.756 -0.831 . . . . 74.14 108.756 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -57.32 -37.34 72.35 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 125.021 1.328 . . . . 65.21 110.309 179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -68.18 -38.0 81.57 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.042 -0.725 . . . . 72.35 109.042 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -76.68 -48.34 19.25 Favored 'General case' 0 C--N 1.334 -0.097 0 O-C-N 121.457 -0.777 . . . . 63.0 112.106 -179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 80.3 p -71.47 -38.33 71.27 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.567 1.147 . . . . 63.41 111.369 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.55 -2.94 87.57 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 126.906 2.193 . . . . 74.1 111.447 -178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -144.31 145.06 31.77 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 119.137 1.469 . . . . 43.25 112.608 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.408 HG13 ' CG2' ' A' ' 73' ' ' VAL . 55.1 t -64.93 -52.48 53.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.517 -1.66 . . . . 61.14 106.517 178.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -49.17 -51.99 29.25 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.316 1.847 . . . . 74.41 110.674 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.49 -43.49 93.31 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.852 0.861 . . . . 74.13 109.527 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 27.7 m -61.52 -39.42 90.95 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.969 0.908 . . . . 72.54 110.501 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 87.5 t -75.2 -34.62 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 121.247 -0.908 . . . . 65.02 110.131 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -68.18 -39.29 82.54 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 126.113 1.765 . . . . 75.22 111.23 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -79.02 -37.08 40.04 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.877 -0.786 . . . . 75.2 108.877 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -54.67 -54.36 42.7 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 123.943 0.897 . . . . 72.41 109.705 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.13 -18.06 56.02 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.168 0.803 . . . . 74.42 113.168 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -19.26 42.17 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.714 -1.217 . . . . 55.53 107.714 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 83.3 31.7 27.39 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 125.656 1.598 . . . . 70.03 109.658 -178.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -62.59 176.79 0.6 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.866 1.666 . . . . 73.24 111.382 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -83.47 139.11 33.13 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 123.076 0.55 . . . . 64.33 110.284 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -135.88 109.04 7.73 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.284 1.033 . . . . 75.2 108.83 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 67.5 m -91.52 176.1 6.67 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.851 0.861 . . . . 72.04 109.033 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -103.14 155.71 36.3 Favored Pre-proline 0 N--CA 1.45 -0.457 0 C-N-CA 124.873 1.269 . . . . 73.3 108.779 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.409 ' CG ' HH21 ' A' ' 86' ' ' ARG . 29.7 Cg_endo -69.27 161.57 45.34 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.907 2.405 . . . . 54.14 113.628 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.496 ' HD3' ' CE1' ' A' ' 87' ' ' TYR . 37.2 Cg_endo -63.36 145.95 93.08 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 121.94 1.76 . . . . 54.23 107.992 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 90.47 -5.38 82.59 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-O 118.418 -1.212 . . . . 52.24 111.599 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -86.36 -28.32 23.71 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.632 1.716 . . . . 74.15 111.845 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 . . . . . 0 C--O 1.25 1.099 0 C-N-CA 123.805 0.842 . . . . 74.24 111.236 179.114 . . . . . . . . 0 0 . 1 stop_ save_